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A B S T R A C T
Background
In order to prevent overweight and obesity in the general population we need to understand the relationship between the proportion
of energy from fat and resulting weight and body fatness in the general population.
Objectives
Toassess the effects of proportionof energy intake from fat onmeasures ofweight andbody fatness (including obesity, waist circumference
and body mass index) in people not aiming to lose weight, using all appropriate randomised controlled trials (RCTs) and cohort studies
in adults, children and young people
Search methods
We searched CENTRAL to March 2014 and MEDLINE, EMBASE and CINAHL to November 2014. We did not limit the search
by language. We also checked the references of relevant reviews.
Selection criteria
Trials fulfilled the following criteria: 1) randomised intervention trial, 2) included children (aged ≥ 24 months), young people or
adults, 3) randomised to a lower fat versus usual or moderate fat diet, without the intention to reduce weight in any participants, 4) not
multifactorial and 5) assessed a measure of weight or body fatness after at least six months. We also included cohort studies in children,
young people and adults that assessed the proportion of energy from fat at baseline and assessed the relationship with body weight or
fatness after at least one year. We duplicated inclusion decisions and resolved disagreement by discussion or referral to a third party.
Data collection and analysis
We extracted data on the population, intervention, control and outcome measures in duplicate. We extracted measures of weight and
body fatness independently in duplicate at all available time points. We performed random-effects meta-analyses, meta-regression,
subgrouping, sensitivity and funnel plot analyses.
1Effects of total fat intake on body weight (Review)
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Main results
We included 32 RCTs (approximately 54,000 participants) and 30 sets of analyses of 25 cohorts. There is consistent evidence from
RCTs in adults of a small weight-reducing effect of eating a smaller proportion of energy from fat; this was seen in almost all included
studies and was highly resistant to sensitivity analyses. The effect of eating less fat (compared with usual diet) is a mean weight reduction
of 1.5 kg (95% confidence interval (CI) -2.0 to -1.1 kg), but greater weight loss results from greater fat reductions. The size of the
effect on weight does not alter over time and is mirrored by reductions in body mass index (BMI) (-0.5 kg/m2, 95% CI -0.7 to -0.3)
and waist circumference (-0.3 cm, 95% CI -0.6 to -0.02). Included cohort studies in children and adults most often do not suggest
any relationship between total fat intake and later measures of weight, body fatness or change in body fatness. However, there was a
suggestion that lower fat intake was associated with smaller increases in weight in middle-aged but not elderly adults, and in change in
BMI in the highest validity child cohort.
Authors’ conclusions
Trials where participants were randomised to a lower fat intake versus usual or moderate fat intake, but with no intention to reduce
weight, showed a consistent, stable but small effect of low fat intake on body fatness: slightly lower weight, BMI and waist circumference
compared with controls. Greater fat reduction and lower baseline fat intake were both associated with greater reductions in weight.
This effect of reducing total fat was not consistently reflected in cohort studies assessing the relationship between total fat intake and
later measures of body fatness or change in body fatness in studies of children, young people or adults.
P L A I N L A N G U A G E S U M M A R Y
Effect of cutting down the fat we eat on body weight
The ideal proportion of energy from fat in our food and its relation to body weight is not clear. This review looked at the effect of
cutting down the proportion of energy from fat in our food on body weight and fatness in both adults and children who are not aiming
to lose weight. The review found that cutting down on the proportion of fat in our food leads to a small but noticeable decrease in
body weight, body mass index and waist circumference. This effect was found both in adults and children. The effect did not change
over time.
2Effects of total fat intake on body weight (Review)
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Low dietary fat compared with usual fat for body fatness
Patient or population: children, young people and adults from the general population
Settings: general population
Intervention: low dietary fat
Comparison: usual fat
Methods: randomised controlled trials
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual fat Low dietary fat
Weight, kg (adults)
body weight in kg
Follow-up: 6 to 96
months
Median weight change -
0.04kg1
The mean weight, kg
(adults) in the low fat
groups was
1.54 lower
(1.97 to 1.12 lower)
- 53,647
(30 RCTs)
⊕⊕⊕⊕
high2,3,4,5,6,7,8
-
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RCT: randomised controlled trial
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1The median weight change in the control groups over the course of each study was -0.04kg, ranging from -1.91kg to 2.13kg.
2While most studies were unblinded for participants and allocation concealment was often unclear (as randomisation was described
poorly), RCT results in adults were remarkably consistent in their direction. Sensitivity analyses removing studies without clear allocation
concealment did not lose the statistically significant relative weight reduction in the low fat arm, and neither did running fixed-effect
(rather than random-effects) meta-analysis or removing studies with attention bias favouring those in the low fat arm, or those with other
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interventions alongside the fat reduction. The consistent weight loss was despite the fact that none of the studies included intended to
alter weight in either arm, so that publication bias on this outcome is unlikely. Together this suggests that the risk of bias was low.
3The direction of effects in these RCTs was remarkably consistent - in almost every study participants eating lower total fat intakes were
lower in weight (on average) at the study end than participants eating a higher percentage of total fat. The only inconsistency (where
heterogeneity arose) was in the size of this effect. The heterogeneity was partly explained by the degree of reduction of fat intake, and
by the level of control group fat intake, which together explained 56% of between-study variance (in meta-regression). The reduction
in weight in those taking on lower fat diets was seen in very different populations and from six months to several years. It was also
consistent when we excluded studies that gave additional support, time or encouragement to the low fat arms, and where we excluded
studies that delivered additional dietary interventions (on top of the change in dietary fats). The results were consistent in direction, and
much of the heterogeneity in the size of the effect was explained by the selected factors.
4All included RCTs directly compared (and randomised participants to) lower versus usual fat intake; therefore there was no indirectness
in intervention. All studies were conducted in industrialised countries so the potential to generalise to other cultural contexts is limited.
Nonetheless there is no reason to believe that the effect would be different in different populations. There are changes in diets in many
countries around the world, which are resulting in greater similarity in diets in developed and developing countries. Additionally, the
industrialised countries represented included a wide variety of baseline (or control group) fat intakes, and the effect was apparent at all
of these levels. The studies all addressed weight directly and did not use proxy measures.
5Imprecision was unlikely, as over 40,000 participants were included in RCTs of at least six months duration, and effect sizes were
highly statistically significant. There was little imprecision. If the true effect on weight was at either end of the 95% CI we would see the
effect in the same way.
6The funnel plot did not suggest publication bias.
7Subgrouping supported the presence of a dose response gradient in that studies that altered the total fat intake between intervention
and control by less than 5% of energy had a negligible effect on weight, while greater differences in total fat intake were associated
with statistically significant differences in weight. This was supported by the meta-regression, which suggested a statistically significant
relationship between the degree of fat reduction and of weight loss.
8The effects on body weight are supported by similar effects on BMI in adults (-0.50 kg/m2, 95% CI -0.74 to -0.26, 10 RCTs, >45,000
participants), waist circumference in adults (-0.30 cm, 95% CI -0.58 to -0.02, one RCT, > 15,000 participants) and BMI reduction in
the one RCT in children.
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B A C K G R O U N D
The Joint Food and Agriculture Organization of the United Na-
tions (FAO)/World Health Organization (WHO) expert consul-
tation on fats and fatty acids in human nutrition debated opti-
mal intakes of total fat in 2008. In light of the rising levels of
overweight and obesity, particularly in low- and middle-income
countries undergoing rapid nutrition transition, this consultation
agreed that any effect of total fat intake on body weight was piv-
otal in making global recommendations on total fat intake. Over-
weight and obesity are associated with increased risk of many can-
cers, coronary heart disease and stroke (Manson 1990; Song 2004;
WCRF/AICR 2009).
A previous systematic review found no randomised controlled tri-
als (RCTs) of lower total fat intake that aimed to assess effects
on body weight (Kelly 2006), but we were aware of RCTs that
had randomised participants to low fat versus usual fat diets, and
measured weight or BMI as a process measure (Hooper 2012a).
Additionally, meta-regression within a systematic review assessing
RCTs on the effects of step I and II diets (diets designed by the
National Heart, Lung and Blood Institute national cholesterol ed-
ucation programme to reduce the risk of cardiovascular disease
in the general population and those at increased cardiovascular
risk, respectively), found a strong relation between total fat intake
and body weight (Yu-Poth 1999). This review, however, included
studies that were as short as three weeks in duration and studies
in which weight loss was a goal of the intervention, which may
have overstated any relation because the advice was to lower both
fat and energy intake. It also excluded many trials of reduction in
total fat intake that did not fit the step I or II criteria.
More recent reviews that have explored the long-term effects of low
fat diets either did not exploreweight or body fatness as an outcome
(Schwingshackl 2013), or looked at low fat intake as part of a
wider health promotion intervention (Ni 2010). Other systematic
reviews have explored the relationship between fat intake and body
fatness but were either limited to the effect low fat dairy versus
high fat dairy consumption (Benatar 2013), or investigated it as
part of looking at the overall dietary patterns (Ambrosini 2014),
or diet quality (Aljadani 2015).
In order to aid the WHO’s understanding of the relation be-
tween total fat intake and body weight with a view to updating
their guidelines on total fat intake, the WHO Nutrition Guid-
ance Expert Advisory Group (NUGAG) subgroup on diet and
health (http://www.who.int/nutrition/topics/advisory_group/nu-
gag_dietandhealth_topics/en/) was requested to assess the rela-
tionship. The expert advisory group aimed to generate a recom-
mendation on the population impact of total fat intake in the
development of obesity. The NUGAG group agreed to exclude
studies of populations recruited specifically for weight loss and
interventions intended to result in weight loss. These studies were
potentially confounded by the implicit objective of reducing calo-
rie intake to produce weight loss and might therefore lead to an
overemphasis on studies carried out in highly selected obese pop-
ulations in North America and Europe, which may have limited
transferability to non-obese populations or those in developing
countries or in countries in transition.
To fulfil the requirements for the new guideline, a systematic re-
view was needed of all available evidence of the longer-term ef-
fects of total fat intake on body fatness, in studies not intending to
cause weight loss. TheWHO therefore commissioned a systematic
review and meta-analysis to assess the relationship between total
fat intake and indicators of body fatness (including obesity, waist
circumference and body mass index) using all appropriate RCTs
and cohort studies in adults and children (Hooper 2012b), which
has been updated in 2015.
O B J E C T I V E S
To assess the effects of proportion of energy intake from fat on
measures of weight and body fatness (including obesity, waist cir-
cumference and body mass index) in people not aiming to lose
weight, using all appropriate RCTs and cohort studies in adults,
children and young people.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials ( RCTs) of adults and children:
trials of reduced fat intake compared with usual diet or modified
fat intake with no intention to reduce weight (in any participants
in either or both arms), continued for at least six months, uncon-
founded by non-nutritional interventions and assessing a measure
of body fatness at least six months after the intervention was ini-
tiated.
Randomisation of individuals was accepted, or of larger groups
where there were at least six of these groups (clusters) randomised.
We excluded studies where allocation was not truly randomised
(e.g. divisions based on days of the week or first letter of the family
name were excluded) or where allocation was not stated as ran-
domised (and no further information was available from the au-
thors). We excluded cross-over studies (as previous weight gain or
weight loss is likely to affect future weight trends) unless the first
half of the cross-over could be used independently.
Cohort studies of adults and children: prospective cohort studies
that followed participants for (and assessed final or change in body
fatness) at least 12 months after assessment of total fat, and related
baseline total fat intake to absolute or change in body fatness at
least 12 months later.
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Types of participants
We accepted studies of adults (≥ 18 years, no upper age limit)
or children and young people (aged ≥ 24 months) at any risk
of cardiovascular disease (with or without existing cardiovascular
disease). Participants could be of either sex, but we excluded those
who were acutely ill, pregnant or lactating. We excluded interven-
tion studies where participants were chosen for raised weight or
body mass index (as most appeared to aim to reduce body weight
within interventions, even when this was not explicitly stated in
the intervention goals).
Types of interventions
Interventions
We considered all randomised controlled trials (RCTs) of inter-
ventions stating an intention to reduce dietary fat, when compared
with a usual or modified fat intake.
We considered a low fat intake to be one that aimed to reduce fat
intake to ≤ 30% energy (≤ 30%E) from fat, and at least partially
replace the energy lost with carbohydrates (simple or complex),
protein or fruit and vegetables. We considered a modified fat diet
to be one that aimed to include > 30% energy from total fats, and
included higher levels of mono-unsaturated or poly-unsaturated
fats than a ’usual’ diet.
As we were interested in the effects of fat intake on body weight
and fatness in everyday dietary intake (rather than in people aim-
ing to reduce their body weight in weight-reducing diets) we ex-
cluded studies aiming to reduce the weight of some or all partic-
ipants, as well as those that included only participants who had
recently lost weight, or recruited participants according to a raised
body weight or BMI. We excluded multifactorial interventions
other than diet or supplementation (unless the effects of diet or
supplementation could be separated, so the additional interven-
tion was consistent between the intervention and control groups).
We excluded Atkins-type diets aiming to increase protein and fat
intake, as well as studies where fat was reduced by means of a fat
substitute (likeOlestra).We excluded enteral and parenteral feeds,
as well as formula weight-reducing diets.
Examples
We included studies that reduced fats and encouraged physical
activity in one arm and compared this with encouraging physical
activity in the control. We excluded studies that reduced fats and
encouraged physical activity in one arm and compared this with
no intervention in the control. We included studies that reduced
fats and encouraged fruit and vegetables in one arm and compared
this with no intervention in the control.
We included all trials that intended to reduce dietary fat to ≤
30%E in one arm compared to usual or modified fat intake (>
30%E from fat) in another arm regardless of the degree of differ-
ence between fat intake in the two arms (dose). We explored the
effects of the difference in %E from fat between control and in-
tervention groups, as well as the effects of fat intake in the control
groups and dietary fat goals in the intervention groups, in sub-
grouping.
Exposures
For cohort studies total fat intake, in grams or as a percentage of
dietary energy intake, had to be assessed at baseline and related
to a measure of body fatness, or change in body fatness, at least
a year later. For cohorts that used multiple dietary assessments to
model later body fatness or change in body fatness more than half
of the assessments included in the model had to be at least a year
before the assessment of body fatness (or the final assessment for
a change measure) used in the model.
Types of outcome measures
Primary outcomes
Themain outcomesweremeasures of body fatness, including body
weight, body mass index, waist circumference, skinfold thickness
or percentage fat. Studies had to report at least one of these mea-
sures, or a change in these measures, to be included in the review.
Secondary outcomes
Secondary outcomes included other classic cardiovascular risk fac-
tors (systolic or diastolic blood pressure, serum total, low density
lipoprotein (LDL) or high density lipoprotein (HDL) cholesterol
and triglyceride) and quality of life measures (including informal
outcomes such as feelings of health and time off work).
Tertiary outcomes
Tertiary outcomes were process outcomes and included changes
in saturated and total fat intakes, as well as other macronutrients,
sugars and alcohol.
This is not a systematic review of the effects of reduced fat on these
secondary or tertiary outcomes, but we collated the outcomes from
included studies in order to understand whether any effects on
weight might be compromised by negative effects on secondary or
tertiary outcomes.
Search methods for identification of studies
Electronic searches
The search to June 2010 is described in Hooper 2012b. We up-
dated the searches toNovember 2014 and ran these inMEDLINE
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(Ovid, see Appendix 1). EMBASE (Ovid) and CINAHL (EBSCO
host) searches were based on the MEDLINE search (Appendix 2;
Appendix 3). The Cochrane Heart Group ran the update search
for adult RCTs on 5 March 2014 in CENTRAL (2014, Issue 1)
for a sister review, Hooper 2015 (Appendix 4), and we checked
the references for this review.
Searching other resources
We searched the bibliographies of all related identified systematic
reviews for further trials and cohort studies for the update, includ-
ing Aljadani 2015, Ajala 2013, Aljadani 2013, Ambrosini 2014,
Benatar 2013, Chaput 2014, Gow 2014, Havranek 2011, Hu
2012, Kratz 2013, Ni 2010, Schwingshackl 2013, Schwingshackl
2013a and Yang 2013.
Data collection and analysis
Selection of studies
We only rejected articles on the initial screen if the review author
could determine from the title and abstract that the article was not
a relevant RCT or cohort study. We rejected articles if they were
not the report of a RCT; the trial did not address a low fat intake;
the trial was exclusively in infants (less than 24 months old), preg-
nant women or the critically ill; participants were chosen for being
overweight or obese; there was an intention to reduce weight in
some or all participants; the trial was of less than six months du-
ration; or the intervention was multifactorial. We rejected cohort
studies where they were not prospective; where participants’ total
fat intake was not assessed; where they did not follow participants
for at least 12 months after assessment of total fat; or where the
relationship between total fat at baseline and ameasure of absolute
or change in body fatness at least 12 months later was not assessed.
When a title/abstract could not be rejected with certainty, we ob-
tained the full text of the article for further evaluation. LH and AA
assessed the inclusion of studies independently in duplicate, and
we collected studies identified by either review author. LH and AA
assessed the full texts collected for inclusion independently in du-
plicate, and discussed disagreements until agreement was reached.
Data extraction and management
We extracted data concerning participants, interventions or expo-
sures and outcomes, and trial or cohort quality characteristics onto
a form designed for the review. We extracted data on potential
effect modifiers from RCTs (including duration of intervention,
control group fat intake, sex, year of first publication, difference in
% energy from fat between the intervention and control groups,
type of intervention (food or advice provided), the dietary fat goals
set for each arm, baseline BMI and health at baseline). Where pro-
vided, we collected data on risk factors for cardiovascular disease
(secondary and tertiary outcomes).
All trial outcomes were continuous and where possible we ex-
tracted change data (change in the outcome from baseline to out-
come assessment) with relevant data on variance for intervention
and control arms (along with numbers of participants at that time
point). Where change data were not available, we extracted data at
study end (or other relevant time point) along with variance and
numbers of participants for each arm. LH and AA extracted all
data independently in duplicate.
Assessment of risk of bias in included studies
We carried out ’Risk of bias’ assessment independently in dupli-
cate. We assessed trial risk of bias using the Cochrane tool for as-
sessment of risk of bias (Higgins 2011b). For included RCTs we
also assessed whether trials were free of differences in diet (between
intervention and control arms) other than dietary fat intake, and
whether there was any systematic difference in attention or care or
time given between the intervention and control groups, as we felt
that these factors may also cause differences in weight.We used the
category ’other bias’ to note any further issues of methodological
concern. Funding was not formally a part of our assessment of bias
in RCTs as it is not a core part of the Cochrane ’Risk of bias’ tool.
For cohort studies we assessed the number of participants lost to
follow-up (with reasons), baseline similarity by total fat intake,
funding, type of control group (internal or external), method of
assessment of total fat intake, number of total fat assessments and
factors adjusted for.We also noted factors not adjusted for (age, sex,
energy intake, ethnicity, physical activity (and/or TV watching)
and socioeconomic (including educational) status for adults and
age, sex, energy intake, ethnicity, parental BMI, physical activity
(and/or TVwatching) and socioeconomic (including educational)
status in children).
Measures of treatment effect
The effect measure of choice for continuous outcomes (all review
outcomes were continuous outcomes) was the mean difference
(MD).
Unit of analysis issues
We did not include any cluster-randomised or cross-over trials in
this review.
Where there was more than one relevant intervention arm but
only one control arm we pooled the relevant intervention arms
to create a single pair-wise comparison (where the intervention
arms were equivalently appropriate for this review) as described
in Higgins 2011a. We excluded intervention arms that were not
appropriate for this review, or less appropriate than another arm.
When two arms were appropriate for different subgroups then we
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used the control group once with each intervention arm, but we
did not pool the subgroups overall.
When weight or BMI were assessed at more than one time point
we used the data from the latest time point available in general
analyses, but we extracted data for all time points for use in sub-
grouping by study duration.
Dealing with missing data
Where included studies used methods to infer missing data (such
as carrying the latest weight data forward) then we used these data
in analyses.Where this was not done we used the data as presented.
Assessment of heterogeneity
We examined heterogeneity using the I2 statistic and considered
heterogeneity important where the I2 was above 50% (Higgins
2003; Higgins 2011a).
Assessment of reporting biases
Wedrew funnel plots to examine the possibility of publication bias
for measures of body fatness with at least 10 included comparisons
(Egger 1997).
Data synthesis
All trial outcomes were continuous and where possible we ex-
tracted change data (change in the outcome from baseline to out-
come assessment) with relevant data on variance for intervention
and control arms (along with numbers of participants at that time
point). Where change data were not available, we extracted data at
study end (or other relevant time point) along with variance and
numbers of participants for each arm. We did not use end data
where the difference between the intervention and control groups
at baseline was greater than the change in that measure between
baseline and endpoint in both arms (instead we used change data
in forest plots, but without standard deviations (SDs), so the data
did not add to the meta-analyses but provided comparative infor-
mation).
We combined data by the inverse variance method in random-
effects meta-analysis to assess mean differences between lower and
higher fat intake arms.
We planned to conduct separate meta-analyses of data from adult
RCTs, data from child RCTs, data from adult cohort studies and
data from child cohort studies, where data from separate studies
were similar enough to be combined.
We created a ’Summary of findings’ table assessing the effects of
low dietary fat compared with usual fat for body weight in adults
using RCT data.
Subgroup analysis and investigation of heterogeneity
For this update we classified all dietary interventions as low fat
versus usual or modified fat. Pre-specified subgroups for body fat
outcomes, to explore the stability of findings in different study
subgroups, included:
• duration of intervention (6 to < 12 months, 12 to < 24
months, 24 to < 60 months, and 60+ months);
• control group total fat intake (> 35%E from fat, > 30%E to
35%E from fat, > 25%E to 30%E from fat);
• year of first publication of results (1960s, 1970s, 1980s,
1990s, 2000s, 2010s);
• sex (studies of women only, of men only, of men and
women mixed);
• difference in %E from fat between control and reduced fat
groups (up to 5%E from fat, 5%E to < 10%E from fat, 10%E to
< 15%E from fat, 15+%E from fat, or unknown difference);
• type of intervention (dietary advice, advice plus
supplements and diet provided);
• by total fat goal in the intervention arm (10%E to < 15%E
from fat, 15%E to < 20%E from fat, 20%E to < 25%E from fat,
25%E to < 30%E from fat, 30%E from fat, and no specific goal
stated);
• achieving fat goals (achieved 30%E from fat or less, did not
achieve this);
• mean BMI at baseline (< 25, 25 to < 30, 30+);
• state of health at baseline (not recruited on the basis of risk
factors or disease, recruited on the basis of risk factors such as
lipids, hormonal levels etc., recruited on the basis of having or
having had diseases such as diabetes, myocardial infarction,
cancer, polyps);
• assessed energy reduction in the intervention compared
with the control group during the intervention period (E intake
the same or greater in the low fat group, E intake 1 to 100 kcal/d
lower in the low fat group, 101 to 200 kcal/d lower in the low fat
group, > 200 Kcal/d lower in the low fat group).
For subgrouping factors that appeared to suggest significant dif-
ferences in effect size between subgroups we explored the effects
using meta-regression on weight (we also intended to explore the
effects on other outcomes, but no other outcome had more than
10 relevant comparisons). We performed random-effects meta-
regression (Berkley 1995) using the STATA command metareg
(Sharp 1998; Sterne 2001; Sterne 2009).
Sensitivity analysis
We carried out sensitivity analyses for primary outcomes, assessing
the effect of:
• running fixed-effect meta-analyses (rather than random-
effects) (Higgins 2011a);
• excluding the largest study (WHI with CVD 2006, WHI
2006);
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• excluding studies that were not free of systematic
differences in care (or unclear);
• excluding studies that were not free of dietary differences
other than fat (or unclear);
• excluding studies with unclear or inadequate allocation
concealment.
R E S U L T S
Description of studies
The study flow is shown in Figure 1. The perceived importance
of obesity and overweight has increased over the past few years,
therefore many trials of reduced fat diets now explicitly or implic-
itly aim at weight loss. To guard against inclusion of studies that
intended weight loss without stating this clearly we decided to
exclude RCTs that only included people based according to their
BMI or weight classification (i.e. specifically including only peo-
ple with a BMI > 25). For this reason (and to ensure consistency)
we have excluded three RCTs included in the previous version of
this review, Hooper 2012b, from this current review (CARMEN
2000; CARMENMS sub-study; German Fat Reduced), while we
have included an additional adult RCT (Diet andHormone Study
2003).
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Figure 1. Study flow diagram for this systematic review (update searches run November 2014).
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Results of the search
The search for RCTs and cohort studies in the original version
of this review identified 32,220 titles and abstracts from the elec-
tronic searches plus 28 further potential studies fromother sources.
For this update the electronic searches identified 7729 possible
titles and abstracts, plus we assessed a further 24 potential studies
following our check of potentially relevant trials and cohort stud-
ies included in other systematic reviews. Of these 7753 potential
update titles and abstracts, we assessed 218 full-text articles for
eligibility (additional to the 465 assessed for the original review).
We included a total of 32 RCTs (31 in adults, one in children) and
25 prospective cohort studies (17 sets of analyses of 14 cohorts in
adults and 13 sets of analyses of 11 cohorts in children) (Figure 1).
We included 29 adult RCTs (including 34 comparisons) in meta-
analyses.
Included studies
Of the 31 RCTs in adults (36 comparisons, including roughly
53,626 participants - exact numbers depending on time point in
study and endpoint used), 21were fromNorth America, nine from
Europe and one from New Zealand, with none from developing
or transitional countries. The duration of the trials varied from
six months to more than eight years. In four trials the participants
were all men, in 15 all women and in 12 both sexes (one of which
reported outcomes by sex). Mean ages and states of health (low,
moderate or high risk of cardiovascular disease or breast cancer)
varied. The single trial in children analysed 191 Greek 12- to 13
-year old boys and girls, followed up for 17 months (VYRONAS
2009). See Characteristics of included studies for detailed charac-
teristics of the RCTs in adults and young people.
When discussing the 31 RCTs, the de Bont study (de Bont
1981 non-obese; de Bont 1981 obese), DEER study (DEER
1998 exercise men; DEER 1998 exercise women; DEER 1998 no
exercise men; DEER 1998 no exercise wom), and Kuopio study
(Kuopio Reduced & Mod 1993; Kuopio Reduced Fat 1993) are
each referred to and counted as a single study, although they appear
as individual arms in analyses and in the validity table (suggesting
36 intervention arms).
We included 17 sets of analyses from 14 adult cohorts, with a
follow-up one year to over 16 years (median five years). Most were
of mixed sex, though one was men only and two women only.
Recruitment included young people (13 years and over in one
mixed cohort although most participants recruited were adults,
18 years and over in fully adult cohorts), middle aged and elderly
adults (up to 75 years at baseline). Cohorts were recruited inNorth
America (eight cohorts), Europe (five cohorts) and Australia (one).
The 13 sets of analyses from the 11 included cohorts that recruited
children and young people were followed for one to 23 years (me-
dian four years). They recruited children aged from two years to
14 years (although one study may have recruited four- to 19-year
olds, so included a few young people older than 14 at baseline),
and followed up until later in childhood or early adulthood. Five
were based in North America, three in Europe, two in Australia
and one in Korea.
The table of characteristics of the adult cohort studies, along with
their references, is found in Table 1, and of cohorts of children
and young people in Table 2.
Excluded studies
Reasons for exclusion of the 345 adult RCTs that we read in full
text but excluded from this review are found in Characteristics of
excluded studies. Reasons for exclusion of child RCTs are found in
Table 3, adult cohort studies in Table 4, and child cohort studies
in Table 5, along with their references.
Risk of bias in included studies
To understand the risk of bias in the individual included RCTs in
a visual way, see Figure 2. ’Risk of bias’ assessments of included
adult cohort analyses are found in Table 6, and of child and young
people’s cohort analyses in Table 7.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each methodological quality item for
each included adult and child RCT comparison.
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Validity of RCTs
Allocation
Twenty-two RCTs and the single child RCT, VYRONAS 2009,
had low risk of bias from random sequence generation; the re-
mainder were at unclear risk. Eleven adult RCTs and the single
child RCT were at low risk of selection bias arising from poor or
unclear allocation concealment or randomisation, one was at high
risk (Sondergaard 2003), and the remaining RCTs were at unclear
risk.
Blinding
There was a high risk of performance and detection bias due to
lack of blinding (which is usual in dietary trials) in all included
RCTs except the National Diet and Heart Studies (NDHS Open
1st L&M 1968; NDHS Open 2nd L&M 1968), which provided
trial shops that blinded purchases of usual or low fat products.
Incomplete outcome data
For RCTs we assessed those studies that lost more than 5% of
participants per year as at high risk of attrition bias; others were at
low risk of attrition bias. Eight RCTs were at low risk of attrition
bias, two were unclear and the remainder (including the one child
RCT) at high risk.
Selective reporting
MostRCTswere at unclear risk of reporting bias (due to the paucity
of accessible protocols, so that we could not assess reporting bias),
but three adult RCTs were at low risk and one at high risk of bias.
We examined the possible presence of reporting bias by using the
list of included studies from a recent review of RCTs of the ef-
fects of reduced andmodified fat on cardiovascular events (Hooper
2012b). Of 48 included RCTs in the other review, we included 21
in the current review. Of the remaining 27 RCTs, 10 did not com-
pare reduced fat intake with usual fat intake (they were included
as they modified fat compared with usual fat intake), 13 aimed
to reduce weight in some or all participants and three included
only participants with a high BMI. Only one trial was eligible for
this review but was not included as no data were provided on any
measure of body fatness (Toronto Polyp Prev 1994). The risk of
reporting bias, related to the proportion of studies not included
in a meta-analysis, seems minimal here (Furukawa 2007).
Other potential sources of bias
We considered all the adult RCTs to be at low risk of other types of
bias, but the child RCT, VYRONAS 2009, was felt to be at high
risk due to individual randomisation in a school setting, which
raised the issue of contamination of the intervention between in-
tervention and control children. Eight adult RCTs had low risk
of systematic differences in level of care between the intervention
and control groups, while 24 had high risk of such differences in
care, as did the child RCT. Differences in attention, training, time
from health professionals, number of health checks and/or group
support could potentially alter feelings of self efficacy and increase
contact with healthcare professionals offering various types of sup-
port, and alter participants’ ability to look after themselves and
maintain a healthy weight. Some dietary interventions to reduce
fat also had specific goals around fruit, vegetables, fibre, alcohol
etc., which raises the possibility that any changes in weight may
result from these alterations, not from change in fat intake. Ten
adult RCTs and the child RCT were at high risk of effects from
dietary differences other than fat; the remaining 22 RCTs were at
low risk of effects from other dietary advice.
Validity of cohort studies
We considered the cohort studies to be at either moderate or high
risk of bias. Moderate risk of bias was suggested where less than
20% were lost to follow-up, two factors or fewer were unadjusted
for in the design or analysis (of age, sex, energy intake, ethnicity,
physical activity and/or TV watching and socioeconomic status
(which includes educational status for adult cohorts), and diet was
assessed using a 24-hour recall or diet diary. For child cohorts fac-
tors assessed for adjustment included age, sex, energy intake, eth-
nicity, parental BMI, physical activity and/or TV watching) and
socioeconomic factors, including educational status. We consid-
ered all other studies to be at high risk of bias.
We considered all adult cohort analyses to be at high risk of bias,
apart from the MONICA study analysis. We likewise we consid-
ered all cohort studies of children and young people to be at high
risk of bias, except for Davison 2001, which was at moderate risk
of bias. Cohort studies overall suffered from high dropout rates,
lack of complete adjustment for relevant potential confounders
and poor assessment of total fat intake.
Effects of interventions
See: Summary of findings for themain comparison Low dietary
fat compared with usual fat for controlling body fatness
A ’Summary of findings’ table assessing the effects of low dietary
fat compared with usual fat for body weight in adults using ran-
domised controlled trial (RCT) data is presented (Summary of
findings for the main comparison).
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Effects of reducing dietary fat on weight and body
fatness in adults (as seen in RCTs)
Weight
Eating a lower proportion of energy as fat results in lower weight
(or lower weight gain, or greater weight reductions) than eating
the usual proportion of fat (-1.5 kg, 95% confidence interval (CI)
-2.0 to -1.1, 53,647 participants, 24 estimable comparisons, I2
= 77%, Analysis 1.1; Figure 3). The effect was small but statisti-
cally significant, and the best estimate of effect being a reduction
in weight was consistent across 21 of the 24 comparisons with
numerical data. Additionally, all of the six comparisons that did
not have an estimable effect size, due to lack of variance data or
large baseline differences, were consistent with greater weight re-
duction in the reduced fat arms (Figure 3). The same effect was
reported in two of the three comparisons that were not included
in the forest plot (as they provided insufficient information). The
exception was Sondergaard 2003, which reported “in both groups,
body weight remained unchanged after 12 months”.
Figure 3. Forest plot of comparison: 1 Fat reduction versus usual fat diet, adult RCTs, outcome: 1.1 Weight,
kg.
The statistical significance of this relative weight reduction was not
lost when we removed studies providing greater time or resources
to the reduced fat group (-1.3 kg, 95% CI -2.1 to -0.4), when
we removed studies with additional dietary interventions (-1.9 kg,
95% CI -2.6 to -1.3), when we used fixed-effect meta-analysis
(rather than random-effects analysis) (-1.0 kg, 95% CI -1.2 to -
0.9), when we removed the largest RCT (WHI 2006) (-1.6 kg,
95% CI -2.1 to -1.2), or when we removed studies with high or
unclear risk of selection bias (-1.0 kg, 95% CI -1.4 to -0.5).
We examined the influence of potential effect modifiers through
subgrouping (Table 8). Therewas a suggestionof a dose effect, with
studies that reduced total fat in the intervention group by a greater
amount compared with the control group showing greater reduc-
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tions in weight (test for subgroup differences: P value = 0.003).
Where the reduction in total fat was less than 5%E compared with
control, weight loss was not statistically significant (mean differ-
ence (MD) -0.2 kg, 95% CI -0.9 to 0.6), but as the difference in
total fat increased, weight reductions were seen (5%E to < 10%E
from fat difference between intervention and control groups, MD
-2.1 kg, 95%CI -2.9 to -1.4, and 10%E to < 15%E from fat differ-
ence, MD -1.3 kg, 95% CI -1.7 to -1.0). As few studies altered the
%E from fat by 15% or more, power was limited so the suggested
effect size was large but non-significant (MD -3.9 kg, 95% CI -
8.8 to 1.0). Similarly there was a suggestion that in low fat arms
with greater reductions in energy intake there were greater relative
falls in weight (test for subgroup differences: P value = 0.04).
The time point at which weight is assessed following the onset of a
reduced comparedwith amoderate fat dietmay be important. The
effect in studies that assessed weight from six to up to 12 months,
12 to up to 24 months and 24 to up to 60 months was statistically
significant, but at 60+ months (MD -0.7 kg, 95% CI -1.7 to 0.3)
statistical significance was lost (test for subgroup differences: P
value = 0.04).
The level of fat in the control groupmay also be important.Weight
loss was statistically significant where the control group intake was
over 35% of energy from fat, over 30% to 35% of energy or over
25% to 30% of energy, with a suggestion of greater weight loss in
groupswith lower baseline fat intake (test for subgroup differences:
P value < 0.00001) (see Table 8).
There was a suggestion that dietary advice was more effective in
weight reduction with low fat eating than provision of low fat
foods, however the power of the analysis was limited (only one
study that provided foods also supplied numerical data for meta-
analysis (test for subgroup differences: P value = 0.04).
There were no clear effects of: sex on weight (studies in men, in
women and in mixed sexes all showed significant weight loss; test
for subgroup differences: P value = 0.20), year of first publication
(studies published in the 1960s, 1980s, 1990s and 2000s were
all statistically significant; test for subgroup differences: P value =
0.07), the total fat intake goal in the intervention group (test for
subgroup differences: P value = 0.34), whether the low fat arm
achieved a fat intake of ≤ 30%E or not (test for subgroup differ-
ences: P value = 0.42), body mass index at baseline (test for sub-
group differences: P value = 0.17), or whether participants were
recruited as healthy, with risk factors (such as lipids, hormone lev-
els or breast cancer risk factors), or with existing disease (such as
diabetes, previous myocardial infarction or polyps) (test for sub-
group differences: P value = 0.12). For all of these subgroupings all
of the subgroups examined showed statistically significant weight
loss in the low fat arms compared with the control arms.
Meta-regression (multiple regression model on dose, duration and
control group fat intake, all at once) suggested that the degree of
fat reduction was significantly associated with the degree of weight
loss in the intervention arm compared with the control arm (co-
efficient -0.20 kg/1% energy from total fat reduction, 95% CI -
0.34 to -0.05, P value = 0.010), suggesting that greater reduction
in fat intake was associated with greater weight loss. Fat intake
in the control group (equivalent to baseline fat intake) was also
significantly associated with the degree of weight loss in the in-
tervention group (coefficient 0.17 kg/1% energy from fat in the
control group, 95% CI 0.04 to 0.29, P value = 0.010), suggest-
ing that a reduction in fat intake was more effective at reducing
weight in those with a lower baseline fat intake. There was no
clear association between trial duration and degree of weight loss
(coefficient 0.01 kg/month, 95% CI -0.006 to 0.030, P value =
0.19). Together these factors explained 56% of variance between
studies, using the equation: weight change (kg) = -5.97 kg + 0.17
kg/1% energy from total fat in control group -0.20 kg/1% de-
crease in energy from total fat in intervention group + 0.01 kg/
months’ duration.
Body mass index (BMI), waist circumference and other
measures of body fatness
Fewer studies reported BMI than weight, but the effect of a lower
proportion of energy from fat on BMI appeared similar to that
on weight (-0.5 kg, 95% CI -0.7 to -0.3, 45,703 participants, 10
comparisons, I2 = 74%) (Analysis 1.2; Figure 4). As there were
fewer studies than for weight, we did not attempt sensitivity anal-
yses and subgrouping for BMI.
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Figure 4. Forest plot of comparison: 1 Fat reduction versus usual fat diet, adult RCTs, outcome: 1.2 BMI,
kg/m2.
Only one RCT reported waist circumference, finding that waist
circumference in those on low fat diets was significantly lower than
in those on usual fat diets at five and seven years (by 0.3 cm, 95%
CI -0.6 to -0.02, 15,671 women) (WHI 2006). No adult RCTs
reported other measures of body fatness.
Secondary outcomes - lipids and blood pressure
There was no suggestion of harms associated with low fat diets
that might mitigate any benefits on weight.
Effects of reduced fat compared with usual or modified fat diets
suggested that the lower fat diets were associated with lower total
and low-density lipoprotein (LDL) cholesterol, without impor-
tant effects on high-density lipoprotein (HDL) or triglycerides.
Effects on LDL (-0.1 mmol/L, 95% CI -0.2 to -0.03, 7285 par-
ticipants, 18 comparisons, I2 = 65%) were similar to those on to-
tal cholesterol (-0.2 mmol/L, 95% CI -0.3 to -0.1, 7715 partici-
pants, 20 comparisons, I2 = 54%). The effect on HDL suggested
slight harm from lower fat diets (-0.01 mmol/L, 95% CI -0.03
to 0.00, P value = 0.11, 7166 participants, 19 comparisons, I2 =
0%). Given the weight loss, there was little evidence of a benefit on
triglycerides (-0.02 mmol/L, 95% CI -0.12 to 0.08, 6976 partici-
pants, 17 comparisons, I2 = 56%). There was a reduction in total
cholesterol/HDL ratio over the seven comparisons that reported
it (-0.10, 95% CI -0.16 to -0.04, 3332 participants, I2 = 0%).
There were small and statistically significant beneficial effects of
a lower fat diet on systolic and diastolic blood pressure (although
these were reported in relatively few studies). The effect on sys-
tolic blood pressure (-1.2 mmHg, 95% CI -2.0 to -0.4, 5159 par-
ticipants, nine comparisons, I2 = 0%) was greater than that on
diastolic blood pressure (-0.7 mmHg, 95% CI -1.4 to -0.1, 5159
participants, nine comparisons, I2 = 23%).
Secondary outcomes - effects of reducing fat intake on
intakes of energy, protein, carbohydrate, sugars and alcohol
Indications were that during the studies energy intake was usually
lower in the low fat group than in the control or usual fat groups.
Sugar intake was not measured often but where reported sugar
intake appeared higher in low fat arms (except inMeDiet 2006, see
Table 9). Carbohydrate intakes appeared almost universally higher
in low fat arms than in usual fat arms, and protein intakes were
sometimes higher and sometimes similar. There was no consistent
pattern in alcohol intake.
Secondary outcomes - effects of reducing fat intake on
quality of life measures
Quality of life outcomes were rarely measured or reported. It ap-
pears that quality of life was assessed in WHI 2006 but we were
unable to find any reference to this outcome by dietary interven-
tion group. No other relevant data were located.
Publication bias
The funnel plot of studies assessing effects on weight did not sug-
gest any serious publication bias (Figure 5), and neither did the
funnel plot of effects on BMI (not shown). The studies that as-
sessed weight, but where we could not include the data provided in
meta-analysis, did not appear to differ importantly in their results
from the studies that provided variance data and were included in
the analyses.
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Figure 5. Funnel plot of comparison: 1 Fat reduction versus usual fat diet, outcome: 1.1 Weight, kg.
Effects of reducing dietary fat on weight and body
fatness in children (as seen in RCTs)
As part of the single RCT in children, VYRONAS 2009 ran-
domised 213 students aged 12 to 13 years at baseline to interven-
tion or usual diet, of whom 191 were analysed at 17 months. The
validity of this RCT was discussed with the adult RCTs and is
shown in Figure 2). The intervention group (n = 98) had a 12-week
school-based health and nutrition interventional programme with
a 17-month follow-up period. After 17 months, total fat intake
(as %E) showed a significant reduction 31.3% (standard deviation
(SD) 4.4) compared with baseline intake of 35.4% (SD 4.7) in
the intervention group (P value < 0.001). In the control group fat
intake at 17 months was 36.2% (SD 5.2) compared with 36.9%
(SD 4.8) at baseline (P value = 0.343). Mean BMI (kg/m2) also
decreased significantly (adjusting for age and sex) to 23.3 kg/m2
(SD 2.8) compared with 24.0 kg/m2 (SD 3.1) at baseline in the
intervention group (P value < 0.001), but remained practically
unchanged in the control group (24.8 (SD 3.8) versus 24.3 (SD
3.3), P value = 0.355). The difference in weight between inter-
vention and control arms was not reported, and as the difference
between intervention and control groups for baseline BMI was
greater than the changes in BMI in either arm a direct compar-
ison of BMI is probably inappropriate statistically. Mean change
in BMI was a fall of 0.7 kg/m2 in the intervention group and an
increase of 0.5 kg/m2 in the control group, a difference of 1.2 kg/
m2 (but we do not have variance data for these changes, so cannot
comment on statistical significance). Analysis of 17-month BMI
data by the review authors in RevMan (RevMan 2014) suggested
that the effect of a low fat diet compared with a usual fat diet in
children was -1.50 kg/m2 (95% CI -2.45 to -0.55), however this
was assessed on adjusted data, with a large baseline difference in
BMI between groups. Without analysis of the original data set this
should therefore be considered with caution.
Associations between total dietary fat and measures
of body fatness in adults (as seen in cohorts)
Of the 14 adult cohorts (17 analyses), 12 (13 analyses) reported
on the relationship between total fat and later change in body
weight (for characteristics of these studies see Table 1).We consid-
ered meta-analysis of beta values, but the different methodologies,
methods of modelling, numbers of baseline dietary assessments,
numbers of relevant statistical analyses per single cohort (from one
to eight), time periods between dietary assessment and body fat-
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ness assessment, ages at baseline and outcome measures (weight,
change in weight, BMI, change in BMI, waist circumference) were
so varied that we felt combining studies in meta-analysis was in-
appropriate.
The single study at moderate risk of bias (Danish MONICA,
Iqbal 2006, Table 1) found no relationship between fat intake and
change in weight. Three further analyses reported no relationship
between fat intake andweight change in the whole cohort or in any
reported subgroup.Nine reported relationships in some subgroups
but not others (a reduction in weight with replacement of protein
by fat but no relationship when replacing carbohydrates; when
replacing carbohydrate with fat; an increase in weight associated
with increases in total fat in younger but not older men; in women
but not in men; in younger women but not older women or men;
in sedentary but not more active women). The final study was
unclear as to whether any relationship was statistically significant
or not.
The two analyses to assess the relationship between total fat intake
and change in BMI (DCCT/EDIC and SEASONS) found no
relationship between total fat intake and change in BMI. One
cohort (two analyses) found no relationship with change in waist
circumference (Danish Diet, Cancer & Health Study); another
found no relationship in women, but a negative effect in men
(Memphis).
Relationships with absolute body weight were assessed in two co-
horts. One found that greater total fat intake was associated with
greater weight in blackmen and women, but not in white men and
women, while the other found it associated with greater weight
overall, and in subgroups of younger but not older people. One
study found no relationship with absolute BMI, and one found
that greater total fat was associated with greater waist circumfer-
ence (overall and in younger, but not older, participants). Overall
there was little consistent suggestion of a relationship between to-
tal fat intake and change in or later measures of body fatness, but
the relationship may exist in younger adults.
Overall, the included adult cohorts reported 39 analyses of the
relationship between total fat intake and measures of body fatness
in adults. Twelve suggested a positive relationship, three a negative
relationship and one was unclear. The remainder (23 analyses)
were neutral (no statistically significant relationship).
Associations between total dietary fat in youth and
measures of body fatness in children, young people
and adults (as seen in cohorts)
Of the 10 analyses of nine child or young person cohorts that as-
sessed effects on body fatness in childhood or adolescence, three
cohorts (four analyses, including the study at moderate risk of
bias, Davison 2001) suggested that higher dietary fat intakes pre-
dicted greater body fatness (assessed as % body fat, BMI, change
in BMI and change in weight: Carruth & Skinner 2001; Davi-
son 2001; and Viva la Familia). The remaining four cohorts (nine
analyses) suggested no clear relationship between fat intake and
fatness (assessed as BMI, change in BMI, BMI percentile, triceps
skinfold, sub-scapular skinfolds, % body fat), reporting effects in
some measures of body fatness or some analysed age groups but
not others (for details of these cohort studies see Table 2).
We considered meta-analysis, but the different methodologies,
methods of modelling, numbers of baseline dietary assessments,
numbers of relevant statistical analyses per single cohort (from 1 to
63), time periods between dietary assessment and body fatness as-
sessment, ages at baseline and outcome measures (weight, change
in weight, BMI, change in BMI z-score, change in BMI, body fat
percentage, various skinfold measures) were so varied that we felt
combining studies in meta-analysis was inappropriate.
The two cohorts (two analyses of the Amsterdam Growth and
Health Longitudinal Study, and one of ELANCE, Table 2), which
assessed the relationship between fat intake in childhood and body
fatness in early adulthood (ages 20, 27 and 36), found no clear
relationshipswithBMI, percentage body fat, sumof skinfolds or%
triceps skinfold. The exception was ELANCE, which found that
greater total fat intake in youthwas related to lower percentage sub-
scapular skinfold and fat mass (though not to BMI or % triceps
skinfold).
Overall, the included cohorts reported a total of 101 analyses of
the relationship between total fat intake and body fatness in co-
horts recruiting children and young people. Nine suggested posi-
tive relationships and three suggested negative relationships. The
vast majority were neutral.
D I S C U S S I O N
Summary of main results
Randomised controlled trials (RCTs) of the effects on body fat-
ness of reducing total fat intake (without any intention to reduce
body weight) show a small but consistent reduction in weight in
the low fat arm compared with the usual fat arm. There is some
heterogeneity between studies in the size of this effect, but not in
its presence, and the effect was highly resistant to sensitivity anal-
yses. The heterogeneity was explained by the degree of total fat
reduction and baseline total fat intake (in meta-regression and in
subgrouping). The small reduction in weight (1.5 kg, 95% confi-
dence interval (CI) -2.0 to -1.1 kg) was also reflected in a reduc-
tion in body mass index (BMI) (-0.50 kg/m2, 95% CI -0.74 to
-0.26) and waist circumference (0.3 cm, 95% CI -0.6 to -0.02)
in the adult studies that reported these data, and in a suggested
reduction in BMI in the one child study (VYRONAS 2009): a fall
of 0.7 kg/m2 in the intervention arm and a rise of 0.5 kg/m2 in
the control arm). Additionally, there was no suggestion of harms
that might mitigate any benefits on weight, and some suggestion
of benefit to serum lipids and blood pressure resulting from low
fat diets.
18Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cohort studies in adults and children generally found no clear
relationship between total fat intake and measures of body fatness
later in life, but a few did see positive relationships (higher total
fat intake was associated with higher later body fatness), and fewer
suggested negative relationships.
Overall completeness and applicability of
evidence
We have searched very carefully and used a set of comprehensive
search strategies to find the full set of RCTs and cohort studies
assessing the relationship between total fat intake and measures
of body fatness. We did this by searching for trials that reduced
total fat in one arm and not in the other, regardless of the primary
aims or outcomes mentioned in the title or abstracts. Indeed, the
included RCTs rarely had weight as a key outcome. Reflecting this,
there was little suggestion (from the funnel plot of adult RCTs
assessing effects on weight and BMI) that we have missed a sample
of RCTs. However, we are limited in how well we are able to assess
this for cohort studies, where the risk of missing studies is keener
(where sometimes the relevant analysis is added into the text as an
afterthought (e.g.Working Well 1996) and does not appear in the
title or abstract).
The studies are highly applicable to the question, allowing us to
draw conclusions on the effect of altering the percentage of energy
from total fat on body fatness.
Quality of the evidence
The included RCTs were often at unclear risk of selection bias due
to unclear allocation concealment, but this did not appear to affect
the results of the review as omitting all RCTs with unclear or poor
allocation concealment still resulted in a statistically significant
weight reduction in the intervention arms. Lack of blinding was
a validity issue in most included RCTs, reflecting the difficulties
of blinding dietary intervention studies. We assessed the effects of
attention bias in sensitivity analyses, removing studies that pro-
vided more time or review or education to the intervention group
compared with the control group, and also the effect of removing
studies that provided dietary advice other than on dietary fat (in
case effects were being driven by other dietary interventions) and
in neither case did we lose the significant weight reduction seen in
the low fat arms. In each case the higher validity trials reflect the
main message, that eating a lower proportion of energy from fat
results in slightly lower body fatness.
The included cohort studies were generally at high risk of bias due
to the high proportion of participants lost to follow-up or lack
of adjustment for potential confounders. Although the included
cohorts reported on a large number of participants, they did not
add significantly to the conclusions of the review as their findings
were not conclusive.
Potential biases in the review process
When compiling the included studies we tried to locate RCTs that
investigated the effects of reducing total dietary fat for at least six
months. There was a high degree of heterogeneity among trials
from different sources, including the type and number of partici-
pants, the duration and nature of interventions, control methods
and follow-up. However, our sensitivity analyses and subgrouping
to examine the effect of the potential effect modifiers mentioned
above did not affect the statistical significance of the suggested
effect, finding it remarkably robust to subgroup and sensitivity
analyses.
Our review included only published studies (we did not seek un-
published data), which could bias the results due to the lack of
publication of negative or inconclusive studies. However, our fun-
nel plots did not suggest serious publication bias (Figure 5).
Our decision to exclude trials that explicitly or implicitly aimed
to reduce weight may have led to missing some trials or restricting
the number of included studies, especially excluding studies where
there was no energy restriction, no explicit aim of weight loss, or
encouraging of weight loss for some and not all participants. How-
ever, this decision makes the effect we found on weight and other
measures of body fatness more reliable and avoids the potential
confounding effects of dieting and unconscious energy restriction
or other diet changes.
The restriction of inclusion to studies with a minimum of six
months duration for RCTs or one year for cohorts led to missing
some potentially relevant studies (for example, studies of 24 weeks
duration, which just missed the 26-week limit). However, it is
essential to draw the line at some point, and longer trials and
follow-up ensure that the data are relevant to long-term fatness,
which affects long-term health.
A limitation of the review was that we did not assess the causal
pathway between restriction of energy from fat and weight and so
the mechanism of the effect is not clear. It is likely that restricting
energy from fat also reduces energy intake (see Table 9), which
leads to lower body weight. Further evidence that energy intake is
important in mediating the effect of lowering fat intake on body
weight is suggested by a higher relative weight loss in the low fat
arms with greater energy reduction.
Most (22 of 32) included RCTs were published before the year
2000 - this is primarily becausemost recent studies have focused on
weight reduction so were ineligible for this review. However, there
was no suggestion when subgrouping by decade of publication
that effects have altered over time.
Agreements and disagreements with other
studies or reviews
The conclusions of this updated review have not altered in overall
import from the original review (Hooper 2012b). Yu-Poth 1999
found that dietary trials (excluding trials that also assessed exercise
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interventions) of the National Cholesterol Education Program’s
Step I and Step II dietary intervention programmes resulted in
weight reductions (compared with control groups) of just under
3 kg, and that this was related to the degree of total fat reduction.
Their regression suggested that for every 1% decrease in energy as
total fat, there was a 0.28 kg decrease in body weight, while our
meta-regression found that for every 1%decrease in energy as total
fat there was a slightly smaller 0.20 kg decrease in weight (95% CI
-0.34 to -0.05, P value = 0.010). The slightly smaller effect size in
this review may be due to our excluding shorter duration studies
and studies that aimed to reduce weight in the intervention arm.
However, some recent cardiovascular disease prevention guidelines
have not mentioned total fat intake as regards to either weight con-
trol or prevention of cardiovascular disease (Joint ESC guidelines
2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Attempts should be made to reduce total fat intake in populations
where mean total fat intake is 30% or more of energy, in order to
support maintenance of healthy weights. For populations where
themean total fat intake is below30%of energy, then interventions
to restrict increases in total fat intake to over 30% of energy may
help to avoid obesity.
Implications for research
High quality trials are needed to investigate the effect on body
weight of reducing fat intake in developing or transitional coun-
tries with total fat intakes greater than 30% of energy, and of pre-
venting total fat intake rising above 30% of energy in countries
with total fat intakes of 25% to 30% of energy. High quality trials
are also required in children.
A C K N OW L E D G E M E N T S
We thank the members of the WHO NUGAG subgroup on diet
and health for their work in setting up the question and the proto-
col for this review (agreed in outline at its first meeting in February
2010, but not published), offering further studies for examina-
tion and assessment for inclusion during the initial version of this
review, and in ensuring robust analysis. We thank the WHO for
funding the update of this review and agreeing with the publica-
tion of this systematic review as a scientific paper.
R E F E R E N C E S
References to studies included in this review
Auckland reduced fat 1999 {published and unpublished data}
∗ Ley SJ,Metcalf PA, Scragg RKR, Swinburn BA. Long-term
effects of a reduced fat diet intervention on cardiovascular
disease risk factors in individuals with glucose intolerance.
Diabetes Research and Clinical Practice 2004;63:103–12.
Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year)
effects of a reduced-fat diet intervention in individuals with
glucose intolerance. Diabetes Care 2001;24(4):619–24.
Swinburn BA, Woollard GA, Chang EC, Wilson MR.
Effects of reduced-fat diets consumed ad libitum on intake
of nutrients particularly antioxidant vitamins. Journal of the
American Dietetic Association 1999;99(11):1400–5.
BDIT Pilot Studies 1996 {published and unpublished data}
Boyd NF, Cousins M, Beaton M, Fishell E, Wright B, Fish
E, et al. Clinical trial of low-fat, high-carbohydrate diet
in subjects with mammographic dysplasia: report of early
outcomes. Journal of the National Cancer Institute 1988;80:
1244–8.
Boyd NF, Cousins M, Beaton M, Han L, McGuire V.
Methodological issues in clinical trials of dietary fat
reduction in patients with breast dysplasia. Progress in
Clinical and Biological Research 1986;222:117–24.
Boyd NF, Cousins M, Beaton M, Kriukov V, Lockwood G,
Tritchler D. Quantitative changes in dietary fat intake and
serum cholesterol in women: results from a randomized,
controlled trial. American Journal of Clinical Nutrition
1990;52(3):470–6.
Boyd NF, Cousins M, Kriukov V. A randomised controlled
trial of dietary fat reduction: the retention of subjects and
characteristics of drop outs. Journal of Clinical Epidemiology
1992;45(1):31–8.
Boyd NF, Cousins M, Lockwood G, Tritchler D. Dietary
fat and breast cancer risk: the feasibility of a clinical trial of
breast cancer prevention. Lipids 1992;27(10):821–6.
Boyd NF, Cousins M, Lockwood G, Tritchler D. The
feasibility of testing experimentally the dietary fat-breast
cancer hypothesis. Progress in Clinical and Biological Research
1990;346:231–41.
∗ Boyd NF, Martin LJ, Beaton M, Cousins M, Kriukov V.
Long-term effects of participation in a randomized trial
of a low-fat, high-carbohydrate diet. Cancer Epidemiology,
Biomarkers and Prevention 1996;5(3):217–22.
Lee-Han H, Cousins M, Beaton M, McGuire V, Kriukov V,
Chipman M, et al. Compliance in a randomized clinical
trial of dietary fat reduction in patients with breast dysplasia.
American Journal of Clinical Nutrition 1988;48(3):575–86.
beFIT 1997 {published and unpublished data}
Retzlaff BM, Walden CE, McNeney WB, Buck BL,
McCann BS, Knopp RH. Nutritional intake of women and
20Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
men on the NCEP Step I and Step II diets. Journal of the
American College of Nutrition 1997;16(1):52–61.
Walden CE, Retzlaff BM, Buck BL, McCann BS, Knopp
RH. Lipoprotein lipid response to the National Cholesterol
Education Program Step II diet by hypercholesterolemic and
combined hyperlipidemic women and men. Arteriosclerosis,
Thrombosis and Vascular Biology 1997;17:375–82.
Walden CE, Retzlaff BM, Buck BL, Wallick S, McCann
BS, Knopp RH. Differential effect of National Cholesterol
Education Program (NCEP) Step II Diet on HDL
cholesterol, its subfractions, and apoprotein A-1 levels
in hypercholesterolemic women and men after 1 year:
the beFIT study. Arteriosclerosis, Thrombosis and Vascular
Biology 2000;20(6):1580–7.
Bloemberg 1991 {published and unpublished data}
Bloemberg BPM, Kromhout D, Goddijn HE, Jansen A,
Obermann de Boer GL. The impact for the guidelines
for a healthy diet of the Netherlands Nutrition Council
on total and high density lipoprotein cholesterol in
hypercholesterolemic free living men. American Journal of
Epidemiology 1991;134:39–48.
BRIDGES 2001 {published and unpublished data}
∗ Hebert JR, Ebbeling CB, Olendzki BC, Hurley TG,
Ma Y, Saal N, et al. Change in women’s diet and body
mass following intensive intervention for early-stage breast
cancer. Journal of the American Dietetic Association 2001;
101(4):421–31.
Canadian DBCP 1997 {published data only (unpublished sought but
not used)}
Boyd NF, Greenberg C, Lockwood G, Little L, Martin
L, Byng J, et al. Effects at two years of a low-fat, high-
carbohydrate diet on radiologic features of the breast: results
from a randomized trial. Canadian Diet and Breast Cancer
Prevention Study Group. Journal of the National Cancer
Institute 1997;89(7):488–96.
Boyd NF, Greenberg C, Martin L, Stone J, Hammond
G, Minkin S, et al. Lack of effect of a low-fat high-
carbohydrate diet on ovarian hormones in premenopausal
women: results from a randomized trial. IARC Scientific
Publications 2002;156:445–50.
Boyd NF, Lockwood GA, Greenberg CV, Martin LJ,
Tritchler DL, Boyd NF, et al. Effects of a low-fat high-
carbohydrate diet on plasma sex hormones in premenopausal
women: results from a randomized controlled trial.
Canadian Diet and Breast Cancer Prevention Study Group.
British Journal of Cancer 1997;76(1):127–35.
Knight JA, Martin LJ, Greenberg CV, Lockwood GA, Byng
JW, Yaffe MJ, et al. Macronutrient intake and change
in mammographic density at menopause: results from
a randomized trial. Cancer Epidemiology, Biomarkers &
Prevention 1999;8(2):123–8.
Leyenaar J, Sutherland HJ, Lockwood GA, Martin LJ,
Kriukov V, Greenberg CV, et al. Self-reported physical and
emotional health of women in a low-fat, high-carbohydrate
dietary trial (Canada). Cancer Causes & Control 1998;9(6):
601–10.
Martin LJ, Greenberg CV, Kriukov V, Minkin S, Jenkins
DJ, Boyd NF, et al. Intervention with a low-fat, high-
carbohydrate diet does not influence the timing of
menopause. American Journal of Clinical Nutrition 2006;84
(4):920–8.
Martin LJ, Greenberg CV, Kriukov V, Minkin S, Jenkins
DJ, Yaffe M, et al. Effect of a low-fat, high-carbohydrate
dietary intervention on change in mammographic density
over menopause. Breast Cancer Research & Treatment 2009;
113(1):163–72.
Martin LJ, Lockwood GA, Kristal AR, Kriukov V,
Greenberg C, Shatuck AL, et al. Assessment of a food
frequency questionnaire as a screening tool for low fat
intakes. Controlled Clinical Trials 1997;18(3):241–50.
Sutherland HJ, Carlin K, Harper W, Martin LJ, Greenberg
CV, Till JE, et al. A study of diet and breast cancer
prevention in Canada: why healthy women participate in
controlled trials. Cancer Causes & Control 1993;4(6):521–8.
de Bont 1981 non-obese {published and unpublished data}
de Bont AJ, Baker IA, St Leger AS, Sweetnam PM, Wragg
KG, Stephens SM, et al. A randomised controlled trial
of the effect of low fat diet advice on dietary response in
insulin independent diabetic women. Diabetologia 1981;21
(6):529–33.
de Bont 1981 obese {published and unpublished data}
de Bont AJ, Baker IA, St Leger AS, Sweetnam PM, Wragg
KG, Stephens SM, et al. A randomised controlled trial
of the effect of low fat diet advice on dietary response in
insulin independent diabetic women. Diabetologia 1981;21
(6):529–33.
DEER 1998 exercise men {published data only}
Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR.
Metabolic syndrome and changes in body fat from a low-
fat diet and/or exercise randomized controlled trial. Obesity
2010;18(3):548–54. [DOI: 10.1038/oby.2009.304]
Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes
in C-reactive protein from low-fat diet and/or physical
activity in men and women with and without metabolic
syndrome. Metabolism 2010;59(1):54–61. [DOI: 10.1016/
j.metabol.2009.07.008]
∗ Stefanick ML, Mackey S, Sheehan RD, Ellsworth N,
Haskell WL, Wood PD. Effects of diet and exercise in
men and postmenopausal women with low levels of HDL
cholesterol and high levels of LDL cholesterol. New England
Journal of Medicine 1998;339(1):12–20.
DEER 1998 exercise women {published data only}
Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR.
Metabolic syndrome and changes in body fat from a low-
fat diet and/or exercise randomized controlled trial. Obesity
2010;18(3):548–54. [DOI: 10.1038/oby.2009.304]
Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes
in C-reactive protein from low-fat diet and/or physical
activity in men and women with and without metabolic
syndrome. Metabolism 2010;59(1):54–61. [DOI: 10.1016/
j.metabol.2009.07.008]
∗ Stefanick ML, Mackey S, Sheehan RD, Ellsworth N,
Haskell WL, Wood PD. Effects of diet and exercise in
men and postmenopausal women with low levels of HDL
21Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
cholesterol and high levels of LDL cholesterol. New England
Journal of Medicine 1998;339(1):12–20.
DEER1998no exercisemen {published data only (unpublished sought
but not used)}
Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR.
Metabolic syndrome and changes in body fat from a low-
fat diet and/or exercise randomized controlled trial. Obesity
2010;18(3):548–54. [DOI: 10.1038/oby.2009.304]
Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes
in C-reactive protein from low-fat diet and/or physical
activity in men and women with and without metabolic
syndrome. Metabolism 2010;59(1):54–61. [DOI: 10.1016/
j.metabol.2009.07.008]
∗ Stefanick ML, Mackey S, Sheehan RD, Ellsworth N,
Haskell WL, Wood PD. Effects of diet and exercise in
men and postmenopausal women with low levels of HDL
cholesterol and high levels of LDL cholesterol. New England
Journal of Medicine 1998;339(1):12–20.
DEER 1998 no exercise wom {published data only}
Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR.
Metabolic syndrome and changes in body fat from a low-
fat diet and/or exercise randomized controlled trial. Obesity
2010;18(3):548–54. [DOI: 10.1038/oby.2009.304]
Camhi SM, Stefanick ML, Ridker PM, Young DR. Changes
in C-reactive protein from low-fat diet and/or physical
activity in men and women with and without metabolic
syndrome. Metabolism 2010;59(1):54–61. [DOI: 10.1016/
j.metabol.2009.07.008]
∗ Stefanick ML, Mackey S, Sheehan RD, Ellsworth N,
Haskell WL, Wood PD. Effects of diet and exercise in
men and postmenopausal women with low levels of HDL
cholesterol and high levels of LDL cholesterol. New England
Journal of Medicine 1998;339(1):12–20.
Diet and Hormone Study 2003 {published data only (unpublished
sought but not used)}
Gann PH, Chatterton RT, Gapstur SM, Liu K, Garside
D, Giovannazzi S, et al. The effects of a low-fat/high-
fiber diet on sex hormone levels and menstrual cycling in
premenopausal women: a 12-month randomized trial (the
Diet and Hormone Study). Cancer 2003;98:1870–9.
Kentucky Low Fat 1990 {published and unpublished data}
Anderson JW, Garrity TF, Smith BM, Whitis SE. Follow-up
on a clinical trial comparing the effects of two lipid lowering
diets. Arteriosclerosis 1990;10(5):882a.
Anderson JW, Garrity TF, Wood CL, Whitis SE, Smith
BM, Oeltgen PR. Prospective, randomized, controlled
comparison of the effects of low-fat and low-fat plus high-
fiber diets on serum lipid concentrations. American Journal
of Clinical Nutrition 1992;56(5):887–94.
Kuopio Reduced & Mod 1993 {published and unpublished data}
Makinen E, Uusitupa MI, Pietinen P, Aro A, Penttila I.
Long term effects of three fat modified diets on serum lipids
in free living hypercholesterolaemic subjects (abstract).
European Heart Journal 1991;12:162.
∗ Sarkkinen E. Long-term feasibility and effects of three
different fat-modified diets in free-living hypercholesterolemic
subjects [PhD Thesis]. Department of Clinical Nutrition,
Faculty of Medicine, University of Kuopio, 1995.
Sarkkinen ES, Agren JJ, Ahola I, Ovaskainen ML, Uusitupa
MI. Fatty acid composition of serum cholesterol esters, and
erythrocyte and platelet membranes as indicators of long-
term adherence to fat-modified diets. American Journal of
Clinical Nutrition 1994;59(2):364–70.
Sarkkinen ES, Uusitupa MI, Nyyssonen K, Parviainen
M, Penttila I, Salonen JT. Effects of two low-fat diets,
high and low in polyunsaturated fatty acids, on plasma
lipid peroxides and serum vitamin E levels in free-living
hypercholesterolaemic men. European Journal of Clinical
Nutrition 1993;47(9):623–30.
Sarkkinen ES, Uusitupa MI, Pietinen P, Aro A, Ahola I,
Penttila I, et al. Long-term effects of three fat-modified
diets in hypercholesterolemic subjects. Atherosclerosis 1994;
105(1):9–23.
Uusitupa MI, Sarkkinen ES, Torpstrom J, Pietinen P, Aro
A. Long-term effects of four fat-modified diets on blood
pressure. Journal of Human Hypertension 1994;8(3):209–18.
Kuopio Reduced Fat 1993 {published and unpublished data}
Makinen E, Uusitupa MI, Pietinen P, Aro A, Penttila I.
Long term effects of three fat modified diets on serum lipids
in free living hypercholesterolaemic subjects (abstract).
European Heart Journal 1991;12:162.
∗ Sarkkinen E. Long-term feasibility and effects of three
different fat-modified diets in free-living hypercholesterolemic
subjects [PhD Thesis]. Department of Clinical Nutrition,
Faculty of Medicine, University of Kuopio, 1995.
Sarkkinen ES, Agren JJ, Ahola I, Ovaskainen ML, Uusitupa
MI. Fatty acid composition of serum cholesterol esters, and
erythrocyte and platelet membranes as indicators of long-
term adherence to fat-modified diets. American Journal of
Clinical Nutrition 1994;59(2):364–70.
Sarkkinen ES, Uusitupa MI, Nyyssonen K, Parviainen
M, Penttila I, Salonen JT. Effects of two low-fat diets,
high and low in polyunsaturated fatty acids, on plasma
lipid peroxides and serum vitamin E levels in free-living
hypercholesterolaemic men. European Journal of Clinical
Nutrition 1993;47(9):623–30.
Sarkkinen ES, Uusitupa MI, Pietinen P, Aro A, Ahola I,
Penttila I, et al. Long-term effects of three fat-modified
diets in hypercholesterolemic subjects. Atherosclerosis 1994;
105(1):9–23.
Uusitupa MI, Sarkkinen ES, Torpstrom J, Pietinen P, Aro
A. Long-term effects of four fat-modified diets on blood
pressure. Journal of Human Hypertension 1994;8(3):209–18.
Mastopathy Diet 1988 {published and unpublished data}
∗ Boyd NF, McGuire V, Shannon P, Cousins M, Kriukov V,
Mahoney L, et al. Effect of a low-fat high-carbohydrate diet
on symptoms of cyclical mastopathy. Lancet 1988;2(8603):
128–32.
MeDiet 2006 {published and unpublished data}
Carruba G, Granata OM, Pala V, Campisi I, Agostara
B, Cusimano R, et al. A traditional Mediterranean diet
22Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
decreases endogenous estrogens in healthy postmenopausal
women. Nutrition and Cancer 2006;56(2):253–9.
∗ Castagnetta L, Granata OM, Cusimano R, Ravazzolo B,
Liquori M, Polito L, et al. The Mediet Project. Annals of
the New York Academy of Science 2002;963:282–9.
Granata OM, Traina A, Ramirez S, Campisi I, Zarcone M,
Amodio R, et al. Dietary enterolactone affects androgen and
estrogen levels in healthy postmenopausal women. Annals
of the New York Academy of Science 2009;1155:232–6.
Moy 2001 {published and unpublished data}
Moy TF, Yanek LR, Raqueno JV, Bezirdjian PJ, Blumenthal
RS, Wilder LB, et al. Dietary counseling for high blood
cholesterol in families at risk of coronary disease. Preventive
Cardiology 2001;4(4):158–64.
MSFAT 1995 {published and unpublished data}
Velthuis-te WE, van Leeuwen REW, Hendriks HF, Verhagen
H, Loft S, Poulsen HE, et al. Short-term moderate energy
restriction does not affect indicators of oxidative stress and
genotoxicity in humans. Journal of Nutrition 1995;125:
2631–9.
Velthuis-te Wierik EJ, van den Berg H, Weststrate JA, van
het Hof KH, de Graaf C. Consumption of reduced-fat
products: effects on parameters of anti-oxidative capacity.
European Journal of Clinical Nutrition 1996;50(4):214–9.
Weststrate JA, van het Hof KH, van den Berg H, Velthuis-te
WE, de Graaf C, Zimmermanns NJ, et al. A comparison of
the effect of free access to reduced fat products or their full
fat equivalents on food intake, body weight, blood lipids
and fat-soluble antioxidants levels and haemostasis variables.
European Journal of Clinical Nutrition 1998;52:389–95.
∗ van het Hof KH, Weststrate JA, van den Berg H, Velthuis-
te Wierik EJ, de Graaf C, Zimmermanns NJ, at al. A long-
term study on the effect of spontaneous consumption of
reduced fat products as part of a normal diet on indicators of
health. International Journal of Food Sciences and Nutrition
1997;48(1):19–29.
NDHS Open 1st L&M 1968 {published data only}
Anon. The National Diet-Heart Study. Nutrition Reviews
1968;26(5):133–6.
Baker BM, Frantz ID Jr, Keys A, Kinsell LW, Page IH,
Stamler J, et al. The National Diet-Heart Study: an initial
report. JAMA 1963;185:105–6.
Brown HB. The National Diet Heart Study - implications
for dietitians and nutritionists. Journal of the American
Dietetic Association 1968;52:279–87.
NDHS. The national diet-heart study final report.
Circulation 1968;37(II):1–428.
Page IH, Brown HB. Some observations on the National
Diet-Heart Study. Circulation 1968;37:313–5.
NDHS Open 2nd L&M 1968 {published data only}
Anon. The National Diet-Heart Study. Nutrition Reviews
1968;26(5):133–6.
Baker BM, Frantz ID Jr, Keys A, Kinsell LW, Page IH,
Stamler J, et al. The National Diet-Heart Study: an initial
report. JAMA 1963;185:105–6.
Brown HB. The National Diet Heart Study - implications
for dietitians and nutritionists. Journal of the American
Dietetic Association 1968;52:279–87.
∗ NDHS. The national diet-heart study final report.
Circulation 1968;37(II):1–428.
Page IH, Brown HB. Some observations on the National
Diet-Heart Study. Circulation 1968;37:313–5.
Nutrition & Breast Health {published and unpublished data}
Djuric Z, Poore KM, Depper JB, Uhley VE, Lababidi S,
Covington C, et al. Methods to increase fruit and vegetable
intake with and without a decrease in fat intake: compliance
and effects on body weight in the Nutrition and Breast
Health Study. Nutrition and Cancer 2002;43(2):141–51.
Pilkington 1960 {published and unpublished data}
Pilkington TRE, Stafford JL, Hankin VS, Simmonds FM,
Koerselman HB. Practical diets for lowering serum lipids.
British Medical Journal 1960;2 Jan:23–5.
Polyp Prevention 1996 {published and unpublished data}
Lanza E, Schatzkin A, Ballard BR, Clifford DC, Paskett
E, Hayes D, et al. The polyp prevention trial II: dietary
intervention program and participant baseline dietary
characteristics. Cancer Epidemiology, Biomarkers and
Prevention 1996;5(5):385–92.
Schatzkin A, Lanza E, Freedman LS, Tangrea J, Cooper MR,
Marshall JR, et al. The polyp prevention trial I: rationale,
design, recruitment, and baseline participant characteristics.
Cancer Epidemiology, Biomarkers and Prevention 1996;5(5):
375–83.
Rivellese 1994 {published and unpublished data}
Rivellese AA, Auletta P, Marotta G, Saldalamacchia G,
Giacoo A, Mastrilli V, et al. Long term metabolic effects
of two dietary methods of treating hyperlipidaemia. BMJ
1994;308:227–31.
Simon Low Fat Breast CA {published and unpublished data}
Djuric Z, Heilbrun LK, Reading BA, Boomer A, Valeriote
FA, Martino S. Effects of a low fat diet on levels of oxidative
damage to DNA in human peripheral nucleated blood cells.
Journal of the National Cancer Institute 1991;83(11):766–9.
Djuric Z, Martino S, Heilbrun LK, Hart RW. Dietary
modulation of oxidative DNA damage. Advances In
Experimental Medicine and Biology 1994;354:71–83.
Kasim SE, Martino S, Kim P-N, Khilnani S, Boomer A,
Depper J, et al. Dietary and anthropometric determinants
of plasma lipoproteins during a long-term low-fat diet in
healthy women. American Journal of Clinical Nutrition
1993;57:146–53.
∗ Simon MS, Heilbrun LK, Boomer A, Kresge C, Depper
J, Kim PN, et al. A randomised trial of a low-fat dietary
intervention in women at high risk for breast cancer.
Nutrition and Cancer 1997;27(2):136–42.
Sondergaard 2003 {published and unpublished data}
Sondergaard E, Moller JE, Egstrup K. Effect of dietary
intervention and lipid-lowering treatment on brachial
vasoreactivity in patients with ischemic heart disease and
hypercholesterolemia. American Heart Journal 2003;145
(5):E19.
23Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Strychar 2009 {published and unpublished data}
Strychar I, Cohn JS, Renier G, Rivard M, Aris-Jilwan
N, Beauregard H, et al. Effects of a diet higher in
carbohydrate/lower in fat versus lower in carbohydrate/
higher in monounsaturated fat on postmeal triglyceride
concentrations and other cardiovascular risk factors in type
1 diabetes. Diabetes Care 2009;32(9):1597–9.
Swedish Breast CA 1990 {published data only (unpublished sought
but not used)}
Holm LE, Nordevang E, Ikkala E, Hallstrom L, Callmer E.
Dietary intervention as adjuvant therapy in breast cancer
patients--a feasibility study. Breast Cancer Research and
Treatment 1990;16(2):103–9.
Nordevang E, Callmer E, Marmur A, Holm LE. Dietary
intervention in breast cancer patients: effects on food
choice. European Journal of Clinical Nutrition 1992;46(6):
387–96.
Nordevang E, Ikkala E, Callmer E, Hallstrom L, Holm
LE. Dietary intervention in breast cancer patients: effects
on dietary habits and nutrient intake. European Journal of
Clinical Nutrition 1990;44(9):681–7.
Veterans Dermatology 1994 {published and unpublished data}
∗ Black HS, Herd JA, Goldberg LH, Wolf-JE J, Thornby JI,
Rosen T, et al. Effect of a low-fat diet on the incidence of
actinic keratosis. New England Journal of Medicine 1994;
330(18):1272–5.
Black HS, Thornby JI, Wolf-JE J, Goldberg LH, Herd JA,
Rosen T, et al. Evidence that a low-fat diet reduces the
occurrence of non-melanoma skin cancer. International
Journal of Cancer 1995;62(2):165–9.
Jaax S, Scott LW, Wolf-JE J, Thornby JI, Black HS. General
guidelines for a low-fat diet effective in the management
and prevention of nonmelanoma skin cancer. Nutrition and
Cancer 1997;27(2):150–6.
VYRONAS 2009 {published data only}
∗ Mihas C, Mariolis A, Manios Y, Naska A, Arapaki A,
Mariolis-Sapsakos T, et al. Evaluation of a nutrition
intervention in adolescents of an urban area in Greece:
short- and long-term effects of the VYRONAS study. Public
Health Nutrition 2010;13(5):712–9. [DOI: 10.1017/
S1368980009991625]
WHEL 2007 {published data only}
Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-
Israel S, Natarajan L, et al. The relative importance of
specific risk factors for insomnia in women treated for early-
stage breast cancer. Psycho-Oncology 2008;17(1):9–18.
Caan BJ, Flatt SW, Rock CL, Ritenbaugh C, Newman V,
Pierce JP, et al. Low-energy reporting in women at risk
for breast cancer recurrence. Women’s Healthy Eating
and Living Group. Cancer Epidemiology, Biomarkers &
Prevention 2000;9(10):1091–7.
Gold EB, Flatt SW, Pierce JP, Bardwell WA, Hajek
RA, Newman VA, et al. Dietary factors and vasomotor
symptoms in breast cancer survivors: the WHEL Study.
Menopause 2006;13(3):423–33.
Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin
GA, Caan BJ, et al. Dietary pattern influences breast cancer
prognosis in women without hot flashes: the women’s
healthy eating and living trial. Journal of Clinical Oncology
2009;27(3):352–9.
Hernandez-Valero MA, Thomson CA, Hernandez M, Tran
T, Detry MA, Theriault RL, et al. Comparison of baseline
dietary intake of Hispanic and matched non-Hispanic white
breast cancer survivors enrolled in the Women’s Healthy
Eating and Living study. Journal of the American Dietetic
Association 2008;108(8):1323–9.
Hong S, Bardwell WA, Natarajan L, Flatt SW, Rock CL,
Newman VA, et al. Correlates of physical activity level
in breast cancer survivors participating in the Women’s
Healthy Eating and Living (WHEL) Study. Breast Cancer
Research & Treatment 2007;101(2):225–32.
Hyder JA, Thomson CA, Natarajan L, Madlensky L, Pu
M, Emond J, et al. Adopting a plant-based diet minimally
increased food costs in WHEL Study. American Journal of
Health Behavior 2009;33(5):530–9.
Madlensky L, Natarajan L, Flatt SW, Faerber S, Newman
VA, Pierce JP, et al. Timing of dietary change in response
to a telephone counseling intervention: evidence from the
WHEL study. Health Psychology 2008;27(5):539–47.
Mortimer JE, Flatt SW, Parker BA, Gold EB, Wasserman L,
Natarajan L, et al. Tamoxifen, hot flashes and recurrence in
breast cancer. Breast Cancer Research & Treatment 2008;108
(3):421–6.
Newman VA, Thomson CA, Rock CL, Flatt SW, Kealey S,
Bardwell WA, et al. Achieving substantial changes in eating
behavior among women previously treated for breast cancer-
-an overview of the intervention. Journal of the American
Dietetic Association 2005;105(3):382–91.
Pierce JP, Faerber S, Wright FA, Rock CL, Newman V,
Flatt SW, et al. A randomized trial of the effect of a plant-
based dietary pattern on additional breast cancer events and
survival: the Women’s Healthy Eating and Living (WHEL)
Study. Controlled Clinical Trials 2002;23(6):728–56.
Pierce JP, Natarajan L, Caan BJ, Flatt SW, Kealey S, Gold
EB, et al. Dietary change and reduced breast cancer events
among women without hot flashes after treatment of early-
stage breast cancer: subgroup analysis of the Women’s
Healthy Eating and Living Study. American Journal of
Clinical Nutrition 2009;89(5):1565S–71S.
Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER,
Flatt SW, et al. Influence of a diet very high in vegetables,
fruit, and fiber and low in fat on prognosis following
treatment for breast cancer: the Women’s Healthy Eating
and Living (WHEL) randomized trial. JAMA 2007;298(3):
289–98.
Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER,
Flatt SW, et al. Influence of a diet very high in vegetables,
fruit, and fiber and low in fat on prognosis following
treatment for breast cancer: the Women’s Healthy Eating
and Living (WHEL) randomized trial. [see comment].
JAMA 2007;298(3):289–98.
Pierce JP, Natarajan L, Sun S, Al-Delaimy W, Flatt
SW, Kealey S, et al. Increases in plasma carotenoid
concentrations in response to a major dietary change
24Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in the women’s healthy eating and living study. Cancer
Epidemiology, Biomarkers & Prevention 2006;15(10):
1886–92.
Pierce JP, Newman VA, Flatt SW, Faerber S, Rock CL,
Natarajan L, et al. Telephone counseling intervention
increases intakes of micronutrient- and phytochemical-rich
vegetables, fruit and fiber in breast cancer survivors. Journal
of Nutrition 2004;134(2):452–8.
Pierce JP, Pierce John P. Diet and breast cancer prognosis:
making sense of the Women’s Healthy Eating and Living
and Women’s Intervention Nutrition Study trials. [Review]
[33 refs]. Current Opinion in Obstetrics & Gynecology 2009;
21(1):86–91.
Pierce JPF. A randomized trial of the effect of a plant-
based dietary pattern on additional breast cancer events and
survival: The Women’s Healthy Eating and Living (WHEL)
Study. Controlled Clinical Trials 2002;23(6):728–56.
Rock CL, Flatt SW, Laughlin GA, Gold EB, Thomson CA,
Natarajan L, et al. Reproductive steroid hormones and
recurrence-free survival in women with a history of breast
cancer. Cancer Epidemiology, Biomarkers & Prevention 2008;
17(3):614–20.
Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN,
Stefanick ML, et al. Factors associated with weight gain in
women after diagnosis of breast cancer. Women’s Healthy
Eating and Living Study Group. Journal of the American
Dietetic Association 1999;99(10):1212–21.
Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman
VA, Jones L, et al. Plasma triacylglycerol and HDL
cholesterol concentrations confirm self-reported changes in
carbohydrate and fat intakes in women in a diet intervention
trial. Journal of Nutrition 2004;134(2):342–7.
Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman
VA, Jones L, et al. Plasma triacylglycerol and HDL
cholesterol concentrations confirm self-reported changes in
carbohydrate and fat intakes in women in a diet intervention
trial. Journal of Nutrition 2004;134(2):342–7.
Rock CL, Natarajan L, PuM, Thomson CA, Flatt SW, Caan
BJ, et al. Longitudinal biological exposure to carotenoids is
associated with breast cancer-free survival in the Women’s
Healthy Eating and Living Study. Cancer Epidemiology,
Biomarkers & Prevention 2009;18(2):486–94.
Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell
WA, Caan B, et al. Weight gain and recovery of pre-cancer
weight after breast cancer treatments: evidence from the
women’s healthy eating and living (WHEL) study. Breast
Cancer Research & Treatment 2007;105(2):177–86.
Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL,
Pierce JP, et al. Disclosure to physicians of CAM use by
breast cancer patients: findings from the Women’s Healthy
Eating and Living Study. Integrative Cancer Therapies 2008;
7(3):122–9.
WHI 2006 {published data only}
Anderson G, Cummings S, Freedman LS, Furberg C,
Henderson M, Johnson SR, et al. Design of the Women’s
Health Initiative clinical trial and observational study.
Controlled Clinical Trials 1998;19(1):61–109.
Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis
S, et al. Implementation of the Women’s Health Initiative
study design. Annals of Epidemiology 2003;13(9 Suppl):
S5–17.
Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL,
Snetselaar LG, Black HR, et al. Low-fat dietary pattern and
risk of colorectal cancer: the Women’s Health Initiative
Randomized Controlled Dietary Modification Trial. JAMA
2006;295(6):643–54.
Bowen D, Ehret C, Pedersen M, Snetselaar L, Johnson M,
Tinker L, et al. Results of an adjunct dietary intervention
program in the Women’s Health Initiative. Journal of the
American Dietetic Association 2002;102(11):1631–7.
Curb JD, McTiernan A, Heckbert SR, Kooperberg C,
Stanford J, Nevitt M, et al. Outcomes ascertainment and
adjudication methods in the Women’s Health Initiative.
Annals of Epidemiology 2003;13(9 Suppl):S122–8.
Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M,
Allen C, et al. The Women’s Health Initiative recruitment
methods and results. Annals of Epidemiology 2003;13(9
Suppl):S18–77.
Hebert JR, Patterson RE, Gorfine M, Ebbeling CB, St Jeor
ST, Chlebowski RT, et al. Differences between estimated
caloric requirements and self-reported caloric intake in the
women’s health initiative. Annals of Epidemiology 2003;13
(9):629–37.
Howard BV. Dietary fat and cardiovascular disease: putting
the Women’s Health Initiative in perspective. Nutrition
Metabolism & Cardiovascular Diseases 2007;17(3):171–4.
Howard BV, Curb JD, Eaton CB, Kooperberg C, Ockene J,
Kostis JB, et al. Low-fat dietary pattern and lipoprotein risk
factors: the Women’s Health Initiative Dietary Modification
Trial. American Journal of Clinical Nutrition 2010;91:
860–74.
Howard BV, Manson JE, Stefanick ML, Beresford SA,
Frank G, Jones B, et al. Low-fat dietary pattern and weight
change over 7 years: the Women’s Health Initiative Dietary
Modification Trial. JAMA 2006;295(1):39–49.
∗ Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick
ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern
and risk of cardiovascular disease: the Women’s Health
Initiative Randomized Controlled Dietary Modification
Trial. JAMA 2006;295(6):655–66.
Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham
SA, Horn LV, et al. Use of recovery biomarkers to calibrate
nutrient consumption self-reports in the Women’s Health
Initiative. American Journal of Epidemiology 2008;167(10):
1247–59.
Patterson RE, Kristal A, Rodabough R, Caan B, Lillington
L, Mossavar-Rahmani Y, et al. Changes in food sources
of dietary fat in response to an intensive low-fat dietary
intervention: early results from the Women’s Health
Initiative. Journal of the American Dietetic Association 2003;
103(4):454–60.
Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP,
Agurs-Collins T, et al. Measurement characteristics of the
25Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Women’s Health Initiative food frequency questionnaire.
Annals of Epidemiology 1999;9(3):178–87.
Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller
LH, Ockene JK, et al. Low-fat dietary pattern and risk
of invasive breast cancer: the Women’s Health Initiative
Randomized Controlled Dietary Modification Trial. JAMA
2006;295(6):629–42.
Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson
GL, Beresford SA, et al. Low-fat dietary pattern and
cancer incidence in the Women’s Health Initiative Dietary
Modification Randomized Controlled Trial. Journal of the
National Cancer Institute 2007;99(20):1534–43.
Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B,
Fels-Tinker L, Howard B, et al. The Women’s Health
Initiative Dietary Modification trial: overview and baseline
characteristics of participants. Annals of Epidemiology 2003;
13(9 Suppl):S87–97.
Rossouw JE, Finnegan LP, Harlan WR, Pinn VW, Clifford
C, McGowan JA. The evolution of the Women’s Health
Initiative: perspectives from the NIH. Journal of the
American Medical Women’s Association 1995;50(2):50–5.
The Women’s Health Initiative Study Group. Design of the
Women’s Health Initiative clinical trial and observational
study. Controlled Clinical Trials 1998;19(1):61–109.
Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard
BV, Larson J, et al. Low-fat dietary pattern and risk of
treated diabetes mellitus in postmenopausal women: the
Women’s Health Initiative randomized controlled dietary
modification trial. Archives of Internal Medicine 2008;168
(14):1500–11.
Tinker LF, Perri MG, Patterson RE, Bowen DJ, McIntosh
M, Parker LM, et al. The effects of physical and emotional
status on adherence to a low-fat dietary pattern in the
Women’s Health Initiative. Journal of the American Dietetic
Association 2002;102(6):789–800.
Tinker LF, Rosal MC, Young AF, Perri MG, Patterson
RE, Van Horn L, et al. Predictors of dietary change and
maintenance in the Women’s Health Initiative Dietary
Modification Trial. Journal of the American Dietetic
Association 2007;107(7):1155–66.
Women’s Health Initiative Study Group. Dietary adherence
in the Women’s Health Initiative Dietary Modification
Trial. Journal of the American Dietetic Association 2004;104
(4):654–8.
WHT:FSMP 2003 {published and unpublished data}
∗ Hall WD, Feng Z, George VA, Lewis CE, Oberman A,
Huber M, et al for the WHT:FSMP. Low-fat diet: effect on
anthropometrics, blood pressure, glucose and insulin in
older women. Ethnicity and Disease 2003;13:337–43.
WHT Feasibility 1990 {published and unpublished data}
Bowen D, Clifford CK, Coates R, Evans M, Feng Z, Fouad
M, et al. The Women’s Health Trial Feasibility Study in
Minority Populations: design and baseline descriptions.
Annals of Epidemiology 1996;6(6):507–19.
Hall WD, Feng Z, George VA, Lewis CE, Oberman A,
Huber M, et al. Low-fat diet: effect on anthropometrics,
blood pressure, glucose, and insulin in older women.
Ethnicity and Disease 2003;13:337–43.
WINS 1993 {published and unpublished data}
Chlebowski RT, Blackburn GL, Buzzard IM, Rose DP,
Martino S, Khandekar JD, et al. Adherence to a dietary
fat intake reduction program in postmenopausal women
receiving therapy for early breast cancer. The Women’s
Intervention Nutrition Study. Journal of Clinical Oncology
1993;11(11):2072–80.
Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW,
Shapiro A, Hoy MK, et al. Dietary fat reduction and breast
cancer outcome: interim efficacy results from the Women’s
Intervention Nutrition Study. JNCI Journal of the National
Cancer Institute 2006;98(24):1767–76.
Chlebowski RT, Rose DP, Buzzard IM, Blackburn GL, York
M, Insull W, et al. Dietary fat reduction in adjuvant breast
cancer therapy: current rationale and feasibility issues.
Adjuvant Ther Cancer 1990;6:357–63.
Hoy MK, Winters BL, Chlebowski RT, Papoutsakis C,
Shapiro A, Lubin MP, et al. Implementing a low-fat eating
plan in the Women’s Intervention Nutrition Study. Journal
of the American Dietetic Association 2009;109(4):688–96.
Rose DP, Chlebowski RT, Connolly JM, Jones LA, Wynder
EL. Effects of tamoxifen adjuvant therapy and a low-fat
diet on serum binding proteins and estradiol bioavailability
in postmenopausal breast cancer patients. Cancer Research
1992;52:5386–90.
Rose DP, Connolly JM, Chlebowski RT, Buzzard IM,
Wynder EL. The effects of a low-fat dietary intervention
and tamoxifen adjuvant therapy on the serum estrogen
and sex hormone-binding globulin concentrations of
postmenopausal breast cancer patients. Breast Cancer
Research & Treatment 1993;27(3):253–62.
Wynder EL, Cohen LA, Winters BL. The challenges of
assessing fat intake in cancer research investigations. Journal
of the American Dietetic Association 1997;97(7 Suppl):
S5–S8.
References to studies excluded from this review
Agewall 2001 {published data only}
Agewall S. Multiple risk intervention trial in high risk
hypertensive men: comparison of ultrasound intima-media
thickness and clinical outcome during 6 years of follow-up.
Journal of Internal Medicine 2001;249(4):305–14.
Ammerman 2003 {published data only}
Ammerman AS, Keyserling TC, Atwood JR, Hosking JD,
Zayed H, Krasny C. A randomized controlled trial of a
public health nurse directed treatment program for rural
patients with high blood cholesterol. Preventive Medicine
2003;36(3):340–51.
Anti-Coronary C 1966 {published data only}
Christakis G, Rinzler SH, Archer M, Kraus A. Effect of the
Anti-Coronary Club Program on coronary heart disease risk
factor status. JAMA 1969;198:129–36.
Christakis G, Rinzler SH, Archer M, Maslansky E.
Summary of the research activities of the Anti-Coronary
26Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Club. Public Health Reports (Washington) 1966;81:64–70.
Jolliffe N, Baumgarter L, Rinzler SH, ArcherM, Stephenson
JH, Christakis GJ. The Anti-Coronary Club: the first four
years. New York State Journal of Medicine 1963;63:69–79.
Singman HS, Berman SN, Cowell C, Maslansky E, Archer
M. The Anti-Coronary Club: 1957-1972. American Journal
of Clinical Nutrition 1980;33(6):1183–91.
Aquilani 2000 {published data only}
Aquilani R, Tramarin R, Pedretti RFE, Bertolotti G,
Sommaruga M, Mariani P, et al. Can a very-low-fat diet
achieve cholesterol goals in CAD?. Cardiology Review 2000;
17(10):36–40.
Arne 2014 {published data only}
∗ Arne A. Diet in the role of prevention and management
of obesity: from caloric restriction to optimized diet
composition. Obesity Reviews 2014;15(Suppl S2):PL01.
Arntzenius 1985 {published data only}
∗ Arntzenius AC, Kromhout D, Bartn JE, Reiber JHC,
Bruschke AVG, Buis Van Gent CM. Diet, lipoprotiens
and progression of coronary atherosclerosis: the Leiden
intervention trial. New England Journal of Medicine 1985;
312:805–8.
Aro 1990 {published data only}
∗ Aro A, Ahola I, Jauhiainen M, et al. Effects of plasma
phospholipid fatty acids of rapeseed oil and sunflower oil
diets [Abstract]. Arteriosclerosis 1990;10:877a.
ASSIST 2001 {published data only}
Moher M, Yudkin P,Wright L, Turner R, Fuller A, Schofield
T, et al. Cluster randomised controlled trial to compare
three methods of promoting secondary prevention of
coronary heart disease in primary care. BMJ 2001;322
(7298):1338.
Australian Polyp Prev {published and unpublished data}
MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P,
Gratten H, et al. Randomized trial of intake of fat, fiber,
and beta carotene to prevent colorectal adenomas. The
Australian Polyp Prevention Project. Journal of the National
Cancer Institute 1995;87(23):1760–6.
MacLennan R, et al. Effect of fat, fibre and beta-carotene
on colorectal adenomas after 24 months. Gastroenterology
1991;100:A382.
Macrae FA, Hughes NR, Bhathal PS, Tay D, Selbie L,
MacLennan R. Dietary suppression of rectal epthelial cell
proliferation. Gastroenterology 1991;100:A383.
Baer 1993 {published data only}
∗ Baer JT. Improved plasma cholesterol levels in men after a
nutrition education program at the worksite. Journal of the
American Dietetic Association 1993;93(6):658–63.
Bakx 1997 {published data only}
∗ Bakx JC, Stafleu A, van SW, van-den HH, van WC. Long-
term effect of nutritional counseling: a study in family
medicine. American Journal of Clinical Nutrition 1997;65(6
Suppl):1946S–50S.
Barnard 2009 {published data only}
Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy
G, Gloede L, Green A, et al. A low-fat vegan diet and
a conventional diabetes diet in the treatment of type
2 diabetes: a randomized, controlled, 74-wk clinical
trial. American Journal of Clinical Nutrition 2009;89(5):
1588S–96S.
Barndt 1977 {published data only}
∗ Barndt R, Blankenhorn CH, Crawford DW, et al.
Regression and progression of early femoral atherosclerosis
in treated hyperlipidaemic patients. Annals of Internal
Medicine 1977;86:139–46.
Baron 1990 {published data only}
∗ Baron JA, Gleason R, Crowe B, Mann JI. Preliminary trial
of the effect of general practice based nutritional advice.
British Journal of General Practice 1990;40(333):137–41.
Barr 1990 {published data only}
∗ Barr SL, Ramakrishnan R, Holleran S, et al. A 30%
fat diet high in polyunsaturates and a 30% fat diet high
in monounsaturates both lower total and low density
lipoprotein cholesterol levels in normal males [Abstract].
Arteriosclerosis 1990;10:872a.
Baumann 1982 {published data only}
∗ Baumann J, Martschick R. Therapy of hyperlipidemia
with xanthinol nicotinate as opposed to low fat diet
[Therapie der Hyperlipidamie mit Xantinolnicotinat
gegenuber fettarmer Diat]. Die Medizinische Welt 1982;33
(4):139–41.
Bazzano 2012 {published data only}
∗ Bazzano LA, Hu T, Reynolds K, Yao L, Bunol C, Liu
Y, et al. Effects of low-carbohydrate and low-fat diets: a
randomized trial. Annals of Internal Medicine 2014;161(5):
309–18. [10.7326/P14–9029; PMID: 25178581]]
Bazzano LAR. Effect of a low-carbohydrate diet on weight
and cardiovascular risk factors: a randomized controlled
trial. Circulation 2012;125:AP306.
Beckmann 1988 {published data only}
∗ Beckmann SL, Os I, Kjeldsen SE, Mogensen B, Norum
KR, Hjermann I. Non-pharmacological treatment of mild
to moderate hypertension. A randomized, controlled
study--results 1 1/2 years later. Tidsskrift For Den Norske
Laegeforening 1988;108:1593–7.
Beckmann 1995 {published data only}
∗ Beckmann SL, Os I, Kjeldsen SE, Eide IK, Westheim AS,
Hjermann I. Effect of dietary counselling on blood pressure
and arterial plasma catecholamines in primary hypertension.
American Journal of Hypertension 1995;8(7):704–11.
Beresford 1992 {published data only}
∗ Beresford SAA, Farmer EMZ, Feingold L, Graves KL,
Sumner SK, Baker RM. Evaluation of a self-help dietary
intervention in a primary care setting. American Journal of
Public Health 1992;82:79–84.
Bergstrom 1967 {published data only}
∗ Bergstrom G, Svanborg A. Dietary treatment of acute
myocardial infarction. Acta Medica Scandinavica 1967;181
(6):717–21.
Bierenbaum 1963 {published data only}
Bierenbaum ML, Fleischman AI, Raichelson RI, Hayton
T, Watson P. Ten year experience of modified fat diets on
27Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
younger men with coronary heart disease. Lancet 1973;i:
1404–7.
Bierenbaum ML, Green DP, Florin A, Fleischman AI,
Caldwell AB. Modified-fat dietary management of the
young male with coronary disease. A five-year report.
JAMA 1967;202(13):1119–23.
∗ Bierenbaum ML, Green DP, Gherman C, Florin A,
Caldwell AB. The effects of two low fat dietary patterns on
the blood cholesterol levels of young male coronary patients.
Journal of Chronic Diseases 1963;16:1073–83.
Bloomgarden 1987 {published data only}
∗ Bloomgarden ZT, Karmally W, Metzger MJ, Brothers M,
Nechemias C, Bookman J, et al. Randomized, controlled
trial of diabetic patient education: improved knowledge
without improved metabolic status. Diabetes Care 1987;10:
263–72.
Bonnema 1995 {published data only}
∗ Bonnema SJ, Jespersen LT, Marving J, Gregersen G.
Supplementation with olive oil rather than fish oil increases
small arterial compliance in diabetic patients. Diabetes,
Nutrition and Metabolism Clinical and Experimental 1995;8:
81–7.
Bosaeus 1992 {published data only}
∗ Bosaeus I, Belfrage L, Lindgren C, Andersson H. Olive oil
instead of butter increases net cholesterol excretion from the
small bowel. European Journal of Clinical Nutrition 1992;46
(2):111–5.
Boyar 1988 {published data only}
∗ Boyar AP, Rose DP, Loughridge JR, Engle A, Palge A,
Laakso K, et al. Response to a diet low in total fat in women
with postmenopausal breast cancer: a pilot study. Nutrition
and Cancer 1988;11:93–9.
Brehm 2009 {published data only (unpublished sought but not used)}
Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist
GM, Jandacek RJ, et al. One-year comparison of a high-
monounsaturated fat diet with a high-carbohydrate diet in
type 2 diabetes. Diabetes Care 2009;32(2):215–20.
Brensike 1982 {published data only}
∗ Brensike JF, Kelsey SF, Passamani ER, Fisher MR,
Richardson JM, Loh IK, et al. National Heart, Lung,
and Blood Institute type II Coronary Intervention Study:
design, methods, and baseline characteristics. Controlled
Clinical Trials 1982;3(2):91–111.
Broekmans 2003 {published and unpublished data}
∗ Broekmans WMR, Klopping-Ketelaars IAA, Weststrate
JA, Tijburg LBM, van Poppel G, Vink AA, et al. Decreased
carotenoid concentrations due to dietary sucrose polyesters
do not affect possible markers of disease risk in humans.
Journal of Nutrition 2003;133:720–6.
Brown 1984 {published data only}
∗ Brown GD, Whyte L, Gee MI, Crockford PM, Grace
M, Oberle K, et al. Effects of two “lipid-lowering” diets
on plasma lipid levels of patients with peripheral vascular
disease. Journal of the American Dietetic Association 1984;84
(5):546–50.
Bruce 1994 {published data only}
∗ Bruce SL, Grove SK. The effect of a coronary artery risk
evaluation program on serum lipid values and cardiovascular
risk levels. Applied Nursing Research 1994;7(2):67–74.
Bruno 1983 {published data only}
∗ Bruno R, Arnold C, Jacobson L, Winick M, Wynder
E. Randomized controlled trial of a nonpharmacologic
cholesterol reduction program at the worksite. Preventive
Medicine 1983;12(4):523–32.
Butcher 1990 {published data only}
∗ Butcher LA, O’Dea K, Sinclair AJ, Parkin JD, Smith IL,
Blombery P. The effects of very low fat diets enriched with
fish or kangaroo meat on cold-induced vasoconstriction and
platelet function. Prostaglandins Leukot Essent. Fatty Acids
1990;39(3):221–6.
Butowski 1998 {published data only}
∗ Butowski PF, Winder AF. Usual care dietary practice,
achievement and implications for medication in the
management of hypercholesterolaemia. European Heart
Journal 1998;19:1328–33.
Byers 1995 {published data only}
∗ Byers T, Mullis R, Anderson J, Dusenbury L, Gorsky
R, Kimber C, et al. The costs and effects of a nutritional
education program following work-site cholesterol
screening. American Journal of Public Health 1995;85(5):
650–5.
Caggiula 1996 {published data only}
∗ Caggiula AW, Watson JE, Kuller LH, Olson MB, Milas
NC, Berry M, et al. Cholesterol-lowering intervention
program. Effect of the step I diet in community office
practices. Archives of Internal Medicine 1996;156(11):
1205–13.
CARMEN 2000 {published and unpublished data}
Poppitt SD, Keogh GF, Prentice AM, Williams DEM,
Sonnemans HMW, Valk EEJ, et al. Long-term effects of
ad libitum low-fat, high-carbohydrate diets on body weight
and serum lipids in overweight subjects with metabolic
syndrome. American Journal of Clinical Nutrition 2002;75:
11–20.
Raben A, Astrup A, Vasilaras TH, Prentice AM, Zunft
H-JF, Formiguera X, et al. The CARMEN study
[CARMEN–studiet]. Ugeskrift fur Laeger 2002;164(5):
627–31.
Saris WHM, Astrup A, Prentice AM, Zunft FJF, Formiguera
X. CARMEN Project: European multicentre study on the
impact of dietary fat/CHO ratio and simple/complex CHO
changes on long term weight control in overweight subjects.
International Journal of Obesity 1997;21(Suppl 2):S71.
∗ Saris WHM, Astrup A, Prentice AM, Zunft HJF,
Formiguera X, Verboeket-van de Venne WPHG, et
al. Randomized controlled trial of changes in dietary
carbohydrate/fat ratio and simple vs complex carbohydrates
on body weight and blood lipids: the CARMEN study.
International Journal of Obesity 2000;24:1310–8.
Vasilaras TH, Astrup A, Raben A. Micronutrient intake in
overweight subjects is not deficient on and ad libitum fat-
28Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
reduced, high-simple carbohydrate diet. European Journal of
Clinical Nutrition 2004;58:326–36.
CARMENMS sub-study {published and unpublished data}
Poppitt SD, Keogh GF, Prentice AM, Williams DEM,
Sonnemans HMW, Valk EEJ, et al. Long-term effects of
ad libitum low-fat, high-carbohydrate diets on body weight
and serum lipids in overweight subjects with metabolic
syndrome. American Journal of Clinical Nutrition 2002;75:
11–20.
Cerin 1993 {published data only}
∗ Cerin A, Collins A, Landgren BM, Eneroth P. Hormonal
and biochemical profiles of premenstrual syndrome.
Treatment with essential fatty acids. Acta Obstetricia et
Gynecologica Scandinavica 1993;72(5):337–43.
Chan 1993 {published data only}
∗ Chan JK, McDonald BE, Gerrard JM, Bruce VM, Weaver
BJ, Holub BJ. Effect of dietary alpha-linolenic acid and its
ratio to linolenic acid on platelet and plasma fatty acids and
thrombogenesis. Lipids 1993;28:811–7.
Chapman 1950 {published data only}
∗ Chapman CB, Gibbons T, Henschel A. The effect of the
rice-fruit diet on the composition of the body. New England
Journal of Medicine 1950;243:899–905.
Charbonnier 1975 {published data only}
∗ Charbonnier A, Nepveux P, Fluteau G, Fluteau D.
Immediate effects of ingestion of olive oil on the principal
lipid constituents of the plasma. Comparison with other
edible fats. Médecine & Chirurgie Digestives 1975;4 Suppl
2:73–9.
Cheng 2004 {published data only}
Cheng C, Graziani C, Diamond JJ, Cheng C, Graziani
C, Diamond JJ. Cholesterol-lowering effect of the Food
for Heart Nutrition Education Program. Journal of the
American Dietetic Association 2004;104(12):1868–72.
Chicago CPEP 1977 {published data only}
∗ Farinaro E, Stamler J, Upton M, Mojonnier L, Hall Y,
Moss D, et al. Plasma glucose levels: long term effect of diet
in the Chicago Coronary Prevention Evaluation Program.
Annals of Internal Medicine 1977;86:147–54.
Chiostri 1988 {published data only}
∗ Chiostri JE, Kwiterovich PO. Effect of American Heart
Association Phase 2 diet versus eater’s choice based diet on
hypercholesterolaemia. Circulation 1988;78(4):II–385.
Choudhury 1984 {published data only}
∗ Choudhury S, Jackson P, Katan MB, Marenah CB,
Cortese C, Miller NE, et al. A multifactorial diet in the
management of hyperlipidaemia. Atherosclerosis 1984;50:
93–103.
Clark 1997 {published data only}
∗ Clark M, Ghandour G, Miller NH, Taylor CB, Bandura
A, DeBusk RF. Development and evaluation of a computer-
based system for dietary management of hyperlipidemia.
Journal of the American Dietetic Association 1997;97(2):
146–50.
Clifton 1992 {published data only}
∗ Clifton PM, Wight MB, Nestel PJ. Is fat restriction
needed with HMGCoA reductase inhibitor treatment?.
Atherosclerosis 1992;93(1-2):59–70.
Cobb 1991 {published data only}
∗ Cobb MM, Teitelbaum HS, Breslow JL. Lovastatin
efficacy in reducing low-density lipoprotein cholesterol
levels on high- vs low-fat diets. JAMA 1991;265(8):
997–1001.
Cohen 1991 {published data only}
∗ Cohen MD, D’Amico FJ, Merenstein JH. Weight
reduction in obese hypertensive patients. Family Medicine
1991;23(1):25–8.
Cole 1988 {published data only}
∗ Cole TG, Schmeisser D, Prewitt TE, et al. AHA phase 3
diet reduces cholesterol in moderately hypercholesterolemic
premenopausal women [Abstract]. Circulation 1988;78(4):
II–73.
Colquhoun 1990 {published data only}
∗ Colquhoun DM, Moores D, Somerset SM. Comparison
of the effects of an avocado enriched and American Heart
Association diets on lipid levels [Abstract]. Arteriosclerosis
1990;10:875a.
Consolazio 1946 {published data only}
∗ Consolazio FC, Forbes WH. The effects of high fat diet
in a temperate environment. Journal of Nutrition 1946;32:
195–204.
Coppell 2010 {published data only}
Coppell KJK. Nutritional intervention in patients with
type 2 diabetes who are hyperglycaemic despite optimised
drug treatment - Lifestyle over and above drugs in diabetes
(LOADD) study: randomised controlled trial. BMJ 2010;
341:237.
Cox 1996 {published data only}
∗ Cox RH, Gonzales-Vigilar MCRV, Novascone MA, Silva-
Barbeau I. Impact of a cancer intervention on diet-related
cardiovascular disease risks of white and African-American
EFNEP clients. Journal of Nutrition Education 1996;28:
209–18.
Croft 1986 {published data only}
∗ Croft PR, Brigg D, Smith S, Harrison CB, Branthwaite
A, Collins MF. How useful is weight reduction in the
management of hypertension?. Journal of the Royal College
of General Practitioners 1986;36(291):445–8.
Crouch 1986 {published data only}
∗ Crouch M, Sallis JF, Farquar JW, Haskell WL,
Ellsworth NM, King AB, et al. Personal and mediated
health counselling for sustained dietary reduction of
hypercholesterolaemia. Preventive Medicine 1986;15:
282–91.
Dalgard 2001 {published data only}
Dalgard C, Thuroe A, Haastrup B, Haghfelt T, Stender S.
Saturated fat intake is reduced in patients with ischemic
heart disease 1 year after comprehensive counseling but
not after brief counseling. Journal of the American Dietetic
Association 2001;101(12):1420–9.
29Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Da Qing IGT 1997 {published data only}
∗ Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX,
et al. Effects of diet and exercise in preventing NIDDM in
people with impaired glucose tolerance. The Da Qing IGT
and Diabetes Study. Diabetes Care 1997;20(4):537–44.
DAS 1989 {published data only}
Bovbjerg VE, McCann BS, Brief DJ, Follette WC, Retzlaff
BM, Dowdy AA, et al. Spouse support and long-term
adherence to lipid-lowering diets. American Journal of
Epidemiology 1995;141(5):451–60.
Knopp RH, Retzlaff B, Walden C, Fish B, Buck B,
McCann B. One-year effects of increasingly fat-restricted,
carbohydrate-enriched diets on lipoprotein levels in free-
living subjects. Proceedings of the Society for Experimental
Biology & Medicine 2000;225(3):191–9.
Knopp RH, Walden CE, McCann BS, Retzlaff B, Dowdy
A, Gey G, et al. Serial changes in lipoprotein cholesterol
in hypercholesterolemic men treated with alternative diets
[abstract]. Arteriosclerosis 1989;9:745A.
Knopp RH, Walden CE, Retzlaff BM, McCann BS,
Dowdy AA, Albers JJ, et al. Long-term cholesterol-lowering
effects of 4 fat-restricted diets in hypercholesterolaemic and
combined hyperlipidaemic men: The Dietary Alternatives
Study. JAMA 1997;278:1509–15.
Walden CE, McCann BS, Retzlaff B, Dowdy A, Hanson
M, Fish B, et al. Alternative fat-restricted diets for
hypercholesterolemia and combined hyperlipidemia:
feasibility, design, subject recruitment, and baseline
characteristics of the. Journal of the American College of
Nutrition 1991;10(5):429–42.
DASH 1997 {published data only}
∗ Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey
LP, Sacks FM, et al. A clinical trial of the effects of dietary
patterns on blood pressure. DASH Collaborative Research
Group. New England Journal of Medicine 1997;336(16):
1117–24.
Blackburn GL. Functional foods in the prevention and
treatment of disease: significance of the Dietary Approaches
to Stop Hypertension Study. American Journal of Clinical
Nutrition 1997;66(5):1067–71.
Davey Smith 2005 {published data only}
Davey Smith G, Bracha Y, Svendsen KH, Neaton JD,
Haffner SM, Kuller LH, et al. Incidence of type 2 diabetes
in the randomized multiple risk factor intervention trial.
Annals of Internal Medicine 2005;142(5):313–22.
de Boer 1983 {published data only}
de Boer AC, Turek JV, Pannebakker MA, den OG. The
effect of diets high in polyunsaturated and high in saturated
fatty acids on blood lipids and platelet tests in patients with
coronary artery disease (CAD) [abstract]. Thrombosis And
Haemostasis 1983;50:96.
DeBusk 1994 {published data only}
∗ DeBusk RF, Miller NH, Superko HR, Dennis CA,
Thomas RJ, Lew HT, et al. A case-management system for
coronary risk factor modification after acute myocardial
infarction [see comments]. Annals of Internal Medicine
1994;120(9):721–9.
Delahanty 2001 {published data only}
Delahanty LM, Hayden D, Ammerman A, Nathan
DM. Medical nutrition therapy for hypercholesterolemia
positively affects patient satisfaction and quality of life
outcomes. Annals of Behavioral Medicine 2002;24(4):
269–78.
Delahanty LM, Sonnenberg LM, Hayden D, Nathan DM.
Clinical and cost outcomes of medical nutrition therapy
for hypercholesterolemia: a controlled trial. Journal of the
American Dietetic Association 2001;101(9):1012–23.
Delius 1969 {published data only}
∗ Delius L. Treatment of hypotensive circulatory
disorder [Die Behandlung der hypotonen
Kreislaufregulationsstorung]. Deutsche Medizinische
Wochenschrift 1969;94(42):2172–3.
Demark 1990 {published data only}
∗ Demark WW, Bowering J, Cohen PS. Reduced serum
cholesterol with dietary change using fat-modified and oat
bran supplemented diets. Journal of the American Dietetic
Association 1990;90(2):223–9.
Dengel 1995 {published data only}
∗ Dengel JL, Katzel LI, Goldberg AP. Effect of an American
Heart Association diet, with or without weight loss, on
lipids in obese middle-aged and older men. American
Journal of Clinical Nutrition 1995;62(4):715–21.
Denke 1994 {published data only}
∗ Denke MA, Grundy SM. Individual responses to
a cholesterol lowering diet in 50 men with moderate
hypercholesterolaemia. Archives of Internal Medicine 1994;
154:17–25.
Diabetes CCT 1995 {published data only}
Anon. Effect of intensive diabetes management on
macrovascular events and risk factors in the Diabetes
Control and Complications Trial. American Journal of
Cardiology 1995;75:894–903.
DIET 1998 {published data only}
∗ Dornelas EA, Wylie-Rosett J, Swencionis C. The DIET
study: long term outcomes of a cognitive-behavioural
weight control intervention in independent-living elders.
Journal of the American Dietetic Association 1998;98(11):
1276–81.
Ding 1992 {published data only}
∗ Ding Q. Clinical study of qianxining in the treatment of
60 cases of yang hyperactivity due to yin deficiency type of
hypertension. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih
1992;12:409-11, 388.
DIRECT 2009 {published data only (unpublished sought but not
used)}
Ben-Avraham S, Harman-Boehm I, Schwarzfuchs D, Shai I.
Dietary strategies for patients with type 2 diabetes in the era
of multi-approaches; review and results from the Dietary
Intervention Randomized Controlled Trial (DIRECT).
Diabetes Research and Clinical Practice 2009;86(Suppl 1):
S41–8.
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S,
Greenberg I, et al for the Dietary Intervention Randomized
30Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Controlled Trial (DIRECT) Group. Weight loss with a low-
carbohydrate, Mediterranean, or low-fat diet. New England
Journal of Medicine 2008;359:229–41.
Dobs 1991 {published data only}
∗ Dobs AS, Sarma PS, Wilder L. Lipid-lowering diets in
patients taking pravastatin, a new HMG-CoA reductase
inhibitor: compliance and adequacy. American Journal of
Clinical Nutrition 1991;54(4):696–700.
DO IT 2004 {published and unpublished data}
Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen
H, Pedersen JI, et al. Supplementation with fish oil affects
the association between very long-chain n-3 polyunsaturated
fatty acids in serum non-esterified fatty acids and soluble
vascular cell adhesion molecule-1. Clinical Science 2003;
105(1):13–20.
Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad
S, Ellingsen I, et al. Consumption of fruit and berries is
inversely associated with carotid atherosclerosis in elderly
men.[Erratum appears in Br J Nutr. 2008 Mar;99(3):697].
British Journal of Nutrition 2008;99(3):674–81.
Ellingsen I, Seljeflot I, Arnesen H, Tonstad S. Vitamin C
consumption is associated with less progression in carotid
intima media thickness in elderly men: a 3-year intervention
study. Nutrition Metabolism & Cardiovascular Diseases
2009;19(1):8–14.
Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen
H, Furenes EB, et al. Long-term influence of diet and/
or omega-3 fatty acids on matrix metalloproteinase-9 and
pregnancy-associated plasma protein-A in men at high risk
of coronary heart disease. [Review] [39 refs]. Scandinavian
Journal of Clinical & Laboratory Investigation 2008;68(3):
177–84.
Hjerkinn EM, Abdelnoor M, Breivik L, Bergengen L,
Ellingsen I, Seljeflot I, et al. Effect of diet or very long
chain omega-3 fatty acids on progression of atherosclerosis,
evaluated by carotid plaques, intima-media thickness
and by pulse wave propagation in elderly men with
hypercholesterolaemia. European Journal of Cardiovascular
Prevention & Rehabilitation 2006;13(3):325–33.
Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann
I, Sandvik L, et al. Influence of long-term intervention with
dietary counselling, long-chain n-3 fatty acid supplements,
or both on circulating markers of endothelial activation in
men with long-standing hyperlipidemia. American Journal
of Clinical Nutrition 2005;81(3):583–9.
Lindman AS, Pedersen JI, Hjerkinn EM, Arnesen H,
Veierod MB, Ellingsen I, et al. The effects of long-term diet
and omega-3 fatty acid supplementation on coagulation
factor VII and serum phospholipids with special emphasis
on the R353Q polymorphism of the FVII gene. Thrombosis
& Haemostasis 2004;91(6):1097–104.
Troseid M, Arnesen H, Hjerkinn EM, Seljeflot I. Serum
levels of interleukin-18 are reduced by diet and n-3 fatty
acid intervention in elderly high-risk men. Metabolism:
Clinical & Experimental 2009;58(11):1543–9.
Troseid M, Seljeflot I, Hjerkinn EM, Arnesen H.
Interleukin-18 is a strong predictor of cardiovascular events
in elderly men with the metabolic syndrome: synergistic
effect of inflammation and hyperglycemia. Diabetes Care
2009;32(3):486–92.
Duffield 1982 {published data only}
Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt
JN, Colchester AC. Treatment of hyperlipidaemia retards
progression of symptomatic femoral atherosclerosis. A
randomised controlled trial. Lancet 1983;2(8351):639–42.
Duffield RG, Miller NE, Jamieson CW, Lewis B. A
controlled trial of plasma lipid reduction in peripheral
atherosclerosis--an interim report. British Journal of Surgery
1982;69 Suppl:S3–S5.
Dullaart 1997 {published and unpublished data}
∗ Dullaart RP, Hoogenberg K, Riemens SC, Groener JE,
van Tol A, Sluiter WJ, Stulp BK. Cholesteryl ester transfer
protein gene polymorphism is a determinant of HDL
cholesterol and of the lipoprotein response to a lipid-
lowering diet in type 1 diabetes. Diabetes 1997;46(12):
2082–7.
Dutch Nutrition Guide {published data only (unpublished sought but
not used)}
Verheiden MW, van der Veen JE, van Zadelhoff WM,
Bakx C, Koelen MA, van den Hoogen HJM, et al.
Nutrition guidance in Dutch family practice: behavioural
determinants of reduction in fat consumption. American
Journal of Clinical Nutrition 2003;77(Suppl):1058S–64S.
Eating Patterns 1997 {published and unpublished data}
Beresford SA, Curry SJ, Kristal AR, Lazovich D, Feng Z,
Wagner EH. A dietary intervention in primary care practice:
the Eating Patterns Study. American Journal of Public Health
1997;87(4):610–6.
Eckard 2013 {published data only}
Eckard C, Cole R, Lockwood J, Torres DM, Williams CD,
Shaw JC, et al. Prospective histopathologic evaluation of
lifestyle modification in nonalcoholic fatty liver disease: a
randomized trial. Therapeutic Advances in Gastroenterology
2013;6:249–59.
Ehnholm 1982 {published data only}
∗ Ehnholm C, Huttunen JK, Pietinen P, Leino U, Mutanen
M, Kostiainen E, et al. Effect of diet on serum lipoproteins
in a population with a high risk of coronary heart disease.
New England Journal of Medicine 1982;307:850–5.
Ehnholm 1984 {published data only}
∗ Ehnholm C, Huttunen JK, Pietinen P, Leino U, Mutanen
M, Kostiainen E, et al. Effect of a diet low in saturated fatty
acids on plasma lipids, lipoproteins, and HDL subfractions.
Arteriosclerosis 1984;4(3):265–9.
Eisenberg 1990 {published data only}
∗ Eisenberg S. The effect of dietary substitution of
monounsaturated fatty acids with carbohydrates on
lipoprotein levels, structure, and function in a free-living
population [abstract]. Arteriosclerosis 1990;10:872A.
Elder 2000 {published data only}
Elder JP, Candelaria JI, Woodruff SI, Criqui MH, Talavera
GA, Rupp JW. Results of language for health: cardiovascular
31Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
disease nutrition education for Latino English-as-a-second-
language students. Health Education & Behavior 2000;27
(1):50–63.
Ellegard 1991 {published data only}
∗ Ellegard L, Bosaeus I. Sterol and nutrient excretion in
ileostomists on prudent diets. European Journal of Clinical
Nutrition 1991;45(9):451–7.
Esposito 2003 {published data only}
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella
M, Marfella R, et al. Effect of weight loss and lifestyle
changes on vascular inflammatory markers in obese women:
a randomized trial. JAMA 2003;289(14):1799–804.
Esposito 2004 {published data only}
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano
F, Giugliano G, et al. Effect of a Mediterranean-style
diet on endothelial dysfunction and markers of vascular
inflammation in the metabolic syndrome: a randomized
trial. JAMA 2004;292(12):1440–6.
Esposito 2014 {published data only}
Esposito K, Maiorino MI, Petrizzo M, Bellastella G,
Giugliano D. The effects of a Mediterranean diet on the
need for diabetes drugs and remission of newly diagnosed
type 2 diabetes: follow-up of a randomized trial. Diabetes
Care 2014;37:1824–30.
EUROACTION 2008 {published data only}
Wood DA, Kotseva K, Connolly S, Jennings C, Mead
A, Jones J, et al. Nurse-coordinated multidisciplinary,
family-based cardiovascular disease prevention programme
(EUROACTION) for patients with coronary heart disease
and asymptomatic individuals at high risk of cardiovascular
disease: a paired, cluster-randomised controlled trial. Lancet
2008;371(9629):1999–2012.
FARIS 1997 {published data only}
∗ Goble A, Jackson B, Phillips P, Race E, Oliver
RG, Worcester MC. The Family Atherosclerosis Risk
Intervention Study (FARIS): risk factor profiles of patients
and their relatives following an acute cardiac event.
Australian and New Zealand Journal of Medicine 1997;27:
568–77.
Fasting HGS 1997 {published data only}
∗ Dyson PA, Hammersley MS, Morris RJ, Holman RR,
Turner RC. The Fasting Hyperglycaemia Study: II.
Randomized controlled trial of reinforced healthy-living
advice in subjects with increased but not diabetic fasting
plasma glucose. Metabolism 1997;46(12 Suppl 1):50–5.
Ferrara 2000 {published data only}
∗ Ferrara LA, Raimondi AS, d’Episcopo L, Guida L,
Dello Russo A, Marotta T. Olive oil and reduced need for
antihypertensive medications. Archives of Internal Medicine
2000;160:837–42.
Fielding 1995 {published data only}
∗ Fielding CJ, Havel RJ, Todd KM, Yeo KE, Schloetter
MC, Weinberg V, et al. Effects of dietary cholesterol and fat
saturation on plasma lipoproteins in an ethnically diverse
population of healthy young men. Journal of Clinical
Investigation 1995;95(2):611–8.
Finckenor 2000 {published data only}
Finckenor M. Nutrition intervention group program
based on preaction-stage-oriented change processes of
the transtheoretical model promotes long-term reduction
in dietary fat intake. Journal of the American Dietetic
Association 2000;100(3):335–42.
Finnish Diabetes 2000 {published data only}
Uusitupa M, Louheranta A, Lindstrom J, Valle T, Sundvall
J, Eriksson J, et al. The Finnish Diabetes Prevention Study.
British Journal of Nutrition 2000;83 Suppl 1:S137–42.
Finnish Mental 1972 {published data only}
Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R,
Paavilainen E. Effect of cholesterol-lowering diet on
mortality from coronary heart-disease and other causes. A
twelve-year clinical trial in men and women. Lancet 1972;2
(782):835–8.
Miettinen M, Turpeinen O, Karvonen MJ, Pekkarinen M,
Paavilainen E, Elosuo R. Dietary prevention of coronary
heart disease in women: the Finnish mental hospital study.
International Journal of Epidemiology 1983;12(1):17–25.
Turpeinen O, Miettinen M, Karvonen M, Roine P,
Pekkarinen M, Lehtosuo EJ, et al. Dietary prevention
of coronary heart disease: long-term experiment. I.
Observations on male. American Journal of Clinical
Nutrition 1968;21(4):255–76.
Fisher 1981 {published data only}
∗ Fisher EA, Breslow JL, Zannis VI, Shen G, Blum CB.
Dietary saturated fat, not cholesterol, affects plasma lipids
and Apo E. Arteriosclerosis 1981;1(5):364a.
Fleming 2002 {published data only}
∗ Fleming RM. The effect of high-, moderate-, and low-fat
diets on weight loss and cardiovascular disease risk factors.
Preventive Cardiology 2002;5:110–5.
Fortmann 1988 {published data only}
∗ Fortmann SP, Haskell WL, Wood PD. Effects of
weight loss on clinic and ambulatory blood pressure in
normotensive men. American Journal of Cardiology 1988;62
(1):89–93.
Foster 2003 {published data only}
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill
C, Mohammed BS, et al. A randomized trial of a low-
carbohydrate diet for obesity. New England Journal of
Medicine 2003;348(21):2082–90.
FRESH START 2007 {published data only}
Denmark-Wahnefried W, Clipp EC, Lipkus IM, Lobach
D, Snyder DC, Sloane R, et al. Main outcomes of the
FRESH START trial: a sequentially tailored, diet and
exercise mailed print intervention among breast and prostate
cancer survivors. Journal of Clinical Oncology 2007;25(19):
2709–18.
Friedman 2012 {published data only}
Friedman AN, Ogden LG, Foster GD, Klein S, Stein R,
Miller B, et al. Comparative effects of low-carbohydrate
high-protein versus low-fat diets on the kidney. Clinical
Journal of the American Society of Nephrology 2012;7:
1103–11.
32Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gambera 1995 {published data only}
∗ Gambera PJ, Schneeman BO, Davis PA. Use of the Food
Guide Pyramid and US Dietary Guidelines to improve
dietary intake and reduce cardiovascular risk in active-
duty Air Force members. Journal of the American Dietetic
Association 1995;95(11):1268–73.
Gaullier 2007 {published data only}
∗ Gaullier J-M, Halse J, Hoivik HO, Hoye K, Syvertsen
C, Nurminiemi M, et al. Six months supplementation
with conjugated linoleic acid induces regional-specific fat
mass decreases in overweight and obese. British Journal of
Nutrition 2007;97:550–60.
German Fat Reduced {published and unpublished data}
∗ Seppelt B, Weststrate JA, Reinert A, Johnson D, Luder
W, Zunft HJ. Long-term effects of nutrition with fat-
reduced foods on energy consumption and body weight
[Langzeiteffekte einer Ernahrung mit fettreduzierten
Lebensmitteln auf die Energieaufnahme und das
Korpergewicht]. Zeitschrift fur Ernahrungswissenschaft 1996;
35(4):369–77.
Ginsberg 1988 {published data only}
∗ Ginsberg H. Both a high monounsaturated fat diet and
the step 1 AHA diet significantly reduce plasma cholesterol
levels in healthy males [abstract]. Circulation 1988;78:II73.
Gjone 1972 {published data only}
∗ Gjone E, Nordoy A, Blomhoff JP,Wiencke I. The effects of
unsaturated and saturated dietary fats on plasma cholesterol,
phospholipids and lecithin: cholesterol acyltransferase
activity. Acta Medica Scandinavica 1972;191(6):481–4.
Glatzel 1966 {published data only}
∗ Glatzel H. The relationship between postprandial
triglyceridemia and the fat content of the basic diet
[Die Abhangigkeit der postcenalen Triglyceridamie von
Fettgehalt der Grundkost]. Klinische Wochenschrift 1966;44
(5):283–4.
Goodpaster 1999 {published data only}
∗ Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete
FL. Effects of weight loss on regional fat distribution and
insulin sensitivity in obesity. Diabetes 1999;48:839–47.
Gower 2012 {published data only}
∗ Gower B A, Goree L L, Chandler-Laney P C, Ellis A C,
Casazza K, Granger W M. A higher-carbohydrate, lower-
fat diet reduces fasting glucose concentration and improves
beta-cell function in individuals with impaired fasting
glucose. Metabolism 2012;61:358–65.
Gower BAG. Impact of dietary macronutrient composition
on insulin sensitivity, fasting glucose, and beta-cell response
in healthy, overweight, men and women. Endocrine Reviews
2011;Conference:SAT–110.
Gregg 2013 {published data only}
Gregg EWK. An intensive lifestyle intervention increased
remission from type 2 diabetes in overweight adults. Annals
of Internal Medicine 2013;158:4.
Grundy 1986 {published data only}
∗ Grundy SM, Nix D, Whelan MF, Franklin L. Comparison
of three cholesterol-lowering diets in normolipidaemic men.
JAMA 1986;256:2351–5.
Gudlaugsson 2013 {published data only}
Gudlaugsson J, Gudnason V. Effects of exercise training
and nutrition counseling on body composition and
cardiometabolic factors in old individuals. European
Geriatric Medicine 2013;4:431–7.
Guelinckx 2010 {published data only}
Guelinckx I, Devlieger R, Mullie P, Vansant G. Effect of
lifestyle intervention on dietary habits, physical activity,
and gestational weight gain in obese pregnant women: a
randomized controlled trial. American Journal of Clinical
Nutrition 2010;91:373–80.
Guldbrand 2012 {published data only}
Guldbrand H, Dizdar B, Bunjaku B, Lindstrom T,
Bachrach-Lindstrom M, Fredrikson M, et al. In type
2 diabetes, randomisation to advice to follow a low-
carbohydrate diet transiently improves glycaemic control
compared with advice to follow a low-fat diet producing a
similar weight loss. Diabetologia 2012;55:2118–27.
Hardcastle 2008 {published data only}
Hardcastle S, Taylor A, Bailey M, Castle R. A randomised
controlled trial on the effectiveness of a primary health care
based counselling intervention on physical activity, diet and
CHD risk factors. Patient Education & Counseling 2008;70
(1):31–9.
Harris 1990 {published data only}
∗ Harris WS, Feldman EB. Intensive dietary intervention in
hypercholesterolemic patients. Observed versus predicted
changes in cholesterol levels [abstract]. Arteriosclerosis 1990;
10:853A.
Hartman 1993 {published data only}
∗ Hartman T, McCarthy P, Himes J. Use of eating pattern
messages to evaluate changes in eating behaviors in a
worksite cholesterol education program. Journal of the
American Dietetic Association 1993;93:1119–23.
Hartwell 1986 {published data only}
∗ Hartwell SL, Kaplan RM, Wallace JP. Comparison of
behavioral interventions for control of type II diabetes
mellitus. Behavior Therapy 1986;17:447–61.
Hashim 1960 {published data only}
∗ Hashim SA, Arteaga A, Van Itallie TB. Effect of saturated
medium-chain triglyceride on serum-lipids in man. Lancet
1960;1:1105–7.
Haynes 1984 {published data only}
∗ Haynes RB, Harper AC, Costley SR, Johnston M, Logan
AG, Flanagan PT, et al. Failure of weight reduction to
reduce mildly elevated blood pressure: a randomized trial.
Journal of Hypertension 1984;2(5):535–9.
Heber 1991 {published data only}
∗ Heber D, Ashley JM, Leaf DA, Barnard JA. Reduction
of serum estradiol in postmenopausal women given free
access to low-fat high carbohydrate diet. Nutrition 1991;7:
137–41.
33Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Heine 1989 {published and unpublished data}
∗ Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van
der Veen EA. Linoleic-acid-enriched diet: long-term effects
on serum lipoprotein and apolipoprotein concentration
and insulin sensitivity in noninsulin-dependent diabetic
patients. American Journal of Clinical Nutrition 1989;49:
448–56.
Heller 1993 {published and unpublished data}
Heller RF, Knapp JC, Valenti LA, Dobson AJ. Secondary
prevention after acute myocardial infarction. American
Journal of Cardiology 1993;72(11):759–62.
Heller RF, Walker RJ, Boyle CA, O’Connell DL,
Rusakaniko S, Dobson AJ. A randomised controlled trial of
a dietary advice program for relatives of heart attack victims.
Medical Journal of Australia 1994;161(9):529–31.
Hildreth 1951 {published data only}
∗ Hildreth EA, Mellinkoff SM, Blair GW, Hildreth DM.
The effect of vegetable fat ingestion on human serum
cholesterol concentration. Circulation 1951;3:641–?.
Hood 1965 {published data only}
∗ Hood B, Sanne H, Orndahl G, Ahlstrom M, Welin G.
Long term prognosis in essential hypercholesterolaemia: the
effect of a strict diet. Acta Medica Scandinavica 1965;178:
161–73.
Horlick 1957 {published data only}
∗ Horlick L, Craig BM. Effect of long-chain polyunsaturated
and saturated fatty acids on the serum-lipids of man. Lancet
1957;2:566–9.
Horlick 1960 {published data only}
∗ Horlick L, O’Neil JB. Effect of modified egg-yolk fats on
blood-cholesterol levels [letter]. Lancet 1960;1:438.
Howard 1977 {published data only}
∗ Howard AN, Marks J. Hypocholesterolaemic effect of
milk [letter]. Lancet 1977;2(8031):255–6.
Hunninghake 1990 {published data only}
∗ Hunninghake DB, Laskarzewski PM. Gender difference in
the response to lovastatin administration with and without
a cholesterol lowering diet [abstract]. Arteriosclerosis 1990;
10:786A.
Hutchison 1983 {published data only}
∗ Hutchison K, Oberle K, Crockford P, Grace M, Whyte L,
Gee M, et al. Effects of dietary manipulation on vascular
status of patients with peripheral vascular disease. JAMA
1983;249(24):3330.
Hyman 1998 {published and unpublished data}
∗ Hyman DJ, Ho KSI, Dunn K, Simons-Morton D.
Dietary intervention for cholesterol reduction in public
clinic patients. American Journal of Preventive Medicine
1998;15:139–45.
Iacono 1981 {published data only}
∗ Iacono JM, Judd JT, Marshall MW, Canary JJ, Dougherty
RM, Mackin JF, et al. The role of dietary essential fatty acids
and prostaglandins in reducing blood pressure. Progress in
Lipid Research 1981;20:349–64.
IMPACT 1995A {published data only}
∗ Fielding JE, Mason T, Knight K, Klesges R, Pelletier KR.
A randomized trial of the IMPACT worksite cholesterol
reduction program. American Journal Of Preventive
Medicine 1995;11:120–3.
Ishikawa 1995 {published data only}
∗ Ishikawa H, Akedo I, Suzuki T, Otani T, Sobue T.
Interventional trial for colorectal cancer prevention in
Osaka: an introduction to the protocol. Japanese Journal of
Cancer Research 1995;86(8):707–10.
Iso 1991 {published data only}
∗ Iso H, Konishi M, Terao A, Kiyama M, Tanigaki M,
Baba M, et al. A community-based education program for
serum cholesterol reduction in urban hypercholesterolemic
persons--comparison of intensive and usual education
groups. Nippon Koshu Eisei Zasshi 1991;38(9):751–61.
Ives 1993 {published data only}
∗ Ives DG, Kuller LH, Traven ND. Use and outcomes of a
cholesterol-lowering intervention for rural elderly subjects.
American Journal of Preventive Medicine 1993;9(5):274–81.
Jalkanen 1991 {published data only}
∗ Jalkanen L. The effect of a weight reduction program on
cardiovascular risk factors among overweight hypertensives
in primary health care. Scandinavian Journal of Social
Medicine 1991;19(1):66–71.
Janus 2012 {published data only}
Janus ED, Best JD, Davis-Lameloise N, Philpot B, Hernan
A, Bennett CM, et al. Scaling-up from an implementation
trial to state-wide coverage: results from the preliminary
Melbourne Diabetes Prevention Study. Trials [Electronic
Resource] 2012;13:152.
Jepson 1969 {published data only}
∗ Jepson EM, Fahmy MF, Torrens PE, Billimoria JD,
Maclagan NF. Treatment of essential hyperlipidaemia.
Lancet 1969;2(7634):1315–9.
Jerusalem Nut 1992 {published data only}
∗ Berry EM, Eisenberg S, Friedlander Y, Harats D,
Kaufmann NA, Norman Y, et al. Effects of diets rich in
monounsaturated fatty acids on plasma lipoproteins--the
Jerusalem Nutrition Study. II. Monounsaturated fatty acids
vs carbohydrates. American Journal of Clinical Nutrition
1992;56(2):394–403.
Jonasson 2014 {published data only}
Jonasson L, Guldbrand H, Lundberg AK, Nystrom FH.
Advice to follow a low-carbohydrate diet has a favourable
impact on low-grade inflammation in type 2 diabetes
compared with advice to follow a low-fat diet. Annals of
Medicine 2014;46:182–7.
Juanola-Falgarona 2014 {published data only}
Juanola-Falgarona M, Salas-Salvado J, Ibarrola-Jurado N,
Rabassa-Soler A, Bullo M. Effect of dietary glycemic index
and glycemic load on body weight and cardiovascular risk
factors: The GLYNDIET Study. Obesity Facts. 20th
34Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
European Congress on Obesity, ECO 2013 Liverpool
United Kingdom. 2013; Vol. 6:111.
Juanola-Falgarona Martí, Salas-Salvado Jordi, Ibarrola-
Jurado Núria, Rabassa-Soler Antoni, Diaz-Lopez Andres,
Guasch-Ferré Marta, et al. Effect of the glycemic index of
the diet on weight loss, modulation of satiety, inflammation,
and other metabolic risk factors: a randomized controlled
trial. American Journal of Clinical Nutrition 2014;100:
27–35.
Juanola-Falgarona Martí, Salas-Salvado Jordi, Ibarrola-
Jurado Núria, Rabassa-Soler Antoni, Diaz-Lopez Andres,
Guasch-Ferré Marta, et al. Effect of the glycemic index of
the diet on weight loss, modulation of satiety, inflammation,
and other metabolic risk factors: a randomized controlled
trial. American Journal of Clinical Nutrition 2014;100:
27–35.
Jula 1990 {published data only}
∗ Jula A, Ronnemaa T, Rastas M, Karvetti RL, Maki
J. Long-term nopharmacological treatment for mild to
moderate hypertension. Journal of Internal Medicine 1990;
227(6):413–21.
Junker 2001 {published data only}
Junker R, Pieke B, Schulte H, Nofer R, Neufeld M,
Assmann G, et al. Changes in hemostasis during treatment
of hypertriglyceridemia with a diet rich in monounsaturated
and n-3 polyunsaturated fatty acids in comparison with a
low-fat diet. Thrombosis Research 2001;101(5):355–66.
Karmally 1990 {published data only}
∗ Karmally W, Carpentiri C, Viscardi T, Cheverez
V, Holleran S, Ramakrishnan R, et al. Replacing
monounsaturated by polyunsaturated fatty acids within
an AHA step I diet does not affect the plasma levels or
metabolism of low density and high density lipoproteins in
normal men [abstract]. Arteriosclerosis 1990;10:877A.
Karvetti 1992 {published data only}
∗ Karvetti RL, Hakala P. A seven-year follow-up of a weight
reduction programme in Finnish primary health care.
European Journal of Clinical Nutrition 1992;46:743–52.
Kastarinen 2002 {published data only}
Kastarinen MJ, Puska PM, Korhonen MH, Mustonen JN,
Salomaa VV, Sundvall JE, et al. Non-pharmacological
treatment of hypertension in primary health care: a 2-year
open randomized controlled trial of lifestyle intervention
against hypertension in eastern Finland. Journal of
Hypertension 2002;20(12):2505–12.
Kather 1985 {published data only}
∗ Kather H, Wildenberg U, Wieland E. Influence of
different dietary conditions in ideal-weight subjects on
serum levels of free fatty acids and of glycerol in vivo and on
lipid mobilization in vitro [abstract]. European Journal of
Clinical Investigation 1985;15:A.
Kattelmann 2010 {published data only}
Kattelmann KK, Conti K, Ren C, Kattelmann Kendra K,
Conti Kibbe, Ren Cuirong. The Medicine Wheel nutrition
intervention: a diabetes education study with the Cheyenne
River Sioux Tribe.[Reprint of J Am Diet Assoc. 2009 Sep;
109(9):1532-9; PMID: 19699832]. Journal of the American
Dietetic Association 2010;110:S44–51.
Katzel 1995 {published data only}
∗ Katzel LI, Coon PJ, Dengel J, Goldberg AP. Effect of an
American Heart Association Step I diet and weight loss on
lipoprotein lipid levels in obese men with silent myocardial
ischaemia and reduced high density lipoprotein cholesterol.
Metabolism 1995;44:307–14.
Katzel 1995A {published data only}
∗ Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin
JD, Goldberg AP. Effects of weight loss vs aerobic exercise
training on risk factors for coronary disease in healthy, obese,
middle-aged and older men. A randomized controlled trial
[see comments]. JAMA 1995;274(24):1915–21.
Kawamura 1993 {published data only}
∗ Kawamura M, Akasaka T, Kasatsuki T, Nakajima J,
Onodera S, Fujiwara T, et al. Blood pressure is reduced by
short-time calorie restriction in overweight hypertensive
women with a constant intake of sodium and potassium.
Journal of Hypertension. Supplement 1993;11 Suppl 5:
S320–1.
Keidar 1988 {published data only}
∗ Keidar S, Krul ES, Goldberg AC, Bateman J, Schonfield
G. Fat-free diet modulates epitope expression of LDL-apo˙
[abstract]. Arteriosclerosis 1988;8:565A.
Kempner 1948 {published data only}
∗ Kempner W. Treatment of hypertensive vascular disease
with rice diet. American Journal of Medicine 1948;4:545–77.
Keys 1952 {published data only}
∗ Keys A. Human atherosclerosis and the diet. Circulation
1952;5:115–8.
Keys 1957 {published data only}
∗ Keys A, Anderson JT, Grande F. Serum-cholesterol
response to dietary fat [letter]. Lancet 1957;1:787.
Keys 1957A {published data only}
∗ Keys A, Anderson JT, Grande F. Essential fatty acids,
degree of unsaturation, and effect of corn (maize) oil on the
serum-cholesterol level in man. Lancet 1957;1:66–8.
Keys 1957B {published data only}
Keys A. Prediction of serum-cholesterol responses of man to
changes in fats in the diet. Lancet 1957;2:959–66.
Khan 2003 {published and unpublished data}
∗ Khan F, Elherik K, Bolton-Smith C, Barr R, Hill A, Murrie
I, et al. The effects of dietary fatty acid supplementation on
endothelial function and vascular tone in healthy subjects.
Cardiovascular Research 2003;59:955–62.
King 2000 {published data only}
King S, David S, Newton H, Hevey D, Rafferty F, Horgan
JH. The effect of dietary modification on the training
outcome and body composition in patients undergoing a
cardiac rehabilitation programme. Coronary Health Care
2000;4(2):76–81.
Kingsbury 1961 {published data only}
∗ Kingsbury KJ, Morgan DM, Aylott C, Emmerson R.
Effects of ethyl arachidonate, cod-liver oil, and corn oil
35Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
on the plasma-cholesterol level: a comparison in normal
volunteers. Lancet 1961;1:739–41.
Klemsdal 2010 {published data only}
Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad
S, Klemsdal TO, et al. Effects of a low glycemic load
diet versus a low-fat diet in subjects with and without
the metabolic syndrome. Nutrition Metabolism &
Cardiovascular Diseases 2010;20:195–201.
Kohler 1986 {published data only}
∗ Kohler VH, Voigt H, Reuter W, Peters H-J, Kuklinski
B, Scheel H, et al. Results of a long-term study of
arteriosclerotic circulatory disorders with polyene fatty
acid therapy [German]. Zeitschrift für die Gesamte Innere
Medizin und ihre Grenzgebiete 1986;41:91–3.
Kontogianni 2012 {published data only}
Kontogianni MDL. Changes in dietary habits and their
association with metabolic markers after a non-intensive,
community-based lifestyle intervention to prevent type 2
diabetes, in Greece. The DEPLAN study. Diabetes Research
and Clinical Practice 2012;95:207–14.
Koopman 1990 {published data only}
∗ Koopman H, Spreeuwenberg C, Westerman RF, Donker
AJ. Dietary treatment of patients with mild to moderate
hypertension in a general practice: a pilot intervention study
(2). Beyond three months. Journal of Human Hypertension
1990;4(4):372–4.
Koranyi 1963 {published data only}
Koranyi A. Prophylaxis and treatment of the coronary
syndrome. Therapia Hungarica 1963;11:17–20.
Korhonen 2003 {published data only}
Korhonen M, Kastarinen M, Uusitupa M, Puska P, Nissinen
A. The effect of intensified diet counseling on the diet of
hypertensive subjects in primary health care: a 2-year open
randomized controlled trial of lifestyle intervention against
hypertension in eastern Finland. Preventive Medicine 2003;
36(1):8–16.
Kriketos 2001 {published data only}
Kriketos AD, Robertson RM, Sharp TA, Drougas H,
Reed GW, Storlien LH, et al. Role of weight loss and
polyunsaturated fatty acids in improving metabolic fitness
in moderately obese, moderately hypertensive subjects.
Journal of Hypertension 2001;19(10):1745–54.
Kris 1994 {published data only}
∗ Kris EP, Mustad VA. Chocolate feeding studies: a novel
approach for evaluating the plasma lipid effects of stearic
acid. American Journal of Clinical Nutrition 1994;60(6
Suppl):1029S–36S.
Kristal 1997 {published data only}
∗ Kristal AR, Shattuck AL, Bowen DJ, Sponzo RW, Nixon
DW. Feasibility of using volunteer research staff to deliver
and evaluate a low-fat dietary intervention: the American
Cancer Society Breast Cancer Dietary Intervention Project.
Cancer Epidemiology, Biomarkers and Prevention 1997;6(6):
459–67.
Kromhout 1987 {published data only}
∗ Kromhout D, Arntzenius AC, Kempen-Voogd N,
Kempen HJ, Barth JD, van der Voort HA, et al. Long-
term effects of linoleic-acid enriched diet, changes in body
weight and alcohol consumption on serum total and HDL
cholesterol. Atherosclerosis 1987;66:99–105.
Kummel 2008 {published data only}
Kummel MV. Effects of an intervention on health behaviors
of older coronary artery bypass (CAB) patients. Archives of
Gerontology and Geriatrics 2008;2(2):227–44.
Laitinen 1993 {published data only}
∗ Laitinen JH, Ahola IE, Sarkkinen ES, Winberg RL,
Harmaakorpi IP, Uusitupa MI. Impact of intensified
dietary therapy on energy and nutrient intakes and fatty
acid composition of serum lipids in patients with recently
diagnosed non-insulin-dependent diabetes mellitus. Journal
of the American Dietetic Association 1993;93(3):276–83.
Laitinen 1994 {published data only}
∗ Laitinen J, Uusitupa M, Ahola I, Siitonen O. Metabolic
and dietary determinants of serum lipids in obese patients
with recently diagnosed non-insulin-dependent diabetes.
Annals of Medicine 1994;26(2):119–24.
Larsen 2011 {published data only}
Larsen RN, Mann NJ, Maclean E, Shaw JE, Larsen
RN, Mann NJ, et al. The effect of high-protein, low-
carbohydrate diets in the treatment of type 2 diabetes: a 12
month randomised controlled trial. Diabetologia 2011;54:
731–40.
Leduc 1994 {published data only}
Leduc CP, Cherniak D, Faucher J. Effectiveness of a
group dietary intervention on hypercholesterolaemia:
a randomised controlled clinical trial (poster abstract).
Atherosclerosis 1994;?:149.
Leibbrandt 2010 {published data only}
Leibbrandt AJ, Kiefte-de Jong JC, Hogenelst MHE, Snoek
FJ, Weijs PJM. Effects of the PRo-active interdisciplinary
Self-MAnagement (PRISMA, Dutch DESMOND)
program on dietary intake in type 2 diabetes outpatients: a
pilot study. Clinical Nutrition 2010;29:199–205.
Lewis 1958 {published data only}
∗ Lewis B. Effect of certain dietary oils on bile-acid secretion
and serum-cholesterol. Lancet 1958;1:1090–2.
Lewis 1981 {published data only}
∗ Lewis B, Hammett F, Katan M, Kay RM, Merkx I, Nobels
A, et al. Towards an improved lipid-lowering diet: additive
effects of changes in nutrient intake. Lancet 1981;2(8259):
1310–3.
Lewis 1985 {published data only}
∗ Lewis B. Randomised controlled trial of the treatment
of hyperlipidaemia on progression of atherosclerosis. Acta
Medica Scandinavica. Supplementum 1985;701:53–7.
Lichtenstein 2002 {published data only}
Lichtenstein AH, Ausman LM, Jalbert SM, Vilella-Bach
M, Jauhiainen M, McGladdery S, et al. Efficacy of a
Therapeutic Lifestyle Change/Step 2 diet in moderately
36Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
hypercholesterolemic middle-aged and elderly female and
male subjects. Journal of Lipid Research 2002;43(2):264–73.
Linko 1957 {published data only}
∗ Linko E. Vegetable oils and serum cholesterol: short-term
experiments with rapeseed and sunflower oils. Acta Medica
Scandinavica. Supplementum 1957;159:475–88.
Lipid Res Clinic 1984 {published data only}
Anon. The Lipid Research Clinics Coronary Primary
Prevention Trial results. I. Reduction in incidence of
coronary heart disease. JAMA 1984;251(3):351–64.
Anon. The Lipid Research Clinics Coronary Primary
Prevention Trial results. II. The relationship of reduction in
incidence of coronary heart disease to cholesterol lowering.
JAMA 1984;251(3):365–74.
Gordon DJ, Salz KM, Roggenkamp KJ. Dietary
determinants of plasma cholesterol change in the
recruitment phase of the Lipid Research Clinics Coronary
Primary Prevention Trial. Arteriosclerosis 1982;2(6):537–48.
Little 1990 {published data only}
∗ Little P, Girling G, Hasler A, Craven A, Trafford A. The
effect of a combination low sodium, low fat, high fibre diet
on serum lipids in treated hypertensive patients. European
Journal of Clinical Nutrition 1990;44(4):293–300.
Little 1991 {published data only}
∗ Little P, Girling G, Hasler A, Trafford A. A controlled
trial of a low sodium, low fat, high fibre diet in treated
hypertensive patients: effect on antihypertensive drug
requirement in clinical practice. Journal of Human
Hypertension 1991;5(3):175–81.
Little 2004 {published data only}
Little P, Kelly J, Barnett J, Dorward M, Margetts B, Warm
D, et al. Randomised controlled factorial trial of dietary
advice for patients with a single high blood pressure reading
in primary care. BMJ 2004;328(7447):1054.
Lottenberg 1996 {published data only}
∗ Lottenberg AM, Nunes VS, Lottenberg SA, Shimabukuro
AF, Carrilho AJ, Malagutti S, et al. Plasma cholesteryl ester
synthesis, cholesteryl ester transfer protein concentration
and activity in hypercholesterolemic women: effects of the
degree of saturation of dietary fatty acids in the fasting and
postprandial states. Atherosclerosis 1996;126(2):265–75.
Luoto 2012 {published data only}
Luoto R, Laitinen K, Nermes M, Isolauri E, Luoto Raakel,
Laitinen Kirsi, et al. Impact of maternal probiotic-
supplemented dietary counseling during pregnancy on
colostrum adiponectin concentration: a prospective,
randomized, placebo-controlled study. Early Human
Development 2012;88:339–44.
Luszczynska 2007 {published data only}
Luszczynska A, Scholz U, Sutton S. Planning to change
diet: a controlled trial of an implementation intentions
training intervention to reduce saturated fat intake among
patients after myocardial infarction. Journal of Psychosomatic
Research 2007;63(5):491–7.
Lyon Diet Heart 1994 {published data only}
∗ De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin
JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-
rich diet in secondary prevention of coronary heart disease.
Lancet 1994;343(8911):1454–9.
De Lorgeril M, Salen P. Mediterranean diet in secondary
prevention of coronary heart disease. Australian Journal of
Nutrition and Dietetics 1998;55(Suppl):s16–s20.
De Lorgeril M, Salen P, Caillat-Vallet E, Hanauer M-T,
Barthelemy JC, Mamelle N. Control of bias in dietary trial
to prevent coronary recurrences: the Lyon diet heart study.
European Journal of Clinical Nutrition 1997;51(2):116–22.
De Lorgeril M, Salen P, Martin J-L, Monjaud I, Delaye J,
Mamelle N. Mediterranean diet, traditional risk factors, and
the rate of cardiovascular complications after myocardial
infarction: final report of the Lyon diet heart study.
Circulation 1999;99:779–85.
De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud
I, Touboul P, et al. Effect of a Mediterranean type of diet
on the rate of cardiovascular complications in patients with
coronary artery disease. Insights into the cardioprotective
effect of certain nutriments. Journal of the American College
of Cardiology 1996;28:1103–8.
De Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P,
Mamelle N. Mediterranean dietary pattern in a randomised
trial. Archives of Internal Medicine 1998;158:1181–7.
Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F,
Mamelle N, et al. Cretan Mediterranean diet for prevention
of coronary heart disease. American Journal of Clinical
Nutrition 1995;61(6 Suppl):1360S–7S.
Lysikova 2003 {published data only}
Lysikova SL, Pogozheva AV, Akol’zina SE, Vasil’ev AV,
Vorob’eva LS. The study of the clinical potency of
antiatherogenic diet containing flavonoids in cardiovascular
patients [Russian]. Voprosy Pitaniia 2003;72(3):8–11.
Macdonald 1972 {published data only}
∗ Macdonald I. Relationship between dietary carbohydrates
and fats in their influence on serum lipid concentrations.
Clinical Science 1972;43(2):265–74.
Mansel 1990 {published data only}
∗ Mansel RE, Harrison BJ, Melhuish J, Sheridan W, Pye JK,
Pritchard G, et al. A randomized trial of dietary intervention
with essential fatty acids in patients with categorized cysts.
Annals of the New York Academy of Sciences 1990;?:288–94.
Marckmann 1993 {published data only}
∗ Marckmann P, Sandstrom B, Jespersen J. Favorable long-
term effect of a low-fat/high fiber diet on human blood
coagulation and fibrinolysis. Arteriosclerosis and Thrombosis
1993;13:505–11.
MARGARIN {published data only}
∗ Bemelmans WJE, Broer J, Feskens EJM, Smit AJ, Muskiet
FAJ, Lefrandt JD, et al. Effect of an increased intake of
alpha-linolenic acid and group nutritional education on
cardiovascular risk factors: the Mediterranean Alpha-
linolenic Enriched Groningen Dietary Intervention
37Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(MARGARIN) study. American Journal of Clinical Nutrition
2002;75:221–7.
Martin 2011 {published data only}
Martin CK, Rosenbaum D, Han H, Geiselman PJ,
Wyatt HR, Hill JO, et al. Change in food cravings, food
preferences, and appetite during a low-carbohydrate and
low-fat diet. Obesity 2011;19:1963–70.
Maruthur 2014 {published data only}
Maruthur N, Yau MS, Jablonski KA, Delahanty L, Franks
PW, Knowler WC, et al. Genetic variation and response to
weight, physical activity, and diet change to prevent diabetes
in the diabetes prevention program. Diabetes. 2014; Vol.
63:A415.
Mattson 1985 {published data only}
∗ Mattson FH, Grundy SM. Comparison of effects of
dietary saturated, monounsaturated and polyunsaturated
fatty acids on plasma lipids and lipoproteins in man. Journal
of Lipid Research 1985;26:194–202.
Mayneris-Perxachs 2014 {published data only}
Mayneris-Perxachs J, Sala-Vila A, Chisaguano M, Castellote
AI, Estruch R, Covas MI, et al. Effects of 1-year
intervention with a Mediterranean diet on plasma fatty acid
composition and metabolic syndrome in a population at
high cardiovascular risk. PloS One 2014;9:e85202.
McCarron 1997 {published data only}
∗ McCarron DA, Oparil S, Chait A, Haynes RB, Kris EP,
Stern JS, et al. Nutritional management of cardiovascular
risk factors. A randomized clinical trial. Archives of Internal
Medicine 1997;157(2):169–77.
McCarron 2001 {published data only}
McCarron DA, Reusser ME. Reducing cardiovascular
disease risk with diet. Obesity Research 2001;9 Suppl 4:
335S–40S.
McManus 2001 {published and unpublished data}
∗ McManus K, Antinoro L, Sacks F. Randomized controlled
trial of a moderate-fat low-energy diet compared with a low
fat, low-energy diet for weight loss in overweight adults.
International Journal of Obesity 2001;25:1503–11.
McNamara 1981 {published data only}
∗ McNamara DJ, Kolb R, Parker T, Batwin H, Brown C,
Samuel P, et al. Diet and cholesterol homeostasis in men
[abstract]. Arteriosclerosis 1981;1:369A.
Medi-RIVAGE 2004 {published and unpublished data}
Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-
Baudry S, et al. Human fasting plasma concentrations
of vitamin E and carotenoids, and their association with
genetic variants in apo C-III, cholesteryl ester transfer
protein, hepatic lipase, intestinal fatty acid binding protein
and microsomal triacylglycerol transfer protein. British
Journal of Nutrition 2009;101(5):680–7.
Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-
Baudry S, et al. Human plasma levels of vitamin E and
carotenoids are associated with genetic polymorphisms in
genes involved in lipid metabolism. Journal of Nutrition
2007;137(12):2653–9.
Gastaldi M, Diziere S, Defoort C, Portugal H, Lairon D,
Darmon M, et al. Sex-specific association of fatty acid
binding protein 2 and microsomal triacylglycerol transfer
protein variants with response to dietary lipid changes in the
3-mo Medi-RIVAGE primary intervention study. American
Journal of Clinical Nutrition 2007;86(6):1633–41.
Vincent S, Gerber M, Bernard MC, Defoort C, Loundou A,
Portugal H, et al. The Medi-RIVAGE study (Mediterranean
Diet, Cardiovascular Risks and Gene Polymorphisms):
rationale, recruitment, design, dietary intervention and
baseline characteristics of participants. Public Health
Nutrition 2004;7(4):531–42.
Vincent-Baudry S, Defoort C, Gerber M, Bernard MC,
Verger P, Helal O, et al. The Medi-RIVAGE study:
reduction of cardiovascular disease risk factors after a 3-
mo intervention with a Mediterranean-type diet or a low-
fat diet. American Journal of Clinical Nutrition 2005;82(5):
964–71.
Mensink 1987 {published data only}
∗ Mensink RP, Katan MB. Effect of monounsaturated
fatty acids versus complex carbohydrates on high-density
lipoproteins in healthy men and women. Lancet 1987;1
(8525):122–5.
Mensink 1989 {published data only}
∗ Mensink RP, Katan MB. Effect of a diet enriched with
monounsaturated or polyunsaturated fatty acids on levels
of low density and high density lipoprotein cholesterol in
healthy women and men. New England Journal of Medicine
1989;321:436–41.
Mensink 1990 {published data only}
∗ Mensink RP, Katan MB. Effect of dietary trans fatty acids
on high density and low density lipoprotein cholesterol
levels in healthy subjects. New England Journal of Medicine
1990;323:439–45.
Mensink 1990A {published and unpublished data}
∗ Mensink RP. Effect of monounsaturated fatty acids on
high-density and low-density lipoprotein cholesterol levels
and blood pressure in healthy men and women. PhD Thesis
1990.
Merrill 2011 {published data only}
Merrill RM, Aldana SG, Garrett J, Ross C, et al.
Effectiveness of a workplace wellness program for
maintaining health and promoting healthy behaviors.
Journal of Occupational & Environmental Medicine 2011;53:
782–7.
Metroville Health 2003 {published data only (unpublished sought but
not used)}
Aziz KU, Dennis B, Davis CE, Sun K, Burke G, Manolio T,
et al. Efficacy of CVD risk factor modification in a lower-
middle class community in Pakistan: the Metroville Health
Study. Asia Pacific Journal of Public Health 2003;15(1):
30–6.
Michalsen 2006 {published and unpublished data}
Michalsen A, Lehmann N, Pithan C, Knoblauch NT,
Moebus S, Kannenberg F, et al. Mediterranean diet has
38Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
no effect on markers of inflammation and metabolic risk
factors in patients with coronary artery disease. European
Journal of Clinical Nutrition 2006;60(4):478–85.
Miettinen 1994 {published data only}
∗ Miettinen TA, Vanhanen H. Dietary sitostanol related
to absorption, synthesis and serum level of cholesterol in
different apolipoprotein E phenotypes. Atherosclerosis 1994;
105(2):217–26.
Millar 1973 {published data only}
∗ Millar JH, Zilkha KJ, Langman MJS, Payling-Wright H,
Smith AD, Belin J, et al. Double-blind trial of linoleate
supplementation of the diet in multiple sclerosis. BMJ
1973;i:765–8.
Miller 1998 {published data only}
∗ Miller ER, Appel LJ, Risby TH. Effect of dietary
patterns on measures of lipid peroxidation: results from a
randomised clinical trial. Circulation 1998;98:2390–5.
Miller 2001 {published and unpublished data}
∗ Miller SL, Reber RJ, Chapman-Novakofski K. Prevalence
of CVD risk factors and impact of a two-year education
program for premenopausal women. Women’s Health Issues
2001;11(6):486–93.
Milne 1994 {published data only}
∗ Milne RM, Mann JI, Chisholm AW, Williams SM. Long-
term comparison of three dietary prescriptions in the
treatment of NIDDM. Diabetes Care 1994;17(1):74–80.
Minnesota HHP 1990 {published data only}
∗ Murray DM, Kurth C, Mullis R, Jeffery RW. Cholesterol
reduction through low-intensity interventions: results from
the Minnesota Heart Health Program. Preventive Medicine
1990;19(2):181–9.
Mishra 2013 {published data only}
Mishra S, Barnard ND, Gonzales J, Xu J, Agarwal U, Levin
S, et al. Nutrient intake in the GEICO multicenter trial:
the effects of a multicomponent worksite intervention.
European Journal of Clinical Nutrition 2013;67:1066–71.
Mitchell 2011 {published data only}
Mitchell D, Alaniz G, Castaneda X, Schenker M.
Application of a diabetes prevention programme in
immigrant Latino farm workers. Occupational and
Environmental Medicine 2011;68:A50.
Mokuno 1988 {published data only}
∗ Mokuno H, Yamada N, Sugimoto T, et al. Cholesterol
free diet in heterozygous familial hypercholesterolaemia:
significant lowering effect on plasma cholesterol (abstract).
Arteriosclerosis 1988;8(5):590a.
Moreno 1994 {published data only}
∗ Moreno VJ, Garcia AJ, Campillo AJ. Influence of diet
and physical exercise on plasma lipid concentrations in an
homogeneous sample of young Spanish Air Force pilots.
European Journal of Applied Physiology 1994;69(1):75–80.
Morrison 1950 {published data only}
∗ Morrison LM, Awierlein M, Wolfson E. The effects of low
fat low cholesterol diets on the serum lipids. Circulation
1950;2:475–6.
Morrison 1951 {published data only}
∗ Morrison LM. Reduction of mortality rate in coronary
atherosclerosis by a low cholesterol low fat diet. American
Heart Journal 1951;42:538–45.
Morrison 1960 {published data only}
∗ Morrison LM. Diet in coronary atherosclerosis. JAMA
1960;173:884–8.
Mortensen 1983 {published data only}
∗ Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J.
The effect of N-6 and N-3 polyunsaturated fatty acids on
hemostasis, blood lipids and blood pressure. Thrombosis
and Haemostasis 1983;50(2):543–6.
Moses 2014 {published data only}
Moses RG, Casey SA, Quinn EG, Cleary JM, Tapsell LC,
Milosavljevic M, et al. Pregnancy and Glycemic Index
Outcomes study: effects of low glycemic index compared
with conventional dietary advice on selected pregnancy
outcomes. American Journal of Clinical Nutrition 2014;99:
517–23.
MRFIT substudy 1986 {published data only}
Daniel GJ, Dolecek TA, Caggiula AW, Van HL, Epley
L, Randall BL. Increasing the use of meatless meals: a
nutrition intervention substudy in the Multiple Risk Factor
Intervention Trial (MRFIT). Journal of the AmericanDietetic
Association 1986;86(6):778–81.
MSDELTA 1995 {published data only}
∗ Ginsberg HN. New directions in dietary studies and heart
disease: the National Heart, Lung and Blood Institute
sponsored Multicenter Study of Diet Effects on Lipoproteins
and Thrombogenic Activity. Advances In Experimental
Medicine and Biology 1995;369:241–7.
MUFObes low fat 2007 {published and unpublished data}
Due A, Larsen TM, Hermansen K, Stender S, Holst
JJ, Toubro S, et al. Comparison of the effects on
insulin resistance and glucose tolerance of 6-mo high-
monounsaturated-fat, low-fat, and control diets. American
Journal of Clinical Nutrition 2008;87(4):855–62.
Due A, Larsen TM, Mu H, Hermansen K, Stender S,
Astrup A. Comparison of 3 ad libitum diets for weight-loss
maintenance, risk of cardiovascular disease, and diabetes:
a 6-mo randomized, controlled trial. American Journal of
Clinical Nutrition 2008;88(5):1232–41.
Rasmussen LG, Larsen TM, Mortensen PK, Due A,
Astrup A, Rasmussen Lone G, et al. Effect on 24-h energy
expenditure of a moderate-fat diet high in monounsaturated
fatty acids compared with that of a low-fat, carbohydrate-
rich diet: a 6-mo controlled dietary intervention trial.
American Journal of Clinical Nutrition 2007;85(4):1014–22.
Sloth B, Due A, Larsen TM, Holst JJ, Heding A, Astrup
A, et al. The effect of a high-MUFA, low-glycaemic index
diet and a low-fat diet on appetite and glucose metabolism
during a 6-month weight maintenance period. British
Journal of Nutrition 2009;101(12):1846–58.
MUFObes low vs mod 2007 {published and unpublished data}
Due A, Larsen TM, Hermansen K, Stender S, Holst
JJ, Toubro S, et al. Comparison of the effects on
39Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
insulin resistance and glucose tolerance of 6-mo high-
monounsaturated-fat, low-fat, and control diets. American
Journal of Clinical Nutrition 2008;87(4):855–62.
Due A, Larsen TM, Mu H, Hermansen K, Stender S,
Astrup A, et al. Comparison of 3 ad libitum diets for
weight-loss maintenance, risk of cardiovascular disease, and
diabetes: a 6-mo randomized, controlled trial. American
Journal of Clinical Nutrition 2008;88(5):1232–41.
Rasmussen LG, Larsen TM, Mortensen PK, Due A,
Astrup A, Rasmussen Lone G, et al. Effect on 24-h energy
expenditure of a moderate-fat diet high in monounsaturated
fatty acids compared with that of a low-fat, carbohydrate-
rich diet: a 6-mo controlled dietary intervention trial.
American Journal of Clinical Nutrition 2007;85(4):1014–22.
Sloth B, Due A, Larsen TM, Holst JJ, Heding A, Astrup
A, et al. The effect of a high-MUFA, low-glycaemic index
diet and a low-fat diet on appetite and glucose metabolism
during a 6-month weight maintenance period. British
Journal of Nutrition 2009;101(12):1846–58.
Mujeres Felices 2003 {published data only}
Fitzgibbon ML, Gapstur SM, Knight SJ. Mujeres felices por
ser saludables: a breast cancer risk reduction program for
Latino women. Preventive Medicine 2003;36(5):536–46.
Fitzgibbon ML, Gapstur SM, Knight SJ. Results of
Mujeres Felices por ser Saludables: a dietary/breast health
randomized clinical trial for Latino women. Annals of
Behavioral Medicine 2004;28(2):95–104.
Munsters 2010 {published data only}
Munsters MJ, Saris WH. The effect of sugar-sweetened
beverage intake on energy intake in an ad libitum 6-month
low-fat high-carbohydrate diet. Annals of Nutrition &
Metabolism 2010;57:116–23.
Mutanen 1997 {published data only}
∗ Mutanen M. Comparison between dietary
monounsaturated and polyunsaturated fatty acids as regards
diet-related diseases. Biomedicine and Pharmacotherapy
1997;51(8):314–7.
Muzio 2007 {published data only}
Muzio F, Mondazzi L, Harris WS, Sommariva D, Branchi
A, Muzio Fulvio, et al. Effects of moderate variations in the
macronutrient content of the diet on cardiovascular disease
risk factors in obese patients with the metabolic syndrome.
American Journal of Clinical Nutrition 2007;86(4):946–51.
Naglak 2000 {published data only (unpublished sought but not used)}
Naglak MC, Mitchell DC, Shannon BM, Pearson TA,
Harkness WL, Kris-Etherton PM. Nutrient adequacy of
diets of adults with hypercholesterolemia after a cholesterol-
lowering intervention: long term assessment. Journal of the
American Dietetic Association 2000;100(11):1385–91.
NAS 1987 {published data only}
∗ Chlebowski RT, Nixon DW, Blackburn GL, Jochimsen
P, Scanlon EF, Insull W, et al. A breast cancer Nutrition
Adjuvant Study (NAS): protocol design and initial patient
adherence. Breast Cancer Research and Treatment 1987;10
(1):21–9.
NCEP weight {published and unpublished data}
Wood PD, Stefanick ML, Williams PT, Haskell WL. The
effects on plasma lipoproteins of a prudent weight-reducing
diet, with or without exercise, in overweight men and
women. New England Journal of Medicine 1991;325(7):
461–6.
Neil 1995 {published data only}
∗ Neil HA, Roe L, Godlee RJ, Moore JW, Clark GM, Brown
J, et al. Randomised trial of lipid lowering dietary advice in
general practice: the effects on serum lipids, lipoproteins,
and antioxidants [see comments]. BMJ 1995;310(6979):
569–73.
Neverov 1997 {published data only}
∗ Neverov NI, Kaysen GA, Tareyeva IE. Effect of lipid-
lowering therapy on the progression of renal disease in
nondiabetic nephrotic patients. Contributions to Nephrology
1997;120:68–78.
Next Step 1995 {published and unpublished data}
Tilley BC, Vernon SW, Glanz K, Myers R, Sanders K,
Lu M, et al. Worksite cancer screening and nutrition
intervention for high-risk auto workers: design and baseline
findings of the Next Step Trial. Preventive Medicine 1997;
26(2):227–35.
Tilley BC, Vernon SW, Myers R, Glanz K, Lu M, Sanders
K, et al. Planning the next step. A screening promotion and
nutrition intervention trial in the work site. Annals of the
New York Academy of Sciences 1995;?:296–9.
Nordoy 1971 {published data only}
∗ Nordoy A, Rodset JM. The influence of dietary fats on
platelets in man. Acta Medica Scandinavica 1971;190(1-2):
27–34.
Norway Veg Oil 1968 {published data only}
∗ Natvig H, Borchgrevink CF, Dedichen J, Owren PA,
Schiotz EH, Westlund K. A controlled trial of the effect
of linolenic acid on incidence of coronary heart disease:
the Norwegian Vegetable Oil Experiment of 1965-66.
Scandinavian Journal of Clinical and Laboratory Investigation.
Supplement 1968;105:1–20.
Novotny 2012 {published data only}
Novotny R, Chen C, Williams AE, Albright CL, Nigg CR,
Oshiro CE, et al. US acculturation is associated with health
behaviors and obesity, but not their change, with a hotel-
based intervention among Asian-Pacific Islanders. Journal of
the Academy of Nutrition & Dietetics 2012;112:649–56.
Nutrition Ed Study 1980 {published data only (unpublished sought
but not used)}
Mojonnier ML, Hall Y, Berkson DM, Robinson E, Wethers
B, Pannbacker B, et al. Experience in changing food
habits of hyperlipidaemic men and women. Journal of the
American Dietetic Association 1980;77:140–8.
O’Brien 1976 {published data only}
∗ O’Brien JR, Etherington MD, Jamieson S. Effect of a
diet of polyunsaturated fats on some platelet-function tests.
Lancet 1976;2(7993):995–6.
40Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ODES 2001 {published data only}
Anderssen S, Holme I, Urdal P, Hjermann I. Diet and
exercise intervention have favourable effects on blood
pressure in mild hypertensives: the Oslo Diet and Exercise
Study (ODES). Blood Pressure 1995;4(6):343–9.
Anderssen SA, Hjermann I, Urdal P, Torjesen PA, Holme
I. Improved carbohydrate metabolism after physical
training and dietary intervention in individuals with the
“atherothrombogenic syndrome’. Oslo Diet and Exercise
Study (ODES). A randomized trial. Journal of Internal
Medicine 1996;240(4):203–9.
Holme I, Haaheim LL, Tonstad S, Hjermann I, Holme I,
Haaheim LL, et al. Effect of dietary and antismoking advice
on the incidence of myocardial infarction: a 16-year follow-
up of the Oslo Diet and Antismoking Study after its close.
Nutrition Metabolism & Cardiovascular Diseases 2006;16(5):
330–8.
Rokling-Andersen MH, Reseland JE, Veierod MB,
Anderssen SA, Jacobs DR Jr, Urdal P, et al. Effects of long-
term exercise and diet intervention on plasma adipokine
concentrations. American Journal of Clinical Nutrition
2007;86(5):1293–301.
The ODES Investigators. The Oslo Diet and Exercise
Study (ODES): design and objectives. Controlled Clinical
Trials 1993;14(3):229–43.
Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I,
Holme I, Urdal P. Lifestyle changes may reverse development
of the insulin resistance syndrome. The Oslo Diet and
Exercise Study: a randomized trial. Diabetes Care 1997;20
(1):26–31.
Oldroyd 2001 {published data only}
Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti
KG, et al. Randomised controlled trial evaluating lifestyle
interventions in people with impaired glucose tolerance.
Diabetes Research & Clinical Practice 2006;72(2):117–27.
Oldroyd JCU. Randomised controlled trial evaluating
the effectiveness of behavioural interventions to modify
cardiovascular risk factors in men and women with impaired
glucose tolerance: outcomes at 6 months. Diabetes Research
and Clinical Practice 2001;?(1):29–43.
Orazio 2011 {published data only}
Orazio LK, Isbel NM, Armstrong KA, Tarnarskyj J, Johnson
DW, Hale RE, et al. Evaluation of dietetic advice for
modification of cardiovascular disease risk factors in renal
transplant recipients. Journal of Renal Nutrition 2011;21:
462–71.
ORIGIN 2008 {published data only}
Origin Trial I, Gerstein H, Yusuf S, Riddle MC, Ryden L,
Bosch J. Rationale, design, and baseline characteristics for a
large international trial of cardiovascular disease prevention
in people with dysglycemia: the ORIGIN Trial (Outcome
Reduction with an Initial Glargine Intervention). American
Heart Journal 2008;155(1):26-32, 32.
Ornish 1990 {published data only}
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong
WT, Ports TA, et al. Can lifestyle changes reverse coronary
heart disease? The Lifestyle Heart Trial. Lancet 1990;336:
129–33.
Oslo Study 1980 {published data only}
Hjerkinn EM, Sandvik L, Hjermann I, Arnesen H. Effect
of diet intervention on long-term mortality in healthy
middle-aged men with combined hyperlipidaemia. Journal
of Internal Medicine 2004;255(1):68–73.
Hjermann I. Intervention of smoking and eating habits in
healthy men carrying high risk for coronary heart disease.
The Oslo Study. Acta Medica Scandinavica. Supplementum
1981;651:281–4.
Hjermann I. Smoking and diet intervention in healthy
coronary high risk men. Methods and 5-year follow-up of
risk factors in a randomized trial. The Oslo study. Journal
of the Oslo City Hospitals 1980;30(1):3–17.
Hjermann I, Leren P, Norman N, Helgeland A, Holme I.
Serum insulin response to oral glucose load during a dietary
intervention trial in healthy coronary high risk men: the
Oslo study. Scandinavian Journal of Clinical and Laboratory
Investigation 1980;40(1):89–94.
Hjermann I, Velve BK, Holme I, Leren P. Effect of diet and
smoking intervention on the incidence of coronary heart
disease. Report from the Oslo Study Group of a randomised
trial in healthy men. Lancet 1981;2(8259):1303–10.
Otago Weight Loss 2005 {published and unpublished data}
McAuley KA, Hopkins CM, Smith KJ, McLay RT,Williams
SM, Taylor RW, et al. Comparison of a high-fat and high-
protein diets with a high-carbohydrate diet in insulin-
resistant obese women. Diabetologia 2005;48:8–16.
McAuley KA, Smith KJ, Taylor RW, McLay RT, Williams
SM, Mann JI. Long-term effects of popular dietary
approaches on weight loss and features of insulin resistance.
International Journal of Obesity 2006;30:342–9.
Pandey 2013 {published data only}
Pandey RM, Agrawal A, Misra A, Vikram NK, Misra P, Dey
S, et al. Population-based intervention for cardiovascular
diseases related knowledge and behaviours in Asian Indian
women. Indian Heart Journal 2013;65:40–7.
Pascale 1995 {published data only}
∗ Pascale RW, Wing RR, Butler BA, Mullen M, Bononi
P. Effects of a behavioral weight loss program stressing
calorie restriction versus calorie plus fat restriction in obese
individuals with NIDDM or a family history of diabetes.
Diabetes Care 1995;18(9):1241–8.
Paz-Tal 2013 {published data only}
Paz-Tal O, Canfi A, Marko R, Katorza E, Karpas Z,
Schwarzfuchs D, et al. Dynamics of magnesium, copper,
selenium and zinc serum concentrations for 2-year dietary
intervention. e-SPEN Journal 2013;8:e100–7.
PEP 2001 {published data only}
Ohrig E, Geib HC, Haas G-M, Schwandt P. The prevention
education program (PEP) Nuremberg: design and baseline
data of a family oriented intervention study. International
Journal of Obesity 2001;25(Suppl 1):S89–92.
41Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PHYLLIS 1993 {published data only}
Anon. Plaque Hypertension Lipid-Lowering Italian
Study (PHYLLIS): a protocol for non-invasive evaluation
of carotid atherosclerosis in hypercholesterolaemic
hypertensive subjects. Journal of Hypertension. Supplement
1993;11(Suppl 5):S314–5.
Bond GM, Crepaldi G, Zanchetti A, Avogaro P, Marubini E,
Maseri A, et al. Plaque hypertension lipid-lowering Italian
study (PHYLLIS): a protocol for non-invasive evaluation
of carotid atherosclerosis in hypercholesterolaemic
hypertensive subjects. Journal of Hypertension 1993;11
(Suppl 5):S314–5.
PREDIMED 2007 {published data only (unpublished sought but not
used)}
Buil-Cosiales P, Irimia P, Ros E, Riverol M, Gilabert R,
Martinez-Vila E, et al. Dietary fibre intake is inversely
associated with carotid intima-media thickness: a cross-
sectional assessment in the PREDIMED study. European
Journal of Clinical Nutrition 2009;63(10):1213–9.
Estruch R, Martinez-Gonzalez MA, Corella D, Salas-
Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of
a Mediterranean-style diet on cardiovascular risk factors:
a randomized trial.[Summary for patients in Ann Intern
Med. 2006 Jul 4;145(1):I11; PMID: 16818920]. Annals of
Internal Medicine 2006;145(1):1–11.
Razquin C, Martinez JA, Martinez-Gonzalez MA, Mitjavila
MT, Estruch R, Marti A, et al. A 3 years follow-up of a
Mediterranean diet rich in virgin olive oil is associated with
high plasma antioxidant capacity and reduced body weight
gain. European Journal of Clinical Nutrition 2009;63(12):
1387–93.
Salas-Salvado J, Fernandez-Ballart J, Ros E, Martinez-
Gonzalez MA, Fito M, Estruch R, et al. Effect of a
Mediterranean diet supplemented with nuts on metabolic
syndrome status: one-year results of the PREDIMED
randomized trial. Archives of Internal Medicine 2008;168
(22):2449–58.
Salas-Salvado J, Garcia-Arellano A, Estruch R, Marquez-
Sandoval F, Corella D, Fiol M, et al. Components of the
Mediterranean-type food pattern and serum inflammatory
markers among patients at high risk for cardiovascular
disease. European Journal of Clinical Nutrition 2008;62(5):
651–9.
Sanchez-Tainta A, Estruch R, Bullo M, Corella D, Gomez-
Gracia E, Fiol M, et al. Adherence to a Mediterranean-type
diet and reduced prevalence of clustered cardiovascular risk
factors in a cohort of 3,204 high-risk patients. European
Journal of Cardiovascular Prevention & Rehabilitation 2008;
15(5):589–93.
Schroder H, de la Torre R, Estruch R, Corella D,
Martinez-Gonzalez MA, Salas-Salvado J, et al. Alcohol
consumption is associated with high concentrations of
urinary hydroxytyrosol. American Journal of Clinical
Nutrition 2009;90(5):1329–35.
Toledo E, Delgado-Rodriguez M, Estruch R, Salas-Salvado
J, Corella D, Gomez-Gracia E, et al. Low-fat dairy products
and blood pressure: follow-up of 2290 older persons at high
cardiovascular risk participating in the PREDIMED study.
British Journal of Nutrition 2009;101(1):59–67.
Waterhouse AL. ”Resveratrol metabolites in urine as
biomarker of wine intake in free-living subjects: The
PREDIMED Study“. Free Radical Biology & Medicine
2009;46(12):1561.
Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventos RM,
Estruch R, Martinez-Gonzalez MA, Bullo M, et al.
Resveratrol metabolites in urine as a biomarker of wine
intake in free-living subjects: The PREDIMED Study. Free
Radical Biology & Medicine 2009;46(12):1562–6.
Zazpe I, Estruch R, Toledo E, Sanchez-Tainta A, Corella D,
Bullo M, et al. Predictors of adherence to a Mediterranean-
type diet in the PREDIMED trial. European Journal of
Nutrition 2010;49(2):91–9.
Zazpe I, Sanchez-Tainta A, Estruch R, Lamuela-Raventos
RM, Schroder H, Salas-Salvado J, et al. A large randomized
individual and group intervention conducted by registered
dietitians increased adherence to Mediterranean-type diets:
the PREDIMED study. Journal of the American Dietetic
Association 2008;108(7):1134–44.
PREMIER 2003 {published and unpublished data}
Appel LJ, Champagne CM, Harsha DW, Cooper LS,
Obarzanek E, Elmer PJ, et al. Effects of comprehensive
lifestyle modification on blood pressure control: main
results of the PREMIER clinical trial. JAMA 2003;289(16):
2083–93.
Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton
D, Stevens VJ, Young DR, et al. Effects of comprehensive
lifestyle modification on diet, weight, physical fitness, and
blood pressure control: 18-month results of a randomized
trial. Annals of Internal Medicine 2006;144(7):485–95.
Ledikwe JH, Rolls BJ, Smiciklas-Wright H, Mitchell DC,
Ard JD, Champagne C, et al. Reductions in dietary energy
density are associated with weight loss in overweight and
obese participants in the PREMIER trial. American Journal
of Clinical Nutrition 2007;85(5):1212–21.
Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein
AC, et al. Effects of PREMIER lifestyle modifications on
participants with and without the metabolic syndrome.
Hypertension 2007;50(4):609–16.
Lin PH, Appel LJ, Funk K, Craddick S, Chen C, Elmer
P, et al. The PREMIER intervention helps participants
follow the Dietary Approaches to Stop Hypertension
dietary pattern and the current Dietary Reference Intakes
recommendations. Journal of the American Dietetic
Association 2007;107(9):1541–51.
Lin PH, Wang Y, Grambow SC, Goggins W, Almirall D.
Dietary saturated fat intake is negatively associated with
weight maintenance among the PREMIER participants.
Obesity 2012;20:571–5.
Lin PH, Yancy WS Jr, Pollak KI, Dolor RJ, Marcello J,
Samsa GP, et al. The influence of a physician and patient
intervention program on dietary intake. Journal of the
Academy of Nutrition & Dietetics 2013;113:1465–75.
Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions
reduce coronary heart disease risk: results from the
42Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PREMIER Trial. Circulation 2009;119(15):2026–31.
McGuire HL, Svetkey LP, Harsha DW, Elmer PJ, Elmer PJ,
Appel LJ, et al. Comprehensive lifestyle modification and
blood pressure control: a review of the PREMIER trial.
Journal of Clinical Hypertension (Greenwich., Conn.) 2004;6
(7):383–90.
Obarzanek E, Vollmer WM, Lin PH, Cooper LS, Young
DR, Ard JD, et al. Effects of individual components of
multiple behavior changes: the PREMIER trial. American
Journal of Health Behavior 2007;31(5):545–60.
Svetkey LP, Erlinger TP, Vollmer WM, Feldstein A, Cooper
LS, Appel LJ, et al. Effect of lifestyle modifications on blood
pressure by race, sex, hypertension status, and age. Journal
of Human Hypertension 2005;19(1):21–31.
Svetkey LP, Harsha DW, Vollmer WM, Stevens VJ,
Obarzanek E, Elmer PJ, et al. Premier: a clinical trial of
comprehensive lifestyle modification for blood pressure
control: rationale, design and baseline characteristics.
Annals of Epidemiology 2003;13(6):462–71.
Pritchard 2002 {published data only}
∗ Pritchard JE, Nowson CA, Billington T, Wark JD.
Benefits of a year-long workplace weight loss program on
cardiovascular risk factors. Nutrition and Dietetics 2002;59
(2):87–96.
Puget Sound EP {published and unpublished data}
∗ Kristal AR, Curry SJ, Shattuck AL, Feng Z, Li S. A
randomized trial of a tailored, self-help dietary intervention:
the Puget Sound Eating Patterns Study. Preventive Medicine
2000;31:380–9.
Rabast 1979 {published data only}
∗ Rabast U, Schonborn J, Kasper H. Dietetic treatment of
obesity with low and high-carbohydrate diets: comparative
studies and clinical results. International Journal of Obesity
1979;3(3):201–11.
Rabkin 1981 {published data only}
∗ Rabkin SW, Boyko E, Streja DA. Relationship of weight
loss and cigarette smoking to changes in high-density
lipoprotein cholesterol. American Journal of Clinical
Nutrition 1981;34:1764–8.
Radack 1990 {published data only}
∗ Radack K, Deck C, Huster G. The comparative
effects of n-3 and n-6 polyunsaturated fatty acids on
plasma fibrinogen levels: a controlled clinical trial in
hypertriglyceridemic subjects. Journal of the American
College of Nutrition 1990;9(4):352–7.
Rasmussen 1995 {published data only}
∗ Rasmussen OW, Thomsen CH, Hansen KW, Vesterlund
M, Winther E, Hermansen K. Favourable effect of olive
oil in patients with non-insulin-dependent diabetes. The
effect on blood pressure, blood glucose and lipid levels of a
high-fat diet rich in monounsaturated fat compared with a
carbohydrate-rich diet [Gunstig virkning af olivenolie hos
ikkeinsulinkraevende diabetikere. Virkningen pa blodtryk,
blodglukose og lipidniveauer af en dioet med et hojt indhold
af monoumoettet fedt sammenlignet med en kulhydratrig
dioet]. Ugeskrift for Laeger 1995;157(8):1028–32.
Reaven 2001 {published data only}
Reaven GM, Abbasi F, Bernhart S, Coulston A, Darnell
B, Dashti N, et al. Insulin resistance, dietary cholesterol,
and cholesterol concentration in postmenopausal women.
Metabolism: Clinical & Experimental 2001;50(5):594–7.
Reid 2002 {published data only}
Reid R, Fodor G, Lydon-Hassen K, D’Angelo MS, McCrea
J, Bowlby M, et al. Dietary counselling for dyslipidemia
in primary care: results of a randomized trial. Canadian
Journal of Dietetic Practice & Research 2002;63(4):169–75.
Renaud 1986 {published data only}
∗ Renaud S, Godsey F, Dumont E, Thevenon C, Ortchanian
E, Martin JL. Influence of long-term diet modification
on platelet function and composition in Moselle farmers.
American Journal of Clinical Nutrition 1986;43:136–50.
Rivellese 2003 {published data only}
Rivellese AA, Maffettone A, Vessby B, Uusitupa M,
Hermansen K, Berglund L, et al. Effects of dietary
saturated, monounsaturated and n-3 fatty acids on fasting
lipoproteins, LDL size and post-prandial lipid metabolism
in healthy subjects. Atherosclerosis 2003;167(1):149–58.
Roderick 1997 {published and unpublished data}
∗ Roderick P, Ruddock V, Hunt P, Miller G. A randomized
trial to evaluate the effectiveness of dietary advice by practice
nurses in lowering diet-related coronary heart disease risk.
British Journal of General Practice 1997;47(414):7–12.
Roman CHD prev 1986 {published data only}
Anon. The Roman Coronary Disease Prevention Project:
effectiveness of intervention and reduction of mortality over
a 10-year period [II Progetto Romano di Prevenzione della
Cardiopatia Coronarica: efficacia dell’intervento e riduzione
della mortalita in 10 anni]. Giornale Italiano di Cardiologia
1986;16(3):196–202.
Research Group of the Rome Project of Coronary Heart
Disease Prevention. Eight-year follow-up results from
the Rome Project of Coronary Heart Disease Prevention.
Research Group of the Rome Project of Coronary Heart
Disease Prevention. Preventive Medicine 1986;15(2):
176–91.
Rose 1987 {published data only}
∗ Rose DP, Boyar AP, Cohen C, Strong LE. Effect of a low
fat diet on hormone levels in women with cystic breast
disease I Serum steroids and gonadotropins. Journal of the
National Cancer Institute 1987;78:623–6.
Rusu 2013 {published data only}
Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta
I, et al. Effects of lifestyle changes including specific dietary
intervention and physical activity in the management of
patients with chronic hepatitis C--a randomized trial.
Nutrition Journal 2013;12:119.
Rusu ED, Jinga M, Enache G, Rusu F, Dragomir A, Ancuta
I, et al. Effects of the prudent diet versus low fat diet in
cytokines profile in patients with diabetes and chronic
hepatitis C. Diabetologia 2012;55:S361–2.
43Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sacks 2009 {published and unpublished data}
Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton
SD, et al. Comparison of weight-loss diets with different
compositions of fat, protein, and carbohydrates. New
England Journal of Medicine 2009;360(9):859–73.
Salas-Salvado 2014 {published data only}
Salas-Salvado J, Bullo M, Estruch R, Ros E, Covas M
I, Ibarrola-Jurado N, et al. Prevention of diabetes with
Mediterranean diets: a subgroup analysis of a randomized
trial. Annals of Internal Medicine 2014;160:1–10.
Sandstrom 1992 {published data only}
∗ Sandstrom B, Marckmann P, Bindslev N. An eight-month
controlled study of a low-fat high-fibre diet: effects on
blood lipids and blood pressure in healthy young subjects.
European Journal of Clinical Nutrition 1992;46(2):95–109.
Sasaki 2000 {published data only}
Sasaki S. Change and 1-year maintenance of nutrient
and food group intakes at a 12-week worksite dietary
intervention trial for men at high risk of coronary heart
disease. Journal of Nutritional Science & Vitaminology 2000;
46(1):15–22.
Schaefer 1995 {published data only}
∗ Schaefer EJ, Lichtenstein AH, Lamon-Fava S, McNamara
JR, Schaefer MM, Rasmussen H, et al. Body weight and low
density lipoprotein cholesterol changes after consumption
of a low fat ad libitum diet. JAMA 1995;274:1450–5.
Schaefer 1995A {published data only}
∗ Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH,
Li Z, Rasmussen H, et al. Efficacy of a National Cholesterol
Education Program Step 2 diet in normolipidaemic and
hypercholesterolaemic middle-aged and elderly men and
women. Arteriosclerosis, Thrombosis, and Vascular Biology
1995;15:1079–85.
Schectman 1996 {published data only}
∗ Schectman G, Wolff N, Byrd JC, Hiatt JG, Hartz A.
Physician extenders for cost-effective management of
hypercholesterolemia. Journal of General Internal Medicine
1996;11(5):277–86.
Schlierf 1995 {published data only}
∗ Schlierf G, Schuler G, Hambrecht R, Niebauer J, Hauer
K, Vogel G, et al. Treatment of coronary heart disease by
diet and exercise. Journal of Cardiovascular Pharmacology
1995;25 Suppl 4:S32–4.
Seppanen-Laakso {published data only}
∗ Seppanen-Laakso T, Vanhanen H, Laakso I, Kohtamaki
H, Viikari J. Replacement of butter on bread by rapeseed oil
and rapeseed oil-containing margarine: effects on plasma
fatty acid composition and serum cholesterol. British
Journal of Nutrition 1992;68:639–54.
Shai 2012 {published data only}
Shai I. The effect of low-carb, Mediterranean and low-
fat diets on renal function; a 2-year dietary intervention
randomized controlled trial (direct). Obesity Facts 2012;5:
19.
Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G,
Rudich A, et al. Dietary intervention to reverse carotid
atherosclerosis. Circulation 2010;121:1200–8.
Singh 1990 {published data only}
∗ Singh RB, Sircar AR, Rastogi SS, Singh R. Dietary
modulators of blood pressure in hypertension. European
Journal of Clinical Nutrition 1990;44(4):319–27.
Singh 1991 {published data only}
Singh RB, Rastogi SS, Sircar AR. Dietary strategies for
risk-factor modification to prevent cardiovascular diseases.
Nutrition 1991;7(3):210–4.
Singh 1992 {published data only}
Singh RB, Niaz MA, Agarwal P, Begom R, Rastogi SS. Effect
of antioxidant-rich foods on plasma ascorbic acid, cardiac
enzyme, and lipid peroxide levels in patients hospitalized
with acute myocardial infarction. Journal of the American
Dietetic Association 1995;95(7):775–80.
Singh RB, Niaz MA, Ghosh S. Effect on central obesity and
associated disturbances of low-energy, fruit- and vegetable-
enriched prudent diet in north Indians. Postgraduate
Medical Journal 1994;70(830):895–900.
∗ Singh RB, Rastogi SS, Verma R, Bolaki L, Singh R. An
Indian experiment with nutritional modulation in acute
myocardial infarction. American Journal of Cardiology 1992;
69(9):879–85.
Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh
S, et al. Randomised controlled trial of cardioprotective diet
in patients with recent acute myocardial infarction: results
of one year follow up. BMJ 1992;304(6833):1015–9.
Siqueira-Catania 2010 {published data only}
Siqueira-Catania A Barros. Cardiometabolic benefits
induced by lifestyle changes are mediated by inflammation
in a Brazilian prevention program. Diabetes 2010;
Conference:2010.
Sirtori 1992 {published data only}
∗ Sirtori CR, Gatti E, Tremoli E, Galli C, Gianfranceschi
G, Franceschini G, et al. Olive oil, corn oil, and n-3 fatty
acids differently affect lipids, lipoproteins, platelets, and
superoxide formation in type II hypercholesterolemia.
American Journal of Clinical Nutrition 1992;56(1):113–22.
SLIM 2008 {published data only}
Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris
WH, Blaak EE, et al. Impact of 3-year lifestyle intervention
on postprandial glucose metabolism: the SLIM study.
Diabetic Medicine 2008;25(5):597–605.
Sollentuna Diet {published and unpublished data}
Hellenius M-L. Prevention of cardiovascular disease: studies on
the role of diet and exercise in the prevention of cardiovascular
disease among middle-aged men [PhD Thesis]. Huddinge,
Sweden: Karolinska Institute, 1995.
Hellenius M-L, Krakau I, De Faire U. Favourable long-term
effects from advice on diet and exercise given to healthy
44Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
men with raised cardiovascular risks. Nutrition, Metabolism
& Cardiovascular Diseases 1997;7:293–300.
Hellenius ML, Brismar KE, Berglund BH, de FU. Effects
on glucose tolerance, insulin secretion, insulin-like growth
factor 1 and its binding protein, IGFBP-1, in a randomized
controlled diet and exercise study in healthy, middle-aged
men. Journal of Internal Medicine 1995;238(2):121–30.
Hellenius ML, Dahlof C, Aberg H, Krakau I, de FU.
Quality of life is not negatively affected by diet and exercise
intervention in healthy men with cardiovascular risk factors.
Quality of Life Research 1995;4(1):13–20.
Hellenius ML, de FU, Berglund B, Hamsten A, Krakau
I. Diet and exercise are equally effective in reducing
risk for cardiovascular disease. Results of a randomized
controlled study in men with slightly to moderately raised
cardiovascular risk factors. Atherosclerosis 1993;103(1):
81–91.
Naslund GK, Fredrikson M, Hellenius ML, de FU. Effect
of diet and physical exercise intervention programmes on
coronary heart disease risk in smoking and non-smoking
men in Sweden. Journal of Epidemiology and Community
Health 1996;50(2):131–6.
Sollentuna Diet & Ex {published and unpublished data}
Hellenius M-L. Prevention of cardiovascular disease: studies on
the role of diet and exercise in the prevention of cardiovascular
disease among middle-aged men [PhD Thesis]. Huddinge,
Sweden: Karolinska Institute, 1995.
Hellenius M-L, Krakau I, De Faire U. Favourable long-term
effects from advice on diet and exercise given to healthy
men with raised cardiovascular risks. Nutrition, Metabolism,
and Cardiovascular Diseases 1997;7:293–300.
Hellenius ML, Brismar KE, Berglund BH, de FU. Effects
on glucose tolerance, insulin secretion, insulin-like growth
factor 1 and its binding protein, IGFBP-1, in a randomized
controlled diet and exercise study in healthy, middle-aged
men. Journal of Internal Medicine 1995;238(2):121–30.
Hellenius ML, Dahlof C, Aberg H, Krakau I, de FU.
Quality of life is not negatively affected by diet and exercise
intervention in healthy men with cardiovascular risk factors.
Quality of Life Research 1995;4(1):13–20.
Hellenius ML, de FU, Berglund B, Hamsten A, Krakau
I. Diet and exercise are equally effective in reducing
risk for cardiovascular disease. Results of a randomized
controlled study in men with slightly to moderately raised
cardiovascular risk factors. Atherosclerosis 1993;103(1):
81–91.
Naslund GK, Fredrikson M, Hellenius ML, de FU. Effect
of diet and physical exercise intervention programmes on
coronary heart disease risk in smoking and non-smoking
men in Sweden. Journal of Epidemiology and Community
Health 1996;50(2):131–6.
Sopotsinskaia 1992 {published data only}
Sopotsinskaia EB, Balitskii KP, Tarutinov VI, Zhukova
VM, Semenchuk DD, Kozlovskaia SG, et al. Experience
with the use of a low-calorie diet in breast cancer patients to
prevent metastasis [Opyt primeneniia nizkokaloriinoi diety
u bol’nykh rakom molochnoi zhelezy s tsel’iu profilaktiki
metastazi]. Voprosy Onkologii 1992;38(5):592–9.
Staff HHP 1994 {published data only}
∗ Barratt A, Reznik R, Irwig L, Cuff A, Simpson JM,
Oldenburg B, et al. Work-site cholesterol screening and
dietary intervention: the Staff Healthy Heart Project.
Steering Committee. American Journal of Public Health
1994;84(5):779–82.
Stanford NAP 1997 {published data only}
∗ Howard PB, Winkleby MA, Albright CL, Bruce B,
Fortmann SP. The Stanford Nutrition Action Program: a
dietary fat intervention for low-literacy adults. American
Journal of Public Health 1997;87(12):1971–6.
Stanford Weight {published and unpublished data}
Williams PT, Krauss RM, Stefanick ML, Vranizan KM,
Wood PD. Effects of low-fat diet, calorie restriction, and
running on lipoprotein subfraction concentrations in
moderately overweight men. Metabolism 1994;43(5):
655–63.
Starmans 1995 {published data only}
∗ Starmans KM, Lustermans FT, Kragten HA, Struijker
BH, Rilla H. Lowering cholesterol in patients with
mild hypercholesterolaemia does not improve functional
properties of large arteries [Abstract]. Netherlands Journal
Of Medicine 1995;46:A70.
Steinbach 1996 {published data only}
∗ Steinbach M. A Romanian contribution to the
epidemiology and prevention of cardiovascular diseases.
Romanian Journal of Internal Medicine 1996;34(1-2):
137–48.
Steptoe 2001 {published data only}
Steptoe A, Kerry S, Rink E, Hilton S. The impact of
behavioral counseling on stage of change in fat intake,
physical activity, and cigarette smoking in adults at increased
risk of coronary heart disease. American Journal of Public
Health 2001;91(2):265–9.
Stevens 2002 {published and unpublished data}
Stevens VJ, Glasgow RE, Toobert DJ, Karanja N, Smith
KS. One-year results from a brief, computer-assisted
intervention to decrease consumption of fat and increase
consumption of fruits and vegetables. Preventive Medicine
2003;36:594–600.
Stevens VJ, Glasgow RE, Toobert DJ, Karanja N, Smith KS.
Randomized trial of a brief dietary intervention to decrease
consumption of fat and increase consumption of fruits and
vegetables. American Journal of Health Promotion 2002;16
(3):129–34.
Stevenson 1988 {published data only}
∗ Stevenson DW, Darga LL, Spafford TR, Ahmad N,
Lucas CP. Variable effects of weight loss on serum lipids
and lipoproteins in obese patients. International Journal of
Obesity 1988;12:495–502.
Sweeney 2004 {published data only}
Sweeney M. Effects of very low-fat diets on anginal
symptoms. Medical Hypotheses 2004;63(3):553.
45Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
TAIM 1989 {published data only}
Davis BR, Blaufox MD, Hawkins CM, Langford HG,
Oberman A, Swencionis C, et al. Trial of antihypertensive
interventions and management. Design, methods, and
selected baseline results. Controlled Clinical Trials 1989;10
(1):11–30.
Davis BR, Blaufox MD, Oberman A, Wassertheil SS,
Zimbaldi N, Cutler JA, et al. Reduction in long-term
antihypertensive medication requirements. Effects of weight
reduction by dietary intervention in overweight persons
with mild hypertension. Archives of Internal Medicine 1993;
153(15):1773–82.
Davis BR, Oberman A, Blaufox MD, Wassertheil SS,
Hawkins CM, Cutler JA, et al. Effect of antihypertensive
therapy on weight loss. The Trial of Antihypertensive
Interventions and Management Research Group.
Hypertension 1992;19(4):393–9.
Langford HG, Davis BR, Blaufox D, Oberman A,
Wassertheil Smoller S, Hawkins M. Effect of drug and diet
treatment of mild hypertension on diastolic blood pressure.
The TAIM Research. Hypertension 1991;17(2):210–7.
Oberman A, Wassertheil Smoller S, Langford HG, Blaufox
MD, Davis BR, Blaszkowski T, et al. Pharmacologic and
nutritional treatment of mild hypertension: changes in
cardiovascular risk status. Annals of Internal Medicine 1990;
112(2):89–95.
Wassertheil Smoller S, Davis BR, Breuer B, Chee JC,
Oberman A, Blaufox MD. Differences in precision of
dietary estimates among different population subgroups.
Annals of Epidemiology 1993;3:619–28.
Wassertheil Smoller S, Oberman A, Blaufox MD, Davis B,
Langford H. The Trial of Antihypertensive Interventions
and Management (TAIM) Study. Final results with regard
to blood pressure, cardiovascular risk, and quality of life.
American Journal of Hypertension 1992;5(1):37–44.
Wylie Rosett J, Wassertheil Smoller S, Blaufox MD,
Davis BR, Langford HG, Oberman A, et al. Trial of
antihypertensive intervention and management: greater
efficacy with weight reduction than with a sodium-
potassium intervention. Journal of the American Dietetic
Association 1993;93(4):408–15.
Take Heart II 1997 {published data only}
∗ Glasgow RE, Terborg JR, Strycker LK, Boles SM,
Hollis JF. Take Heart II: Replication of a worksite health
promotion trial. Journal of Behavioral Medicine 1997;20:
143–61.
Tapsell 2004 {published data only (unpublished sought but not used)}
Tapsell LC, Hokman A, Sebastiao A, Denmeade S, Martin
G, Calvert GD, et al. The impact of usual dietary patterns,
selection of significant foods and cuisine choices on
changing dietary fat under ’free living’ conditions. Asia
Pacific Journal of Clinical Nutrition 2004;13(1):86–91.
Taylor 1991 {published data only}
∗ Taylor CB, Fortmann SP, Flora J, Kayman S, Barrett
DC, Jatulis D, et al. Effect of long-term community
health education on body mass index. The Stanford Five-
City Project. American Journal of Epidemiology 1991;134:
235–49.
THIS DIET 2008 {published data only}
Tuttle KR, Shuler LA, Packard DP, Milton JE, Daratha
KB, Bibus DM, et al. Comparison of low-fat versus
Mediterranean-style dietary intervention after first
myocardial infarction (from The Heart Institute of Spokane
Diet Intervention and Evaluation Trial). American Journal
of Cardiology 2008;101(11):1523–30.
TOHP I 1992 {published data only}
Anon. The effects of nonpharmacologic interventions on
blood pressure of persons with high normal levels. Results
of the Trials of Hypertension Prevention, Phase I. JAMA
1992;267(9):1213–20.
Kumanyika SK, Hebert PR, Cutler JA, Lasser VI, Sugars
CP, Steffen Batey L, et al. Feasibility and efficacy of sodium
reduction in the Trials of Hypertension Prevention, phase I.
Trials of Hypertension Prevention Collaborative Research
Group. Hypertension 1993;22(4):502–12.
Satterfield S, Cutler JA, Langford HG, Applegate WB,
Borhani NO, Brittain E, et al. Trials of hypertension
prevention. Phase I design. Annals of Epidemiology 1991;1
(5):455–71.
Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook
NR, Hebert P, et al. Weight loss intervention in phase
I of the trials of hypertension prevention. The TOHP
Collaborative Research Group. Archives of Internal Medicine
1993;153(7):849–58.
Whelton PK, Hebert PR, Cutler J, Applegate WB, Eberlein
KA, Klag MJ, et al. Baseline characteristics of participants
in phase I of the Trials of Hypertension Prevention. Annals
of Epidemiology 1992;2(3):295–310.
Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani
NO, Hennekens CH, et al. Efficacy of nonpharmacologic
interventions in adults with high-normal blood pressure:
results from phase 1 of the Trials of Hypertension
Prevention. Trials of Hypertension Prevention Collaborative
Research Group. American Journal of Clinical Nutrition
1997;65(2 Suppl):652S–60S.
TONE 1997 {published data only}
Whelton PK, Appel LJ, Espeland MA, Applegate WB,
Ettinger-WH J, Kostis JB, et al. Sodium reduction and
weight loss in the treatment of hypertension in older
persons: a randomized controlled trial of nonpharmacologic
interventions in the elderly (TONE). TONE Collaborative
Research Group. JAMA 1998;279(11):839–46.
Whelton PK, Babnson J, Appel LJ, Charleston J, Cosgrove
N, Espeland MA, et al. Recruitment in the Trial of
Nonpharmacologic Intervention in the Elderly (TONE).
Journal of the American Geriatrics Society 1997;45(2):
185–93.
Toobert 2003 {published data only}
Toobert DJ, Glasgow RE, Strycker LA, Barrera M Jr,
Radcliffe JL, Wander RC, et al. Biologic and quality-of-
life outcomes from the Mediterranean Lifestyle Program:
a randomized clinical trial. Diabetes Care 2003;26(8):
2288–93.
46Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Toronto Polyp Prev 1994 {published and unpublished data}
McKeown-Eyssen GE, Bright SE, Bruce WR, Jazmaji V. A
randomized trial of a low fat high fibre diet in the recurrence
of colorectal polyps. Toronto Polyp Prevention Group.
Journal of Clinical Epidemiology 1994;47(5):525–36.
Towle 1994 {published data only}
∗ Towle LA, Bergman EA, Joseph E. Low-fat bison-hybrid
ground meat has no effects on serum lipid levels in a study
of 12 men. Journal of the American Dietetic Association
1994;94(5):546–8.
TRANSFACT 2006 {published data only}
Chardigny JM, Malpuech-Brugere C, Dionisi F, Bauman
DE, German B, Mensink RP, et al. Rationale and design
of the TRANSFACT project phase I: a study to assess the
effect of the two different dietary sources of trans fatty acids
on cardiovascular risk factors in humans. Contemporary
Clinical Trials 2006;27(4):364–73.
Chardigny JMD. Do trans fatty acids from industrially
produced sources and from natural sources have the same
effect on cardiovascular disease risk factors in healthy
subjects? Results of the trans Fatty Acids Collaboration
(TRANSFACT) study. American Journal of Clinical
Nutrition 2008;108(3):558–66.
Treatwell 1992 {published and unpublished data}
∗ Sorensen G, Morris DM, Hunt MK, Hebert JR, Harris
DR, Stoddard A, et al. Work-site nutrition intervention and
employees’ dietary habits: the Treatwell program. American
Journal of Public Health 1992;82(6):877–80.
Tromso Heart 1989 {published data only}
∗ Knutsen SF, Knutsen R. The Tromso Heart Study: family
approach to intervention on CHD. Feasibility of risk
factor reduction in high-risk persons--project description.
Scandinavian Journal of Social Medicine 1989;17:109–19.
Turku Weight {published and unpublished data}
Hakala P, Karvetti RL. Weight reduction on lactovegetarian
and mixed diets. European Journal of Clinical Nutrition
1989;43:421–30.
Marniemi J, Seppanen A, Hakala P. Long-term effects on
lipid metabolism of weight reduction on lactovegetarian
and mixed diet. International Journal of Obesity 1990;14:
113–25.
Turpeinen 1960 {published data only}
∗ Turpeinen O, Roine P, Pekkarinen M, Karvonen MJ,
Rautanen Y, Runeberg J, et al. Effect on serum-cholesterol
level of replacement of dietary milk fat by soybean oil.
Lancet 1960;1:196–8.
UK PDS 1996 {published data only}
Turner R, Cull C, Holman R. United Kingdom Prospective
Diabetes Study 17: a 9-year update of a randomized,
controlled trial on the effect of improved metabolic control
on complications in non-insulin-dependent diabetes
mellitus. Annals of Internal Medicine 1996;124(1 Pt 2):
136–45.
Turner RC, Holman RR. Lessons from UK prospective
diabetes study. Diabetes Research and Clinical Practice 1995;
28 Suppl:S151–7.
Urbach 1952 {published data only}
∗ Urbach R, Hildreth EA, Wackerman MT. The therapeutic
uses of low fat, low cholesterol diets: I. Treatment of
essential familial xanthomatosis. Journal of Clinical
Nutrition 1952;1:52–6.
Uusitupa 1993 {published data only}
∗ Uusitupa M, Laitinen J, Siitonen O, Vanninen E, Pyorala
K. The maintenance of improved metabolic control after
intensified diet therapy in recent type 2 diabetes. Diabetes
Research and Clinical Practice 1993;19(3):227–38.
Uusitupa 2013 {published data only}
Uusitupa M, Hermansen K, Savolainen M J, Schwab U,
Kolehmainen M, Brader L, et al. Effects of an isocaloric
healthy Nordic diet on insulin sensitivity, lipid profile
and inflammation markers in metabolic syndrome - a
randomized study (SYSDIET). Journal of Internal Medicine
2013;274:52–66.
Vavrikova 1958 {published data only}
∗ Vavrikova J. Essential fatty acids, lipid metabolism, and
atherosclerosis [letter]. Lancet 1958;1:1337.
Wan 2013 {published data only}
Wan Abdul Manan WMW. The effects of physical activity
and dietary management in adults with metabolic syndrome
in a rural district in Malaysia: An intervention study. Annals
of Nutrition and Metabolism 2013;Conference:2013.
Wass 1981 {published data only}
∗ Wass VJ, Jarrett RJ, Meilton V, Start MK, Mattock M,
Ogg CS, et al. Effect of a long-term fat-modified diet on
serum lipoprotein levels of cholesterol and triglyceride in
patients on home haemodialysis. Clinical Science 1981;60
(1):81–6.
Wassertheil 1985 {published data only}
Wassertheil SS, Blaufox MD, Langford HG, Oberman
A, Cutter G, Pressel S. Prediction of response to sodium
intervention for blood pressure control. Journal of
Hypertension. Supplement 1986;4(5):S343–6.
Wassertheil SS, Langford HG, Blaufox MD, Oberman A,
Hawkins M, Levine B, et al. Effective dietary intervention
in hypertensives: sodium restriction and weight reduction.
Journal of the American Dietetic Association 1985;85(4):
423–30.
WATCH {published and unpublished data}
∗ Ockene IS, Hebert JR, Ockene JK, Saperia GM, Stanek E,
Nicolosi R, et al. Effect of a physician-delivered nutrition
counselling training and an office-support program on
saturated fat intake, weight, and serum lipid measurements
in a hyperlipidemic population: Worcester Area Trial for
Counseling in Hyperlipidemia. Archives of Internal Medicine
1999;159:725–31.
Watts 1988 {published data only}
∗ Watts GF, Ahmed W, Quiney J, Houlston R, Jackson P,
Iles C, et al. Effective lipid lowering diets including lean
meat. British Medical Journal (Clinical Research Ed.) 1988;
296(6617):235–7.
47Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Weintraub 1992 {published data only}
∗ Weintraub M, Sundaresan PR, Schuster B. Long-term
weight control study. VII (weeks 0 to 210). Serum lipid
changes. Clinical Pharmacology and Therapeutics 1992;51
(5):634–41.
Westman 2006 {published data only}
Westman EC, Yancy WS Jr, Olsen MK, Dudley T, Guyton
JR, Westman Eric C, et al. Effect of a low-carbohydrate,
ketogenic diet program compared to a low-fat diet on fasting
lipoprotein subclasses. International Journal of Cardiology
2006;110(2):212–6.
Weststrate 1998 {published data only}
∗ Weststrate JA, Meijer GW. Plant sterol enriched
margarines and reduction of plasma total-and LDL-
cholesterol concentrations in normocholesterolaemic and
mildly hypercholesterolaemic subjects. European Journal of
Clinical Nutrition 1998;52:334–43.
WHO primary prev 1979 {published data only}
Anon. Primary prevention of ischaemic heart disease:
WHO coordinated cooperative trial. A summary report.
Bulletin Of The World Health Organization 1979;57:801–5.
WHT {published and unpublished data}
Bowen D. The role of participation in the women’s health
trial: feasibility study in minority populations. Preventive
Medicine 2000;31(5):474–80.
Bowen D, Clifford CK, Coates R, Evans M, Feng Z, Fouad
M, et al. The Women’s Health Trial Feasibility Study in
Minority Populations: design and baseline descriptions.
Annals of Epidemiology 1996;6(6):507–19.
Bowen DJ, Kestin M, McTiernan A, Carrell D, Green
P. Effects of dietary fat intervention on mental health in
women. Cancer Epidemiology, Biomarkers and Prevention
1995;4(5):555–9.
Gorbach SL, Morrill LA, Woods MN, Dwyer JT, Selles
WD, Henderson M, et al. Changes in food patterns during
a low-fat dietary intervention in women. Journal of the
American Dietetic Association 1990;90(6):802–9.
Henderson MM, Kushi LH, Thompson DJ, Gorbach SL,
Clifford CK, Insull W, et al. Feasibility of a randomized
trial of a low-fat diet for the prevention of breast cancer:
dietary compliance in the Women’s Health Trial Vanguard
Study. Preventive Medicine 1990;19(2):115–33.
Insull W, Henderson MM, Prentice RL, Thompson DJ,
Clifford C, Goldman S, et al. Results of a randomized
feasibility study of a low-fat diet. Archives of Internal
Medicine 1990;150(2):421–7.
Kristal AR, White E, Shattuck AL, Curry S, Anderson
GL, Fowler A, et al. Long-term maintenance of a low-fat
diet: durability of fat-related dietary habits in the Women’s
Health Trial. Journal of the American Dietetic Association
1992;92(5):553–9.
Prentice RL, Kakar F, Hursting S, Sheppard L, Klein R,
Kushi LH. Aspects of the rationale for the Women’s Health
Trial. Journal of the National Cancer Institute 1988;80(11):
802–14.
Self S, Prentice R, Iverson D, Henderson M, Thompson D,
Byar D, et al. Statistical design of the Women’s Health Trial.
Controlled Clinical Trials 1988;9(2):119–36.
Sheppard L, Kristal AR, Kushi LH. Weight loss in women
participating in a randomised trial of low-fat diets. American
Journal of Clinical Nutrition 1991;54:821–8.
Urban N, Baker M. The Women’s Health Trial as an
investment. Medical Decision Making 1989;9(1):59–64.
White E, Shattuck AL, Kristal AR, Urban N, Prentice
RL, Henderson MM, et al. Maintenance of a low-fat
diet: follow-up of the Women’s Health Trial. Cancer
Epidemiology, Biomarkers and Prevention 1992;1(4):315–23.
Wilke 1974 {published data only}
∗ Wilke H, Frahm H. Influence of low-caloric-diet and d-
triiodothyronine on serum lipids and body weight (author’s
trans) [Verhalten der Serumlipide und des Korpergewichts
unter Reduktionsdiat und medikamentoser Behandlung
mit D–Trijodthyronin]. Medizinische Klinik 1974;69(48):
1986–9.
Williams 1990 {published data only}
∗ Williams PT, Krauss RM, Vranizan KM, Wood PS.
Changes in lipoprotein subfractions during diet-induced
and exercise-induced weight loss in moderately overweight
men. Circulation 1990;81:1293–304.
Williams 1992 {published data only}
∗ Williams PT, Krauss RM, Vranizan KM, Albers JJ,
Wood PD. Effects of weight-loss by exercise and by
diet on apolipoproteins A-I and A-II and the particle-
size distribution of high-density lipoproteins in men.
Metabolism: Clinical and Experimental 1992;41:441–9.
Williams 1994 {published data only}
∗ Williams PT, Stefanick ML, Vranizan KM, Wood PD.
The effects of weight loss by exercise or by dieting on
plasma high-density lipoprotein (HDL) levels in men with
low, intermediate, and normal-to-high HDL at baseline.
Metabolism 1994;43(7):917–24.
Wilmot 1952 {published data only}
∗ Wilmot VA, Swank RL. The influence of low fat diet
on blood lipid levels in health and in multiple sclerosis.
American Journal of the Medical Sciences 1952;223:25–34.
Wing 1998 {published data only}
∗ Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W.
Lifestyle intervention in overweight individuals with a
family history of diabetes. Diabetes Care 1998;21(3):350–9.
Wolever 2008 {published data only}
Wolever TM, Gibbs AL, Mehling C, et al. The Canadian
Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled
trial of low-glycemic-index dietary carbohydrate in type 2
diabetes: no effect on glycated hemoglobin but reduction in
C-reactive protein. American Journal of Clinical Nutrition
2008;87(1):114–25.
WOMAN 2007 {published data only}
Kuller LH, Kriska AM, Kinzel LS, Simkin-Silverman LR,
Sutton-Tyrrell K, Johnson BD, et al. The clinical trial of
Women On the Move through Activity and Nutrition
(WOMAN) study. Contemporary Clinical Trials 2007;28
(4):370–81.
48Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wood 1988 {published data only}
∗ Wood PD, Stefanick ML, Dreon DM, Frey HB, Garay
SC, Williams PT, et al. Changes in plasma lipids and
lipoproteins in overweight men during weight loss through
dieting as compared with exercise. New England Journal of
Medicine 1988;319(18):1173–9.
Woollard 2003 {published data only}
Woollard J, Burke V, Beilin LJ, Verheijden M, Bulsara MK.
Effects of a general practice-based intervention on diet, body
mass index and blood lipids in patients at cardiovascular
risk. Journal of Cardiovascular Risk 2003;10(1):31–40.
Working Well 1996 {published data only}
Sorensen G, Thompson B, Glanz K, Feng Z, Kinne S,
DiClemente C, et al. Work site-based cancer prevention:
primary results from the Working Well Trial. American
Journal of Public Health 1996;86(7):939–47.
Young 2010 {published data only}
Young DR, Coughlin J, Jerome GJ, Myers V, Chae SE,
Brantley PJ, et al. Effects of the PREMIER interventions on
health-related quality of life. Annals of Behavioral Medicine
2010;40:302–12.
Zock 1995 {published and unpublished data}
Zock PL. Dietary fatty acids and risk factors for coronary
heart disease: controlled studies in healthy volunteers. PhD
Thesis 1995.
Zock PL, Mensink RP, Harryvan J, de VJ, Katan MB.
Fatty acids in serum cholesteryl esters as quantitative
biomarkers of dietary intake in humans. American Journal
of Epidemiology 1997;145(12):1114–22.
Additional references
Ajala 2013
Ajala O, English P, Pinkney J. Systematic review and meta-
analysis of different dietary approaches to the management
of type 2 diabetes. American Journal of Clinical Nutrition
2013;97:505–16.
Aljadani 2013
Aljadani H, Patterson A, Sibbritt D, Collins C. The
association between diet quality and weight change in
adults over time: a systematic review of prospective
cohort studies. Diet Quality: An Evidence Based Approach.
2. New York: Springer, 2013:3–27. [DOI: 10.1007/
978-1-4614-7315-2˙1]
Aljadani 2015
Aljadani H, Patterson A, Sibbritt D, Collins CE. Diet
quality and weight change in adults over time: a systematic
review of cohort studies. Current Nutrition Reports 2015;4:
88–101.
Ambrosini 2014
Ambrosini GL. Childhood dietary patterns and later
obesity: a review of the evidence. Proceedings of the Nutrition
Society 2014;73:137–46.
Benatar 2013
Benatar JR, Sidhu K, Stewart RA, Benatar JR, Sidhu K,
Stewart RAH. Effects of high and low fat dairy food on
cardio-metabolic risk factors: a meta-analysis of randomized
studies. PloS One 2013;8:e76480.
Berkley 1995
Berkley CS, Hoaglin DC, Mosteller F, Colditz GA. A
random-effects regression model for meta-analysis. Statistics
in Medicine 1995;14:395–411.
Chaput 2014
Chaput JP. Findings from the Quebec Family Study on
the Etiology of Obesity: Genetics and Environmental
Highlights. Current Obesity Reports 2014;3:54–66.
Egger 1997
Egger M, Davey Smith G, Schneider M, Minder C. Bias
in meta-analysis detected by a simple graphical test. BMJ
1997;315:629–34.
Furukawa 2007
Furukawa TA, Watanabe N, Montori VM, Guyatt GH.
Association between unreported outcomes and effect size
estimates in Cochrane meta-analyses. JAMA 2007;297:
468–70.
Gow 2014
Gow ML, Ho M, Burrows TL, Baur LA, Stewart L,
Hutchesson MJ, et al. Impact of dietary macronutrient
distribution on BMI and cardiometabolic outcomes in
overweight and obese children and adolescents: a systematic
review. Nutrition Reviews 2014;72:453–70.
Havranek 2011
Havranek EP. A Mediterranean diet reduces cardiovascular
risk factors in overweight patients compared with a low-fat
diet. ACP Journal Club 2011;155(12):JC6–3.
Higgins 2003
Higgins JPT, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003;327:
557–60.
Higgins 2011a
Higgins JPT, Green S (editors). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 [updated
March 2011]. The Cochrane Collaboration, 2011.
Available from www.cochrane-handbook.org. Available
from www.cochrane–handbook.org: The Cochrane
Collaboration.
Higgins 2011b
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter
8: Assessing risk of bias in included studies. In: Higgins
JPT, Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March
2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Hooper 2012a
Hooper L, Summerbell CD, Thompson R, Sills D, Roberts
FG, Moore HJ, et al. Reduced or modified dietary fat
for preventing cardiovascular disease. Cochrane Database
of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/
14651858.CD002137]
Hooper 2015
Hooper L, Martin N, Abdelhamid A, Davey Smith G.
Reduction in saturated fat intake for cardiovascular disease.
49Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cochrane Database of Systematic Reviews 2015, Issue 6.
[DOI: 10.1002/14651858.CD011737]
Hu 2012
Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy
WS Jr, et al. Effects of low-carbohydrate diets versus
low-fat diets on metabolic risk factors: a meta-analysis of
randomized controlled clinical trials. American Journal of
Epidemiology 2012;176 Suppl 7:S44–54.
Joint ESC guidelines 2012
The Fifth Joint Task Force of the European Society of
Cardiology and Other Societies on Cardiovascular Disease
Prevention in Clinical Practice. European guidelines on
cardiovascular disease prevention in clinical practice (version
2012). European Heart Journal 2012;33:1635–701. [DOI:
10.1093/eurheartj/ehs092]
Kelly 2006
Kelly S, Hillier F, Whittaker V, Ells LJ, Edmunds LD,
Smith S, et al. The associations between food, nutrition,
physical activity and the risk of weight gain, overweight and
obesity and underlying mechanisms: systematic literature
review. Food, Nutrition, Physical Activity, and the Prevention
of Cancer: a Global Perspective (www.dietandcancerreport.org/
cancer˙resource˙center/downloads/SLR/Obesity˙SLR.pdf.5).
World Cancer Research Fund/American Institute for
Cancer Research, 2006.
Kratz 2013
Kratz MB. The relationship between high-fat dairy
consumption and obesity, cardiovascular, and metabolic
disease. European Journal of Nutrition 2013;52:1–24.
Manson 1990
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner
B, Monson RR, et al. A prospective study of obesity and
risk of coronary heart disease in women. New England
Journal of Medicine 1990;322:882–9. [DOI: 10.1056/
NEJM199003293221303]
Ni 2010
Ni MC, Aston LM, Jebb SA. Effects of worksite health
promotion interventions on employee diets: a systematic
review. BMC Public Health 2010;10:62.
RevMan 2014
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). 5.3. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014.
Schwingshackl 2013
Schwingshackl L, Hoffmann G. Comparison of effects of
long-term low-fat vs high-fat diets on blood lipid levels in
overweight or obese patients: a systematic review and meta-
analysis. Journal of the Academy of Nutrition & Dietetics
2013;113:1640–61.
Schwingshackl 2013a
Schwingshackl L, Hoffmann G. Long-term effects of low-
fat diets either low or high in protein on cardiovascular
and metabolic risk factors: a systematic review and meta-
analysis. Nutrition Journal 2013;12:48.
Sharp 1998
Sharp S. Meta-analysis regression. Stats Technical Bulletin
1998;42:16–22.
Song 2004
Song Y-M, Sung J, Davey Smith G, Ebrahim S. Body mass
index and ischemic and hemorrhagic stroke: a prospective
study in Korean men. Stroke 2004;35:831–6.
Sterne 2001
Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in
STATA. In: Egger M, Davey Smith G, Altman DG editor
(s). Systematic Reviews in Health Care: Meta-analysis in
Context. London: BMJ Books, 2001.
Sterne 2009
Sterne JAC. Meta-analysis in Stata: an Updated Collection
from the Stata Journal. Texas, USA: STATA Press, 2009.
WCRF/AICR 2009
World Cancer Research Fund/American Institute for Cancer
Research. Preventability of cancer by food, nutrition, and
physical activity: Appendix A. Policy and Action for Cancer
Prevention. Food, Nutrition, and Physical Activity: a Global
Perspective. Washington DC: AICR, 2009.
Yang 2013
Yang Z, Huffman SL. Nutrition in pregnancy and early
childhood and associations with obesity in developing
countries. Maternal & Child Nutrition 2013;9(Suppl 1):
105–19.
Yu-Poth 1999
Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda
S, Kris-Etherton PM. Effects of the National Cholesterol
Education Program’s Step I and Step II dietary intervention
programs on cardiovascular disease risk factors: a meta-
analysis. American Journal of Clinical Nutrition 1999;69:
632–46.
References to other published versions of this review
Hooper 2000
Hooper L, Summerbell CD, Higgins JPT, Thompson RL,
Clements G, Capps N, et al. Reduced or modified dietary
fat for prevention of cardiovascular disease. Cochrane
Database of Systematic Reviews 2000, Issue 2. [DOI:
10.1002/14651858.CD002137]
Hooper 2001
Hooper L, Summerbell CD, Higgins JPT, Thompson RL,
Capps N, Davey Smith G, et al. Dietary fat intake and
prevention of cardiovascular disease: systematic review.
BMJ 2001;322:757–63.
Hooper 2012b
Hooper L, Abdelhamid A, Moore HJ, Douthwaite W,
Skeaff CM, Summerbell CD. Effect of reducing total fat
intake on body weight: systematic review and meta-analysis
of randomised controlled trials and cohort studies. BMJ
2012;345:e7666. [DOI: 10.1136/bmj.e7666]
∗ Indicates the major publication for the study
50Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Auckland reduced fat 1999
Methods RCT
Participants People with impaired glucose intolerance or high normal blood glucose (New Zealand)
CVD risk: moderate
Control: unclear how many randomised (176 between both groups), 51 analysed
Intervention: unclear how many randomised (176 between both groups), 48 analysed
Mean years in trial: 4.1 over whole trial
% male: control 80%, intervention 68%
Age: mean control 52.0 (SE 0.8), intervention 52.5 (SE 0.8)
Baseline BMI: mean control 29.1 (SE 0.6), intervention 29.3 (SE 0.6)
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: reduced fat diet (no specific goal stated)
Control methods: usual intake
Interventionmethods:monthlymeetings to follow a 1-year structured programme aimed
at reducing fat in the diet; includes education, personal goal setting, self monitoring
Weight goals: weight and calories not mentioned, diet was ”aimed solely at reducing the
total amount of fat in their diet“
Total fat intake (at 1 year): low fat 26.1 (SD 7.7), cont 33.6 (SD 7.8) %E
Saturated fat intake (at 1 year): low fat 10.0 (SD 4.2), cont 13.4 (SD 4.7) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids, glucose, blood pressure
Available outcomes: weight, total, LDL and HDL cholesterol, TG, BP
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Unmarked opaque envelopes were opened by the person recruit-
ing, unable to alter allocation later
Allocation concealment (selection bias) Low risk Unmarked opaque envelopes were opened by the person recruit-
ing, unable to alter allocation later
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were not blinded, outcome assessors were
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Auckland reduced fat 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 77 of 176 recruited lost to follow-up, 44% over 5 years (> 5%
per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk See ’Control methods’ and ’Intervention methods’ in the ’Inter-
ventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
BDIT Pilot Studies 1996
Methods RCT
Participants Women with mammographic dysplasia (Canada)
CVD risk: low
Control: 147 randomised, 78 analysed
Intervention: 148 randomised, 76 analysed
Mean years in trial: control 7.5, intervention 6.8
% male: 0
Age: mean control 45, intervention 44 (all > 30)
Baseline BMI: mean intervention 24.3 (SD 3.8), control 24.3 (SD 3.6)
Interventions Reduced fat intake vs usual diet
Control aims: healthy diet advice, no alteration in dietary fat advised, aim to maintain
weight
Intervention aims: total fat 15%E, replace fat by complex CHO, aim to maintain weight
Control methods: seen for advice once every 4 months for 12 months
Intervention methods: seen for advice once a month for 12 months
Weight goal: low fat group - ”isocaloric exchange of complex carbohydrate for fat. We
tried to maintain an isocaloric diet to avoid weight loss...“. Not discussed for control
group
Total fat intake (at 9.2 years): low fat 31.7 (SD 7.3) %E, control 35.3 (SD 5.6) %E
Saturated fat intake (at 9.2 years): low fat 10.6 (SD 4.6) %E, control 12.3 (SD 4.6) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary fat, serum cholesterol
Available outcomes: weight, BMI, total and HDL cholesterol
Notes Weight data available for 1 year, 2 years and 9 years. Unclear whether participants were
still in the trial by 9 years, so 2-year data used in main analysis
Risk of bias
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BDIT Pilot Studies 1996 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomly allocated“
Allocation concealment (selection bias) Unclear risk Randomisation not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants not blinded, but outcome assessors blinded to in-
tervention
Incomplete outcome data (attrition bias)
All outcomes
High risk 141 of 295 (48%) lost over 8 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Minor: women in intervention group seen more frequently. See
’Control methods’ and ’Intervention methods’ in the ’Interven-
tions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
beFIT 1997
Methods RCT
Participants Women and men with mild hypercholesterolaemia (USA)
CVD risk: moderate
Control: unclear how many randomised, 192 analysed
Intervention: unclear how many randomised, 217 analysed
Mean years in trial: unclear (max duration 0.5 years)
% male: 52 (not divided by intervention group)
Age: mean 43.2 (not divided by intervention group) (all > 30)
Baseline BMI (not reported by intervention): women with hypercholesterolaemia (n =
84) mean 25.9 (SD 4.9), women with combined hyperlipidaemia (n = 94) mean 29.
2 (SD 6.1), men with hypercholesterolaemia (n = 123) mean 26.6 (SD 3.3), men with
combined hyperlipidaemia (n = 108) mean 27.5 (SD 3.2)
Interventions Reduced and modified fat vs usual diet
Control aims: asked to delay dietary changes (provided intervention after the randomised
trial)
Intervention aims: total fat < 30%E, SFA < 7%E, dietary cholesterol < 200 mg/d
Control methods: usual intake
Intervention methods: 8 weekly classes with nutrition info and behaviour modification
with spouses, plus individual appointments at 3 and 6 months
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beFIT 1997 (Continued)
Weight goals: intervention group ”assigned food group pattern for their calorie needs“,
no information for control group
Total fat intake (at 6 months): intervention 25.2 (SD unclear) %E, control unclear - no
significant difference from baseline 34 (SD unclear) %E
Saturated fat intake (at 6 months): intervention 7.6% (SD unclear) %E, control unclear
- no significant difference from baseline 12 (SD unclear)%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Available outcomes: weight, total, LDL and HDL cholesterol, TG (but variance data
only provided for the randomised comparison for LDL cholesterol)
Notes Weight: control ’no change’, intervention -2.7 kg at 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified random sampling scheme
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants knew their allocation, unclear for outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear what proportion lost over trial as unclear how many
recruited
Selective reporting (reporting bias) High risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Intensive intervention for intervention group, but no interven-
tion during the 6 months of the randomised part of the study
for the control group. See ’Control methods’ and ’Intervention
methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
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Bloemberg 1991
Methods RCT
Participants Men with untreated raised total cholesterol (the Netherlands)
CVD risk: moderate
Control: randomised 41, analysed 40
Intervention: randomised 39, analysed 39
Mean years in trial: control 0.5, randomised 0.5
% male: 100%
Age: mean control 47.5 (SD 8.0), intervention 47.2 (SD 8.3)
Baseline BMI: mean control 26.3 (SD 2.3), intervention 26.0 (SD 2.6)
Interventions Reduced and modified fat vs usual diet
Control aims: usual diet
Intervention aims: 30%E from fat, PUFA/SFA 1.0, dietary cholesterol 20 mg
Control methods: no advice provided
Intervention methods: individual advice provided face to face, followed by 2 phone calls
and 5 mailings of information on healthy foods
Weight goals: weight and calories not mentioned
Total fat intake (change to 6 months): intervention -5.0 (SD 6.5) (33.5 overall), control
-1.5 (SD 5.9) (36.8 overall) %E
Saturated fat intake (change to 6 months): intervention-4.3 (SD 3.9), control -0.7 (SD
2.9) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Available outcomes: weight, total and HDL cholesterol
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomised“ and stratified by age and BMI (each di-
chotomised)
Allocation concealment (selection bias) Unclear risk No method stated (as above)
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, yes for laboratory staff
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 of 80 (< 1%) lost over 0.5 years (< 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
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Bloemberg 1991 (Continued)
Free of systematic difference in care? High risk Much more time spent on those in the intervention group
Free of dietary differences other than fat? Low risk Dietary focus on fats alone
BRIDGES 2001
Methods RCT
Participants Women diagnosed with stage I or II breast cancer over the past 2 years (USA)
CVD risk: low
Control: randomised unclear (at least 56), analysed 46
Intervention: randomised unclear (at least 50), analysed 48
Mean years in trial: unclear (1 year max follow-up)
% male: 0
Age: mean control unclear (71% postmenopausal), intervention unclear (56% post-
menopausal) (all 20 to 65)
Baseline BMI: not reported
Interventions Reduced fat vs usual diet
Control aims: no formal intervention
Intervention diet aims: total fat 20%E, high fibre, plant-based micronutrients
Intervention stress: separate parallel arm, stress reduction programme (data not used
here)
Control methods: no formal intervention
Intervention methods: nutrition intervention programme, 15 sessions (42 hours) over
15 weeks, group-based, dietitian led, 2 individual sessions using social cognitive theory
and patient centred counselling to increase self efficacy and confidence
Weight goals: ”reduction in body mass was not a primary goal of NEP. (NEP was neither
designed nor presented to participants as a weight loss or weight control program).“ The
control group was presented as ”individual choice“
Total fat intake (at 12 months): low fat 29.9 (SD unclear), control 33.6 (SD unclear)
%E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet and BMI
Available outcomes: weight
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomised“, stratified by medical centre, cancer stage and age,
randomised number/envelope method by project co-ordinator
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BRIDGES 2001 (Continued)
Allocation concealment (selection bias) Low risk The project co-ordinator had contact with those from the Uni-
versity of Massachusetts, but not those from the other 3 centres,
and allocation could not be altered later
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants not blinded, unclear about researchers
Incomplete outcome data (attrition bias)
All outcomes
High risk Unclear how many recruited, so unclear how many were lost to
follow-up (at least 12 of 106 (11%) over 1 year, so > 5%/year
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk High-intensity programme for intervention group, nothing for
control group. See ’Control methods’ and ’Intervention meth-
ods’ in the ’Interventions’ section above
Free of dietary differences other than fat? High risk Intervention also focused on fibre and plant based micronutri-
ents. See ’Control aims’ and ’Intervention aims’ in the ’Inter-
ventions’ section above
Canadian DBCP 1997
Methods RCT
Participants Women with mammographic densities > 50% breast area (Canada)
CVD risk: low
Control: randomised 448+, analysed 401
Intervention: randomised 448+, analysed 388
Mean years in trial: control 2.0, randomised 2.0 (note, papers suggest a 10-year follow-
up overall)
% male: 0%
Age: mean control 45.9 (SD unclear), intervention 46.5 (SD unclear)
Baseline BMI: mean control 23.6, intervention 23.4, no variance reported
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: total fat 15%E, protein 20%E, CHO 65%E, isocaloric diet
Control methods: encouraged to continue usual diet, interviewed by dietitian every 4
months during first year, then every 3 months in the second year
Intervention methods: dietary prescription using food exchange (fat calories replaced
by CHO), met with dietitian monthly during first year, then every 3 months. Scales,
recipes, shopping guide provided
Weight goals: ”calories derived from fat were replaced by isocaloric exchange with car-
bohydrate“
Total fat intake (at 2 years): intervention 21.3 (SD 6.2), control 31.8 (SD 6.7) %E
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Canadian DBCP 1997 (Continued)
Saturated fat intake (at 2 years): intervention 7.1 (SD 2.5), control 11.5 (SD 3.3) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: incidence of breast cancer
Available outcomes: weight
Notes Weight data available for 1 and 2 years, 2-year data used in main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly allocated by telephone to Dept. of Biostatistics at
Ontario Cancer Institute, stratified by centre
Allocation concealment (selection bias) Low risk As above
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants knew what arm they were in
Incomplete outcome data (attrition bias)
All outcomes
High risk At least 107 of at least 896 (12%) lost over 2 years (> 5% per
year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Minor difference in attention for participants in intervention
and control in first year
Free of dietary differences other than fat? Low risk Focus on dietary fat
de Bont 1981 non-obese
Methods RCT
Participants Women with type 2 diabetes (UK)
CVD risk: moderate
Control: randomised unclear (total in control and intervention 148), analysed 65 (for
obese and non-obese)
Intervention: randomised unclear, analysed 71 (for obese and non-obese)
Mean years in trial: control 0.5, randomised 0.5
% male: 0%
Age: mean control 54 (SD 8), intervention 56 (SD 7), (all 35 to 64) (for obese and non-
obese)
Baseline BMI: chosen for BMI < 28, mean not reported
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de Bont 1981 non-obese (Continued)
Interventions Reduced and modified fat vs usual diet
Control aims: usual diet but with CHO ≤ 40%E
Intervention aims: 30%E from fat, focus on reducing meat fat, dairy foods and substi-
tuting margarines to improve the SFA/PUFA ratio, CHO increased to maintain energy
intake
Control methods: 3 home visits from a nutritionist over the 6 months of the trial
Intervention methods: 3 home visits from a nutritionist over the 6 months of the trial
Weight goals: to maintain the required total energy intake the proportion of carbohy-
drates in these diets was increased
Total fat intake (change to 6months): intervention-10.1 (SD10.8) (overall 31.1), control
-1.0 (SD 10.5) (overall 41.8) %E (for obese and non-obese)
Saturated fat intake (change to 6 months): intervention-8.1 (SD 5.8), control -1.1 (SD
5.7) %E (for obese and non-obese)
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet, weight, lipids
Available outcomes: weight, total and HDL cholesterol, triglycerides
Notes Outcome data separated by those obese (BMI ≥ 28) or not obese at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomly allocated“
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, unclear for outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk 12 of 148 (8%) lost over 0.5 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? Low risk Follow-up similar
Free of dietary differences other than fat? Low risk Diet focusses on fat
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de Bont 1981 obese
Methods RCT
Participants Women with type 2 diabetes (UK)
CVD risk: moderate
Control: randomised unclear (total in control and intervention 148), analysed 71 (for
obese and non-obese)
Intervention: randomised unclear, analysed 65 (for obese and non-obese)
Mean years in trial: control 0.5, randomised 0.5
% male: 0%
Age: mean control 54 (SD 8), intervention 56 (SD 7), (all 35 to 64) (for obese and non-
obese)
Baseline BMI: chosen for BMI ≥ 28, mean not reported
Interventions Reduced and modified fat vs usual diet
Control aims: usual diet but with CHO ≤ 40%E
Intervention aims: 30%E from fat, focus on reducing meat fat, dairy foods and substi-
tuting margarines to improve the SFA/PUFA ratio, CHO increased to maintain energy
intake
Control methods: 3 home visits from a nutritionist over the 6 months of the trial
Intervention methods: 3 home visits from a nutritionist over the 6 months of the trial
Weight goals: to maintain the required total energy intake the proportion of carbohy-
drates in these diets was increased
Total fat intake (change to 6months): intervention-10.1 (SD10.8) (overall 31.1), control
-1.0 (SD 10.5) (overall 41.8) %E (for obese and non-obese)
Saturated fat intake (change to 6 months): intervention-8.1 (SD 5.8), control -1.1 (SD
5.7) %E (for obese and non-obese)
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet, weight, lipids
Available outcomes: weight, total and HDL cholesterol, triglycerides
Notes Outcome data separated by those obese (BMI ≥ 28) or not obese at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomly allocated“
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, unclear for outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk 12 of 148 (8%) lost over 0.5 years (> 5% per year)
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de Bont 1981 obese (Continued)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? Low risk Similar follow-up
Free of dietary differences other than fat? Low risk Focus on fat
DEER 1998 exercise men
Methods RCT
Participants Men with raised LDL and low HDL cholesterol (USA)
CVD risk: moderate
Control: randomised 50, analysed 47
Intervention: randomised 51, analysed 48
Mean years in trial: control 1.0, intervention 1.0
% male: 100%
Age: mean 47.8 (SD 8.9) for all men (including the non-exercise part of this trial)
Baseline BMI: intervention 26.6 (SD 2.6), control 26.9 (SD 2.6)
Interventions Reduced fat vs usual diet
Control aims: usual diet (and exercise intervention)
Intervention aims: NCEP step 2 diet: < 30%E from fat, < 7%E from SFA, < 200 mg/d
cholesterol (and exercise intervention)
Control methods: no advice provided
Intervention methods: individual advice provided face to face, followed by 8 1-hour
group sessions during first 12 weeks, then monthly contact with dietitians by mail,
phone, individual or group appointment
Weight goals: ”weight loss was not emphasised“
Total fat intake (change to 12 months): intervention-8.2 (SD 5.9) (22.2 overall), control
-0.5 (SD 5.7) (29.9 overall) %E
Saturated fat intake (change to 12 months): intervention-3.9 (SD 2.6), control -0.1 (SD
2.6) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake and lipids
Available outcomes: weight, total, LDL and HDL cholesterol, triglycerides, systolic and
diastolic BP
Notes Factorial trial re. exercise and reported by sex
Risk of bias
Bias Authors’ judgement Support for judgement
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DEER 1998 exercise men (Continued)
Random sequence generation (selection
bias)
Low risk Assignments by computer, modified Efron procedure, balanced
by HDL and LDL
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of randomisation group
Incomplete outcome data (attrition bias)
All outcomes
High risk 6 of 101 (6%) lost over 1 year (> 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Very different levels of attention and review
Free of dietary differences other than fat? Low risk Dietary focus on fat
DEER 1998 exercise women
Methods RCT
Participants Postmenopausal women with raised LDL and low HDL cholesterol (USA)
CVD risk: moderate
Control: randomised 44, analysed 43
Intervention: randomised 43, analysed 43
Mean years in trial: control 1.0, intervention 1.0
% male: 0%
Age: mean 56.9 (SD 5.1) for all women (including the non-exercise part of this trial)
Baseline BMI: intervention 26.4 (SD 3.5), control 25.9 (SD 2.4)
Interventions Reduced fat vs usual diet
Control aims: usual diet (and exercise intervention)
Intervention aims: NCEP step 2 diet: < 30%E from fat, < 7%E from SFA, < 200 mg/d
cholesterol (and exercise intervention)
Control methods: no advice provided
Intervention methods: individual advice provided face to face, followed by 8 1-hour
group sessions during first 12 weeks, then monthly contact with dietitians by mail,
phone, individual or group appointment
Weight goals: ”weight loss was not emphasised“
Total fat intake (change to 12 months): intervention-8.0 (SD 5.8) (20.4 overall), control
0.3 (SD 6.9) (28.7 overall) %E
Saturated fat intake (change to 12 months): intervention-3.0 (SD 2.3), control 0.2 (SD
3.1) %E
Style: diet advice
Setting: community
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DEER 1998 exercise women (Continued)
Outcomes Stated trial outcomes: dietary intake and lipids
Available outcomes: weight, total, LDL and HDL cholesterol, triglycerides, systolic and
diastolic BP
Notes Factorial trial re. exercise and reported by sex
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments by computer, modified Efron procedure, balanced
by HDL and LDL
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of randomisation group
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 of 87 (1%) lost over 1 year (< 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Very different levels of attention and review
Free of dietary differences other than fat? Low risk Focus on dietary fat
DEER 1998 no exercise men
Methods RCT
Participants Men with raised LDL and low HDL cholesterol (USA)
CVD risk: moderate
Control: randomised 47, analysed 46
Intervention: randomised 49, analysed 49
Mean years in trial: control 1.0, intervention 1.0
% male: 100%
Age: mean 47.8 (SD 8.9) for all men (including the exercise part of this trial)
Baseline BMI: intervention 26.9 (SD 3.1), control 26.7 (SD 3.2)
Interventions Reduced fat vs usual diet
Control aims: usual diet (and usual exercise)
Intervention aims: NCEP step 2 diet: < 30%E from fat, < 7%E from SFA, < 200 mg/d
cholesterol (and usual exercise)
Control methods: no advice provided
63Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
DEER 1998 no exercise men (Continued)
Intervention methods: individual advice provided face to face, followed by 8 1-hour
group sessions during first 12 weeks, then monthly contact with dietitians by mail,
phone, individual or group appointment
Weight goals: ”weight loss was not emphasised“
Total fat intake (change to 12 months): intervention-8.0 (SD 8.1) (22.4 overall), control
-0.7 (SD 5.9) (29.7 overall) %E
Saturated fat intake (change to 12 months): intervention-3.4 (SD 3.2), control 0.0 (SD
2.4) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake and lipids
Available outcomes: weight, total, LDL and HDL cholesterol, triglycerides, systolic and
diastolic BP
Notes Factorial trial re. exercise and reported by sex
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments by computer, modified Efron procedure, balanced
by HDL and LDL
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of randomisation group
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 of 96 (1%) lost over 1 year (< 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Very different levels of attention and review
Free of dietary differences other than fat? Low risk Focus on dietary fat
DEER 1998 no exercise wom
Methods RCT
Participants Postmenopausal women with raised LDL and low HDL cholesterol (USA)
CVD risk: moderate
Control: randomised 47, analysed 46
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DEER 1998 no exercise wom (Continued)
Intervention: randomised 46, analysed 45
Mean years in trial: control 1.0, intervention 1.0
% male: 0%
Age: mean 56.9 (SD 5.1) for all women (including the exercise part of this trial)
Baseline BMI: intervention 26.6 (SD 2.8), control 26.0 (SD 3.9)
Interventions Reduced fat vs usual diet
Control aims: usual diet (and usual exercise)
Intervention aims: NCEP step 2 diet: < 30%E from fat, < 7%E from SFA, < 200 mg/d
cholesterol (and usual exercise)
Control methods: no advice provided
Intervention methods: individual advice provided face to face, followed by 8 1-hour
group sessions during first 12 weeks, then monthly contact with dietitians by mail,
phone, individual or group appointment
Weight goals: ”weight loss was not emphasised“
Total fat intake (change to 12 months): intervention-5.7 (SD 7.4) (overall 22.7), control
-0.2 (SD 6.7) (overall 28.2) %E
Saturated fat intake (change to 12 months): intervention-2.4 (SD 2.8), control 0.2 (SD
2.8) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake and lipids
Available outcomes: weight, total, LDL and HDL cholesterol, triglycerides, systolic and
diastolic BP
Notes Factorial trial re. exercise and reported by sex
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments by computer, modified Efron procedure, balanced
by HDL and LDL
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of randomisation group
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 of 93 (2%) lost over 1 year (< 5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Very different levels of attention and review
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DEER 1998 no exercise wom (Continued)
Free of dietary differences other than fat? Low risk Focus on dietary fat
Diet and Hormone Study 2003
Methods RCT
Participants Healthy premenopausal women aged 20 to 40 years (USA)
CVD risk: low
Control: randomised 107, analysed 96
Intervention: randomised 106, analysed 81
Mean years in trial: control 0.95, intervention 0.88
% male: 0%
Age: control mean 33.3, intervention 33.5 (SDs not given)
Baseline BMI: mean control 23.8 (SD 3.5), intervention 23.7 (SD 4.2)
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: < 20%E from fat, 25 to 30 g/dfibre, > 8 servings/d fruit and vegetables,
CHO 60% to 65%E, protein 15% to 20%E
Control methods: received a pamphlet on healthy eating (minimal intervention)
Intervention methods: classroom nutrition education (18 group classes) plus 2 individ-
ual counselling sessions over 12 months covering knowledge and behavioural skills, ap-
propriate foods served at intervention sessions
Weight goals: ”not encouraged to reduce total caloric intake and weight was monitored
to maintain within 2 kg of baseline weight“
Total fat intake (at 12 cycles/months): intervention 22.2 (SD 7.2), control 30.7 (SD 7.
5) %E
Saturated fat intake (at 12 cycles/months): intervention 14.9 (SD 6.7), control 23.9 (SD
13.2) g/d
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: hormonal responses
Available outcomes: weight, BMI, dietary intake, hormones, menstrual cycle length
Notes No answer to requests for data on deaths or health events.Weight and BMI data provided
at 4 and 12 cycles
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomly assigned by reference to a random number table“
Allocation concealment (selection bias) Unclear risk Not described
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Diet and Hormone Study 2003 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of randomisation group, unclear for assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk 36 of 213 (17%) lost over 1 year (> 5% per year). Reasons not
stated, greater losses in intervention group
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Very different levels of attention and review
Free of dietary differences other than fat? High risk Intervention group also asked to increase fibre, fruit and vegeta-
bles substantially
Kentucky Low Fat 1990
Methods RCT
Participants Moderately hypercholesterolaemic, non-obese Caucasian men and women aged 30 to
50 (USA)
CVD risk: moderate
Control: randomised 62, analysed 51
Intervention: randomised 56, analysed 47
Mean years in trial: control 0.91, intervention 0.92
% male: control 61, intervention 66
Age: mean control 40.3 (SD 5.4), intervention 40.7 (SD 5.2) (all 30 to 50)
Baseline BMI: not reported
Interventions Reduced fat diet vs usual diet
Control aims: no diet intervention
Intervention aims: 25%E from fats, 20%E from protein, 55%E from CHO, < 200 mg
cholesterol/day
(Also an intervention arm with similar aims plus increased fibre intake)
Control methods: no intervention
Intervention methods: seminars and individual eating patterns taught, 10 weeks teaching
and 40 weeks maintenance
Weight goals: participants were directed to maintain initial body weight throughout the
study
Total fat intake (at 1 year): low fat 30 (SD 7.5), control 31 (SD 5.7) %E
Saturated fat intake (at 1 year): low fat 9 (SD 2.7), control 10 (SD 2.9) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet composition, lipids
Available outcomes: weight, total, LDL and HDL cholesterol
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Kentucky Low Fat 1990 (Continued)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”matched on age, gender & cholesterol level, randomly assigned
to intervention group using systematic random procedure“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were aware of their dietary advice, researchers were
not
Incomplete outcome data (attrition bias)
All outcomes
High risk 20 of 118 (17%) lost over 1 year (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk See ’Control methods’ and ’Intervention methods’ in the ’Inter-
ventions’ section above
Free of dietary differences other than fat? Low risk (As the high fibre arm has not been used in the data set). See
’Control aims’ and ’Intervention aims’ in the ’Interventions’ sec-
tion above
Kuopio Reduced & Mod 1993
Methods RCT (4 arms have been used here as 2 RCTs)
Participants Free-living people aged 30 to 60 with serum total cholesterol levels 6.5 to 8.0 mmol/L
(Finland)
CVD risk: moderate
Control (monoene enriched): randomised 41, analysed 41
Intervention AHA: randomised 41, analysed 41
Mean years in trial: for all 4 groups 0.5
% male: control 46, AHA 46
Age: mean control 46.4, AHA 47.3 (all 30 to 60)
Baseline BMI: mean control 26.6 (SD 3.8), intervention 26.2 (SD 4.0)
Interventions Reduced and modified fat vs modified fat diet
Control aimsmono: total fat 38%E, SFA<14%E,MUFA18%E, PUFA<6%E, rapeseed
oil, rapeseed spread and skimmed milk provided
Intervention aims AHA: total fat 30%E, SFA < 10%E, MUFA 10%E, PUFA 10%E,
sunflower oil, sunflower spread and skimmed milk provided
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Kuopio Reduced & Mod 1993 (Continued)
Control and intervention methods: given written dietary instructions and a diet plan
with checking and reinforcement for 3 visits, then at 2, 6, 12, 18 and 26 weeks
Weight goals: dietary written instructions were designed for 5 energy levels (1800, 2000,
2400, 2800 and 3200) based on individual diet and activity assessment
Total fat intake (weeks 14 to 28): low and mod fat 34 (SD 4), control 35 (SD 5) %E
Saturated fat intake (weeks 14 to 28): low and mod fat 11 (SD 2), control 11 (SD 2)
%E
Style: dietary advice and supplement (food)
Setting: community
Outcomes Stated trial outcomes: lipids and blood pressure
Available outcomes: BMI, total, LDL and HDL cholesterol, TG, BP
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomisation stratified for men and
women, singles and couples, random num-
ber tables“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly de-
scribed
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants and researchers knew alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
Low risk 0 of 82 (0%) lost over 0.5 years (< 5% per
year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Similar intensity and duration in both
groups. See ’Control methods’ and ’Inter-
ventionmethods’ in the ’Interventions’ sec-
tion above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’
in the ’Interventions’ section above
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Kuopio Reduced Fat 1993
Methods RCT (4 arms have been used here as 2 RCTs)
Participants Free-living people aged 30 to 60 with serum total cholesterol levels 6.5 to 8.0 mmol/L
(Finland)
CVD risk: moderate
Control (high saturated fat): randomised 37, analysed 12
Intervention low fat: randomised 40, analysed 40
Mean years in trial: for both groups 0.5
% male: control 46, low fat 48
Age: mean control 43.2, low fat 45.8 (all 30 to 60)
Baseline BMI: mean control 25.6 (SD 4.2), intervention 26.5 (SD 3.4)
Interventions Reduced fat vs usual diet (low fat vs control)
Control aims: advised total fat 38%E, SFA < 18%E, MUFA 15%E, PUFA < 5%E,
rapeseed oil, butter and semi-skimmed milk provided
Intervention aims low fat: total fat 28%E to 30%E, SFA < 14%E, MUFA 10%E, PUFA
4%E, butter and rapeseed spread and skimmed milk provided
Control and intervention methods: given written dietary instructions and a diet plan
with checking and reinforcement for 3 visits, then at 2, 6, 12, 18 and 26 weeks
Weight goals: dietary written instructions were designed for 5 energy levels (1800, 2000,
2400, 2800 and 3200) based on individual diet and activity assessment
Total fat intake (weeks 14 to 28): low fat 31 (SD 5), control 36 (SD 5) %E
Saturated fat intake (weeks 14 to 28): low fat 12 (SD 2), control 15 (SD 2) %E
Style: dietary advice and supplement (food)
Setting: community
Outcomes Stated trial outcomes: lipids and blood pressure
Available outcomes: BMI, total, LDL and HDL cholesterol, TG, BP
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomisation stratified for men and
women, singles and couples, random num-
ber tables“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly de-
scribed
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants and researchers knew alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
High risk 25 of 77 (32%) lost over 0.5 years (> 5%
per year)
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Kuopio Reduced Fat 1993 (Continued)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Similar intensity and duration in both
groups. See ’Control methods’ and ’Inter-
ventionmethods’ in the ’Interventions’ sec-
tion above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’
in the ’Interventions’ section above
Mastopathy Diet 1988
Methods RCT
Participants Women with severe cyclical mastopathy for at least 5 years (Canada)
CVD risk: low
Control: randomised 10, analysed 9
Intervention: randomised 11, analysed 10
Mean years in trial: control 0.45, intervention 0.45
% male: 0%
Age: mean control 36, intervention 38 (variances unclear)
Baseline BMI: no data provided
Interventions Reduced fat vs usual diet
Control aims: given principles of healthy diet, not counselled to alter fat content
Intervention aims: total fat 15%E, CHO 65%E
Controlmethods: seen every 2months tomonitor symptoms, nutrition andbiochemistry
Intervention methods: seen monthly to monitor symptoms, nutrition and biochemistry,
teaching materials included food guide, recipes, product information and advice on
eating out
Weight goals: the intervention goals included the isocaloric replacement of complex
carbohydrate for fat (no mention for control group)
Total fat intake (at 6 months): low fat 22.8 (SD unclear), control 33.4 (SD unclear) %E
Saturated fat intake (at 6 months): low fat 8.8 (SD unclear), control 12.3 (SD unclear)
%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: mastopathy symptoms, plasma hormone and lipids
Available outcomes: weight, total cholesterol (but variance data not provided)
Notes Total cholesterol rose by 0.09mmol/L in control group (from4.5 to 4.59) and fell by 0.15
mmol/L in intervention group (4.84 to 4.69). Weight changed in the intervention group
(mean fall of 2.1 kg over 6 months, no variance provided), but change, or otherwise, in
control group not mentioned
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Mastopathy Diet 1988 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomly allocated“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were not blinded, those assessing physical outcomes
were blinded, those assessing symptoms were not
Incomplete outcome data (attrition bias)
All outcomes
High risk 2 of 21 (10%) lost over 0.5 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Minor differences in follow-up frequency. See ’Controlmethods’
and ’Intervention methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
MeDiet 2006
Methods RCT
Participants Healthy postmenopausal women with above median serum testosterone (Italy)
CVD risk: low
Control: randomised 57, analysed at 6 months 55
Intervention: randomised 58, analysed at 6 months 51
Mean years in trial: control 4.38, intervention 4.28
% male: 0
Age: mean unclear (age range 48 to 69)
Baseline BMI: not reported
Interventions Reduced and modified fat vs usual diet
Control aims: advised to increase fruit and vegetable intake
Intervention aims: taught Sicilian diet including reduced total, saturated and omega-6
fats, increased blue fish (high in omega 3), increased whole cereals, legumes, seeds, fruit
and vegetables
Control methods: advice
Intervention methods: taught Sicilian diet and cooking by professional chefs, with a
weekly cooking course including social dinners
Weight goals: not mentioned
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MeDiet 2006 (Continued)
Total fat intake (at 6 months): low and mod fat 30.9 (SD 11.4), control 34.0 (SD 11.8)
%E
Saturated fat intake (at 6 months): low and mod fat 8.4 (SD 3.0), control 11.2 (SD 5.
0) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: breast cancer, weight, lipids, well being
Available outcomes: weight
Notes Weight data provided at 6 months (fall of 0.6 kg in control group, fall of 1.3 kg in
intervention group), but without variance information
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”individually randomised“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were aware of assignment, researchers unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk 9 of 115 (8%) lost over 4 years (< 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Intensive cookery course with social element compared with
brief advice. See ’Control methods’ and ’Intervention methods’
in the ’Interventions’ section above
Free of dietary differences other than fat? High risk Both groups encouraged to increase fruit and vegetables, but
intervention group also encouraged to increase fish, pulses, seeds
and whole grains
Moy 2001
Methods RCT
Participants Middle-aged siblings of people with early CHD, with at least one CVD risk factor (USA)
CVD risk: moderate
Control: randomised 132, analysed 118
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Moy 2001 (Continued)
Intervention: randomised 135, analysed 117
Mean years in trial: 1.9
% male: control 49%, intervention 55%
Age: control mean 45.7 (SD 7), intervention 46.2 (SD 7)
Baseline BMI: control mean 29.5 (SD 7), intervention 28.5 (SD 5)
Interventions Reduced fat intake vs usual diet
Control: physician management (physicians informed on risk factor management)
Intervention: nurse management, aim total fat 40 g/d or less
Control methods: physician management with risk factor management at 0, 1 and 2
years
Intervention methods: nurse management, appointments 6- to 8-weekly for 2 years
Weight goals: not mentioned
Total fat intake (at 2 years): low fat 34.1 (SD unclear), control 38.0 (SD unclear) %E
Saturated fat intake (at 2 years): low fat 11.5 (SD unclear), control 14.4 (SD unclear)
%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake
Available outcomes: BMI, HDL and LDL cholesterol, TG
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly assigned via computerised schema after all eligible
siblings from a family had been screened
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants and trialists clear about their allocation
Incomplete outcome data (attrition bias)
All outcomes
High risk 32 of 267 (12%) lost over 2 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Differences in frequency of follow-up, but unclear what differ-
ences in care occurred between the physician and nurse-led care.
See ’Control methods’ and ’Intervention methods’ in the ’Inter-
ventions’ section above
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Moy 2001 (Continued)
Free of dietary differences other than fat? Unclear risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
MSFAT 1995
Methods RCT
Participants Healthy people aged 20 to 55 (Netherlands)
CVD risk: low
Control: randomised unclear (120?), analysed 103
Intervention: randomised unclear (120?), analysed 117
Mean years in trial: control 0.46, intervention 0.49
% male: control 50%, intervention 50%
Age: mean control men 35.6 (SD 10), control women 36.0 (SD 11), intervention men
35.5 (SD 11), intervention women 36.0 (SD 12) (all 19 to 55)
Baseline BMI: mean control men 24.9 (SD 2.2), control women 25 (SD 2), intervention
men 24.9 (SD 2.3), intervention women 24.7 (SD 2)
Interventions Reduced fat vs usual diet
Control aims: advised to use products from trial shop ad lib. (usual fat products provided)
Intervention aims: advised to use products from trial shop ad lib. (low fat products
provided)
Control methods: participants obtained foods in a study shop at least once a week
Intervention methods: participants obtained foods in a study shop at least once a week
Weight goals: ad libitum diet
Total fat intake (at 6 months): low fat 34.7 (SD unclear), control 42.7 (SD unclear) %E
Saturated fat intake (at 6 months): low fat 14.2 (SD unclear), control 18.2 (SD unclear)
%E
Style: food provided
Setting: community
Outcomes Stated trial outcomes: weight, vitamin and fatty acid intake, anti-oxidative capacity
Available outcomes: weight (for subgroup), weight and lipids provided for larger group,
but without variance data
Notes Change from baseline to 6 months for whole group (control 103, intervention 117):
Weight, kg: 1.1, 0.4
Total cholesterol, mmol/L: 0.07, -0.09
HDL cholesterol, mmol/L: -0.03, -0.06
LDL cholesterol, mmol/L: 0.15, 0.16
TG, mmol/L: 0.04, -0.04
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”stratified randomisation (according to sex, age, QI index and
eating behaviour) by co-ordinating centre“, a statistician at
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MSFAT 1995 (Continued)
Unilever Research, SAS software, and allocation could not be
altered later
Allocation concealment (selection bias) Low risk ”stratified randomisation (according to sex, age, QI index and
eating behaviour) by co-ordinating centre“, a statistician at
Unilever Research, SAS software, and allocation could not be
altered later
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of allocation, those analysing biochemistry
were not
Incomplete outcome data (attrition bias)
All outcomes
High risk 20 of 240 (8%) lost over 0.5 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Both groups used study shop. See ’Control methods’ and ’Inter-
vention methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
NDHS Open 1st L&M 1968
Methods RCT
Participants Free-living men (USA)
CVD risk: low
Control: randomised 382, analysed 348
Intervention B: randomised 385, analysed 332
Intervention X: randomised 54, analysed 46
Mean years in trial: control 1.0, B 0.9, C 0.9, X 0.9
% male: 100
Age: unclear (all 45 to 54)
Baseline BMI: not reported
Interventions Reduced and modified fat diet vs usual diet
Control aims: total fat 40%E, SFA 16%E to 18%E, dietary cholesterol 650 to 750 mg/
d, P/S 0.4
Intervention B: total fat 30%E, SFA < 9%E, dietary cholesterol 350 to 450 mg/d, PUFA
15%E, P/S 1.5
Intervention X: total fat 30%E, SFA < 9%E, dietary cholesterol 350 to 450 mg/d, PUFA
15%E, P/S 1.5
Control methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-
up visits with nutritionist), purchase of ’usual fat’ items from a trial shop
Intervention B methods: dietary advice to reduce saturated fat and cholesterol (plus 10
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NDHS Open 1st L&M 1968 (Continued)
follow-up visits with nutritionist), plus purchase of appropriately reduced and modified
fat items from a trial shop
Intervention X methods: dietary advice but no trial shop
Weight goals: weight and calories not mentioned
Total fat intake (through study): B 29.7 (SD unclear) %E, X 31.7 (SD unclear), control
34.9 (SD unclear) %E
Saturated fat intake (through study): B 7.1 (SDunclear) %E, X 8.9 (SD unclear), control
11.6 (SD unclear) %E
Style: B diet provided, X - diet advice
Setting: community
Outcomes Stated trial outcomes: lipid levels and dietary assessment
Available outcomes: total cholesterol (someweight andBPdata presented but no variance
info)
Notes At 52 weeks weight change in the control was not presented, weight change in B was -
2.4 kg. Average weight change over the first year (mean of weights at weeks 6, 12, 20,
28, 36 and 44 weeks) was -2.45 kg (-5.4lb) for the low fat group (B) and -1.91 kg (-4.
2lb) for the modified fat group (C) and -1.95 kg (-4.3lb) for the control group (D)
At 52 weeks diastolic BP change from baseline was -2.2 kg in control, -1.9 in B and -5.
8 in X
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified randomisation by the statistical centre
Allocation concealment (selection bias) Low risk Stratified randomisation by the statistical centre
Blinding (performance bias and detection
bias)
All outcomes
Low risk Intervention B: all reduced saturated fat and purchased blinded
foods from a trial shop, double-blind
InterventionX: no trial shop, so participants not blinded, though
those analysing blood samples etc. were
Incomplete outcome data (attrition bias)
All outcomes
High risk 87 of 821 (11%) lost over 1 year (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Yes for intervention B (as both intervention and control received
dietary advice and purchased food from trial shop). No for in-
tervention X (as it did not include a trial shop as in the control
group). See ’Control methods’ and ’Intervention methods’ in
the ’Interventions’ section above
77Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NDHS Open 1st L&M 1968 (Continued)
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
NDHS Open 2nd L&M 1968
Methods RCT
Participants Free-living men who had participated in NDHS 1st studies (USA)
CVD risk: low
Control: randomised 304, analysed 215
Intervention BC (this study had a range of interventions, we were interested in BC for
the systematic revview): randomised 194, analysed 179
Mean years in trial: control 0.6, intervention BC 0.6
% male: 100
Age: unclear (all 45 to 54)
Baseline BMI: not reported
Interventions Reduced and modified fat vs usual diet
Control aims: total fat 40%E, SFA 16%E to 18%E, dietary cholesterol 650 to 750 mg/
d, P/S 0.4, X - advice to continue usual diet
Intervention aims: BC total fat 30%E to 40%E, SFA reduced, dietary cholesterol 350
to 450 mg/d, increased PUFA, P/S 1.5 to 2.0
Control methods: dietary advice to reduce saturated fat and cholesterol (plus 10 follow-
up visits with nutritionist), purchase of ’usual fat’ items from a trial shop
Intervention BC methods: dietary advice to reduce saturated fat and cholesterol (plus 10
follow-up visits with nutritionist), plus purchase of appropriately reduced and modified
fat items from a trial shop
Weight goals: weight and calories not mentioned
Total fat intake (through study): BC 32.5 (SD unclear) %E, control 35.5 (SD unclear)
%E
Saturated fat intake (through study): BC 7.4 (SDunclear)%E, control 12.0 (SDunclear)
%E
Style: food provided
Setting: community
Outcomes Stated trial outcomes: lipid levels and dietary assessment
Available outcomes: weight
Notes Weight data provided for the BC intervention group -1.8 kg (-4 lb over 6 months), and
-0.9 kg (-2 lb) for modified fat diet G, -1.4 kg (-3 lb) for modified fat diet F. No info
provided for the control group (D)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified randomisation by the statistical centre
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NDHS Open 2nd L&M 1968 (Continued)
Allocation concealment (selection bias) Low risk Stratified randomisation by the statistical centre
Blinding (performance bias and detection
bias)
All outcomes
Low risk Some participants continued with advice to reduce saturated fat
and purchased blinded foods from a trial shop, but half of the
participantswere instructed in their ownpurchase of appropriate
foods from normal shops to compile their own dietary regimen
Incomplete outcome data (attrition bias)
All outcomes
High risk 104 of 498 (21%) lost over 0.6 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Trial shop used by both groups, plus dietary advice. See ’Con-
trol methods’ and ’Intervention methods’ in the ’Interventions’
section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
Nutrition & Breast Health
Methods RCT
Participants Pre-menopausal women at increased risk of breast cancer (USA)
CVD risk: low
Control: randomised 53, analysed 50
Intervention: randomised 69, analysed 47
Mean years in trial: control 1.0, intervention 0.8
% male: control 0%, intervention 0%
Age: mean 38 (SD 7) - not provided by study arm (all 21 to 50)
Baseline BMI: not reported
Interventions Reduced fat vs usual diet
Control aims: followed usual diet, given daily food guide pyramid (half of this group
randomised to 9 portions/d of fruit and vegetables advice)
Intervention aims: total fat 15%E (half of this group randomised to 9 portions/d of fruit
and vegetables advice)
Control methods: no dietary counselling (offered this at the end of study), but those
given fruit and vegetables advice had support as below
Intervention methods: met dietitian every 2 weeks until compliant, monthly group
meetings, counselling on home diets, restaurants, parties, social support, eating at work,
exchange booklets, cookbook
Weight goals: ”goals were derived such that baseline energy intake would be maintained
while meeting study goals“
Total fat intake (at 12 months): low fat 15.7 (SD 5.1) %E, control 32.7 (SD 6.1) %E
Saturated fat intake (at 12 months): low fat 7.2 (SD unclear) %E, control 11.6 (SD
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Nutrition & Breast Health (Continued)
unclear) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: body weight, dietary compliance
Available outcomes: weight, total, LDL and HDL cholesterol, TG, BMI (but variance
data not provided for any but weight)
Notes Change from baseline to 12 months for the control (n = 23), control plus fruit and
vegetables (n = 25), low fat (n = 24), low fat plus fruit and vegetables (n = 23):
Total cholesterol mg/dl: 9, 2, -8, 0
TG mg/dl: -7, 1, 5, 8
HDL cholesterol mg/dl: 0, 0, -4, 0
LDL cholesterol mg/dl: 11, 2, -6, -2
BMI kg/m2: 0, 4, -13, 0
For weight end data only are provided (no change data) although the intervention group
were considerably heavier at baseline (149 lb and 154 lb) than control groups (both 143
lb)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The statistician made envelopes ahead of time, dietitians handed
out envelopes at first visit
Allocation concealment (selection bias) Low risk Allocation could not be altered once made
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were aware of allocation, researchers and those as-
sessing lipids were not
Incomplete outcome data (attrition bias)
All outcomes
High risk 15 of 122 (12%) lost over 1 year (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk High levels of intervention for those on low fat or high fruit
and vegetable diets. See ’Control methods’ and ’Intervention
methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? Low risk Randomisation to fruit and vegetable intervention was indepen-
dent of low fat allocation
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Pilkington 1960
Methods RCT
Participants Men with angina or who have had a MI (UK)
CVD risk: high
Reduced fat: randomised unclear, analysed 12
Modified fat: randomised unclear, analysed 23
Mean years in trial:reduced fat 1.1, modified fat 1.1
% male: reduced fat 100%, modified fat 100%
Age: not stated
Baseline BMI: not reported
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 20 g/d, advice to avoid dairy fats except skimmed milk plus
1 egg or 21 g cheese/d. Lean meat and fish each allowed once/d, other non-fatty foods
allowed in unlimited quantities
Modified fat aims: fat aims not stated, dairy produce avoided except skimmed milk, 90
ml/d soya oil provided, lean meat originally prohibited but allowed after 6 months along
with 113 g/wk of ’relatively unsaturated margarine’. Fish and vegetables allowed freely
Reduced fat methods: unclear, ”dietary histories taken before and during treatment“
Modified fat methods: unclear, ”dietary histories taken before and during treatment“
Weight goals: non-fatty foods not restricted, no weight goals mentioned
Total fat intake (during treatment): low fat 15.8 (SD unclear) %E, mod fat 36 (SD
unclear) %E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: lipids
Available outcomes: weight, total and LDL cholesterol
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomised“
Allocation concealment (selection bias) Unclear risk No details provided
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, unclear for outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear exactly how many were randomised, but paper suggests
that all randomised participants were analysed
Selective reporting (reporting bias) Unclear risk No protocol found
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Pilkington 1960 (Continued)
Other bias Low risk
Free of systematic difference in care? Low risk Appear to be similar levels of assessment and support in both
arms
Free of dietary differences other than fat? Low risk Dietary focus entirely on fat
Polyp Prevention 1996
Methods RCT
Participants People with at least one adenomatous polyp of the large bowel removed (USA)
CVD risk: low
Control: 1042 randomised, 943 analysed
Intervention: 1037 randomised, 943 analysed
Mean years in trial: control 3.05, intervention 3.05
% male: control 64%, intervention 66%
Age: mean control 61.5, intervention 61.4 (all at least 35)
Baseline BMI: mean control 27.5 (SE 0.12), intervention 27.6 (SE 0.13)
Interventions Low fat vs usual diet
Control: general dietary guidelines
Intervention: total fat 20%E, 18 g fibre/1000 kcal, 5 to 8 servings fruit and vegetables
daily
Control methods: leaflet, no additional information or behaviour modification
Intervention methods: > 50 hours of counselling over 4 years, included skill building,
behaviour modification, self monitoring and nutritional materials
Weight goals: ”weight loss is permitted but not encouraged....counselled to replace fat
intake with increased intake of fruit, vegetable and grain products rather than reduce
total calorie intake.“
Total fat intake (at 4 years): low fat 23.8 (SD 6.0), control 33.9 (SD 5.9) %E
Saturated fat intake: unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: recurrence of polyps, prostate cancer
Available outcomes: weight, total cholesterol
Notes Weight data reported at 1, 2, 3 and 4 years. 3-year data used in main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”randomly assigned“ by computer randomisation centre, strati-
fied according to centre
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Polyp Prevention 1996 (Continued)
Allocation concealment (selection bias) Low risk Phone call to computer randomisation centre, stratified accord-
ing to centre
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessors blinded, participants not
Incomplete outcome data (attrition bias)
All outcomes
Low risk 193 of 2079 (9%) lost over 3 years (< 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk 50 hours behaviour modification in intervention group, not in
control. See ’Control methods’ and ’Intervention methods’ in
the ’Interventions’ section above
Free of dietary differences other than fat? High risk Fibre, fruit and vegetable goals in intervention group
Rivellese 1994
Methods RCT
Participants Adults with primary hyperlipoproteinaemia (Italy)
CVD risk: moderate
Intervention reduced fat: 33 randomised, 27 analysed
Intervention modified fat: 30 randomised, 17 analysed
Mean years in trial: reduced fat 0.4, modified fat 0.4
% male: reduced fat 82%, modified fat 63%
Age, years: reduced fat 47.4 mean (SD 10.3), modified fat 48.6 (SD 8.1)
Baseline BMI: reduced fat 24.4 mean (SD 2.9), modified fat 25.2 (SD 2.7)
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 25%E, SFA 8%E,MUFA 15%, PUFA 2%, dietary cholesterol
< 300 mg/d, CHO 58%, protein 17%E, soluble fibre 41 g/d
Modified fat aims: total fat 38%E, SFA < 10%E, MUFA 20%E, PUFA 10%E, dietary
cholesterol < 300 mg/d, CHO 47%E, protein 15%E, soluble fibre 19 g/d
Reduced fat methods: seen monthly by dietitian and doctor, feedback based on 7-day
food diary each time
Modified fat methods: seen monthly by dietitian and doctor, feedback based on 7-day
food diary each time
Weight goals: neither weight or energy intake goals mentioned for either group
Total fat intake (at 5 to 6 months): low fat 27 (SD unclear) %E, mod fat 36 (SD unclear)
%E
Saturated fat intake (at 5 to 6 months): low fat 6 (SD unclear) %E, mod fat 7 (SD
unclear) %E
Style: diet advice
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Rivellese 1994 (Continued)
Setting: community
Outcomes Stated trial outcomes: metabolic effects
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes Weight data were presented without variance info. Participants in the low fat arm lost 1.
8 kg over the 6 months, the modified fat diet arm lost 1.6 kg
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Following 3 or 6 weeks compliance with control diet run-in,
stratified block randomisation with tables of random numbers
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk None
Incomplete outcome data (attrition bias)
All outcomes
High risk 19 of 63 (30%) lost over 0.4 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Identical follow-up. See ’Control methods’ and ’Intervention
methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? High risk Some differences in soluble fibre intake
Simon Low Fat Breast CA
Methods RCT
Participants Women with a high risk of breast cancer (USA)
CVD risk: low
Control: randomised 96, analysed 38
Intervention: randomised 98, analysed 34
Mean years in trial: control 1.8, intervention 1.7
% male: 0
Age: mean control 46, intervention 46
Baseline BMI: mean intervention 25.2 (SE 0.8), control 28.1 (SE 0.8)
Interventions Reduced fat vs usual diet
Control aims: usual diet
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Simon Low Fat Breast CA (Continued)
Intervention aims: total fat 15%E
Control methods: continued usual diet
Intervention methods: biweekly individual dietetic appointments over 3 months fol-
lowed by monthly individual or group appointments, including education, goal setting,
evaluation, feedback and self monitoring
Weight goals: weight and calorie goals not discussed
Total fat intake (at 12 months): low fat 18.0 (SD 5.6), control 33.8 (SD 7.4) %E
Saturated fat intake (at 12 months): low fat 6.0 (SD unclear), control 11.3 (SD unclear)
%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: intervention feasibility
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by age and randomised (block size 2)
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants knew their allocation, unclear whether physicians
did
Incomplete outcome data (attrition bias)
All outcomes
High risk 122 of 194 (63%) lost over 2 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Very different contact time with dietitian, but medical appoint-
ments same in both groups. See ’Control methods’ and ’Inter-
vention methods’ in the ’Interventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
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Sondergaard 2003
Methods RCT
Participants People with IHD plus total cholesterol at least 5 mmol/L (Denmark)
CVD risk: high
Control: 63 randomised, 52 analysed
Intervention: 68 randomised, 63 analysed
Mean years in trial: 1.0
% male: control 79%, intervention 62%
Age: control mean 62.8 (SD 10.5), intervention mean 62.1 (SD 9.3)
Baseline BMI: intervention 26.6 (SD 3.9), control 26.7 (SD 4.2)
Interventions Reduced and modified fat intake vs usual diet
Control: aims unclear
Intervention: aims reductions in total and saturated fat, replace fats with oils, 600 g fruit
and vegetables/d, fatty fish at least once a week, eat plenty of bread and cereals
Control methods: booklets plus one dietetic interview, and 3 monthly clinical review
Intervention methods: 1-hour nutrition interview every 3 months, plus 3 monthly clin-
ical review
Weight goals: weight not mentioned
Total fat intake (at 12 months): low and mod fat 26.2 (SD 5.1), control 28.9 (SD 7.9)
%E
Saturated fat intake (at 12 months): unclear
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: endothelial function
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes No outcome data provided on weight, except the statement ”in both groups, body weight
remained unchanged after 12 months“
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomised in unblinded 1:1 fashion“
Allocation concealment (selection bias) High risk ”randomised in unblinded 1:1 fashion“
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of allocation, unclear about others
Incomplete outcome data (attrition bias)
All outcomes
High risk 16 of 131 (12%) lost over 1 year (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
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Sondergaard 2003 (Continued)
Other bias Low risk
Free of systematic difference in care? High risk Additional dietetic time for intervention group. See ’Control
methods’ and ’Intervention methods’ in the ’Interventions’ sec-
tion above
Free of dietary differences other than fat? High risk Additional dietary advice for intervention group (fruit, vegeta-
bles, fish, cereals)
Strychar 2009
Methods RCT
Participants People with well controlled type I diabetes mellitus (Canada)
CVD risk: moderate
Intervention reduced fat: 18 randomised, 15 analysed
Intervention modified fat: 17 randomised, 15 analysed
Mean years in trial: reduced fat 0.46, modified fat 0.47
% male: reduced fat unclear, modified fat unclear
Age, years: 37.9 (8.1 SD) (not specified by study arm)
Baseline BMI: mean reduced fat 24.3 (SD 2.6), modified fat 24.3 (SD 2.7)
Interventions Reduced fat vs modified fat diet
Reduced fat aims: total fat 27%E to 30%E, SFA ≤ 10%E, MUFA 10%, CHO 54% to
57%
Modified fat aims: total fat 37%E to40%E, SFA ≤ 10%E, MUFA 20%E, CHO 43%E
to 46%E
Reduced fatmethods: after initial dietary advicemonitoredweekly by phone by a dietitian
(24-hour food recall). Glycaemia, insulin doses, CHO at meals, hypoglycaemic attacks
all self monitored daily and reported weekly
Modified fat methods: after initial dietary advice monitored weekly by phone by a
dietitian (24-hour food recall). Glycaemia, insulin doses, CHO at meals, hypoglycaemic
attacks all self monitored daily and reported weekly
Total fat intake (at 6 months): not stated
Saturated fat intake (at 6 months): not stated
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: triglycerides and other CVD risk factors
Available outcomes: weight; BMI; total, LDL and HDL cholesterol; TG; systolic and
diastolic blood pressure
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
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Strychar 2009 (Continued)
Random sequence generation (selection
bias)
Unclear risk ”randomly assigned“
Allocation concealment (selection bias) Unclear risk No details provided
Blinding (performance bias and detection
bias)
All outcomes
High risk No details provided, but participants had to make decisions
about what they ate
Incomplete outcome data (attrition bias)
All outcomes
High risk 5 of 35 (14%) lost over 0.5 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? Low risk Similar intervention in both groups
Free of dietary differences other than fat? Low risk Focus on fat and CHO intake
Swedish Breast CA 1990
Methods RCT
Participants Women who had had surgery for breast cancer (Sweden)
CVD risk: low
Control: randomised 121, analysed 63
Intervention: randomised 119, analysed 106
Mean years in trial: control 1.9, randomised 1.5
% male: 0%
Age: mean 58 (not described by randomisation group)
Baseline BMI: intervention 6 BMI < 20, 81 BMI 20 to 24.9, 34 BMI ≥ 25; control 9
BMI < 20, 74 BMI 20 to 24.9, 36 BMI ≥ 25
Interventions Reduced fat vs usual diet
Control aims: usual diet
Intervention aims: 20%E to 25%E from fat, increase energy from CHO to replace lost
energy
Control methods: no advice provided, only seen at baseline and 2 years
Intervention methods: 4 to 6 sessions during the first 2 months, group meetings every
6 to 8 weeks, evening classes in low fat cooking, 3 monthly counselling during the first
year, then at 18 months
Weight goals: ”The total energy and/or protein intake was to be held constant“
Total fat intake (at 2 years): intervention -12.9 (SD unclear) (24 overall), control -3.1
(SD unclear) (34.1 overall) %E
Saturated fat intake (change to 2 years): intervention -6.8 (SD unclear), control -1.9 (SD
unclear) %E
Style: diet advice
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Swedish Breast CA 1990 (Continued)
Setting: community
Outcomes Stated trial outcomes: dietary intake
Available outcomes: weight, BMI
Notes No exact variance or P values reported for weight and BMI outcomes, so have estimated
variance from P value < 0.05 for the difference between the 2 arms for weight. As P value
> 0.05 for BMI no variance could be estimated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomly assigned“
Allocation concealment (selection bias) Unclear risk No details provided
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, unclear for those assessing outcomes
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcome data ignored for those who dropped out (48% of the
intervention group), > 5%/year
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias Low risk
Free of systematic difference in care? High risk Different levels of time and follow-up in the 2 groups
Free of dietary differences other than fat? Low risk Focus on fat
Veterans Dermatology 1994
Methods RCT
Participants People with non-melanoma skin cancer (USA)
CVD risk: low
Control: randomised 67, analysed 58
Intervention: randomised 66, analysed 38
Mean years in trial: 1.9
% male: control 67%, intervention 54%
Age: mean control 52.3 (SD 13.2), intervention 50.6 (SD 9.7)
Baseline BMI: data not provided
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Veterans Dermatology 1994 (Continued)
Interventions Reduced fat vs usual diet
Control aims: no dietary advice
Intervention aims: total fat 20%E, protein 15%E, CHO 65%E
Control methods: no dietary change, 4 monthly clinic visits
Intervention methods: 8 weekly classes, with behavioural techniques, plus 4 monthly
clinic visits
Weight goals: “to maintain body weight .... patients were instructed to increase their
intake of carbohydrate, particularly complex carbohydrate”
Total fat intake (“during study” months 4 to 24): low fat 20.7 (SD 5.5), control 37.8
(SD 4.1) %E
Saturated fat intake (“during study, months 4 to 24): low fat 6.6 (SD 1.8), control 12.8
(SD 2.0) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: incidence of actinic keratosis and non-melanoma skin cancer
Available outcomes: none (weight data provided, but no variance info)
Notes At 2 years control -1.5 kg n = 50?, intervention -1 kg n = 51?
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”list of randomly generated numbers“
Allocation concealment (selection bias) Unclear risk Randomisation method not clearly described
Blinding (performance bias and detection
bias)
All outcomes
High risk Physician blinding: adequate
Participant blinding: inadequate
Incomplete outcome data (attrition bias)
All outcomes
High risk 37 of 133 (28%) lost over 2 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Minor: all have 4 monthly clinic visits, the intervention group
had 8 behavioural technique classes that the control group did
not have
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
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VYRONAS 2009
Methods RCT
Participants 12 to 13-year olds attending schools in Vyronas, Athens (Greece)
CVD risk: low
Control: randomised n = 105, analysed at 17 months n = 93
Intervention: randomised n = 108, analysed at 17 months n = 98
Mean years in trial: control 1.3, intervention 1.4
% male: control 49.5%, intervention 49.0%
Age: control mean 13.3 (SD 0.9), intervention 13.1 (SD 0.8)
Baseline BMI: control mean 24.3 (SD 3.3), intervention 24 (SD 3.1)
Interventions Reduced fat vs usual diet
Control aims: not stated, usual intake assumed
Intervention aims: unclear, but appears to have been low fat and dental hygiene
Control methods: screening results were posted to parents, no other information
Intervention methods: 12 hours of classroom materials over 12 weeks, taught by home
economics teacher supervised by health visitor or family doctor, including multicom-
ponent workbooks, ”interactions among environmental, cognitive and behavioural fac-
tors“, ”classroom modules developed behavioural capability, expectations and self-effi-
cacy for healthful eating and healthy foods selection“, 2meetings including presentations
were held with parents
Weight goals: not mentioned except that note was made of obese children (unclear in
what respect)
Total fat intake (at 17 months): low fat 31.3 (SD 4.4), control 36.9 (SD 4.8) %E
Saturated fat intake (at 17 months): low fat 10.3 (SD 1.9), control 13.4 (SD 2.8) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: diet, nutrition intake and BMI
Available outcomes: nutritional intake, BMI
Notes BMI reported compared with baseline in each group, but change in BMI not directly
compared between intervention and control groups (calculated by review authors)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”computerised random number generator“
Allocation concealment (selection bias) Low risk Recruitment appeared to have been completed before allocation
occurred
Blinding (performance bias and detection
bias)
All outcomes
High risk ”Because of the nature of the intervention, blinding was not
feasible“
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VYRONAS 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Similar in both arms, paper mentions loss of 5 participants dur-
ing trial (due to health problems, lack of interest and move to
other schools). Of 109 allocated in each arm 10 were not in-
cluded in analysis of the intervention group and 12 in the con-
trol (reasons unclear). 22 of 213 (10%) lost over 17 months (>
5% per year)
Selective reporting (reporting bias) Unclear risk No protocol found
Other bias High risk Unclear how interventionwas delivered to some children but not
others as randomisation appeared to be individual, not by class.
Intervention methods imply an individualised intervention, but
unclear what elements were individualised
Free of systematic difference in care? High risk No, intervention group appear to have received modules de-
signed to develop behavioural capability, expectations and self
efficacy, and included motivational methods and strategies as
well as social influence
Free of dietary differences other than fat? High risk Exact goals of intervention unclear, but appears to have focused
on ”mainly dietary issues, but also dental health hygiene and
consumption attitudes“
WHEL 2007
Methods RCT
Participants Women with previously treated early breast cancer (USA)
CVD risk: low
Control: randomised 1561, analysed 1313
Intervention: randomised 1546, analysed 1308
Mean years in trial: unclear, 11 years max, around 11 years mean?
% male: 0
Age: control mean 53.0 (SD 9.0), intervention mean 53.3 (SD 8.9)
Baseline BMI: control mean 27.2 (SD 6.1), intervention mean 27.2 (SD 6.1)
Interventions Reduced fat intake vs usual diet
Control: aim 30%E from fat
Intervention: aim 15%E to 20%E from fat, 5 vegetables/d, 3 fruit/d, 16 oz vegetable
juice and 30 g/d fibre
Control methods: given print materials only
Interventionmethods: telephone counselling programme (31 calls by study end), cooking
classes (12 offered in first year, 4 attended on average) and monthly newsletters (48 by
study end), all focused on self efficacy, self monitoring and barriers, retaining motivation
Weight goal: intervention goal was to achieve the change in dietary pattern without
weight reduction, weight and calories not mentioned in the control group
Total fat intake (at 72 months): low fat 28.9 (SD 9.0), control 32.4 (SD 8.0) %E
Saturated fat intake (at 72 months): low fat 7.2 (SD unclear), control 8.9 (SD unclear)
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WHEL 2007 (Continued)
%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: mortality, invasive breast cancer
Available outcomes: weight, total, LDL and HDL cholesterol, TG
Notes Weight reported at 1, 2, 3, 4 and 6 years, and 3-year data used in main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation via computer program
Allocation concealment (selection bias) Low risk Randomisation via computer program
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 486 of 3107 (16%) lost over 11 years (< 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk High-intensity intervention compared with leaflets. See ’Con-
trol methods’ and ’Intervention methods’ in the ’Interventions’
section above
Free of dietary differences other than fat? High risk Fruit and vegetable intervention in low fat arm, not in control
WHI 2006
Methods RCT
Participants Postmenopausal women aged 50 to 79 (USA)
CVD risk: mixed, mostly low but some participants had CVD at baseline
Control: randomised 29,294, analysed 25,056
Intervention: randomised 19,541, analysed 16,297
Mean years in trial: control 8.1, intervention 8.1
% male: 0
Age: mean intervention 62.3 (SD 6.9), control 62.3 (SD 6.9)
Baseline BMI: mean intervention 29.1 (SD 5.9), control 29.1 (SD 5.9)
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WHI 2006 (Continued)
Interventions Reduced fat vs usual diet
Control: diet-related education materials
Intervention: low fat diet (20%E from fat) with increased fruit and vegetables
Control methods: given copy of ’Dietary Guidelines for Americans’
Intervention methods: 18 group sessions with trained and certified nutritionists in the
first year, quarterly maintenance sessions thereafter, focusing on diet and behaviour
modification
Weight goals: ”the intervention did not include total energy reduction or weight-loss
goals“
Total fat intake (at 6 years): intervention 28.8 (SD 8.4) %E, control 37.0 (SD 7.3) %E
Saturated fat intake (at 6 years): intervention 9.5 (SD 3.2) %E, control 12.4 (SD 3.1)
%E
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: breast cancer, mortality, other cancers, cardiovascular events, dia-
betes
Available outcomes: weight, BMI, total, LDL and HDL cholesterol, TG, systolic and
diastolic BP
Notes Weight data available at 1 year, 3 years and 6 years. Year 3 data used for main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer algorithm
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants aware of allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7482 of 48,835 (15%) lost over 8 years (< 5% per year)
Selective reporting (reporting bias) Low risk Weight and secondary outcomes reported as in protocol
Other bias Low risk
Free of systematic difference in care? High risk Intervention participants received 18 group sessions with be-
havioural modification plus quarterly maintenance sessions
thereafter. See ’Control methods’ and ’Intervention methods’ in
the ’Interventions’ section above
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WHI 2006 (Continued)
Free of dietary differences other than fat? High risk Also fruit and vegetable intervention. See ’Control aims’ and
’Intervention aims’ in the ’Interventions’ section above
WHT Feasibility 1990
Methods RCT
Participants Women at increased risk of breast cancer (USA)
CVD risk: low
Control: randomised 184, analysed 159
Intervention: randomised 119, analysed 102
Mean years in trial: control 1.9, randomised 1.9
% male: 0%
Age: mean control 55.6 (SD 6.3), intervention 55.6 (SD 6.2)
Baseline BMI: mean intervention 26 (SD 4), control 25 (SD 4)
Interventions Reduced fat vs usual diet
Control aims: maintain usual diet
Intervention aims: 20%E from fat
Control methods: no advice provided, only seen at baseline, then 6, 12 and 24 months
for assessment
Intervention methods: women were given flexible diet plans and responsible for their
ownmonitoring, they had individual appointments with a nutritionist at 2 and 12weeks,
plus small group meetings (weekly for 8 weeks, then biweekly for 8 weeks, then monthly
to 2 years)
Weight goals: weight and calories not mentioned
Total fat intake (at 2 years): intervention 22.6 (SD 7.1), control 36.8 (SD 8.0) %E
Saturated fat intake (at 2 years): intervention 7.2 (SD 2.7), control 12.3 (SD 3.6) %E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake/feasibility
Available outcomes: weight, total cholesterol
Notes Weight data provided at 6, 12 and 24 months. 2-year data used in main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomised“
Allocation concealment (selection bias) Unclear risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants were not blinded
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WHT Feasibility 1990 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 42 of 303 (14%) lost over 2 years (> 5% per year)
Selective reporting (reporting bias) Low risk Design paper published, weight and serum total cholesterol re-
ported
Other bias Low risk
Free of systematic difference in care? High risk Different levels of attention and time
Free of dietary differences other than fat? Low risk Focus on fat only
WHT:FSMP 2003
Methods RCT
Participants Postmenopausal women from diverse ethnic and socioeconomic backgrounds (USA)
CVD risk: low
Control: randomised 883, analysed 649 at 6 mo, 443 at 12 mo, 194 at 18 mo
Intervention: randomised 1325, analysed 1071 at 6 mo, 698 at 12 mo, 285 at 18 mo
Mean years in trial: unclear, follow-up from 6 to 18 months
% male: 0%
Age: mean control 59.8 (SD 6.6), intervention 60.1 (SD 6.6)
Baseline BMI: 28.8 (SD 4.7) for all
Interventions Reduced fat vs usual diet
Control aims: maintain usual diet
Intervention aims: up to 20%E from fat, reduced saturated fat and dietary cholesterol,
increased fruit, vegetables and whole grains
Control methods: pamphlet on general dietary guidelines provided, no other follow-up,
seen at baseline, then 6, 12 and 18 months for assessment
Intervention methods: women allocated to groups of 8 to 15 women with a nutritionist
leader, meeting weekly for 6 weeks, bi-weekly for 9 months then quarterly. Women
provided with personal fat gram goals
Weight goals: weight and calories not mentioned
Total fat intake (at 1 year): intervention 25.4 (SD unclear), control 36.0 (SD unclear)
%E
Saturated fat intake (at 1 year): intervention 8.7 (SD unclear), control 12.1 (SD unclear)
%E
Style: diet advice
Setting: community
Outcomes Stated trial outcomes: dietary intake/feasibility
Available outcomes: weight, BMI, blood pressure
Notes Weight and BMI data only found for 6 months of intervention
Risk of bias
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WHT:FSMP 2003 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”randomised“
Allocation concealment (selection bias) Unclear risk Not discussed
Blinding (performance bias and detection
bias)
All outcomes
High risk No for participants, though outcome assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk All those randomised were analysed for weight
Selective reporting (reporting bias) Low risk For weight
Other bias Low risk
Free of systematic difference in care? High risk Greater time and support provided to intervention group
Free of dietary differences other than fat? High risk Suggestion to intervention group to increase fruit, vegetable and
whole grain intakes
WINS 1993
Methods RCT
Participants Women with localised resected breast cancer (USA)
CVD risk: low
Control: 1462 randomised, 998 analysed
Intervention: 975 randomised, 386 analysed
Mean years in trial: overall 5.0
% men: 0
Age: control mean 58.5 (95% CI 43.6 to 73.4), intervention mean 58.6 (95% CI 44.4
to 72.8) (all postmenopausal)
Baseline BMI: mean intervention 27.6 (95% CI 27.2 to 28.0), control 27.5 (95% CI
27.2 to 27.8)
Interventions Reduced fat intake vs usual diet
Control aims: minimal nutritional counselling focused on nutritional adequacy
Intervention aims: total fat 15%E to 20%E
Control methods: 1 baseline dietetic session plus 3-monthly sessions
Intervention methods: 8 bi-weekly individual dietetic sessions, then optional monthly
group sessions, incorporating individual fat gram goals, social cognitive theory, self mon-
itoring, goal setting, modelling, social support and relapse prevention and management
Weight goals: ”fat gram goals were based on energy needed to maintain weight, and no
counselling on weight reduction was provided“, not mentioned for control
Total fat intake (at 1 year): low fat 20.3 (SD 8.1), control 29.2 (SD 7.4) %E
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WINS 1993 (Continued)
Saturated fat intake (at 1 year): low fat 10.4 (SD 6.7), control 16.6 (SD 9.3) %E
Style: dietary advice
Setting: community
Outcomes Stated trial outcomes: dietary fat intake, total cholesterol, weight and waist
Available outcomes: weight, BMI
Notes Weight data reported at 1, 3 and 5. 3-year data used in main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random stratified permuted block design, carried out at the
statistical co-ordinating centre of WINS
Allocation concealment (selection bias) Low risk
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants not blinded, not relevant for assessment ofmortality
by researchers
Incomplete outcome data (attrition bias)
All outcomes
High risk 1053 of 2437 (43%) lost over 5 years (> 5% per year)
Selective reporting (reporting bias) Unclear risk Protocol not seen
Other bias Low risk
Free of systematic difference in care? High risk Differences in attention - more time for those in intervention
group. See ’Control methods’ and ’Intervention methods’ in the
’Interventions’ section above
Free of dietary differences other than fat? Low risk See ’Control aims’ and ’Intervention aims’ in the ’Interventions’
section above
Abbreviations:
%E: percentage of total energy intake
AHA: American Heart Association
BC:
BMI: body mass index
BP: blood pressure
CHD: coronary heart disease
CHO: carbohydrates
CI: confidence interval
CVD: cardiovascular disease
HDL: high-density lipoprotein
IHD: ischaemic heart disease
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LDL: low-density lipoprotein
MI: myocardial infarction
MUFA: monounsaturated fatty acid
NCEP: National Cholesterol Education Program
NEP: Nutrition Education Program
NDHS: National Diet-Heart Study
P/S: polyunsaturated/saturated fat ratio
PUFA: polyunsaturated fatty acid
RCT: randomised controlled trial
SD: standard deviation
SE: standard error
SFA: saturated fatty acid
TG: triglycerides
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Agewall 2001 Multifactorial intervention
Ammerman 2003 No appropriate control group (and not low fat vs modified fat)
Anti-Coronary C 1966 Not randomised
Aquilani 2000 No appropriate control group (and not low fat vs modified fat)
Arne 2014 Intervention aimed at weight management
Arntzenius 1985 No appropriate control group (and not low fat vs modified fat)
Aro 1990 Intervention and randomised follow-up less than 6 months
ASSIST 2001 Intervention is not dietary fat modification or low fat diet
Australian Polyp Prev Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Baer 1993 Not randomised
Bakx 1997 Multifactorial intervention
Barnard 2009 Weight reduction encouraged in the conventional diet, but not in the vegan diet arm
Barndt 1977 No appropriate control group (and not low fat vs modified fat)
Baron 1990 Multifactorial intervention
Barr 1990 Intervention and randomised follow-up less than 6 months
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Baumann 1982 Intervention and randomised follow-up less than 6 months
Bazzano 2012 Participants selected on basis of BMI (30 to 45)
Beckmann 1988 Not randomised
Beckmann 1995 Intervention is not dietary fat modification or low fat diet
Beresford 1992 Intervention and randomised follow-up less than 6 months
Bergstrom 1967 Intervention and randomised follow-up less than 6 months
Bierenbaum 1963 No appropriate control group (and not low fat vs modified fat)
Bloomgarden 1987 Multifactorial intervention
Bonnema 1995 No appropriate control group (and not low fat vs modified fat)
Bosaeus 1992 Intervention and randomised follow-up less than 6 months
Boyar 1988 Not randomised
Brehm 2009 Participants recruited on basis of being overweight or obese
Brensike 1982 No appropriate control group (and not low fat vs modified fat)
Broekmans 2003 Intervention is not dietary fat modification or low fat diet
Brown 1984 No appropriate control group (and not low fat vs modified fat)
Bruce 1994 No appropriate control group (and not low fat vs modified fat)
Bruno 1983 Multifactorial intervention
Butcher 1990 Intervention and randomised follow-up less than 6 months
Butowski 1998 Not randomised
Byers 1995 No appropriate control group (and not low fat vs modified fat)
Caggiula 1996 No appropriate control group (and not low fat vs modified fat)
CARMEN 2000 Participants recruited on basis of BMI (26 to 34)
CARMEN MS sub-study Substudy of CARMEN 2000, participants recruited on basis of BMI
Cerin 1993 Intervention and randomised follow-up less than 6 months
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Chan 1993 Intervention and randomised follow-up less than 6 months
Chapman 1950 Intervention and randomised follow-up less than 6 months
Charbonnier 1975 Intervention and randomised follow-up less than 6 months
Cheng 2004 Intervention and randomised follow-up less than 6 months
Chicago CPEP 1977 Not randomised
Chiostri 1988 Intervention and randomised follow-up less than 6 months
Choudhury 1984 Intervention and randomised follow-up less than 6 months
Clark 1997 Multifactorial intervention
Clifton 1992 Intervention and randomised follow-up less than 6 months
Cobb 1991 Intervention and randomised follow-up less than 6 months
Cohen 1991 Intervention is not dietary fat modification or low fat diet
Cole 1988 Intervention and randomised follow-up less than 6 months
Colquhoun 1990 Intervention and randomised follow-up less than 6 months
Consolazio 1946 Intervention and randomised follow-up less than 6 months
Coppell 2010 Weight loss recommended
Cox 1996 Multifactorial intervention
Croft 1986 Intervention is not dietary fat modification or low fat diet
Crouch 1986 Not randomised
Da Qing IGT 1997 Intervention is not dietary fat modification or low fat diet
Dalgard 2001 No appropriate control group (and not low fat vs modified fat)
DAS 1989 No appropriate control group (and not low fat vs modified fat)
DASH 1997 Intervention and randomised follow-up less than 6 months
Davey Smith 2005 Multifactorial intervention
de Boer 1983 Intervention and randomised follow-up less than 6 months
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DeBusk 1994 Multifactorial intervention
Delahanty 2001 No appropriate control group (and not low fat vs modified fat)
Delius 1969 Intervention is not dietary fat modification or low fat diet
Demark 1990 Intervention and randomised follow-up less than 6 months
Dengel 1995 No appropriate control group (and not low fat vs modified fat)
Denke 1994 Intervention and randomised follow-up less than 6 months
Diabetes CCT 1995 Intervention is not dietary fat modification or low fat diet
DIET 1998 Multifactorial intervention
Ding 1992 Intervention and randomised follow-up less than 6 months
DIRECT 2009 Weight reduction aim
DO IT 2004 ”Overweight subjects were encouraged to adopt a calorie-restricted diet“
Dobs 1991 No appropriate control group (and not low fat vs modified fat)
Duffield 1982 Multifactorial intervention
Dullaart 1997 Not randomised
Dutch Nutrition Guide No data on weight or body fatness, or any cardiovascular outcomes
Eating Patterns 1997 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Eckard 2013 Energy restricted diet
Ehnholm 1982 Intervention and randomised follow-up less than 6 months
Ehnholm 1984 Intervention and randomised follow-up less than 6 months
Eisenberg 1990 Intervention and randomised follow-up less than 6 months
Elder 2000 No appropriate control group (and not low fat vs modified fat)
Ellegard 1991 Intervention and randomised follow-up less than 6 months
Esposito 2003 No appropriate control group (and not low fat vs modified fat)
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Esposito 2004 No appropriate control group (both groups aimed at < 30%E from fat)
Esposito 2014 Energy restricted diet
EUROACTION 2008 Multifactorial intervention
FARIS 1997 Multifactorial intervention
Fasting HGS 1997 No appropriate control group (and not low fat vs modified fat)
Ferrara 2000 No appropriate control group (and not low fat vs modified fat)
Fielding 1995 Intervention and randomised follow-up less than 6 months
Finckenor 2000 Not randomised
Finnish Diabetes 2000 Multifactorial intervention
Finnish Mental 1972 Not randomised (cluster-randomised, but < 6 clusters)
Fisher 1981 Intervention and randomised follow-up less than 6 months
Fleming 2002 No appropriate control group (and not low fat vs modified fat)
Fortmann 1988 Intervention is not dietary fat modification or low fat diet
Foster 2003 Weight reduction in one arm but not the other
FRESH START 2007 Participants were newly diagnosed with cancer
Friedman 2012 Weight loss diets
Gambera 1995 Intervention and randomised follow-up less than 6 months
Gaullier 2007 No appropriate control group (and not low fat vs modified fat)
German Fat Reduced Participants recruited on basis of their BMI (24 to 29)
Ginsberg 1988 Intervention and randomised follow-up less than 6 months
Gjone 1972 Intervention and randomised follow-up less than 6 months
Glatzel 1966 No appropriate control group (and not low fat vs modified fat)
Goodpaster 1999 No appropriate control group (and not low fat vs modified fat)
Gower 2012 Participants recruited on basis of high BMI
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Gregg 2013 Participants recruited on basis of high BMI
Grundy 1986 Intervention and randomised follow-up less than 6 months
Gudlaugsson 2013 Multifactorial intervention
Guelinckx 2010 Participants recruited on basis of high BMI
Guldbrand 2012 Weight loss intended
Hardcastle 2008 Multifactorial intervention
Harris 1990 Intervention and randomised follow-up less than 6 months
Hartman 1993 No appropriate control group (and not low fat vs modified fat)
Hartwell 1986 No appropriate control group (and not low fat vs modified fat)
Hashim 1960 Intervention and randomised follow-up less than 6 months
Haynes 1984 Intervention is not dietary fat modification or low fat diet
Heber 1991 Intervention and randomised follow-up less than 6 months
Heine 1989 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Heller 1993 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Hildreth 1951 No appropriate control group (and not low fat vs modified fat)
Hood 1965 Not randomised
Horlick 1957 Intervention and randomised follow-up less than 6 months
Horlick 1960 Intervention and randomised follow-up less than 6 months
Howard 1977 Intervention and randomised follow-up less than 6 months
Hunninghake 1990 Intervention and randomised follow-up less than 6 months
Hutchison 1983 No appropriate control group (and not low fat vs modified fat)
Hyman 1998 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
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Iacono 1981 Not randomised; intervention and randomised follow-up less than 6 months
IMPACT 1995A Multifactorial intervention
Ishikawa 1995 Not randomised
Iso 1991 No appropriate control group (and not low fat vs modified fat)
Ives 1993 Multifactorial intervention
Jalkanen 1991 Multifactorial intervention
Janus 2012 Weight loss intended
Jepson 1969 Not randomised
Jerusalem Nut 1992 Intervention and randomised follow-up less than 6 months
Jonasson 2014 Energy restricted diet
Juanola-Falgarona 2014 Energy restricted diet
Jula 1990 Multifactorial intervention
Junker 2001 Intervention and randomised follow-up less than 6 months
Karmally 1990 Intervention and randomised follow-up less than 6 months
Karvetti 1992 Multifactorial intervention
Kastarinen 2002 Multifactorial intervention
Kather 1985 Intervention and randomised follow-up less than 6 months
Kattelmann 2010 Weight loss intended
Katzel 1995 Not randomised
Katzel 1995A Intervention is not dietary fat modification or low fat diet
Kawamura 1993 Intervention and randomised follow-up less than 6 months
Keidar 1988 Intervention and randomised follow-up less than 6 months
Kempner 1948 No appropriate control group (and not low fat vs modified fat)
Keys 1952 Not randomised
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Keys 1957 Intervention and randomised follow-up less than 6 months
Keys 1957A Intervention and randomised follow-up less than 6 months
Keys 1957B Intervention and randomised follow-up less than 6 months
Khan 2003 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
King 2000 Intervention and randomised follow-up less than 6 months
Kingsbury 1961 Intervention and randomised follow-up less than 6 months
Klemsdal 2010 Participants recruited on basis of high BMI
Kohler 1986 Not randomised
Kontogianni 2012 Not randomised
Koopman 1990 Intervention and randomised follow-up less than 6 months
Koranyi 1963 Unclear whether randomised
Korhonen 2003 Multifactorial intervention
Kriketos 2001 Intervention and randomised follow-up less than 6 months
Kris 1994 Intervention and randomised follow-up less than 6 months
Kristal 1997 Multifactorial intervention
Kromhout 1987 No appropriate control group (and not low fat vs modified fat)
Kummel 2008 Intervention is not dietary fat modification or low fat diet
Laitinen 1993 Multifactorial intervention
Laitinen 1994 Multifactorial intervention
Larsen 2011 Energy restricted diet
Leduc 1994 Multifactorial intervention
Leibbrandt 2010 Participants recruited on basis of high BMI
Lewis 1958 Intervention and randomised follow-up less than 6 months
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Lewis 1981 Intervention and randomised follow-up less than 6 months
Lewis 1985 Multifactorial intervention
Lichtenstein 2002 Intervention and randomised follow-up less than 6 months
Linko 1957 Intervention and randomised follow-up less than 6 months
Lipid Res Clinic 1984 No appropriate control group (and not low fat vs modified fat)
Little 1990 Intervention and randomised follow-up less than 6 months
Little 1991 Not randomised
Little 2004 Intervention is not dietary fat modification or low fat diet
Lottenberg 1996 Intervention and randomised follow-up less than 6 months
Luoto 2012 No assessment of total fat intake
Luszczynska 2007 No appropriate control group (and not low fat vs modified fat)
Lyon Diet Heart 1994 Intervention is not dietary fat modification or low fat diet
Lysikova 2003 Intervention and randomised follow-up less than 6 months
Macdonald 1972 Intervention and randomised follow-up less than 6 months
Mansel 1990 Intervention is not dietary fat modification or low fat diet
Marckmann 1993 Not randomised
MARGARIN No appropriate control group (and not low fat vs modified fat)
Martin 2011 Participants recruited on basis of high BMI
Maruthur 2014 No relevant outcomes available
Mattson 1985 Intervention and randomised follow-up less than 6 months
Mayneris-Perxachs 2014 No assessment of total fat intake
McCarron 1997 Intervention and randomised follow-up less than 6 months
McCarron 2001 Intervention is not dietary fat modification or low fat diet
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McManus 2001 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
McNamara 1981 Intervention and randomised follow-up less than 6 months
Medi-RIVAGE 2004 Weight reduction for some low fat diet participants (those with BMI > 25) but not in Mediterranean
group
Mensink 1987 Intervention and randomised follow-up less than 6 months
Mensink 1989 Intervention and randomised follow-up less than 6 months
Mensink 1990 Intervention and randomised follow-up less than 6 months
Mensink 1990A Intervention and randomised follow-up less than 6 months
Merrill 2011 Multifactorial intervention
Metroville Health 2003 No assessment of outcomes further than reduction in fat
Michalsen 2006 Diet plus stress management vs no intervention
Miettinen 1994 Intervention and randomised follow-up less than 6 months
Millar 1973 No appropriate control group (and not low fat vs modified fat)
Miller 1998 Intervention and randomised follow-up less than 6 months
Miller 2001 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Milne 1994 No appropriate control group (and not low fat vs modified fat) - the high CHO diet is neither ’usual’
or ’low fat’ to compare with the modified fat diet
Minnesota HHP 1990 No appropriate control group (and not low fat vs modified fat)
Mishra 2013 Intervention and randomised follow-up less than 6 months
Mitchell 2011 No relevant outcomes available
Mokuno 1988 Intervention and randomised follow-up less than 6 months
Moreno 1994 Not randomised
Morrison 1950 Not randomised
Morrison 1951 Not randomised
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Morrison 1960 Not randomised
Mortensen 1983 Intervention and randomised follow-up less than 6 months
Moses 2014 Intervention and randomised follow-up less than 6 months
MRFIT substudy 1986 Intervention and randomised follow-up less than 6 months
MSDELTA 1995 Intervention and randomised follow-up less than 6 months
MUFObes low fat 2007 Trial aims to assess weight maintenance following major weight loss
MUFObes low vs mod 2007 Trial aims to assess weight maintenance following major weight loss
Mujeres Felices 2003 Diet and breast self examination vs no intervention
Munsters 2010 Weight loss intended
Mutanen 1997 Intervention and randomised follow-up less than 6 months
Muzio 2007 Intervention and randomised follow-up less than 6 months
Naglak 2000 Dietary fat intervention unclear
NAS 1987 Intervention and randomised follow-up less than 6 months
NCEP weight Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Neil 1995 No appropriate control group (and not low fat vs modified fat)
Neverov 1997 Multifactorial intervention
Next Step 1995 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Nordoy 1971 Intervention and randomised follow-up less than 6 months
Norway Veg Oil 1968 No appropriate control group (and not low fat vs modified fat)
Novotny 2012 Weight loss intended
Nutrition Ed Study 1980 Those who were overweight were provided with a weight reduction booklet
O’Brien 1976 Intervention and randomised follow-up less than 6 months
ODES 2001 The study aimed for weight loss in some participants
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Oldroyd 2001 Multifactorial intervention
Orazio 2011 Weight loss intended
ORIGIN 2008 Intervention is not dietary fat modification or low fat diet
Ornish 1990 Multifactorial intervention (diet, smoking, stress and exercise) compared to no intervention
Oslo Study 1980 Multifactorial intervention
Otago Weight Loss 2005 Although intake was ad libitum the aim was for weight loss to occur - participants presumably joined
the study on the basis that it was assessing effects on weight loss, so were keen to lose weight
Pandey 2013 Not randomised
Pascale 1995 Multifactorial intervention
Paz-Tal 2013 No relevant outcomes available
PEP 2001 Multifactorial intervention
PHYLLIS 1993 No appropriate control group (and not low fat vs modified fat)
PREDIMED 2007 Modified fat group is clearly defined, but no fat goals were set for the low fat group. We were unable
to verify whether the fat aim was ≤ 30%E
PREMIER 2003 Overweight participants were encouraged to lose weight
Pritchard 2002 The study aimed for weight loss in one arm and not in the comparison arm
Puget Sound EP Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Rabast 1979 Intervention and randomised follow-up less than 6 months
Rabkin 1981 Intervention and randomised follow-up less than 6 months
Radack 1990 Intervention and randomised follow-up less than 6 months
Rasmussen 1995 Intervention and randomised follow-up less than 6 months
Reaven 2001 Intervention and randomised follow-up less than 6 months
Reid 2002 No appropriate control group (and not low fat vs modified fat)
Renaud 1986 Not randomised
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Rivellese 2003 Intervention and randomised follow-up less than 6 months
Roderick 1997 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Roman CHD prev 1986 Multifactorial intervention
Rose 1987 No appropriate control group (and not low fat vs modified fat)
Rusu 2013 Energy restricted diet
Sacks 2009 All arms aimed at a 750 kcal/day deficit to ensure weight loss
Salas-Salvado 2014 No assessment of total fat intake
Sandstrom 1992 Not randomised
Sasaki 2000 Not randomised
Schaefer 1995 Intervention and randomised follow-up less than 6 months
Schaefer 1995A Intervention and randomised follow-up less than 6 months
Schectman 1996 Multifactorial intervention
Schlierf 1995 Multifactorial intervention
Seppanen-Laakso Intervention and randomised follow-up less than 6 months
Shai 2012 Energy restricted diet
Singh 1990 Not randomised
Singh 1991 Multifactorial intervention
Singh 1992 No appropriate control group (and not low fat vs modified fat)
Siqueira-Catania 2010 Weight loss intended
Sirtori 1992 Intervention and randomised follow-up less than 6 months
SLIM 2008 Multifactorial intervention
Sollentuna Diet The study aimed for weight loss in one arm and not in the comparison arm
Sollentuna Diet & Ex The study aimed for weight loss in one arm and not in the comparison arm
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Sopotsinskaia 1992 The study aimed for weight loss in one arm and not in the comparison arm
Staff HHP 1994 Not randomised
Stanford NAP 1997 Intervention and randomised follow-up less than 6 months
Stanford Weight The study aimed for weight loss in one arm and not in the comparison arm
Starmans 1995 Intervention and randomised follow-up less than 6 months
Steinbach 1996 Multifactorial intervention
Steptoe 2001 No appropriate control group (and not low fat vs modified fat)
Stevens 2002 Diet plus breast self examination vs no intervention
Stevenson 1988 No appropriate control group (and not low fat vs modified fat)
Sweeney 2004 Intervention is not dietary fat modification or low fat diet
TAIM 1989 Intervention is not dietary fat modification or low fat diet
Take Heart II 1997 Not randomised
Tapsell 2004 No weight data or cardiovascular outcomes reported
Taylor 1991 Not randomised
THIS DIET 2008 Study states ”although this was not a weight loss intervention, participants who were overweight or
obese were encouraged to reduce calories to facilitate weight loss“
TOHP I 1992 Multifactorial intervention
TONE 1997 Intervention is not dietary fat modification or low fat diet
Toobert 2003 Multifactorial intervention
Toronto Polyp Prev 1994 No weight or BMI data presented
Towle 1994 Intervention and randomised follow-up less than 6 months
TRANSFACT 2006 Intervention and randomised follow-up less than 6 months
Treatwell 1992 Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Tromso Heart 1989 Multifactorial intervention
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Turku Weight Both intervention groups aimed to lose weight, while the control group did not
Turpeinen 1960 Not randomised
UK PDS 1996 No appropriate control group (and not low fat vs modified fat)
Urbach 1952 No appropriate control group (and not low fat vs modified fat)
Uusitupa 1993 Multifactorial intervention
Uusitupa 2013 Intervention and randomised follow-up less than 6 months
Vavrikova 1958 Intervention and randomised follow-up less than 6 months
Wan 2013 Not a RCT
Wass 1981 Intervention and randomised follow-up less than 6 months
Wassertheil 1985 Intervention is not dietary fat modification or low fat diet
WATCH Neither mortality nor cardiovascular morbidity data available (only decided after contact with at least
one author)
Watts 1988 Intervention and randomised follow-up less than 6 months
Weintraub 1992 No appropriate control group (and not low fat vs modified fat)
Westman 2006 Intervention is not dietary fat modification or low fat diet
Weststrate 1998 Intervention and randomised follow-up less than 6 months
WHO primary prev 1979 Multifactorial intervention
WHT Neither mortality nor cardiovascular morbidity data available as such data were not collected in the
study
Wilke 1974 Intervention and randomised follow-up less than 6 months
Williams 1990 Intervention is not dietary fat modification or low fat diet
Williams 1992 Intervention is not dietary fat modification or low fat diet
Williams 1994 Intervention is not dietary fat modification or low fat diet
Wilmot 1952 No appropriate control group (and not low fat vs modified fat)
Wing 1998 No appropriate control group (and not low fat vs modified fat)
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Wolever 2008 Weight loss intended in some participants
WOMAN 2007 Lifestyle intervention includes exercise and weight as well as diet
Wood 1988 Intervention is not dietary fat modification or low fat diet
Woollard 2003 Multifactorial intervention including smoking, weight, exercise and alcohol components
Working Well 1996 Multifactorial intervention
Young 2010 Weight loss intended
Zock 1995 Intervention and randomised follow-up less than 6 months
BMI: body mass index
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Fat reduction versus usual fat diet, adult RCTs
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Weight, kg 30 53647 Mean Difference (IV, Random, 95% CI) -1.54 [-1.97, -1.12]
2 BMI, kg/m2 10 45703 Mean Difference (IV, Random, 95% CI) -0.50 [-0.74, -0.26]
3 Waist circumference, cm 1 15671 Mean Difference (IV, Random, 95% CI) -0.30 [-0.58, -0.02]
4 LDL cholesterol, mmol/L 18 7285 Mean Difference (IV, Random, 95% CI) -0.13 [-0.23, -0.03]
5 HDL cholesterol, mmol/L 19 7166 Mean Difference (IV, Random, 95% CI) -0.01 [-0.03, 0.00]
6 Total cholesterol, mmol/L 20 7715 Mean Difference (IV, Random, 95% CI) -0.20 [-0.29, -0.11]
7 Triglycerides, mmol/L 17 6976 Mean Difference (IV, Random, 95% CI) -0.02 [-0.12, 0.08]
8 Total cholesterol/HDL 7 3332 Mean Difference (IV, Random, 95% CI) -0.10 [-0.16, -0.04]
9 Systolic blood pressure, mmHg 9 5159 Mean Difference (IV, Random, 95% CI) -1.16 [-1.95, -0.37]
10 Diastolic blood pressure,
mmHg
9 5159 Mean Difference (IV, Random, 95% CI) -0.74 [-1.40, -0.08]
Comparison 2. Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1Weight - subgrouped by duration
of advice
30 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 6 to < 12 months 16 5305 Mean Difference (IV, Random, 95% CI) -1.74 [-2.34, -1.13]
1.2 12 to < 24 months 18 51367 Mean Difference (IV, Random, 95% CI) 0.00 [-2.51, -1.48]
1.3 24 to < 60 months 10 49286 Mean Difference (IV, Random, 95% CI) -1.18 [-1.65, -0.70]
1.4 60+ months 4 40838 Mean Difference (IV, Random, 95% CI) -0.68 [-1.66, 0.29]
2 Weight, subgrouped by control
group fat intake
29 54335 Mean Difference (IV, Fixed, 95% CI) -1.01 [-1.15, -0.86]
2.1 > 35%E from fat 13 45103 Mean Difference (IV, Fixed, 95% CI) -0.91 [-1.07, -0.75]
2.2 > 30% to 35%E from fat 11 7123 Mean Difference (IV, Fixed, 95% CI) -0.84 [-1.21, -0.48]
2.3 > 25% to 30%E from fat 5 2109 Mean Difference (IV, Fixed, 95% CI) -2.97 [-3.60, -2.34]
3 Weight, subgrouped by sex 30 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 Studies of women only 17 50154 Mean Difference (IV, Random, 95% CI) -1.42 [-1.93, -0.91]
3.2 Studies of men only 6 1719 Mean Difference (IV, Random, 95% CI) -2.74 [-4.32, -1.17]
3.3 Studies of men and
women
7 2492 Mean Difference (IV, Random, 95% CI) -1.09 [0.00, -0.18]
4 Weight, subgrouped by year of
first publication of results
30 Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 1960s 3 1450 Mean Difference (IV, Random, 95% CI) -4.10 [-8.06, -0.14]
4.2 1970s 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.3 1980s 3 288 Mean Difference (IV, Random, 95% CI) -0.91 [-1.80, -0.01]
4.4 1990s 16 5941 Mean Difference (IV, Random, 95% CI) -1.94 [-2.62, -1.25]
4.5 2000s 8 46686 Mean Difference (IV, Random, 95% CI) -0.94 [-1.59, -0.29]
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4.6 2010s 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Weight, subgrouped by
difference in %E from fat
between control and reduced
fat groups
32 57583 Mean Difference (IV, Random, 95% CI) -1.54 [-1.97, -1.12]
5.1 Up to 5%E from fat 8 4567 Mean Difference (IV, Random, 95% CI) -0.16 [-0.91, 0.59]
5.2 5% to < 10%E from fat 14 44356 Mean Difference (IV, Random, 95% CI) -2.11 [-2.87, -1.35]
5.3 10% to < 15%E from fat 5 8311 Mean Difference (IV, Random, 95% CI) -1.34 [-1.70, -0.98]
5.4 15+%E from fat 4 319 Mean Difference (IV, Random, 95% CI) -3.89 [-8.76, 0.99]
5.5 Unknown difference in
%E from fat
1 30 Mean Difference (IV, Random, 95% CI) -2.43 [-4.20, -0.66]
6 Weight - subgrouped by advice
vs provided
29 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Dietary advice 25 52594 Mean Difference (IV, Random, 95% CI) -1.55 [-2.00, -1.10]
6.2 Advice plus supplements 0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6.3 Diet provided 4 1741 Mean Difference (IV, Random, 95% CI) -0.72 [-1.34, -0.10]
7 Weight subgrouped by fat goals 29 Mean Difference (IV, Random, 95% CI) Subtotals only
7.1 30%E from fat goal 5 1628 Mean Difference (IV, Random, 95% CI) -0.96 [-1.66, -0.26]
7.2 25% to < 30%E from fat
goal
6 509 Mean Difference (IV, Random, 95% CI) -2.45 [-4.27, -0.64]
7.3 20% to < 25%E from fat
goal
6 43878 Mean Difference (IV, Random, 95% CI) -0.90 [-1.24, -0.55]
7.4 15% to < 20%E from fat
goal
8 7860 Mean Difference (IV, Random, 95% CI) -1.28 [-2.19, -0.37]
7.5 10% to < 15%E from fat
goal
0 0 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
7.6 No specific goal stated 4 460 Mean Difference (IV, Random, 95% CI) -2.49 [-5.03, 0.05]
8 Weight, kg subgrouped of above
below 30%E from fat
24 Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 Int achieved > 30%E from
fat
8 1767 Mean Difference (IV, Random, 95% CI) -0.83 [-1.28, -0.37]
8.2 Int achieved 30%E from
fat or less
16 50099 Mean Difference (IV, Random, 95% CI) -1.11 [-1.62, -0.60]
9 Weight, kg subgrouped by BMI
baseline
28 53147 Mean Difference (IV, Random, 95% CI) -1.54 [-1.97, -1.12]
9.1 BMI at baseline < 25 10 1781 Mean Difference (IV, Random, 95% CI) -0.96 [-1.69, -0.22]
9.2 BMI at baseline ≥ 25 to
29.9
17 51297 Mean Difference (IV, Random, 95% CI) -1.83 [-2.38, -1.28]
9.3 BMI at baseline ≥ 30 1 69 Mean Difference (IV, Random, 95% CI) -1.80 [-3.48, -0.12]
10 Weight, kg subgrouped by
healthy vs patient
30 53647 Mean Difference (IV, Random, 95% CI) -1.54 [-1.97, -1.12]
10.1 Healthy - not recruited
on the basis of risk factors or
disease
6 45032 Mean Difference (IV, Random, 95% CI) -0.98 [-1.56, -0.41]
10.2 Recruited on basis of
risk factors, e.g. lipids, BMI,
hormonal levels, breast CA risk
14 2166 Mean Difference (IV, Random, 95% CI) -2.18 [-3.17, -1.20]
10.3 People with disease such
as DM, MI, cancer, polyps
10 6449 Mean Difference (IV, Random, 95% CI) -1.20 [-1.85, -0.56]
11 Weight, kg subgrouped by
energy reduction in int group
26 53459 Mean Difference (IV, Random, 95% CI) -1.52 [-1.97, -1.07]
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11.1 E intake same or greater
in low fat group
6 3352 Mean Difference (IV, Random, 95% CI) -0.51 [-1.49, 0.47]
11.2 E intake 1 to 100 kcal/d
less in low fat group
5 2398 Mean Difference (IV, Random, 95% CI) -1.49 [-2.92, -0.06]
11.3 E intake 101 to 200
kcal/d less in low fat group
6 43755 Mean Difference (IV, Random, 95% CI) -1.14 [-2.24, -0.04]
11.4 E intake > 201 kcal/d less
in low fat group
9 3954 Mean Difference (IV, Random, 95% CI) -2.23 [-2.97, -1.49]
Comparison 3. Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Weight, kg - removing studies
with more attention to low fat
arms
8 1537 Mean Difference (IV, Random, 95% CI) -1.25 [-2.09, -0.41]
2 Weight, kg - removing studies
with dietary interventions
other than fat
22 5516 Mean Difference (IV, Random, 95% CI) -1.92 [-2.57, -1.26]
3 Weight, kg - fixed-effect analysis 30 54005 Mean Difference (IV, Fixed, 95% CI) -1.02 [-1.16, -0.87]
4 Weight, kg - removing WHI 29 12294 Mean Difference (IV, Random, 95% CI) -1.64 [-2.12, -1.16]
5 Weight, kg - removing studies
without good allocation
concealment
11 49617 Mean Difference (IV, Random, 95% CI) -0.95 [-1.40, -0.51]
Comparison 4. Fat reduction versus usual fat, child RCTs
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 BMI, kg/m2 - in child RCTs 1 191 Mean Difference (IV, Random, 95% CI) -1.5 [-2.45, -0.55]
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Analysis 1.1. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 1 Weight, kg.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 1 Weight, kg
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 2.8 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.1 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 5.5 % -1.00 [ -2.02, 0.02 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.3 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 4.6 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.0 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 3.5 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.0 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.5 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 4.7 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 3.8 % -3.50 [ -5.09, -1.91 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 5.4 % 0.62 [ -0.40, 1.64 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 6.8 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.6 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.0 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.3 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.6 % -8.50 [ -13.77, -3.23 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 3.3 % -2.43 [ -4.20, -0.66 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.5 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
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(. . . Continued)
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.0 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 7.9 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.1 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 7.6 % -1.50 [ -1.85, -1.15 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.3 % -2.70 [ -4.50, -0.90 ]
Total (95% CI) 22316 31331 100.0 % -1.54 [ -1.97, -1.12 ]
Heterogeneity: Tau2 = 0.58; Chi2 = 99.49, df = 23 (P<0.00001); I2 =77%
Test for overall effect: Z = 7.14 (P < 0.00001)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
119Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 2 BMI, kg/m2.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 2 BMI, kg/m2
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
BDIT Pilot Studies 1996 76 24.3 (3.8) 81 24.3 (3.6) 3.7 % 0.0 [ -1.16, 1.16 ]
Diet and Hormone Study 2003 81 23.5 (4.4) 96 23.7 (3.5) 3.5 % -0.20 [ -1.39, 0.99 ]
Kuopio Reduced % Mod 1993 41 26 (4) 41 26.3 (3.6) 2.0 % -0.30 [ -1.95, 1.35 ]
Kuopio Reduced Fat 1993 40 26.2 (3.2) 12 25.7 (4.2) 0.8 % 0.50 [ -2.07, 3.07 ]
Moy 2001 117 -0.1 (1) 118 0.21 (2) 15.2 % -0.31 [ -0.71, 0.09 ]
Simon Low Fat Breast CA 34 23.8 (4.7) 38 27.4 (4.9) 1.1 % -3.60 [ -5.82, -1.38 ]
Strychar 2009 15 -0.24 (1) 15 0.56 (0.6) 10.2 % -0.80 [ -1.39, -0.21 ]
WHI 2006 16230 0.03 (3.2) 24943 0.3 (3.1) 26.3 % -0.27 [ -0.33, -0.21 ]
WHT:FSMP 2003 1094 -0.7 (1.2) 646 -0.1 (1.4) 24.9 % -0.60 [ -0.73, -0.47 ]
WINS 1993 755 26.8 (5.608) 1230 27.6 (5.368) 12.3 % -0.80 [ -1.30, -0.30 ]
Total (95% CI) 18483 27220 100.0 % -0.50 [ -0.74, -0.26 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 35.05, df = 9 (P = 0.00006); I2 =74%
Test for overall effect: Z = 4.07 (P = 0.000048)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 3 Waist
circumference, cm.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 3 Waist circumference, cm
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WHI 2006 6154 1.6 (8.6) 9517 1.9 (8.8) 100.0 % -0.30 [ -0.58, -0.02 ]
Total (95% CI) 6154 9517 100.0 % -0.30 [ -0.58, -0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.11 (P = 0.035)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 4 LDL cholesterol,
mmol/L.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 4 LDL cholesterol, mmol/L
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 -0.32 (0.64) 52 -0.16 (1.15) 4.4 % -0.16 [ -0.52, 0.20 ]
beFIT 1997 217 4.2 (0.94) 192 4.42 (0.88) 8.1 % -0.22 [ -0.40, -0.04 ]
DEER 1998 exercise men 48 -0.52 (0.45) 47 -0.09 (0.49) 7.8 % -0.43 [ -0.62, -0.24 ]
DEER 1998 exercise women 43 -0.37 (0.57) 43 -0.14 (0.5) 6.9 % -0.23 [ -0.46, 0.00 ]
DEER 1998 no exercise men 49 -0.3 (0.49) 46 -0.12 (0.55) 7.3 % -0.18 [ -0.39, 0.03 ]
DEER 1998 no exercise wom 46 -0.19 (0.49) 45 -0.06 (0.43) 7.8 % -0.13 [ -0.32, 0.06 ]
Kentucky Low Fat 1990 47 -0.56 (0.55) 51 -0.4 (0.43) 7.6 % -0.16 [ -0.36, 0.04 ]
Kuopio Reduced % Mod 1993 41 4.21 (0.89) 12 4.36 (0.97) 2.0 % -0.15 [ -0.76, 0.46 ]
Kuopio Reduced Fat 1993 40 4.26 (1.03) 12 4.36 (0.97) 1.9 % -0.10 [ -0.73, 0.53 ]
Moy 2001 117 -0.69 (1.1) 118 -0.4 (0.8) 6.5 % -0.29 [ -0.54, -0.04 ]
MSFAT 1995 117 3.68 (0.97) 103 3.79 (0.81) 6.7 % -0.11 [ -0.35, 0.13 ]
Pilkington 1960 12 1.76 (0.39) 23 1.16 (0.29) 6.4 % 0.60 [ 0.35, 0.85 ]
Rivellese 1994 27 4.82 (0.94) 17 4.85 (0.87) 2.5 % -0.03 [ -0.57, 0.51 ]
Simon Low Fat Breast CA 34 2.79 (0.82) 37 3.09 (0.99) 3.6 % -0.30 [ -0.72, 0.12 ]
Sondergaard 2003 63 2.98 (0.7) 52 3.07 (0.81) 5.7 % -0.09 [ -0.37, 0.19 ]
Strychar 2009 15 -0.25 (0.7) 15 -0.21 (0.57) 3.2 % -0.04 [ -0.50, 0.42 ]
WHEL 2007 1308 2.92 (11.902) 1313 2.95 (11.277) 1.1 % -0.03 [ -0.92, 0.86 ]
WHI 2006 1133 -0.251 (0.758) 1699 -0.16 (0.753) 10.7 % -0.09 [ -0.15, -0.03 ]
Total (95% CI) 3408 3877 100.0 % -0.13 [ -0.23, -0.03 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 48.57, df = 17 (P = 0.00007); I2 =65%
Test for overall effect: Z = 2.64 (P = 0.0082)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 5 HDL cholesterol,
mmol/L.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 5 HDL cholesterol, mmol/L
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 0.01 (0.14) 52 0.06 (0.36) 1.7 % -0.05 [ -0.16, 0.06 ]
BDIT Pilot Studies 1996 53 1.62 (0.41) 57 1.56 (0.38) 0.9 % 0.06 [ -0.09, 0.21 ]
Bloemberg 1991 39 -0.02 (0.2) 40 0.01 (0.16) 3.0 % -0.03 [ -0.11, 0.05 ]
de Bont 1981 non-obese 70 -0.09 (0.4) 65 -0.19 (0.43) 1.0 % 0.10 [ -0.04, 0.24 ]
DEER 1998 exercise men 48 0.01 (0.14) 47 0.03 (0.11) 7.4 % -0.02 [ -0.07, 0.03 ]
DEER 1998 exercise women 43 -0.03 (0.17) 43 0.06 (0.17) 3.7 % -0.09 [ -0.16, -0.02 ]
DEER 1998 no exercise men 49 -0.02 (0.11) 46 -0.01 (0.11) 9.7 % -0.01 [ -0.05, 0.03 ]
DEER 1998 no exercise wom 46 0.01 (0.16) 45 0.03 (0.17) 4.1 % -0.02 [ -0.09, 0.05 ]
Kentucky Low Fat 1990 47 0.01 (0.14) 51 0.01 (0.14) 6.2 % 0.0 [ -0.06, 0.06 ]
Kuopio Reduced % Mod 1993 41 1.43 (0.28) 12 1.53 (0.39) 0.3 % -0.10 [ -0.34, 0.14 ]
Kuopio Reduced Fat 1993 40 1.38 (0.34) 12 1.53 (0.39) 0.3 % -0.15 [ -0.39, 0.09 ]
Moy 2001 117 0.044 (0.3) 118 0.01 (0.2) 4.5 % 0.04 [ -0.03, 0.10 ]
MSFAT 1995 117 1.34 (0.32) 103 1.4 (0.41) 2.0 % -0.06 [ -0.16, 0.04 ]
Rivellese 1994 27 1.22 (0.31) 17 1.12 (0.16) 1.0 % 0.10 [ -0.04, 0.24 ]
Simon Low Fat Breast CA 34 1.44 (0.58) 38 1.56 (0.55) 0.3 % -0.12 [ -0.38, 0.14 ]
Sondergaard 2003 63 1.25 (0.36) 52 1.23 (0.37) 1.1 % 0.02 [ -0.11, 0.15 ]
Strychar 2009 15 0.06 (0.27) 15 -0.01 (0.22) 0.6 % 0.07 [ -0.11, 0.25 ]
WHEL 2007 1308 1.45 (4.705) 1313 1.53 (4.345) 0.2 % -0.08 [ -0.43, 0.27 ]
WHI 2006 1133 -0.018 (0.243) 1699 -0.01 (0.264) 52.2 % -0.01 [ -0.03, 0.01 ]
Total (95% CI) 3341 3825 100.0 % -0.01 [ -0.03, 0.00 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 18.03, df = 18 (P = 0.45); I2 =0%
Test for overall effect: Z = 1.61 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 6 Total cholesterol,
mmol/L.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 6 Total cholesterol, mmol/L
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 -0.2 (0.79) 52 -0.15 (1.3) 3.2 % -0.05 [ -0.46, 0.36 ]
BDIT Pilot Studies 1996 54 5.14 (0.84) 61 5.38 (0.81) 5.0 % -0.24 [ -0.54, 0.06 ]
Bloemberg 1991 39 -0.32 (0.85) 40 -0.02 (0.79) 3.9 % -0.30 [ -0.66, 0.06 ]
de Bont 1981 non-obese 70 -0.9 (1.09) 65 -0.28 (0.99) 4.1 % -0.62 [ -0.97, -0.27 ]
DEER 1998 exercise men 48 -0.53 (0.52) 47 -0.13 (0.53) 7.3 % -0.40 [ -0.61, -0.19 ]
DEER 1998 exercise women 43 -0.45 (0.55) 43 0.15 (0.59) 6.4 % -0.60 [ -0.84, -0.36 ]
DEER 1998 no exercise men 49 -0.34 (0.5) 46 -0.1 (0.56) 7.2 % -0.24 [ -0.45, -0.03 ]
DEER 1998 no exercise wom 46 -0.2 (0.53) 45 -0.03 (0.5) 7.2 % -0.17 [ -0.38, 0.04 ]
Kentucky Low Fat 1990 47 -0.59 (0.62) 51 -0.42 (0.57) 6.5 % -0.17 [ -0.41, 0.07 ]
Kuopio Reduced % Mod 1993 41 6.24 (1.06) 12 6.51 (1.07) 1.4 % -0.27 [ -0.96, 0.42 ]
Kuopio Reduced Fat 1993 40 6.35 (1.18) 12 6.51 (1.07) 1.3 % -0.16 [ -0.87, 0.55 ]
MSFAT 1995 117 5.61 (1.08) 103 5.75 (1.01) 5.5 % -0.14 [ -0.42, 0.14 ]
Pilkington 1960 12 5.66 (0.88) 23 5.43 (0.85) 1.7 % 0.23 [ -0.38, 0.84 ]
Polyp Prevention 1996 370 -0.13 (0.77) 374 -0.07 (0.77) 10.6 % -0.06 [ -0.17, 0.05 ]
Rivellese 1994 27 6.78 (0.78) 17 6.63 (0.58) 3.4 % 0.15 [ -0.25, 0.55 ]
Simon Low Fat Breast CA 34 4.87 (0.87) 38 5.21 (0.18) 5.1 % -0.34 [ -0.64, -0.04 ]
Sondergaard 2003 63 4.96 (0.77) 52 5.09 (0.99) 4.5 % -0.13 [ -0.46, 0.20 ]
Strychar 2009 15 -0.12 (0.66) 15 -0.24 (0.66) 2.6 % 0.12 [ -0.35, 0.59 ]
WHEL 2007 1308 5.07 (11.902) 1313 4.99 (11.924) 0.8 % 0.08 [ -0.83, 0.99 ]
WHI 2006 1133 -0.264 (0.828) 1699 -0.18 (0.825) 12.1 % -0.09 [ -0.15, -0.02 ]
Total (95% CI) 3607 4108 100.0 % -0.20 [ -0.29, -0.11 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 40.91, df = 19 (P = 0.002); I2 =54%
Test for overall effect: Z = 4.55 (P < 0.00001)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Favours reduced fat Favours moderate fat
124Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 7 Triglycerides,
mmol/L.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 7 Triglycerides, mmol/L
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 0.37 (0.71) 52 0.12 (1.59) 3.4 % 0.25 [ -0.22, 0.72 ]
de Bont 1981 non-obese 70 -0.03 (0.83) 65 -0.11 (0.6) 8.0 % 0.08 [ -0.16, 0.32 ]
DEER 1998 exercise men 48 -0.08 (0.62) 47 -0.15 (0.57) 8.1 % 0.07 [ -0.17, 0.31 ]
DEER 1998 exercise women 43 -0.12 (0.56) 43 -0.14 (0.51) 8.5 % 0.02 [ -0.21, 0.25 ]
DEER 1998 no exercise men 49 -0.07 (0.67) 46 0.1 (0.94) 5.7 % -0.17 [ -0.50, 0.16 ]
DEER 1998 no exercise wom 46 -0.05 (0.73) 45 0.02 (0.48) 7.7 % -0.07 [ -0.32, 0.18 ]
Kentucky Low Fat 1990 47 -1.05 (1.99) 51 1.06 (2.03) 1.4 % -2.11 [ -2.91, -1.31 ]
Kuopio Reduced % Mod 1993 41 1.24 (0.6) 12 1.38 (0.84) 3.0 % -0.14 [ -0.65, 0.37 ]
Kuopio Reduced Fat 1993 40 1.44 (0.79) 12 1.38 (0.84) 2.8 % 0.06 [ -0.47, 0.59 ]
Moy 2001 117 -0.4 (2) 118 -0.06 (1.9) 3.1 % -0.34 [ -0.84, 0.16 ]
MSFAT 1995 117 1.3 (0.76) 103 1.24 (0.61) 10.2 % 0.06 [ -0.12, 0.24 ]
Rivellese 1994 27 1.5 (0.68) 17 1.57 (0.7) 4.1 % -0.07 [ -0.49, 0.35 ]
Simon Low Fat Breast CA 34 1.35 (1.05) 37 1.25 (0.61) 4.3 % 0.10 [ -0.30, 0.50 ]
Sondergaard 2003 63 1.53 (1.04) 52 1.76 (0.98) 4.9 % -0.23 [ -0.60, 0.14 ]
Strychar 2009 15 0.14 (0.46) 15 -0.03 (0.22) 7.5 % 0.17 [ -0.09, 0.43 ]
WHEL 2007 1308 1.17 (7.842) 1313 1.02 (9.983) 1.8 % 0.15 [ -0.54, 0.84 ]
WHI 2006 1133 0.011 (0.005) 1699 0.01 (0.003) 15.5 % 0.0 [ 0.00, 0.00 ]
Total (95% CI) 3249 3727 100.0 % -0.02 [ -0.12, 0.08 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 36.35, df = 16 (P = 0.003); I2 =56%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 8 Total
cholesterol/HDL.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 8 Total cholesterol/HDL
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 -0.34 (1) 52 -0.53 (1.73) 1.2 % 0.19 [ -0.35, 0.73 ]
DEER 1998 exercise men 48 -0.6 (0.9) 47 -0.3 (1) 2.5 % -0.30 [ -0.68, 0.08 ]
DEER 1998 exercise women 43 -0.2 (0.8) 43 -0.4 (0.8) 3.2 % 0.20 [ -0.14, 0.54 ]
DEER 1998 no exercise men 49 -0.2 (0.9) 46 -0.1 (1) 2.5 % -0.10 [ -0.48, 0.28 ]
DEER 1998 no exercise wom 46 -0.2 (0.7) 45 0 (0.7) 4.4 % -0.20 [ -0.49, 0.09 ]
Strychar 2009 15 -0.22 (0.55) 15 -0.13 (0.37) 3.3 % -0.09 [ -0.43, 0.25 ]
WHI 2006 1133 -0.2 (0.8) 1699 -0.1 (1) 82.9 % -0.10 [ -0.17, -0.03 ]
Total (95% CI) 1385 1947 100.0 % -0.10 [ -0.16, -0.04 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.61, df = 6 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 3.10 (P = 0.0019)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 9 Systolic blood
pressure, mmHg.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 9 Systolic blood pressure, mmHg
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 -3.5 (17.71) 52 1.31 (24.37) 0.9 % -4.81 [ -13.03, 3.41 ]
DEER 1998 exercise men 48 -3 (6.8) 47 -0.6 (7.3) 7.7 % -2.40 [ -5.24, 0.44 ]
DEER 1998 exercise women 43 -3.1 (8.4) 43 -1.1 (8.9) 4.6 % -2.00 [ -5.66, 1.66 ]
DEER 1998 no exercise men 49 -1.7 (6.4) 46 0.3 (7.9) 7.4 % -2.00 [ -4.90, 0.90 ]
DEER 1998 no exercise wom 46 -3.5 (9.2) 45 -2.4 (7.6) 5.2 % -1.10 [ -4.56, 2.36 ]
Kuopio Reduced % Mod 1993 41 -2.59 (11.19) 37 2.49 (15.8) 1.7 % -5.08 [ -11.22, 1.06 ]
Strychar 2009 15 3.9 (14.4) 15 -0.2 (21.1) 0.4 % 4.10 [ -8.83, 17.03 ]
WHI 2006 1133 -2.2 (16.3) 1699 -2.1 (16.4) 41.2 % -0.10 [ -1.33, 1.13 ]
WHT:FSMP 2003 1101 -3.1 (14.5) 648 -1.4 (14.7) 30.9 % -1.70 [ -3.12, -0.28 ]
Total (95% CI) 2527 2632 100.0 % -1.16 [ -1.95, -0.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 7.64, df = 8 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Fat reduction versus usual fat diet, adult RCTs, Outcome 10 Diastolic blood
pressure, mmHg.
Review: Effects of total fat intake on body weight
Comparison: 1 Fat reduction versus usual fat diet, adult RCTs
Outcome: 10 Diastolic blood pressure, mmHg
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 51 -7.16 (12) 52 -4.2 (13.85) 1.7 % -2.96 [ -7.96, 2.04 ]
DEER 1998 exercise men 48 -3 (6.6) 47 -1.1 (7.1) 5.2 % -1.90 [ -4.66, 0.86 ]
DEER 1998 exercise women 43 -2.7 (4.6) 43 -1.4 (5.9) 7.6 % -1.30 [ -3.54, 0.94 ]
DEER 1998 no exercise men 49 -0.3 (5.2) 46 1.8 (6.1) 7.3 % -2.10 [ -4.39, 0.19 ]
DEER 1998 no exercise wom 46 -1.9 (5) 45 -0.6 (5.9) 7.5 % -1.30 [ -3.55, 0.95 ]
Kuopio Reduced % Mod 1993 41 -0.93 (7.13) 37 1.38 (10) 2.8 % -2.31 [ -6.20, 1.58 ]
Strychar 2009 15 4.7 (11) 15 -2.6 (8.9) 0.8 % 7.30 [ 0.14, 14.46 ]
WHI 2006 1133 -2.6 (9.4) 1699 -2.3 (9.4) 34.1 % -0.30 [ -1.01, 0.41 ]
WHT:FSMP 2003 1101 -1.06 (7.4) 648 -0.64 (7.7) 33.0 % -0.42 [ -1.16, 0.32 ]
Total (95% CI) 2527 2632 100.0 % -0.74 [ -1.40, -0.08 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 10.43, df = 8 (P = 0.24); I2 =23%
Test for overall effect: Z = 2.20 (P = 0.028)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 1
Weight - subgrouped by duration of advice.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 1 Weight - subgrouped by duration of advice
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 6 to < 12 months
Auckland reduced fat 1999 66 -2.97 (4.39) 70 -0.08 (3.6) 9.4 % -2.89 [ -4.24, -1.54 ]
BDIT Pilot Studies 1996 100 58 (7) 106 60 (8) 5.9 % -2.00 [ -4.05, 0.05 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 11.8 % -1.00 [ -2.02, 0.02 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 10.7 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 7.5 % -1.80 [ -3.48, -0.12 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 14.9 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 67 63.82 (10.4) 76 68.45 (12.29) 2.3 % -4.63 [ -8.35, -0.91 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 7.1 % -2.43 [ -4.20, -0.66 ]
Veterans Dermatology 1994 57 -3.5 (0) 58 1.5 (0) Not estimable
WHT Feasibility 1990 179 -3.16 (3.7) 113 -0.22 (3) 13.7 % -2.94 [ -3.71, -2.17 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 16.7 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 2705 2600 100.0 % -1.74 [ -2.34, -1.13 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 31.06, df = 9 (P = 0.00029); I2 =71%
Test for overall effect: Z = 5.61 (P < 0.00001)
2 12 to < 24 months
Auckland reduced fat 1999 66 -3.32 (5.52) 70 0.59 (13.47) 1.9 % -3.91 [ -7.33, -0.49 ]
BDIT Pilot Studies 1996 100 59 (7) 106 60 (8) 4.1 % -1.00 [ -3.05, 1.05 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 4.9 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 385 61.4 (8.6) 397 62.9 (9.2) 7.1 % -1.50 [ -2.75, -0.25 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 6.0 % -3.60 [ -5.08, -2.12 ]
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(. . . Continued)
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 6.7 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 7.1 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 5.6 % -3.50 [ -5.09, -1.91 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 8.2 % 0.62 [ -0.40, 1.64 ]
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.9 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.5 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 975 -1.96 (4.06) 989 0.01 (3.46) 11.5 % -1.97 [ -2.30, -1.64 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.9 % -8.50 [ -13.77, -3.23 ]
Veterans Dermatology 1994 57 -2 (0) 58 1 (0) Not estimable
WHEL 2007 1463 73 (17.21) 1484 73.8 (18.11) 6.9 % -0.80 [ -2.08, 0.48 ]
WHI 2006 17026 74 (16.5) 24977 75.9 (16.5) 11.6 % -1.90 [ -2.22, -1.58 ]
WHT Feasibility 1990 177 -2.93 (4.8) 110 -0.62 (3.8) 8.3 % -2.31 [ -3.31, -1.31 ]
WINS 1993 854 -2.3 (15.1) 1310 0 (15.1) 6.8 % -2.30 [ -3.60, -1.00 ]
Subtotal (95% CI) 21477 29890 100.0 % -2.00 [ -2.51, -1.48 ]
Heterogeneity: Tau2 = 0.57; Chi2 = 55.86, df = 16 (P<0.00001); I2 =71%
Test for overall effect: Z = 7.60 (P < 0.00001)
3 24 to < 60 months
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 4.5 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 3.2 % -0.80 [ -3.28, 1.68 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 9.2 % -1.50 [ -2.79, -0.21 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 22.5 % -0.96 [ -1.43, -0.49 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 6.1 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
WHEL 2007 1355 74.2 (18.77) 1363 74.1 (18.46) 8.2 % 0.10 [ -1.30, 1.50 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 27.5 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 11.0 % -1.83 [ -2.96, -0.70 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 7.8 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 20084 29202 100.0 % -1.18 [ -1.65, -0.70 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 18.01, df = 8 (P = 0.02); I2 =56%
Test for overall effect: Z = 4.86 (P < 0.00001)
4 60+ months
Auckland reduced fat 1999 51 1.06 (4.57) 52 1.26 (4.9) 17.5 % -0.20 [ -2.03, 1.63 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 22.1 % 0.40 [ -1.08, 1.88 ]
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Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WHI 2006 14409 75.6 (16.8) 22321 76.2 (16.6) 42.5 % -0.60 [ -0.95, -0.25 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 17.9 % -2.70 [ -4.50, -0.90 ]
Subtotal (95% CI) 16154 24684 100.0 % -0.68 [ -1.66, 0.29 ]
Heterogeneity: Tau2 = 0.55; Chi2 = 7.17, df = 3 (P = 0.07); I2 =58%
Test for overall effect: Z = 1.37 (P = 0.17)
Test for subgroup differences: Chi2 = 8.59, df = 3 (P = 0.04), I2 =65%
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Analysis 2.2. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 2
Weight, subgrouped by control group fat intake.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 2 Weight, subgrouped by control group fat intake
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 > 35%E from fat
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 0.3 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 2.0 % -1.00 [ -2.02, 0.02 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 1.5 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 0.7 % -1.80 [ -3.48, -0.12 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 5.2 % -0.72 [ -1.34, -0.10 ]
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 0.1 % -4.10 [ -8.06, -0.14 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
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Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 51.5 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 1.6 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 16.6 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 18409 26694 79.6 % -0.91 [ -1.07, -0.75 ]
Heterogeneity: Chi2 = 22.12, df = 8 (P = 0.005); I2 =64%
Test for overall effect: Z = 11.14 (P < 0.00001)
2 > 30% to 35%E from fat
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 0.5 % -3.73 [ -5.78, -1.68 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 0.6 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 1.2 % -1.50 [ -2.79, -0.21 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 2.0 % 0.62 [ -0.40, 1.64 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.1 % 0.90 [ -4.26, 6.06 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 9.2 % -0.96 [ -1.43, -0.49 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.1 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 0.7 % -1.70 [ -3.41, 0.01 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 0.9 % 0.40 [ -1.08, 1.88 ]
Subtotal (95% CI) 3339 3784 15.3 % -0.84 [ -1.21, -0.48 ]
Heterogeneity: Chi2 = 29.11, df = 8 (P = 0.00030); I2 =73%
Test for overall effect: Z = 4.52 (P < 0.00001)
3 > 25% to 30%E from fat
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 0.9 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 1.1 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 1.3 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 0.8 % -3.50 [ -5.09, -1.91 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 1.0 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 884 1225 5.2 % -2.97 [ -3.60, -2.34 ]
Heterogeneity: Chi2 = 4.06, df = 4 (P = 0.40); I2 =1%
Test for overall effect: Z = 9.25 (P < 0.00001)
Total (95% CI) 22632 31703 100.0 % -1.01 [ -1.15, -0.86 ]
Heterogeneity: Chi2 = 94.79, df = 22 (P<0.00001); I2 =77%
Test for overall effect: Z = 13.80 (P < 0.00001)
Test for subgroup differences: Chi2 = 39.50, df = 2 (P = 0.00), I2 =95%
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Analysis 2.3. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 3
Weight, subgrouped by sex.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 3 Weight, subgrouped by sex
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Studies of women only
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 3.3 % -0.80 [ -3.28, 1.68 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 5.1 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 7.5 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 8.2 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 5.7 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 7.3 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 6.0 % -3.50 [ -5.09, -1.91 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.9 % 0.90 [ -4.26, 6.06 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.9 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 5.5 % -1.70 [ -3.41, 0.01 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 6.5 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 14.2 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 8.5 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 13.6 % -1.50 [ -1.85, -1.15 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 6.7 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 20734 29420 100.0 % -1.42 [ -1.93, -0.91 ]
Heterogeneity: Tau2 = 0.47; Chi2 = 50.41, df = 14 (P<0.00001); I2 =72%
Test for overall effect: Z = 5.47 (P < 0.00001)
2 Studies of men only
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 31.7 % -1.00 [ -2.02, 0.02 ]
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Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 27.6 % -3.60 [ -5.08, -2.12 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 29.7 % -3.30 [ -4.55, -2.05 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 11.0 % -4.10 [ -8.06, -0.14 ]
Subtotal (95% CI) 659 1060 100.0 % -2.74 [ -4.32, -1.17 ]
Heterogeneity: Tau2 = 1.77; Chi2 = 12.43, df = 3 (P = 0.01); I2 =76%
Test for overall effect: Z = 3.41 (P = 0.00064)
3 Studies of men and women
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 11.7 % -3.73 [ -5.78, -1.68 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 21.4 % 0.62 [ -0.40, 1.64 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 25.8 % -0.72 [ -1.34, -0.10 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 27.2 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 13.9 % -2.43 [ -4.20, -0.66 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
Subtotal (95% CI) 1254 1238 100.0 % -1.09 [ -2.00, -0.18 ]
Heterogeneity: Tau2 = 0.73; Chi2 = 18.91, df = 4 (P = 0.00082); I2 =79%
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Chi2 = 3.21, df = 2 (P = 0.20), I2 =38%
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Analysis 2.4. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 4
Weight, subgrouped by year of first publication of results.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 4 Weight, subgrouped by year of first publication of results
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 1960s
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 100.0 % -4.10 [ -8.06, -0.14 ]
Subtotal (95% CI) 523 927 100.0 % -4.10 [ -8.06, -0.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.03 (P = 0.042)
2 1970s
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 1980s
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 13.0 % -0.80 [ -3.28, 1.68 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 58.5 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 28.5 % -1.80 [ -3.48, -0.12 ]
Subtotal (95% CI) 146 142 100.0 % -0.91 [ -1.80, -0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.56, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.046)
4 1990s
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 5.3 % -3.73 [ -5.78, -1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 8.4 % -1.00 [ -2.02, 0.02 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 7.5 % -1.50 [ -2.79, -0.21 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 6.9 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 7.4 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 7.6 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 6.6 % -3.50 [ -5.09, -1.91 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 8.3 % 0.62 [ -0.40, 1.64 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 9.5 % -0.72 [ -1.34, -0.10 ]
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Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 9.8 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 1.4 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 6.2 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 8.0 % -1.83 [ -2.96, -0.70 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 7.0 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 2806 3135 100.0 % -1.94 [ -2.62, -1.25 ]
Heterogeneity: Tau2 = 1.18; Chi2 = 63.84, df = 13 (P<0.00001); I2 =80%
Test for overall effect: Z = 5.56 (P < 0.00001)
5 2000s
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 9.5 % -0.40 [ -2.21, 1.41 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 1.5 % 0.90 [ -4.26, 6.06 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 9.8 % -2.43 [ -4.20, -0.66 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 12.5 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 34.5 % -0.70 [ -0.90, -0.50 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 32.3 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 19172 27514 100.0 % -0.94 [ -1.59, -0.29 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 21.66, df = 5 (P = 0.00061); I2 =77%
Test for overall effect: Z = 2.83 (P = 0.0047)
6 2010s
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 7.18, df = 3 (P = 0.07), I2 =58%
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Analysis 2.5. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 5
Weight, subgrouped by difference in %E from fat between control and reduced fat groups.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 5 Weight, subgrouped by difference in %E from fat between control and reduced fat groups
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 5%E from fat
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.1 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 5.5 % -1.00 [ -2.02, 0.02 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.3 % -0.40 [ -2.21, 1.41 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 5.4 % 0.62 [ -0.40, 1.64 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.0 % 0.40 [ -1.08, 1.88 ]
Subtotal (95% CI) 2080 2487 20.3 % -0.16 [ -0.91, 0.59 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 5.71, df = 4 (P = 0.22); I2 =30%
Test for overall effect: Z = 0.42 (P = 0.68)
2 5% to < 10%E from fat
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 2.8 % -3.73 [ -5.78, -1.68 ]
beFIT 1997 217 -2.7 (0) 192 0 (0) Not estimable
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.0 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 3.5 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.0 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.5 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 4.7 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 3.8 % -3.50 [ -5.09, -1.91 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 6.8 % -0.72 [ -1.34, -0.10 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.5 % -1.70 [ -3.41, 0.01 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 7.9 % -0.70 [ -0.90, -0.50 ]
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Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.3 % -2.70 [ -4.50, -0.90 ]
Subtotal (95% CI) 17492 26864 49.6 % -2.11 [ -2.87, -1.35 ]
Heterogeneity: Tau2 = 1.17; Chi2 = 61.75, df = 10 (P<0.00001); I2 =84%
Test for overall effect: Z = 5.45 (P < 0.00001)
3 10% to < 15%E from fat
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 4.6 % -1.50 [ -2.79, -0.21 ]
Mastopathy Diet 1988 1491 -2.1 (0) 1676 0 (0) Not estimable
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.3 % -0.96 [ -1.43, -0.49 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.1 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 7.6 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 4306 4005 24.5 % -1.34 [ -1.70, -0.98 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 4.08, df = 3 (P = 0.25); I2 =26%
Test for overall effect: Z = 7.36 (P < 0.00001)
4 15+%E from fat
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.6 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.0 % -4.10 [ -8.06, -0.14 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.6 % -8.50 [ -13.77, -3.23 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
Subtotal (95% CI) 150 169 2.2 % -3.89 [ -8.76, 0.99 ]
Heterogeneity: Tau2 = 12.60; Chi2 = 6.26, df = 2 (P = 0.04); I2 =68%
Test for overall effect: Z = 1.56 (P = 0.12)
5 Unknown difference in %E from fat
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 3.3 % -2.43 [ -4.20, -0.66 ]
Subtotal (95% CI) 15 15 3.3 % -2.43 [ -4.20, -0.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.69 (P = 0.0071)
Total (95% CI) 24043 33540 100.0 % -1.54 [ -1.97, -1.12 ]
Heterogeneity: Tau2 = 0.58; Chi2 = 99.49, df = 23 (P<0.00001); I2 =77%
Test for overall effect: Z = 7.14 (P < 0.00001)
Test for subgroup differences: Chi2 = 16.03, df = 4 (P = 0.00), I2 =75%
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Analysis 2.6. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 6
Weight - subgrouped by advice vs provided.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 6 Weight - subgrouped by advice vs provided
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary advice
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 3.1 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.4 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 6.0 % -1.00 [ -2.02, 0.02 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.6 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 5.1 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.5 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 4.0 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.5 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.9 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 5.2 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 4.2 % -3.50 [ -5.09, -1.91 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 6.0 % 0.62 [ -0.40, 1.64 ]
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.7 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.1 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.9 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.7 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.9 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.5 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 8.5 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.6 % -1.83 [ -2.96, -0.70 ]
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(. . . Continued)
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 8.2 % -1.50 [ -1.85, -1.15 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 4.6 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 21953 30641 100.0 % -1.55 [ -2.00, -1.10 ]
Heterogeneity: Tau2 = 0.62; Chi2 = 93.93, df = 21 (P<0.00001); I2 =78%
Test for overall effect: Z = 6.70 (P < 0.00001)
2 Advice plus supplements
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Diet provided
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 100.0 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Subtotal (95% CI) 679 1062 100.0 % -0.72 [ -1.34, -0.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.26 (P = 0.024)
Test for subgroup differences: Chi2 = 4.42, df = 1 (P = 0.04), I2 =77%
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Analysis 2.7. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 7
Weight subgrouped by fat goals.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 7 Weight subgrouped by fat goals
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 30%E from fat goal
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 46.9 % -1.00 [ -2.02, 0.02 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 35.7 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 17.4 % -1.80 [ -3.48, -0.12 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 689 -1.93 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Subtotal (95% CI) 620 1008 100.0 % -0.96 [ -1.66, -0.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.57, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 2.69 (P = 0.0070)
2 25% to < 30%E from fat goal
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 19.5 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 20.0 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 20.3 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 19.2 % -3.50 [ -5.09, -1.91 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 21.0 % 0.62 [ -0.40, 1.64 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Subtotal (95% CI) 260 249 100.0 % -2.45 [ -4.27, -0.64 ]
Heterogeneity: Tau2 = 3.81; Chi2 = 38.25, df = 4 (P<0.00001); I2 =90%
Test for overall effect: Z = 2.65 (P = 0.0080)
3 20% to < 25%E from fat goal
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.4 % -0.40 [ -2.21, 1.41 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 29.7 % -0.96 [ -1.43, -0.49 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.8 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 57 -2 (0) 58 0.5 (0) Not estimable
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 54.9 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 8.1 % -1.83 [ -2.96, -0.70 ]
Subtotal (95% CI) 17567 26311 100.0 % -0.90 [ -1.24, -0.55 ]
-4 -2 0 2 4
Favours reduced fat Favours moderate fat
(Continued . . . )
141Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Reduced fat Usual fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.05; Chi2 = 5.77, df = 4 (P = 0.22); I2 =31%
Test for overall effect: Z = 5.11 (P < 0.00001)
4 15% to < 20%E from fat goal
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 9.5 % -0.80 [ -3.28, 1.68 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 19.5 % -1.50 [ -2.79, -0.21 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 2.9 % 0.90 [ -4.26, 6.06 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 2.7 % -8.50 [ -13.77, -3.23 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 17.3 % 0.40 [ -1.08, 1.88 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 30.4 % -1.50 [ -1.85, -1.15 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 17.7 % -1.80 [ -3.25, -0.35 ]
Subtotal (95% CI) 3957 3903 100.0 % -1.28 [ -2.19, -0.37 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 14.21, df = 6 (P = 0.03); I2 =58%
Test for overall effect: Z = 2.75 (P = 0.0060)
5 10% to < 15%E from fat goal
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
6 No specific goal stated
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 34.7 % -3.73 [ -5.78, -1.68 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 43.7 % -0.72 [ -1.34, -0.10 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 21.5 % -4.10 [ -8.06, -0.14 ]
Subtotal (95% CI) 228 232 100.0 % -2.49 [ -5.03, 0.05 ]
Heterogeneity: Tau2 = 3.74; Chi2 = 9.90, df = 2 (P = 0.01); I2 =80%
Test for overall effect: Z = 1.92 (P = 0.055)
Test for subgroup differences: Chi2 = 4.52, df = 4 (P = 0.34), I2 =11%
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Analysis 2.8. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 8
Weight, kg subgrouped of above below 30%E from fat.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 8 Weight, kg subgrouped of above below 30%E from fat
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Int achieved > 30%E from fat
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 3.4 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 20.2 % -1.00 [ -2.02, 0.02 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 15.3 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 7.5 % -1.80 [ -3.48, -0.12 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 53.7 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Subtotal (95% CI) 864 903 100.0 % -0.83 [ -1.28, -0.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.82, df = 4 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 3.54 (P = 0.00041)
2 Int achieved 30%E from fat or less
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 4.5 % -3.73 [ -5.78, -1.68 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 5.4 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 8.1 % -1.50 [ -2.79, -0.21 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 10.0 % 0.62 [ -0.40, 1.64 ]
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.9 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.5 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 14.7 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.9 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 5.8 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
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Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 6.9 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 16.4 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 9.2 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 15.6 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 20865 29234 100.0 % -1.11 [ -1.62, -0.60 ]
Heterogeneity: Tau2 = 0.40; Chi2 = 49.41, df = 12 (P<0.00001); I2 =76%
Test for overall effect: Z = 4.26 (P = 0.000021)
Test for subgroup differences: Chi2 = 0.65, df = 1 (P = 0.42), I2 =0.0%
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Analysis 2.9. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 9
Weight, kg subgrouped by BMI baseline.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 9 Weight, kg subgrouped by BMI baseline
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 BMI at baseline < 25
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.1 % -0.80 [ -3.28, 1.68 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 4.6 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.0 % -0.50 [ -1.67, 0.67 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 5.4 % 0.62 [ -0.40, 1.64 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 6.8 % -0.72 [ -1.34, -0.10 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.0 % -4.10 [ -8.06, -0.14 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 3.3 % -2.43 [ -4.20, -0.66 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.5 % -1.70 [ -3.41, 0.01 ]
Subtotal (95% CI) 862 919 31.7 % -0.96 [ -1.69, -0.22 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 15.75, df = 7 (P = 0.03); I2 =56%
Test for overall effect: Z = 2.55 (P = 0.011)
2 BMI at baseline ≥ 25 to 29.9
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 2.8 % -3.73 [ -5.78, -1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 5.5 % -1.00 [ -2.02, 0.02 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.3 % -0.40 [ -2.21, 1.41 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.0 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.5 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 4.7 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 3.8 % -3.50 [ -5.09, -1.91 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.6 % 0.90 [ -4.26, 6.06 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.3 % -0.96 [ -1.43, -0.49 ]
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Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.6 % -8.50 [ -13.77, -3.23 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.0 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 7.9 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.1 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 7.6 % -1.50 [ -1.85, -1.15 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.3 % -2.70 [ -4.50, -0.90 ]
Subtotal (95% CI) 21190 30107 64.7 % -1.83 [ -2.38, -1.28 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 81.09, df = 14 (P<0.00001); I2 =83%
Test for overall effect: Z = 6.51 (P < 0.00001)
3 BMI at baseline ≥ 30
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 3.5 % -1.80 [ -3.48, -0.12 ]
Subtotal (95% CI) 34 35 3.5 % -1.80 [ -3.48, -0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.11 (P = 0.035)
Total (95% CI) 22086 31061 100.0 % -1.54 [ -1.97, -1.12 ]
Heterogeneity: Tau2 = 0.58; Chi2 = 99.49, df = 23 (P<0.00001); I2 =77%
Test for overall effect: Z = 7.14 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.58, df = 2 (P = 0.17), I2 =44%
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Analysis 2.10. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 10
Weight, kg subgrouped by healthy vs patient.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 10 Weight, kg subgrouped by healthy vs patient
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Healthy - not recruited on the basis of risk factors or disease
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 6.8 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 7.9 % -0.70 [ -0.90, -0.50 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 7.6 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 18331 26701 22.2 % -0.98 [ -1.56, -0.41 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 15.38, df = 2 (P = 0.00046); I2 =87%
Test for overall effect: Z = 3.35 (P = 0.00080)
2 Recruited on basis of risk factors, e.g. lipids, BMI, hormonal levels, breast CA risk
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 2.8 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.1 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 5.5 % -1.00 [ -2.02, 0.02 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 4.6 % -1.50 [ -2.79, -0.21 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.0 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.5 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 4.7 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 3.8 % -3.50 [ -5.09, -1.91 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 5.4 % 0.62 [ -0.40, 1.64 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.6 % 0.90 [ -4.26, 6.06 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.6 % -8.50 [ -13.77, -3.23 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.1 % -1.83 [ -2.96, -0.70 ]
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Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 1102 1064 43.6 % -2.18 [ -3.17, -1.20 ]
Heterogeneity: Tau2 = 2.11; Chi2 = 52.62, df = 11 (P<0.00001); I2 =79%
Test for overall effect: Z = 4.35 (P = 0.000014)
3 People with disease such as DM, MI, cancer, polyps
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.3 % -0.40 [ -2.21, 1.41 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.0 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 3.5 % -1.80 [ -3.48, -0.12 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.0 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.3 % -0.96 [ -1.43, -0.49 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 3.3 % -2.43 [ -4.20, -0.66 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.5 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.0 % 0.40 [ -1.08, 1.88 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.3 % -2.70 [ -4.50, -0.90 ]
Subtotal (95% CI) 2883 3566 34.1 % -1.20 [ -1.85, -0.56 ]
Heterogeneity: Tau2 = 0.37; Chi2 = 14.33, df = 8 (P = 0.07); I2 =44%
Test for overall effect: Z = 3.67 (P = 0.00024)
Total (95% CI) 22316 31331 100.0 % -1.54 [ -1.97, -1.12 ]
Heterogeneity: Tau2 = 0.58; Chi2 = 99.49, df = 23 (P<0.00001); I2 =77%
Test for overall effect: Z = 7.14 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.31, df = 2 (P = 0.12), I2 =54%
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Analysis 2.11. Comparison 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping, Outcome 11
Weight, kg subgrouped by energy reduction in int group.
Review: Effects of total fat intake on body weight
Comparison: 2 Fat reduction versus usual fat diet, adult RCTs - subgrouping
Outcome: 11 Weight, kg subgrouped by energy reduction in int group
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 E intake same or greater in low fat group
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.5 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 4.0 % -1.80 [ -3.48, -0.12 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.7 % 0.90 [ -4.26, 6.06 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.5 % 0.40 [ -1.08, 1.88 ]
Subtotal (95% CI) 1655 1697 14.6 % -0.51 [ -1.49, 0.47 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 4.01, df = 3 (P = 0.26); I2 =25%
Test for overall effect: Z = 1.02 (P = 0.31)
2 E intake 1 to 100 kcal/d less in low fat group
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.6 % -0.40 [ -2.21, 1.41 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 8.0 % -0.96 [ -1.43, -0.49 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.7 % -8.50 [ -13.77, -3.23 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.9 % -1.70 [ -3.41, 0.01 ]
Subtotal (95% CI) 1169 1229 16.2 % -1.49 [ -2.92, -0.06 ]
Heterogeneity: Tau2 = 1.24; Chi2 = 8.86, df = 3 (P = 0.03); I2 =66%
Test for overall effect: Z = 2.04 (P = 0.042)
3 E intake 101 to 200 kcal/d less in low fat group
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.4 % -0.80 [ -3.28, 1.68 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.9 % -2.70 [ -4.03, -1.37 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 6.0 % 0.62 [ -0.40, 1.64 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 8.6 % -0.70 [ -0.90, -0.50 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.7 % -2.70 [ -4.50, -0.90 ]
Subtotal (95% CI) 17181 26574 25.6 % -1.14 [ -2.24, -0.04 ]
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(. . . Continued)
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 1.08; Chi2 = 19.74, df = 4 (P = 0.00056); I2 =80%
Test for overall effect: Z = 2.03 (P = 0.042)
4 E intake > 201 kcal/d less in low fat group
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 3.1 % -3.73 [ -5.78, -1.68 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 5.1 % -1.50 [ -2.79, -0.21 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.5 % -3.60 [ -5.08, -2.12 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 5.2 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 4.2 % -3.50 [ -5.09, -1.91 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 7.5 % -0.72 [ -1.34, -0.10 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.6 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 8.3 % -1.50 [ -1.85, -1.15 ]
Subtotal (95% CI) 2218 1736 43.6 % -2.23 [ -2.97, -1.49 ]
Heterogeneity: Tau2 = 0.77; Chi2 = 31.77, df = 7 (P = 0.00004); I2 =78%
Test for overall effect: Z = 5.89 (P < 0.00001)
Total (95% CI) 22223 31236 100.0 % -1.52 [ -1.97, -1.07 ]
Heterogeneity: Tau2 = 0.60; Chi2 = 94.69, df = 20 (P<0.00001); I2 =79%
Test for overall effect: Z = 6.61 (P < 0.00001)
Test for subgroup differences: Chi2 = 8.07, df = 3 (P = 0.04), I2 =63%
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Analysis 3.1. Comparison 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses, Outcome 1
Weight, kg - removing studies with more attention to low fat arms.
Review: Effects of total fat intake on body weight
Comparison: 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome: 1 Weight, kg - removing studies with more attention to low fat arms
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 25.2 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 16.6 % -1.80 [ -3.48, -0.12 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 38.6 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 4.1 % -4.10 [ -8.06, -0.14 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 15.5 % -2.43 [ -4.20, -0.66 ]
Total (95% CI) 752 785 100.0 % -1.25 [ -2.09, -0.41 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 7.19, df = 4 (P = 0.13); I2 =44%
Test for overall effect: Z = 2.91 (P = 0.0036)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses, Outcome 2
Weight, kg - removing studies with dietary interventions other than fat.
Review: Effects of total fat intake on body weight
Comparison: 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome: 2 Weight, kg - removing studies with dietary interventions other than fat
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 4.6 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 3.8 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 6.9 % -1.00 [ -2.02, 0.02 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 6.3 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 6.6 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 5.4 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 5.8 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 6.2 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 6.4 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 5.6 % -3.50 [ -5.09, -1.91 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 6.9 % 0.62 [ -0.40, 1.64 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 7.8 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 1.3 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 2.1 % -4.10 [ -8.06, -0.14 ]
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 1.3 % -8.50 [ -13.77, -3.23 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 5.2 % -2.43 [ -4.20, -0.66 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 5.3 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 6.7 % -1.83 [ -2.96, -0.70 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 5.9 % -1.80 [ -3.25, -0.35 ]
Total (95% CI) 2548 2968 100.0 % -1.92 [ -2.57, -1.26 ]
Heterogeneity: Tau2 = 1.33; Chi2 = 66.85, df = 18 (P<0.00001); I2 =73%
Test for overall effect: Z = 5.76 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses, Outcome 3
Weight, kg - fixed-effect analysis.
Review: Effects of total fat intake on body weight
Comparison: 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome: 3 Weight, kg - fixed-effect analysis
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 0.5 % -3.73 [ -5.78, -1.68 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 0.3 % -0.80 [ -3.28, 1.68 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 2.0 % -1.00 [ -2.02, 0.02 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 0.6 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 1.2 % -1.50 [ -2.79, -0.21 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 1.5 % -0.50 [ -1.67, 0.67 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 0.7 % -1.80 [ -3.48, -0.12 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 0.9 % -3.60 [ -5.08, -2.12 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 1.1 % -2.70 [ -4.03, -1.37 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 1.3 % -3.30 [ -4.55, -2.05 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 0.8 % -3.50 [ -5.09, -1.91 ]
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 1.9 % 0.62 [ -0.40, 1.64 ]
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 5.2 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.1 % 0.90 [ -4.26, 6.06 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 0.1 % -4.10 [ -8.06, -0.14 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 9.1 % -0.96 [ -1.43, -0.49 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.1 % -8.50 [ -13.77, -3.23 ]
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(. . . Continued)
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 0.6 % -2.43 [ -4.20, -0.66 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 0.7 % -1.70 [ -3.41, 0.01 ]
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 0.9 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 51.2 % -0.70 [ -0.90, -0.50 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 1.6 % -1.83 [ -2.96, -0.70 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 16.5 % -1.50 [ -1.85, -1.15 ]
WINS 1993 698 -1.8 (15.1) 1044 0 (15.1) 1.0 % -1.80 [ -3.25, -0.35 ]
Total (95% CI) 22628 31377 100.0 % -1.02 [ -1.16, -0.87 ]
Heterogeneity: Chi2 = 97.25, df = 23 (P<0.00001); I2 =76%
Test for overall effect: Z = 13.98 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses, Outcome 4
Weight, kg - removing WHI.
Review: Effects of total fat intake on body weight
Comparison: 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome: 4 Weight, kg - removing WHI
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Simon Low Fat Breast CA 34 63.4 (11.1) 38 71.9 (11.7) 0.7 % -8.50 [ -13.77, -3.23 ]
Pilkington 1960 12 66.7 (5.9) 23 70.8 (5.2) 1.2 % -4.10 [ -8.06, -0.14 ]
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 3.2 % -3.73 [ -5.78, -1.68 ]
DEER 1998 exercise men 48 -4.2 (4.2) 47 -0.6 (3.1) 4.5 % -3.60 [ -5.08, -2.12 ]
DEER 1998 no exercise wom 46 -2.7 (3.5) 45 0.8 (4.2) 4.2 % -3.50 [ -5.09, -1.91 ]
DEER 1998 no exercise men 49 -2.8 (3.5) 46 0.5 (2.7) 5.1 % -3.30 [ -4.55, -2.05 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 3.7 % -2.70 [ -4.50, -0.90 ]
DEER 1998 exercise women 43 -3.1 (3.7) 43 -0.4 (2.5) 4.9 % -2.70 [ -4.03, -1.37 ]
Strychar 2009 15 -0.83 (3) 15 1.6 (1.8) 3.8 % -2.43 [ -4.20, -0.66 ]
WHT Feasibility 1990 159 -1.91 (4.9) 102 -0.08 (4.3) 5.5 % -1.83 [ -2.96, -0.70 ]
de Bont 1981 obese 34 -2.7 (3.6) 35 -0.9 (3.5) 4.0 % -1.80 [ -3.48, -0.12 ]
Swedish Breast CA 1990 63 -0.4 (5.5) 106 1.3 (5.5) 3.9 % -1.70 [ -3.41, 0.01 ]
WHT:FSMP 2003 1325 -1.8 (4) 883 -0.3 (4.2) 7.6 % -1.50 [ -1.85, -1.15 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 5.0 % -1.50 [ -2.79, -0.21 ]
Bloemberg 1991 39 -0.94 (2.68) 40 0.06 (1.86) 5.8 % -1.00 [ -2.02, 0.02 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 7.3 % -0.96 [ -1.43, -0.49 ]
BDIT Pilot Studies 1996 76 59.6 (7.3) 78 60.4 (8.4) 2.5 % -0.80 [ -3.28, 1.68 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 6.9 % -0.72 [ -1.34, -0.10 ]
de Bont 1981 non-obese 36 -0.4 (2.8) 29 0.1 (2) 5.4 % -0.50 [ -1.67, 0.67 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 3.7 % -0.40 [ -2.21, 1.41 ]
Rivellese 1994 27 -1.8 (0) 17 -1.6 (0) Not estimable
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Veterans Dermatology 1994 38 -2 (0) 58 0.5 (0) Not estimable
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(. . . Continued)
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
MeDiet 2006 51 -1.3 (0) 55 -0.6 (0) Not estimable
Diet and Hormone Study 2003 81 -0.68 (0) 96 -0.14 (0) Not estimable
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 4.5 % 0.40 [ -1.08, 1.88 ]
Kentucky Low Fat 1990 47 1.06 (2.49) 51 0.44 (2.68) 5.8 % 0.62 [ -0.40, 1.64 ]
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.8 % 0.90 [ -4.26, 6.06 ]
Total (95% CI) 6019 6275 100.0 % -1.64 [ -2.12, -1.16 ]
Heterogeneity: Tau2 = 0.75; Chi2 = 79.26, df = 22 (P<0.00001); I2 =72%
Test for overall effect: Z = 6.73 (P < 0.00001)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
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Analysis 3.5. Comparison 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses, Outcome 5
Weight, kg - removing studies without good allocation concealment.
Review: Effects of total fat intake on body weight
Comparison: 3 Fat reduction versus usual fat diet, adult RCTs - sensitivity analyses
Outcome: 5 Weight, kg - removing studies without good allocation concealment
Study or subgroup Reduced fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Auckland reduced fat 1999 48 -1.6 (5.4) 51 2.13 (5) 4.0 % -3.73 [ -5.78, -1.68 ]
BRIDGES 2001 48 0.1 (4.85) 46 0.5 (4.07) 5.0 % -0.40 [ -2.21, 1.41 ]
Canadian DBCP 1997 388 62 (9.1) 401 63.5 (9.4) 8.5 % -1.50 [ -2.79, -0.21 ]
MSFAT 1995 117 0.4 (2.36) 103 1.12 (2.36) 18.9 % -0.72 [ -1.34, -0.10 ]
NDHS Open 1st L%M 1968 332 -2.45 (0) 348 -1.91 (0) Not estimable
NDHS Open 2nd L%M 1968 179 -1.8 (0) 215 -1.2 (0) Not estimable
Nutrition % Breast Health 47 67.3 (13.8) 50 66.4 (12) 0.7 % 0.90 [ -4.26, 6.06 ]
Polyp Prevention 1996 943 -0.65 (5.22) 943 0.31 (5.22) 22.5 % -0.96 [ -1.43, -0.49 ]
WHEL 2007 1308 74.1 (19.53) 1313 73.7 (19.2) 6.9 % 0.40 [ -1.08, 1.88 ]
WHI 2006 16297 -0.8 (10.1) 25056 -0.1 (10.1) 28.4 % -0.70 [ -0.90, -0.50 ]
WINS 1993 386 -2.7 (15.3) 998 0 (15.3) 5.1 % -2.70 [ -4.50, -0.90 ]
Total (95% CI) 20093 29524 100.0 % -0.95 [ -1.40, -0.51 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 17.72, df = 8 (P = 0.02); I2 =55%
Test for overall effect: Z = 4.20 (P = 0.000027)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours reduced fat Favours moderate fat
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Analysis 4.1. Comparison 4 Fat reduction versus usual fat, child RCTs, Outcome 1 BMI, kg/m2 - in child
RCTs.
Review: Effects of total fat intake on body weight
Comparison: 4 Fat reduction versus usual fat, child RCTs
Outcome: 1 BMI, kg/m2 - in child RCTs
Study or subgroup Low fat
Usual or
modified
fat
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
VYRONAS 2009 98 23.3 (2.8) 93 24.8 (3.8) 100.0 % -1.50 [ -2.45, -0.55 ]
Total (95% CI) 98 93 100.0 % -1.50 [ -2.45, -0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.09 (P = 0.0020)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours low fat Favours usual fat
A D D I T I O N A L T A B L E S
Table 1. Characteristics and results of included cohort studies in adults (all or a majority of participants recruited as adults)
Study Participants at baseline + / 0 / - Results and/or estimate of ef-
fect?
CARDIA Ludwig 1999 (1)
USA
2909 healthy black and white
young adults
Baseline age: 18 to 30 yrs
Follow-up: 10 yrs
%E from fat: unclear (lower
quintile < 30, upper > 41.7)
BMI: unclear
+ (weight) in black men and
women
0 (weight) in white men and
women
Adjusted means of 10-year
body weight according to quin-
tiles of total fat as a percentage
of total energy. P for trend 0.
32 in white men and women
(quintile 1 weight 168.6 lb,
quintile 5 weight 169.4 lb), 0.
03 for black men and women
(quintile 1 weight 182.1 lb,
quintile 5 weight 185.7 lb)
DanishDiet Cancer &Health
Study Halkjaer 2009 (2-4)
Denmark
22,570 women and 20,126
men
Baseline age: 50 to 64 yrs
Follow-up: 5 yrs
%E from fat: unclear (approx
32% in women, 33% in men)
BMI:median 24.7 women, 26.
1 men
0 (1 waist) women
0 (1 waist) men
Associationbetween total fat in-
take at baseline and change in
waist circumference over 5 years
suggested no statistically signif-
icant effects in women (mean
change in waist circumference
-0.03 cm/MJ/d total fat, 95%
CI -0.20 to 0.14) or men (mean
158Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Characteristics and results of included cohort studies in adults (all or a majority of participants recruited as adults)
(Continued)
change in waist circumference
0.06 cm/MJ/d total fat, 95%CI
-0.05 to 0.17)
12,353 women and 10,080
men
Baseline age: 50 to 60 yrs
Follow-up: 5 yrs
%E from fat: median 33.8%
women, 35.2% in men
BMI:median 24.4 women, 25.
8 men
0 (1 waist circumference)
0 (1 body weight)
Macronutrient energy substitu-
tion where energy from protein
was replaced by fat or carbohy-
drate.Multiple linear regression
investigated the association be-
tween dietary protein in rela-
tion to change in body weight
or waist circumference over 5
years.No statistically significant
effect of replacing 5%E from
fat with protein on change in
body weight (8.0 g/year, 95%
CI -16.6 to 32.5, P value = 0.
525) or waist circumference (0.
1 mm/year, 95% CI -0.3 to 0.
4, P value = 0.799)
Danish MONICA Iqbal 2006
(5)
Denmark
900 women and 862 men
Baseline age: 30 to 60 yrs
Follow-up: 5 yrs
%E from fat: 43.8% (SD 6.5
women, 42.7 (SD 6.3) men
BMI: 23.4 (SD 3.7 women, 25.
1 (SD 3.3) men
0 (1 weight) women
0 (1 weight) men
Regression assessment of total
fat as %E and other dietary fac-
tors as a function of change
in body weight suggested no
significant effects of %E from
fat on 5-year change in body
weight in women (unadjusted
beta 0.47, SE 0.89, P value =
0.60, adjusted beta 0.86, SE 0.
92, P value = 0.35) or men (un-
adjusted beta -0.14, SE 0.69, P
value = 0.84, adjusted beta 0.
11, SE 0.69, P value = 0.87)
Diabetes Control & Com-
plications Trial (DCCT) &
EDIC
Cundiff 2012 (6)
USA
1055 women and men with di-
abetes, HbA1c ≤ 9.5
Baseline age: 13 to 39 yrs
(mean 27.4)
Follow-up: 14 to 19 yrs (mean
16.4 yrs)
%E from fat: 36.2% (90% CI
26.6 to 45.1)
BMI: 23.4 (90%CI 19.4 to 27.
9)
0 (1 BMI/year) Multiple regression analyses
generated the formula linking
macronutrient intake and exer-
cise at baseline with change in
BMI per year. Univariate anal-
yses suggested no relationship
between total fat (as %E) and
change in BMI per year (β 0.
04 kg/m2/year, P value = 0.
22), and only total fat minus
polyunsaturated fat (%E, not
total fat) was included in the
formula predictingBMI change
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Table 1. Characteristics and results of included cohort studies in adults (all or a majority of participants recruited as adults)
(Continued)
per year
EPIC-PANACEA
Vergnaud 2013 (7)
Europe (10 countries)
EPIC
Beulens 2014 (8)
Europe (15 cohorts)
373,803 men and women from
the general European popula-
tion
Baseline age: 25 to 70 yrs
Follow-up: 5 yrs (2 to 11)
%E from fat: mean 35.4 (SD
unclear)
BMI: mean 25.6 women, 26.7
men (SDs unclear)
0 (1weight) when replacing fat
with CHO in women or men
- (1 weight) when replacing fat
with protein in women or men
Multivariate substitution mod-
els were performed to esti-
mate weight change associated
with replacement of 5%E of
one macronutrient with an-
other. 5% greater proportion
of E from fat at the expense
of carbohydrate was not asso-
ciated with weight change in
women or men (P value = 0.36,
P value = 0.73). Replacing 5%E
from protein with fat was as-
sociated with weight reduction
in women (β 0.4 kg/5 years, P
value < 0.0001) and men (β 0.
3 kg/5 years, P value = 0.003)
6192 people with type 2 dia-
betes
Baseline age: unclear
Follow-up: 5 yrs
%E from fat: unclear
BMI: unclear
- (1 weight) when replacing
CHO with total fat
Linear regression was used to
explore the relationship be-
tween replacement of CHO
with total fat (and also MUFA
and PUFA) and 5-year weight
change. This is an abstract so re-
sults reported as ”5-year weight
change decreased when carbo-
hydrates were substituted with
total fat“ (no further details)
Health Professionals Follow-
Up Study (HPFUS)
Coakley 1998 (9)
USA
19,478 male health profession-
als
Baseline age: 45 to 75 yrs
Follow-up: 4 yrs
%E from fat: unclear, energy
adjusted fat intakemean 69.6 g/
d (SD 13.8)
BMI: unclear
+ (1 weight) 45 to 54 yrs men
+ (1 weight) 55 to 64 yrs men
0 (1 weight) 65+ yrs men
Multivariate regression analyses
determinedwhether total fat in-
take and other habits were pre-
dictive of 4-year weight change,
and found that a change of ad-
justed fat intake of 10 g/d pre-
dicted 0.10 kg of weight change
over 4 years (P value < 0.001 for
ages 45 to 54 and 55 to 64 years,
P value > 0.05 for age 65+)
Melbourne Collaborative Co-
hort Study (MCCS)
MacInnis 2013 (10)
Australia
5879 healthy Australian-born
non-smokers
Baseline age: 40 to 69 yrs
Follow-up: 11.7 yrs
%E from fat: 33% (SD 6)
women, 33 (SD 5) men
BMI: unclear
+ (weight) overall
+ (waist circumference) overall
+ (weight) 40 to 49 yrs
0 (weight) 50 to 59 yrs
0 (weight) 60 to 69 yrs
+ (waist) 40 to 49 yrs
+ (waist) 50 to 59 yrs
0 (waist) 60 to 69 yrs
Multivariable linear regression
was used to predict waist cir-
cumference and weight at 12-
year follow-up. Higher percent-
age of energy from fat at base-
line was associated with weight
(0.26 kg per 10%E from fat,
P value = 0.03) and waist cir-
160Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Characteristics and results of included cohort studies in adults (all or a majority of participants recruited as adults)
(Continued)
cumference (0.85 cmper 10%E
from fat, P value < 0.001) in the
whole sample.When assessed in
age bands, total fat was associ-
ated with weight in those aged
40 to 49 years at baseline (P
value = 0.002), but not in those
aged 50 to 59 (P value = 0.94)
or 60 to 69 years (P value = 0.
79), and with waist circumfer-
ence in those aged 40 to 49 (P
value < 0.001) and 50 to 59 (P
value = 0.01), but not in those
aged 60 to 69 (P value = 0.14)
Memphis
Klesges 1992 (11-13)
USA
152women and142men (Cau-
casian health professionals)
Baseline age: 24 to 52 yrs
Follow-up: 2 yrs
%E from fat:mean 36.8 (SD6.
1) women, 36.0 (SD 5.4) men
BMI: mean 24.8 (SD 5.0)
women, 27.8 (SD 4.3) men
+ (1 weight) women
0 (1 weight) men
0 (1 waist) women
- (1 waist) men
Stepwise multivariate regres-
sion analyses assessed whether
various lifestyle factors were
predictive ofweight change over
2 years. Percentage of energy
as fat was predictive of weight
change inwomen (coefficient 0.
53, SE 0.16, P value = 0.0010)
but not in men (exact data not
provided)
Hierarchical linear regression
assessed the effects of lifestyle
factors on change in waist cir-
cumference over 2 years, and
found no significant effect in
women (coefficient -0.04, P
value = 0.50) but a statistically
significant negative relationship
in men (coefficient -0.05, P
value = 0.04)
NHANES Follow-up
Kant 1995 (14)
USA
4567 women and 2580 men
Baseline age: 25 to 74 yrs
Follow-up: mean 10.6 (SD 5)
yrs
%E from fat:mean 36.4 (SD5.
0) women, 37.0 (SD 10.1) men
BMI: mean 25.2 (SD 5.0)
women, 25.9 (SD 5.0) men
+ (1 weight) < 50 yrs women
0 (1 weight) 50+ yrs women
0 (1 weight) < 50 yrs men
0 (1 weight) 50+ yrs men
Univariate regression analyses
assessed whether fat as %E is
predictive of 10-year weight
change and foundno significant
effects in women (Beta -0.011,
SE 0.017, P value = 0.51) or
men (Beta 0.043, SE 0.022, P
value = 0.06). Effects were sim-
ilar in multivariate regression in
women (Beta -0.033, SE 0.019,
P value = 0.08 for women over-
all, Beta -0.053, SE 0.025, P
value = 0.04 for women aged <
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(Continued)
50 yrs, Beta -0.019, SE 0.030,
P value = 0.55 for women aged
50+) or men (Beta 0.021, SE
0.022, P value = 0.33 for men
overall, Beta -0.004, SE 0.028,
P value = 0.88 for men aged <
50 yrs, Beta -0.058, SE 0.035, P
value = 0.10 for men aged 50+)
Nurses’ Health Study
Colditz 1990 (15)
Field 2007 (16)
USA
31,940 women (nurses)
Baseline age: 30 to 55+
Follow-up: 8 yrs
%E from fat: unclear
BMI: unclear
0 (1 weight) women Correlation between total fat
(g/d) and weight gain over sub-
sequent 4 years (beta -0.0007,
t -0.4), not statistically signifi-
cant
41,518 women (nurses)
Baseline age: 41 to 68 yrs
(mean 53.7, SD 7.1 yrs)
Follow-up: 8 yrs
%E from fat: 32.8 (SD 5.6)
BMI: 25.0 (SD 4.5)
? unclear (1 weight) women Association between a 1% dif-
ference in total fat as %E and
weight change (in pounds over
8 years) was modelled using lin-
ear regression. There was aweak
relationship between total fat
and weight change (β 0.11 lb/
1% total fat difference, P value
< 0.0001 stated in text, but no
statistical significance indicated
in table)
Pawtucket HHP
Parker 1997 (17)
USA
289 women and 176 men
Baseline age: 18 to 64 yrs
Follow-up: 4 yrs
%E from fat: unclear
BMI:mean 26.5 (SD 5.0)
0 (1 weight) women and men Multiple regression assessed as-
sociation of weight change with
different nutrients at baseline.
Found no effect of total fat in
grams on weight change over 4
years (coefficient 2.30, P value
= 0.71)
San Luis Valley Diabetes
Study (SLVDS)
Mosca 2004 (18)
USA
433 women and 349 men
- non-diabetic, Hispanic and
non-Hispanic white
Baseline age: 20 to 74 yrs
Follow-up: 14 yrs
%E from fat: mean 38.3 (SD
8.9) white women, 37.2 (8.
9) Hispanic women, 38.9 (8.7)
white men, 37.8 (9.8) Hispanic
men
BMI: mean 24.3 (SD 4.4)
white women, 25.0 (4.6) His-
panic women, 25.7 (3.3) white
men, 24.7 (3.8) Hispanic men
+ (1 weight) overall (includes
women and men, Hispanic and
non-Hispanic white)
Linear mixed model (random-
effects, PROCMIXED in SAS)
was used to assess whether those
who generally consume a rela-
tively high fat diet gain more
weight over time. They found a
significant association between
%E from total fat and weight
change between participants (β
0.012, P value = 0.0178) af-
ter adjusting for potential con-
founders
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SEASONS
Ma 2005 (19)
USA
275 healthy women and 297
healthy men
Baseline age: 20 to 70 yrs
Follow-up: 1 yr
%E from fat: mean 36.7 (SD
9.0)
BMI:mean 27.4 (SD 5.5)
0 (BMI)women andmen -with
no energy adjustment
Regression analyses to assess ef-
fects of total fat %E on BMI.
Longitudinal effect was not sta-
tistically significant (coefficient
0.005, P value = 0.07)
Women’s Gothenburg
Lissner 1997 (20)
Sweden
361 women
Baseline age: 38 to 60 yrs
Follow-up: 6 yrs
%E from fat: mean 34.1 (SD
4.0) lower fat group, 42.3 (SD
3.0) higher fat group
BMI:mean24.6 (SD4.1) lower
fat group, 24.1 (SD 4.1) higher
fat group
+ (1 weight) sedentary
0 (1 weight) moderate
0 (1 weight) active
Multivariate regression used to
test for interactive effects of
dietary fat intake on weight
change over 6 years. A signifi-
cant effect of high vs low %E
from fat was found in sedentary
women (high fat women gained
2.64 kg while low fat women
lost 0.64 kg over 6 years, P value
= 0.03) but this was lost with
further energy adjustment. No
effects were seen in more active
women (2 categories), where
those with low and high fat in-
takes all gained 1 to 2 kg on av-
erage
Key:
+ = positive relationship found between fat intake and weight outcome.
0 = no relationship found between fat intake and weight outcome.
- = negative (inverse) relationship found between fat intake and weight outcome.
Abbreviations: BMI: body mass index; CHO: carbohydrates; CI: confidence interval; MUFA: monounsaturated fatty acid; PUFA:
polyunsaturated fatty acid; SD: standard deviation; SE: standard error.
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Table 2. Characteristics and results of included cohort studies in children and young people (including all cohorts where
assessment began in childhood or adolescence)
Study Participants at baseline + / 0 / - Results and/or estimate of ef-
fect
Adelaide Nutrition Study
Magarey 2001 (1)
Australia
243 boys and girls
Age: diet analysed at 2, 4, 6, 8,
11, 13 and 15 years old
Follow-up: assessed for each
gap (e.g. 2 to 4 years, 2 to 6
years, 2 to 8 years, 4 to 6 years
etc), 2 to 13 years
%E from fat: boys aged 2 yrs
38.4 (SD 5.8), girls aged 2 38.
1 (SD 13.4), boys aged 15 33.2
(SD 5.6), girls aged 15 yrs 34.4
(SD 5.6)
BMI: boys aged 2 yrs 16.8 (SD
1.7), girls aged 2 16.5 (SD 1.4)
, boys aged 15 20.2 (SD 2.6),
girls aged 15 yrs 21.4 (SD 4.1)
0 (BMI) for 20 of 21 possible
age gaps
0 (triceps skinfold) for 21 of 21
possible age gaps
0 (sub-scapular skinfold) for 20
of 21 possible age gaps
Single dietary assessment for
each of 21 analyses
Analysis: multiple regression
analysis was used to predict
whether body fatness at a spe-
cific age was predicted by
macronutrient intake at previ-
ous ages. For BMI only one of
21 possible gaps showed a sta-
tistically significant relationship
between total fat intake as a
percentage of energy and later
BMI (a significant relationship,
P value < 0.01, was only seen
between fat at age 6 and BMI at
age 8). For triceps skinfold none
of 21 possible gaps showed a
statistically significant relation-
ship between total fat intake as
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Table 2. Characteristics and results of included cohort studies in children and young people (including all cohorts where
assessment began in childhood or adolescence) (Continued)
a percentage of energy and later
triceps skinfold. For subscapu-
lar skinfold only one of 21 pos-
sible gaps showed a statistically
significant relationship between
total fat intake as a percentage
of energy and later sub-scapular
skinfold (a significant relation-
ship, P value < 0.01, was only
seen between fat at age 2 and
skinfold at age 15)
Amsterdam Growth&Health
Long. Study (AGAHLS)
Twisk 1998, Koppes 2009
(2;3)
Netherlands
83 boys (thenmen) and 98 girls
(then women)
Age: recruited aged 13, diet
analysed at ages 13, 14, 15, 16,
21, 27
Follow-up: 14 yrs (age 27)
%E from fat: not reported
BMI: boys aged 13 yrs 17.3
(SD 1.6), girls 18.1 (SD 2.1),
men aged 27 yrs 22.6 (SD 2.2)
, women 21.9 (SD 2.5)
0 (sum of 4 skinfolds)
0 (BMI)
Both for absolute fat intake and
%E from fat
Multiple dietary assessments
Analysis: first order auto-re-
gressive model (fatness at each
time point related to exposure
at the previous time point) es-
timated by generalised estimat-
ing equations. There was no re-
lationship between total fat in-
take (absolute, g/d) and later
fatness as assessed by sum of
four skinfolds (P value = 0.41)
or BMI (P value = 0.23), or
between fat intake as %E and
later fatness as assessed by sum
of four skinfolds (P value = 0.
92) or BMI (P value = 0.69)
168 boys (then men) and 182
girls (then women)
Age: recruited aged 13 (SD 0.
7), diet analysed at ages 13, 14,
15, 16, 21, 27, 32, 36
Follow-up: 23 yrs (age 36)
%E from fat: not reported
BMI: as above
0 (high %body fat at age 36), 0
of 14 analyses
0 (% body fatness) in men or
women
Multiple dietary assessments
Analysis: generalised estimat-
ing equation regression analy-
ses found that dietary fat intake
(%E) at ages 13, 14, 15, 16, 21,
27 or 32 did not predict high
body fatness (> 25% for men,
> 35% for women, assessed by
DEXA at 36 years) in either
men or women (in any of 7
analyses inmen or 7 inwomen).
Regression coefficients using all
available data gathered between
ages 13 and 36 found no rela-
tionship between %E from fat
and sum of skinfolds in either
men (P value = 0.42) or women
(P value = 0.89)
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assessment began in childhood or adolescence) (Continued)
Bogaert 2003 (4)
Australia
29 boys and 30 girls
Age: recruited aged 6 to 9 yrs,
mean 8.6 (SE 0.2) yrs
Follow-up: at 6 and 12 mo
%E from fat: 33.5 (SD 0.8) in
boys aged < 8 yrs, 31.7 (SD 2.
7) girls < 8 yrs, 37.5 (SD 1.2)
boys aged 8+ yrs, 33.6 (SD 1.7)
girls aged 8+ yrs
BMI: z scores boys mean 0.3
(SE 0.1), girls mean 0.5 (SE 0.
3)
0 (1 BMI) Single dietary assessment
Analysis: correlations were cal-
culated to assess the relation
between %E from fat at base-
line and BMI z-score change
frombaseline to 12months. No
”positive relation“ was found
Carruth and Skinner 2001
(5;6)
USA
29 white boys and 24 girls
Age: recruited at 24 months,
diet assessed at 24 to 32, 28 to
36, 42, 48, 54, 60 months old
Follow-up: body fat assessed at
70 months
%E from fat: 31% boys, 32%
girls at 27 months, 31% boys,
33% girls at 60 months
BMI: 15.7 (SD 1.2) in boys
and 15.4 (SD 1.0) in girls at 60
months
+ (%body fat)
+ (g body fat)
Multiple dietary assessments
Analysis: regression analyses
(general linear models) of total
fat intake (averaging over 6 di-
etary assessments aged 27 to 60
months) predicted body fat at
70 months (assessed as %body
fat, P value = 0.02 and grams of
body fat, P value = 0.01, both
assessed by DEXA)
37 white boys and 33 girls
Age: recruited at 24 months
(except 2 joined at 1 year, 6
joined at 2 years from similar
study), diet assessed at 2.0, 2.3,
2.7, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0,
7.0, 8.0 yrs old
Follow-up: BMI assessed at 8
yrs
%E from fat: mean 32% (SD
not stated)
BMI: 16.5 in boys and 16.2 in
girls at 2 yrs, 16.8 in boys and
17.1 in girls at 8 yrs
+ (BMI) by g/d of fat
+ (BMI) by %E from fat
Multiple dietary assessments
Analysis: forward stepwise re-
gression was used to assess the
relationship between dietary fat
(averaged from 9 sets of 3-
day dietary data from ages 2
to 8) and BMI at age 8 years.
Whether assessing fat as g/d (P
value = 0.004) or %E from fat
(P value =0.010) therewas a sig-
nificant relationship (adjusted
for BMI at 2 years and adiposity
rebound age)
Davison 2001 (7)
USA
197 non-Hispanic white girls
Age: 5.4 (0.4) yrs
Follow-up: 2 yrs (age 7.3 ±0.3)
%E from fat: 31 (SD unclear)
BMI: 15.8 (1.4)
+ (1 BMI) Single dietary assessment
Analysis: in hierarchical regres-
sion models, girls’ fat intake (as
%E) at 5 yrs had a significant re-
lationship with change in BMI
from 5 to 7 years, P value = 0.
02
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Table 2. Characteristics and results of included cohort studies in children and young people (including all cohorts where
assessment began in childhood or adolescence) (Continued)
Etude Longitud. Alimenta-
tion Nutrition Croissance des
Enfants (ELANCE)
Rolland-Cachera 2013 (8)
France
40 boys and 33 girls whose diets
were assessed at 2 yrs
Age: 2 yrs
Follow-up: 18 years (age 20)
%E from fat: 31.9 (SD 5.7)
boys, 32.8 (SD 4.5) girls
BMI: unclear
0 (BMI)
0 (% triceps skinfold)
- (% sub-scapular skinfold)
- (fat mass)
Single dietary assessment (for
this analysis)
Analysis: association between
dietary intake at 2 years and
adult body composition was
analysed using linear regression
models. No statistically signif-
icant relationships were found
between %E from fat at 2 years
and BMI (P value = 0.23), %
triceps skinfold (P value = 0.19)
, or fat-free mass (P value = 0.
98) at age 20. Greater total fat
intake predicted lower % sub-
scapular skinfold (P value = 0.
03) and fat mass (P value = 0.
04). All data presented from the
adjusted models
European Youth Heart Study
Brixval 2009 (9)
Denmark
171 girls and 137 boys (but to-
tal of 384 stated also, numbers
vary between tables)
Age: boys 9.7 (SD 0.4) yrs, girls
9.6 (SD0.4) yrs
Follow-up: 6 years (age 15 to
16)
%E from fat: 32.1 (SD 6.6)
boys, 33.3 (SD 6.7) girls
BMI: 17.1 (SD 2.0) boys, 17.2
(SD 2.4) girls
0 (1 BMI z-score) boys
0 (1 BMI z-score) girls
Single dietary assessment.
Analysis: examined the associ-
ations between dietary fat in-
take at 9 years and subsequent
6-year weight development us-
ing regression analysis. None of
the regression models (various
levels of adjustment) suggested
that fat %E was associated with
change in BMI over 6 years (in
boys P value = 0.27, girls P
value = 0.75 in the most ad-
justed model)
Klesges 1995 (10)
USA
110 boys and 93 girls
Age: 3 to 5 yrs (boys 4.4 (0.5),
girls 4.3 (0.5)
Follow-up: 2 yrs
%E from fat: boys and girls 33.
0 (5.0)
BMI: boys 16.1 (1.4), girls 16.
1 (1.2)
0 /+ /0/0 (1 BMI) Multiple dietary assessments
Analysis: assessed
whether baseline %E from fat,
change from baseline to 1 year,
1 yr to 2 yrs, or baseline to 2
yrs (along with other variables)
predicted change in BMI over 2
yrs
Multiple regression
analysis suggested lower base-
line %E from fat correlated to
lower BMI change (regression
coefficient = 0.034, P value = 0.
05 - marginal significance) at 2
yrs, 0.17 k/m2per 5% more E
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Table 2. Characteristics and results of included cohort studies in children and young people (including all cohorts where
assessment began in childhood or adolescence) (Continued)
from fat
Change in %E from fat over
the last year was correlated with
BMI change (regression num-
bers not legible, probably P value
= 0.01), 0.20 kg/m2 per 5%E
from fat change.
Change in %E from fat from
baseline to 1 yr, and baseline to
2 yrs did not predict change in
BMI
Obesity & Metabolic Dis-
orders Cohort in Children
(OMDCC)
Lee 2012 (11)
Korea
1504 1st and 4th grade children
Age:7.3 (SD0.3) in 1st graders,
10.0 (SD 0.4) years in 4th
graders
Follow-up: 2 years
%E from fat: 26.6 (SD 4.9) in
1st graders, 25.2 (SD5.1) in 4th
graders
BMI: 16.0 (SD 2.3) in 1st
graders, 18.1 (SD 3.0) in 4th
graders
0 (1 BMI) Single dietary assessment
Multiple linear regression mod-
elling assessed relationships be-
tween baseline environmental
factors, parental and lifestyle
habits and change in BMI over
2 years. They found no statisti-
cally significant relationship be-
tween fat intake and change in
BMI over 2 years (P value = 0.
104)
Trial of Activity for Adoles-
cent Girls (TAAG)
Cohen 2014 (12)
USA
265 girls in 8th grade
Age: mean 13.9 (SD 0.4) yrs
Follow-up: 2 and 3 yrs
%E from fat: unclear
BMI:mean 22.1 (SD 5.2)
0 (BMI percentile)
- (% body fat)
Single dietary assessment
Multivariable random coeffi-
cients model designed to exam-
ine whether habitual physical
activity, diet and environmen-
tal exposure were predictive of
future weight gain or percent-
age body fat. The multivari-
atemodel foundno relationship
between fat calories at baseline
and BMI percentile (P value =
0.16), but suggested a reduction
in % body fat associated with
increased fat calories (P value =
0.03)
Viva la Familia Study
Butte 2007 (13)
USA
1030 Hispanic boys and girls
(unclear how many of each)
Age: unclear, 4 to 19 yrs?
Follow-up: 1 yr
%E from fat: 34.0 (6.0)
BMI: not stated
+
(1 weight)
Single dietary assessment
Analysis: %E from fat was
positively correlated with 1 yr
weight gain (kg/y)
For
798 participants generalised es-
timating equations (GEE) sug-
gested coefficient 0.044, SD 0.
018, P value = 0.014
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Key:
+ = positive ss relationship found between fat intake and weight outcome.
0 = no ss relationship found between fat intake and weight outcome.
- = negative (inverse) ss relationship found between fat intake and weight outcome.
Abbreviations: BMI: body mass index; DEXA: dual energy X-ray absorptiometry; SD: standard deviation; SE: standard error; ss:
statistically significant
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Table 3. Excluded child RCTs
Study Reason for exclusion
AlexyU, Reinehr T, et al. (2006). Positive changes of dietary habits
after an outpatient training program for overweight children.Nu-
trition Research 26(5): 202-8
Weight loss intention
Amesz EMS. Optimal growth and lower fat mass in preterm in-
fants fed a protein-enriched postdischarge formula. Journal of Pe-
diatric Gastroenterology and Nutrition. 2010;50(2):200-7
Includes infants
Anand SS, Davis AD, et al. (2007). A family-based interven-
tion to promote healthy lifestyles in an aboriginal community in
Canada. Canadian Journal of Public Health Revue Canadienne de
Weight loss intention
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Table 3. Excluded child RCTs (Continued)
Sante Publique. 98(6): 447-52
Angelopoulos PD,MilionisHJ, et al. (2009).Changes in BMI and
blood pressure after a school based intervention: the CHILDREN
study. European Journal of Public Health 19(3): 319-25
Multifactorial intervention
Burrows TJ. Long-term changes in food consumption trends in
overweight children in the HIKCUPS intervention. Journal of
Pediatric Gastroenterology and Nutrition. 2011;53(5):543-7
All obese or overweight at baseline
DalMolinNetto B, LandiMasquioDC,Da SilveiraCamposRM,
De Lima Sanches P, Campos Corgosinho F, Tock L, et al. The
high glycemic index diet was an independent predictor to explain
changes in agouti-related protein in obese adolescents. Nutricion
Hospitalaria. 2014;29(2):305-14
Obese adolescents
Evans RK, Franco RL, et al. (2009). Evaluation of a 6-month
multi-disciplinary healthy weightmanagement program targeting
urban, overweight adolescents: effects on physical fitness, physical
activity, and blood lipid profiles. International Journal of Pediatric
Obesity 4(3): 130-3
Multifactorial intervention, weight loss goal
Forneris T, Fries E, et al. (2010). Results of a rural school-based
peer-led intervention for youth: goals for health. Journal of School
Health 80(2): 57-65
No relevant outcomes
Garnett SPB. Researching Effective Strategies to Improve Insulin
Sensitivity in Children and Teenagers - RESIST. A randomised
control trial investigating the effects of two different diets on
insulin sensitivity in young people with insulin resistance and/
or pre-diabetes. BMC Public Health. 2010;10(pp 575):2010. 2.
Garnett SPD. Optimum macronutrient content of the diet for
adolescents with pre-diabetes; RESIST a randomised control trial
ACTRN12608000416392. Endocrine Reviews. 2012;Conference
(var.pagings)
All obese or overweight at baseline
Hernandez TLA.Women with gestational diabetes randomised to
a low-carbohydrate/higher fat diet demonstrate greater insulin re-
sistance and infant adiposity. Diabetes. 2013;Conference(var.pag-
ings):July
Effect on infants
Horan MKM. The association of maternal characteristics and
macronutrient intake in pregnancy with neonatal body composi-
tion. Archives of Disease in Childhood: Fetal and Neonatal Edition.
2014;Conference(var.pagings):June
Infants
Jebb SA, Frost G, et al. (2007). The RISCK study: Testing the
impact of the amount and type of dietary fat and carbohydrate on
metabolic risk. Nutrition Bulletin 32(2): 154-6
Design paper
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Table 3. Excluded child RCTs (Continued)
Kaitosaari T, Ronnemaa T, et al. (2006). Low-saturated fat dietary
counselling starting in infancy improves insulin sensitivity in 9-
year-old healthy children: the Special Turku Coronary Risk Factor
Intervention Project for Children (STRIP) study. Diabetes Care
29(4): 781-5
No relevant outcomes
Lagstrom H, Hakanen M, et al. (2008) Growth patterns and
obesity development in overweight or normal-weight 13-year-old
adolescents: the STRIP study. Pediatrics 122(4): e876-83
No relevant exposures
Mirza NM, PalmerMG, Sinclair KB,McCarter R,He J, Ebbeling
CB, et al. Effects of a low glycemic load or a low-fat dietary in-
tervention on body weight in obese Hispanic American children
and adolescents: a randomised controlled trial. American Journal
of Clinical Nutrition. 2013;97(2):276-85
All obese at baseline
Mobley CCS. Effect of nutrition changes on foods selected by stu-
dents in a middle school-based diabetes prevention intervention
program: The HEALTHY experience. Journal of School Health.
2012;82(2):82-90
No total fat intake assessment
Niinikoski H, Lagstrom H, Jokinen E, Siltala M, Ronnemaa T,
Viikari J, et al. Impact of repeated dietary counselling between
infancy and 14 years of age on dietary intakes and serum lipids and
lipoproteins: the STRIP study.Circulation. 2007;116(9):1032-40
Aim to reduce saturated fat not total fat
Ramon-Krauel MS. A low-glycemic-load versus low-fat diet in
the treatment of fatty liver in obese children. Childhood Obesity.
2013;9(3):252-60
All obese at baseline
Shalitin S, Ashkenazi-Hoffnung L, et al. (2010). Effects of a
twelve-week randomised intervention of exercise and/or diet on
weight loss and weight maintenance, and other metabolic param-
eters in obese preadolescent children. Hormone Research 72(5):
287-301
Weight loss/unsuitable exposures
Sharma SF. One-year change in energy and macronutrient intakes
of overweight and obese inner-city African American children: Ef-
fect of community-based Taking Action Together type 2 diabetes
prevention program. Eating Behaviors. 2012;13(3):271-4
All obese or overweight at baseline
Singhal A, Kennedy K, Lanigan J, Fewtrell M, Cole TJ, Stephen-
son T, et al. Nutrition in infancy and long-term risk of obesity:
evidence from 2 randomised controlled trials. American Journal of
Clinical Nutrition. 2010;92(5):1133-44
Infants
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Table 3. Excluded child RCTs (Continued)
Thakwalakwa C, Ashorn P, Phuka J, Cheung YB, Briend A, Pu-
umalainen T, et al. A lipid-based nutrient supplement but not
corn-soy blend modestly increases weight gain among 6- to 18-
month-old moderately underweight children in rural Malawi.
Journal of Nutrition 2010;140(11):2008-13
Duration < 26 weeks
Williamson DA, Han H, Johnson WD, Martin CK, Newton RL,
Jr. Modification of the school cafeteria environment can impact
childhood nutrition. Results from theWise Mind and LA Health
studies. Appetite. 2013;61(1):77-84
Weight loss aimed
WilliamsonDA,CopelandAL, et al. (2007).WiseMind project: a
school-based environmental approach for preventing weight gain
in children. Obesity 15(4): 906-17
Multifactorial intervention
Table 4. Excluded adult cohort studies
Study Reason for exclusion
Adams T, Rini A (2007). Predicting 1-year change in body mass
index among college students. Journal of American College Health
55(6): 361-5
No relevant exposures
Aerenhouts D, Deriemaeker P, Hebbelinck M, Clarys P, Aeren-
houts D, Deriemaeker P, et al. Energy and macronutrient intake
in adolescent sprint athletes: a follow-up study. Journal of Sports
Sciences. 2011;29(1):73-82
No relationship between total fat and body fatness
Ahluwalia N, Ferrieres J, et al. (2009). Association of macronutri-
ent intake patterns with being overweight in a population-based
random sample of men in France. Diabetes & Metabolism 35(2):
129-36
Invalid study design
Aljadani HM, Patterson A, Sibbritt D, Hutchesson MJ, Jensen
ME, Collins CE. Diet quality, measured by fruit and vegetable
intake, predictsweight change in youngwomen. Journal ofObesity.
2013;2013:525161
No relevant outcomes
Almoosawi S, PrynneCJ,HardyR, StephenAM.Time-of-day and
nutrient composition of eating occasions: prospective association
with the metabolic syndrome in the 1946 British birth cohort.
International Journal of Obesity. 2013;37(5):725-31
No total fat assessment
Al-Sarraj T, Saadi H, et al. (2010). Metabolic syndrome preva-
lence, dietary intake, and cardiovascular risk profile among over-
weight and obese adults 18-50 years old from the United Arab
Emirates.Metabolic Syndrome & Related Disorders 8(1): 39-46
Cross-sectional study
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Table 4. Excluded adult cohort studies (Continued)
Althuizen E, van Poppel MN, de Vries JH, Seidell JC, van MW,
Althuizen E, et al. Postpartum behaviour as predictor of weight
change from before pregnancy to one year postpartum. BMCPub-
lic Health. 2011;11:165
Total fat assessment is not baseline
Bailey BWS.Dietary predictors of visceral adiposity in overweight
young adults. British Journal of Nutrition. 2010;103(12):1702-5
Cross-sectional
Berg CM, Lappas G, et al. (2008). Food patterns and cardiovas-
cular disease risk factors: the Swedish INTERGENE research pro-
gram. American Journal of Clinical Nutrition 88(2): 289-97
Invalid study design
Bes-Rastrollo M, van Dam RM, et al. (2008) Prospective study
of dietary energy density and weight gain in women. American
Journal of Clinical Nutrition 88(3): 769-77
Not total fat to body fatness
BlackMHW.High-fat diet is associated with obesity-mediated in-
sulin resistance and beta-cell dysfunction in Mexican Americans.
Journal of Nutrition. 2013;143(4):479-85. 2. Black MHW. Vari-
ants in PPARG interact with high-fat diet to influence longitudi-
nal decline in beta-cell function in Mexican Americans at risk for
type 2 diabetes (T2D). Diabetes. 2014;Conference(var.pagings):
June
Not prospective
Bujnowski D, Xun P, Daviglus ML, Van HL, He K, Stamler J, et
al. Longitudinal association between animal and vegetable protein
intake and obesity among men in the United States: the Chicago
WesternElectric Study. Journal of the AmericanDietetic Association.
2011;111(8):1150-5
No total fat intake assessment
Carvalho LKB. Annual variation in body fat is associated with
systemic inflammation in chronic kidney disease patients Stages 3
and 4: A longitudinal study. Nephrology Dialysis Transplantation.
2012;27(4):1423-8
No total fat assessment and chronic kidney disease
Castellanos DC, Connell C, Lee J. Factors affecting weight gain
and dietary intake in Latino males residing in Mississippi: a pre-
liminary study.Hispanic Health Care International. 2011;9(2):91-
8
Cross-sectional
Chang A, Van Horn L, Jacobs Jr DR, Liu K, Muntner P, New-
some B, et al. Lifestyle-related factors, obesity, and incident mi-
croalbuminuria: the CARDIA (Coronary Artery Risk Develop-
ment in Young Adults) Study. American Journal of KidneyDiseases.
2013;62(2):267-75
Assesses dietary patterns
Chopra VP. Dietary factors affecting weight gain in midlife
women. FASEB Journal. 2013;Conference(var.pagings):April
All overweight or obese at baseline
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Table 4. Excluded adult cohort studies (Continued)
deGroot S, PostMW, SnoekGJ, SchuitemakerM, van derWoude
LH. Longitudinal association between lifestyle and coronary heart
disease risk factors among individuals with spinal cord injury.
Spinal Cord. 2013;51(4):314-8
No total fat assessment
de Koning L,Malik VS, KelloggMD, RimmEB,WillettWC,Hu
FB. Sweetened beverage consumption, incident coronary heart
disease, and biomarkers of risk in men.Circulation. 2012;125(14)
:1735-41
No body fatness outcomes
Dujmovic M, Kresic G, Mandic ML, Kenjeric D, Cvijanovic O,
Dujmovic M, et al. Changes in dietary intake and body weight in
lactating and non-lactating women: prospective study in northern
coastal Croatia. Collegium Antropologicum. 2014;38(1):179-87
Follow-up < 1 year
Eghtesadi SS-K. Dietary patterns predicting changes in obesity
indices (BMI,WC,WHR) in longitudinal Tehran lipid and glu-
cose study. Annals of Nutrition and Metabolism. 2013;Conference
(var.pagings):2013
No total fat intake assessment
Erber E, Hopping BN, Grandinetti A, Park SY, Kolonel LN,
Maskarinec G. Dietary patterns and risk for diabetes: the multi-
ethnic cohort. Diabetes Care. 2010;33(3):532-8
No total fat intake assessment and no body fatness outcomes
Ericson U, Rukh G, Stojkovic I, Sonestedt E, Gullberg B, Wirfalt
E, et al. Sex-specific interactions between the IRS1 polymorphism
and intakes of carbohydrates and fat on incident type 2 diabetes.
American Journal of Clinical Nutrition. 2013;97(1):208-16
Cross-sectional
Hairston KGV. Lifestyle factors and 5-year abdominal fat accu-
mulation in a minority cohort: The IRAS family study. Obesity.
2012;20(2):421-7
No total fat intake assessment
Heppe DHMV. Maternal milk consumption, fetal growth, and
the risks of neonatal complications: The Generation R Study.
American Journal of Clinical Nutrition. 2011;94(2):501-9
Fetal growth assessment
Holmberg S, Thelin A, Holmberg S, Thelin A. High dairy fat
intake related to less central obesity: a male cohort study with
12 years’ follow-up. Scandinavian Journal of Primary Health Care.
2013;31(2):89-94
No total fat intake assessment
Ibe YT. Food groups and weight gain in Japanese men. Clinical
Obesity. 2014;4(3):157-64
No relationship between total fat and body fatness assessed
Jaacks LMG. Age, period and cohort effects on adult body mass
index and overweight from 1991 to 2009 in China: The China
Health And Nutrition Survey. International Journal of Epidemiol-
No total fat intake assessment
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Table 4. Excluded adult cohort studies (Continued)
ogy. 2013;42(3):828-37
Jaakkola JH. Eating behavior influences diet, weight, and central
obesity in women after pregnancy. Nutrition. 2013;29(10):1209-
13
No total fat intake assessment
Jarvandi S, Gougeon R, Bader A, Dasgupta K, Jarvandi S,
Gougeon R, et al. Differences in food intake among obese and
non-obese women and men with type 2 diabetes. Journal of the
American College of Nutrition. 2011;30(4):225-32
Cross-sectional
Johns DJ, Ambrosini GL, Jebb SA, Sjöström L, Carlsson LMS,
Lindroos AK. Tracking of an energy-dense, high saturated fat,
low-fibre dietary pattern, foods and nutrient composition over 10
years in the severely obese. Journal of HumanNutrition&Dietetics.
2011;24(4):391-2. 2. Johns DJ, Lindroos AK, Jebb SA, Sjostrom
L,Carlsson LM,AmbrosiniGL, et al. Tracking of a dietary pattern
and its components over 10-years in the severely obese. PLoS One
[Electronic Resource]. 2014;9(5):e97457
No relevant outcomes
Kimokoti RWG. Dietary patterns of women are associated with
incident abdominal obesity but not metabolic syndrome. Jour-
nal of Nutrition. 2012;142(9):1720-7. 2. Kimokoti RWN. Diet
quality, physical activity, smoking status, and weight fluctuation
are associated with weight change in women and men. Journal of
Nutrition. 2010;140(7):1287-93
No total fat intake assessment
Kirk JK, Craven T, Lipkin EW, Katula J, Pedley C, O’Connor
PJ, et al. Longitudinal changes in dietary fat intake and associated
changes in cardiovascular risk factors in adults with type 2 dia-
betes: the ACCORD trial. Diabetes Research & Clinical Practice.
2013;100(1):61-8
Compares PEP score, not total fat
Ko GTC, Chan JCN, et al. (2007). Associations between dietary
habits and risk factors for cardiovascular diseases in a Hong Kong
Chinese working population--the ”Better Health for Better Hong
Kong“ (BHBHK) health promotion campaign. Asia Pacific Jour-
nal of Clinical Nutrition 16(4): 757-65
No relevant exposures
Laatikainen T, Philpot B, Hankonen N, Sippola R, Dunbar JA,
Absetz P, et al. Predicting changes in lifestyle and clinical outcomes
in preventing diabetes: The Greater Green Triangle Diabetes Pre-
vention Project. Preventive Medicine. 2012;54(2):157-61
No relevant outcomes
Manios Y, Kourlaba G, Grammatikaki E, Androutsos O, Ioannou
E, Roma-Giannikou E, et al. Comparison of two methods for
identifying dietary patterns associated with obesity in preschool
children: the GENESIS study. European Journal of Clinical Nutri-
tion. 2010;64(12):1407-14
Cross-sectional
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Table 4. Excluded adult cohort studies (Continued)
Meidtner KF. Variation in genes related to hepatic lipid
metabolism and changes in waist circumference and body weight.
Genes and Nutrition. 2014;9(2)
No total fat intake assessment
Mejean C,Macouillard P, Castetbon K, Kesse-Guyot E, Hercberg
S, Mejean C, et al. Socio-economic, demographic, lifestyle and
health characteristics associated with consumption of fatty-sweet-
ened and fatty-salted foods in middle-aged French adults. British
Journal of Nutrition. 2011;105(5):776-86
No total fat intake assessment
Mirmiran PB. Association between dietary phytochemical index
and 3-year changes in weight, waist circumference and body adi-
posity index in adults: Tehran Lipid and Glucose study.Nutrition
and Metabolism. 2012(9):108
No assessment of total fat on body fatness
Moran LJ, Ranasinha S, Zoungas S,McNaughton SA, BrownWJ,
Teede HJ, et al. The contribution of diet, physical activity and
sedentary behaviour to body mass index in women with and with-
out polycystic ovary syndrome.Human Reproduction. 2013;28(8)
:2276-83
Cross-sectional
Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick
DS, et al. Circulating palmitoleic acid and risk of metabolic ab-
normalities and new-onset diabetes. American Journal of Clinical
Nutrition. 2010;92(6):1350-8
No body fatness outcomes
Naniwadekar AS. Nutritional assessment of patients with chronic
pancreatitis and impact of dietary advice. Gastroenterology.
2010;Conference(var.pagings):S393
Pancreatitis patients
Neeland IJT. Dysfunctional adiposity and the risk of prediabetes
and type 2 diabetes in obese adults. JAMA - Journal of the American
Medical Association. 2012;308(11):1150-9
No total fat intake assessment
Niu J, Seo DC, Niu J, Seo DC. Central obesity and hypertension
in Chinese adults: a 12-year longitudinal examination. Preventive
Medicine. 2014;62:113-8
No relevant outcomes
Noori N, Dukkipati R, Kovesdy CP, Sim JJ, Feroze U, Murali
SB, et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-
3 intake, inflammation, and survival in long-term hemodialysis
patients. American Journal of Kidney Diseases. 2011;58(2):248-56
No total fat assessment and haemodialysis patients
Plotnikoff RC, Karunamuni N, et al. (2009) An examination of
the relationship between dietary behaviours and physical activity
and obesity in adults with type 2 diabetes. Canadian Journal of
Diabetes 33(1): 27-34
No relevant exposures
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Table 4. Excluded adult cohort studies (Continued)
Qi QR. Consumption of branched chain amino acids and risk
of coronary heart disease in us men and women. Circulation.
2013;Conference(var.pagings)
No total fat intake on weight assessment
Quatromoni PA, PencinaM,CobainMR, Jacques PF,D’Agostino
RB. Dietary quality predicts adult weight gain: findings from
the Framingham Offspring Study. Obesity (Silver Spring, Md).
2006;14(8):1383-91
No relevant outcomes
Rautiainen SW. Dairy consumption and risk of becoming over-
weight or obese in middle-aged and older women. Circulation.
2014;Conference(var.pagings):25
No total fat intake assessment
RukhG, Sonestedt E,MelanderO,Hedblad B,Wirfalt E, Ericson
U, et al. Genetic susceptibility to obesity and diet intakes: asso-
ciation and interaction analyses in the Malmo Diet and Cancer
Study. Genes & Nutrition. 2013;8(6):535-47
2. Rukh GS. Genetic susceptibility for obesity increases the risk
of type 2 diabetes and is modified by macronutrient intakes. Di-
abetologia. 2010;Conference(var.pagings):September
3. Rukh GS. Genetic susceptibility to obesity associates with type
2 diabetes and interacts with dietary intake to predispose for obe-
sity. Obesity Reviews. 2010;Conference(var.pagings):July
Not prospective
Sammel MD, Grisson JA, Freeman EW, Hollander L, Liu L, Liu
S, et al. Weight gain among women in the late reproductive years.
Family Practice 2003; 20: 401-9
No total fat assessment
Sanchez-Villegas A, Bes-Rastrollo M, Martinez-Gonzalez MA,
Serra-MajemL. Adherence to aMediterranean dietary pattern and
weight gain in a follow-up study: the SUN cohort. International
Journal of Obesity 2006; 30: 350-8
No relevant outcomes
Sayon-Orea CB-R. Longitudinal association between yogurt con-
sumption and weight gain, and the risk of overweight/obesity:
The SUN cohort study. Obesity Facts. 2014;Conference(var.pag-
ings):May
No total fat intake assessment
Scholz U, Ochsner S, Hornung R, Knoll N, Scholz U, Ochsner
S, et al. Does social support really help to eat a low-fat diet?
Main effects and sex differences of received social support
within the Health Action Process Approach. Applied Psychology.
2013;Health and Well-being. 5(2):270-90
All obese or overweight at baseline
SchulzM,KrokeA, Liese AD,HoffmannK,BergmannMM,Boe-
ing H. Food groups as predictors for short-term weight changes
in men and women of the EPIC Potsdam cohort. Journal of Nu-
trition 2002; 132: 1335-40
No total fat assessment
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Table 4. Excluded adult cohort studies (Continued)
Sherafat-Kazemzadeh R, Egtesadi S,Mirmiran P, GohariM, Fara-
hani SJ, Esfahani FH, et al. Dietary patterns by reduced rank re-
gression predicting changes in obesity indices in a cohort study:
Tehran Lipid and Glucose Study. Asia Pacific Journal of Clinical
Nutrition. 2010;19(1):22-32.2. Sherafat-KazemzadehR, Egtesadi
S, Mirmiran P, Hedayati M, Gohari M, Vafa M, et al. Predicting
of changes in obesity indices regarding to dietary patterns in lon-
gitudinal Tehran lipid and glucose study. Iranian Journal of En-
docrinology & Metabolism. 2010;12(2):197
No assessment of total fat on body fatness
Simpson A, Maynard V, Simpson A, Maynard V. A longitudinal
study of the effect of Antarctic residence on energy dynamics
and aerobic fitness. International Journal of Circumpolar Health.
2012;71:17227
No total fat intake assessment
Tanisawa KI. Strong influence of dietary intake and physical activ-
ity on body fatness in elderly Japanese men: age-associated loss of
polygenic resistance against obesity. Genes and Nutrition. 2014;9
(5)
Cross-sectional
Threapleton DE, Greenwood DC, Burley VJ, Aldwairji M, Cade
JE, ThreapletonDE, et al. Dietary fibre and cardiovascular disease
mortality in the UK Women’s Cohort Study. European Journal of
Epidemiology. 2013;28(4):335-46
No total fat intake assessment
Vadiveloo M, Scott M, Quatromoni P, Jacques P, Parekh N, Vadi-
velooM, et al. Trends in dietary fat and high-fat food intakes from
1991 to 2008 in the FraminghamHeart Study participants.British
Journal of Nutrition. 2014;111(4):724-34. 2. Vadiveloo MS. In-
creases in dietary fat intake among the Framingham heart study
participants: Trends from 1991-2008. Circulation. 2012;Confer-
ence(var.pagings)
No assessment of total fat on body fatness
Verheijden MW, van der Veen JE, van Zadelhoff WM, Bakx C,
Koelen MA, van den Hoogen HJ, et al. Nutrition guidance in
Dutch family practice: behavioral determinants of reduction of
fat consumption. American Journal of Clinical Nutrition. 2003;77
(4 Suppl):1058s-64s
No relevant outcomes
Wang HT. Longitudinal association between dairy consumption
and changes of body weight and waist circumference: The Fram-
ingham Heart Study.International Journal of Obesity. 2014;38(2):
299-305
No total fat intake assessment
Wolongevicz DM, Zhu L, Pencina MJ, Kimokoti RW, Newby
PK, D’Agostino RB, et al. Diet quality and obesity in women:
the Framingham Nutrition Studies. British Journal of Nutrition.
2010;103(8):1223-9
No relevant outcomes
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Table 4. Excluded adult cohort studies (Continued)
YadavVM. Effects of a low fat plant based diet inmultiple sclerosis
(MS): results of a 1-year long randomised controlled (RC) study.
Neurology. 2014;Conference(var.pagings)
Multiple sclerosis patients
Yin JQ. Maternal diet, breastfeeding and adolescent body com-
position: A 16-year prospective study. European Journal of Clinical
Nutrition. 2012;66(12):1329-34
No total fat intake assessment
Yoshimura YK. Relations of nutritional intake to age, sex and
body mass index in Japanese elderly patients with type2 diabetes:
The Japanese Elderly Diabetes Intervention Trial. Geriatrics and
Gerontology International. 2012;12(SUPPL.1):29-40
Cross-sectional
Younossi ZMS. Prevalence and independent predictors of non-
alcoholic fatty liver disease (NAFLD) in lean U.S population.
Hepatology. 2011;Conference(var.pagings):October
NAFLD
Yuan BD. Study on transition of dietary patterns in Jiangsu
province, 1989-2009, China. FASEB Journal. 2011;Confer-
ence(var.pagings):April. 2. Yuan BD. Nutrition transition in
Jiangsu, China, 1989-2009. Annals of Nutrition and Metabolism.
2013;Conference(var.pagings):2013
No total fat intake assessment
ZamoraD,Gordon-Larsen P, JacobsDR, Jr., Popkin BM,Zamora
D, Gordon-Larsen P, et al. Diet quality and weight gain among
black and white young adults: the Coronary Artery Risk Develop-
ment in Young Adults (CARDIA) Study (1985-2005). American
Journal of Clinical Nutrition. 2010;92(4):784-93
No assessment of total fat on body fatness
Zelber-Sagi SL. Non-alcoholic fatty liver disease (NAFLD)
independently predicts type-2 diabetes and pre-diabetes dur-
ing a seven-year prospective follow-up. Journal of Hepatology.
2012;Conference(var.pagings):April
No relevant outcomes
Table 5. Excluded child cohort studies
Study Reason for exclusion
Alexy U, Libuda L, Mersmann S, Kersting M, Alexy U, Libuda
L, et al. Convenience foods in children’s diet and association with
dietary quality andbodyweight status.European Journal of Clinical
Nutrition. 2011;65(2):160-6
Not longitudinal
Ambrosini GLE. Identification of a dietary pattern prospectively
associated with increased adiposity during childhood and ado-
lescence. International Journal of Obesity (2005). 2012;36(10):
1299-305. 2.Ambrosini GLE. Tracking a dietary pattern associ-
No total fat intake assessment
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Table 5. Excluded child cohort studies (Continued)
ated with increased adiposity in childhood and adolescence. Obe-
sity. 2014;22(2):458-65. 3. Ambrosini GLL. An energy-dense,
high fat, low fibre dietary pattern is prospectively associated with
greater adiposity in adolescent girls in the Avon longitudinal study
of parents and children. Obesity Reviews. 2010;Conference(var.
pagings):July
BartonAJ,Gilbert L, et al. (2006). Cardiovascular risk inHispanic
and non-Hispanic preschoolers. Nursing Research 55(3): 172-9
Cross-sectional study
Berz JP, Singer MR, Guo X, Daniels SR, Moore LL, Berz JPB,
et al. Use of a DASH food group score to predict excess weight
gain in adolescent girls in the National Growth and Health Study.
Archives of Pediatrics & Adolescent Medicine. 2011;165(6):540-6
No total fat assessment
Bigornia SJL. Dairy intakes at age 10 years do not adversely affect
risk of excess adiposity at 13 years. Journal of Nutrition. 2014;144
(7):1081-90
No total fat assessment
BorehamC,Twisk J, vanMechelenW, SavageM, Strain J,CranG.
Relationships between the development of biological risk factors
for coronary heart disease and lifestyle parameters during adoles-
cence: The Northern Ireland Young Hearts Project. Public Health.
1999;113(1):7-12
No relevant outcomes
Burke V, Beilin LJ, Simmer K, Oddy WH, Blake KV, Doherty
D, et al. Predictors of body mass index and associations with
cardiovascular risk factors in Australian children: a prospective
cohort study.International Journal of Obesity (Lond). 2005;29(1):
15-23
No baseline fat intake
BurkeV,BeilinLJ, et al. (2006). Television, computer use, physical
activity, diet and fatness in Australian adolescents. International
Journal of Pediatric Obesity 1(4): 248-55
Cross-sectional study
Chaput J-P, Tremblay A, et al. (2008). A novel interaction between
dietary composition and insulin secretion: effects on weight gain
in theQuebec Family Study.American Journal of ClinicalNutrition
87(2): 303-9
No relevant exposures
Davis JN, Alexander KE, et al. Inverse relation between dietary
fiber intake and visceral adiposity in overweight Latino youth.
American Journal of Clinical Nutrition 2009; 90(5): 1160-6
Unsuitable analyses
Deshmukh UJ. Growth and body composition changes in Indian
undernourished children. Annals of Nutrition and Metabolism.
2013;Conference(var.pagings):2013
No relevant outcomes
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Table 5. Excluded child cohort studies (Continued)
Dubois L, Farmer A, et al. (2007). Regular sugar-sweetened bev-
erage consumption between meals increases risk of overweight
among preschool-aged children. Journal of the American Dietetic
Association 107(6): 924-34
Invalid study design
Elliott SAT. Associations of body mass index and waist circumfer-
ence with: energy intake and percentage energy from macronutri-
ents, in a cohort of Australian children.Nutrition Journal. 2011;10
(1)
Cross-sectional
Enes CC, Slater B, Enes CC, Slater B. Variation in dietary in-
take and physical activity pattern as predictors of change in body
mass index (BMI) Z-score among Brazilian adolescents. Revista
Brasileira de Epidemiologia. 2013;16(2):493-501
Not prospective
Faith MS, Dennison BA, et al. (2006). Fruit juice intake pre-
dicts increased adiposity gain in children from low-income fami-
lies: weight status-by-environment interaction. Pediatrics 118(5):
2066-75
No relevant exposures
Frohnert BIJ. Relation between serum free fatty acids and adipos-
ity, insulin resistance, and cardiovascular risk factors from adoles-
cence to adulthood. Diabetes. 2013;62(9):3163-9
No total fat assessment
Heppe DH, Kiefte-de Jong JC, Durmus B, Moll HA, Raat
H, Hofman A, et al. Parental, fetal, and infant risk factors for
preschool overweight: the Generation R Study. Pediatric Research.
2013;73(1):120-7
No total fat intake assessment
Hooley M, Skouteris H, Millar L, Hooley M, Skouteris H, Millar
L. The relationship between childhood weight, dental caries and
eating practices in children aged 4-8 years in Australia, 2004-
2008. Pediatric Obesity. 2012;7(6):461-70
No total fat intake assessment
Hopkins DS. The effect on growth of using cows milk as themain
drink for infants. Annals of Nutrition and Metabolism. 2011;Con-
ference(var.pagings):October
Infants
Huh SYR. Prospective association between milk intake and adi-
posity in preschool-aged children. Journal of the American Dietetic
Association. 2010;110(4):563-70
No total fat intake assessment
Humenikova L, Gates GE (2007). Dietary intakes, physical ac-
tivity, and predictors of child obesity among 4-6th graders in the
Czech Republic. Central European Journal of Public Health 15(1):
23-8
Cross-sectional
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Table 5. Excluded child cohort studies (Continued)
Isharwal S, Arya S, et al. (2008). Dietary nutrients and insulin
resistance in urban Asian Indian adolescents and young adults.
Annals of Nutrition & Metabolism 52(2): 145-51
Invalid study design
Kagura J, Feeley AB, Micklesfield LK, Pettifor JM, Norris SA,
Kagura J, et al. Association between infant nutrition and an-
thropometry, and pre-pubertal body composition in urban South
African children. Journal of Developmental Origins of Health and
Disease. 2012;3(6):415-23
No total fat intake assessment
Khalil HM.Developmental trajectories of bodymass index (BMI)
from birth to late childhood and their relation with paternal and
child nutrients intake. Obesity Facts. 2014;Conference(var.pag-
ings):May
No relevant outcomes
Labayen I, Ruiz JR, Ortega FB, Huybrechts I, Rodríguez G,
Jiménez-Pavón D, et al. High fat diets are associated with higher
abdominal adiposity regardless of physical activity in adolescents;
the HELENA study. Clinical Nutrition. 2014;33(5):859-66
Cross-sectional
Li SF. Dairy consumption with onset of overweight and obe-
sity among U.S. adolescents.FASEB Journal. 2014;Conference
(var.pagings)
No total fat intake assessment
Magnussen CG, Thomson R, Cleland VJ, Ukoumunne OC,
Dwyer T, VennA, et al. Factors affecting the stability of blood lipid
and lipoprotein levels from youth to adulthood: evidence from
the Childhood Determinants of Adult Health Study. Archives of
Pediatrics & Adolescent Medicine. 2011;165(1):68-76
No relevant outcomes
Manios Y. (2006). Design and descriptive results of the ”Growth,
Exercise and Nutrition Epidemiological Study in preSchoolers“:
The GENESIS Study. BMC Public Health 6(32)
No fat to weight relationship
Mete MS. Dietary patterns and depression in a population with
high prevalence of obesity: The strong heart family study. Circu-
lation. 2012;Conference(var.pagings)
No total fat intake assessment
Millar L, Rowland B, Nichols M, Swinburn B, Bennett C, Sk-
outerisH, et al. Relationship between raised BMI and sugar sweet-
ened beverage and high fat food consumption among children.
Obesity. 2014;22(5):E96-103. 2. Millar LMR. Sugar sweetened
beverage and high fat food consumption are related to raised BMI
z-scores among a cohort of Australian children from 4 to 10 years
of age. Obesity Facts. 2013;Conference(var.pagings):May.
No total fat assessment
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Table 5. Excluded child cohort studies (Continued)
Oldewage-Theron W, Napier C, Egal A. Dietary fat intake and
nutritional status indicators of primary school children in a low-
income informal settlement in the Vaal region... [corrected] [pub-
lished erratum appears in S AFR J CLIN NUTR 2011; 24(3):
164]. South African Journal of Clinical Nutrition. 2011;24(2):99-
104
Cross-sectional
Pala VL. Dietary patterns and longitudinal change in body mass
in European children: a follow-up study on the IDEFICS mul-
ticenter cohort. European Journal of Clinical Nutrition. 2013;67
(10):1042-9
No total fat intake assessment
Pan A, Malik VS, Hao T, Willett WC, Mozaffarian D, Hu FB, et
al. Changes in water and beverage intake and long-term weight
changes: results from three prospective cohort studies. Interna-
tional Journal of Obesity. 2013;37(10):1378-85
No total fat intake assessment
Puengputtho WL. Salt intake and salt reduction in secondary
school-age students of Princess Chulabhorn’s College Chiangrai
(Regional science school). Annals of Nutrition and Metabolism.
2013;Conference(var.pagings):2013
No total fat intake on weight assessment
Riedel CV. Interactions of genetic and environmental risk fac-
tors with respect to body fat mass in children: Results from the
ALSPAC study. Obesity. 2013;21(6):1238-42
No total fat intake assessment
Scharf RJ, Demmer RT, Deboer MD. Longitudinal evaluation of
milk type consumed and weight status in preschoolers. Archives of
Disease in Childhood. 2013;98(5):335-40
No total fat intake assessment
Serra-Majem L, Aranceta-Bartrina J, et al. Prevalence and deter-
minants of obesity in Spanish children and young people. British
Journal of Nutrition. 2006;96 Suppl 1: S67-72
Cross-sectional
VazaiouAP. Protein intake of toddlers inGreece and its nutritional
consequences. Hormone Research in Paediatrics. 2011;Conference
(var.pagings):October
No assessment of total fat on body fatness
Weijs PJM. High beverage sugar as well as high animal protein in-
take at infancy may increase overweight risk at 8 years: a prospec-
tive longitudinal pilot study. Nutrition Journal. 2011;10(1)
Infants
Williams CL, Strobino BA. Childhood diet, overweight, and
CVD risk factors: theHealthy Start project.Preventive Cardiology.
2008;11(1):11-20
No relevant outcomes
Wosje KS, Khoury PR, Claytor RP, Copeland KA, Hornung RW,
Daniels SR, et al. Dietary patterns associated with fat and bone
No total fat intake assessment
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Table 5. Excluded child cohort studies (Continued)
mass in young children. American Journal of Clinical Nutrition.
2010;92(2):294-303
Yin JQ. Maternal diet, breastfeeding and adolescent body com-
position: A 16-year prospective study. European Journal of Clinical
Nutrition. 2012;66(12):1329-34
No total fat intake assessment
Zaki MH. Identifying obesogenic dietary factors among Egyptian
obese adolescents.Annals of Nutrition andMetabolism. 2013;Con-
ference(var.pagings):2013
No relevant outcomes
Zhang ZG. Added sugar intake and lipids profile among us ado-
lescents: Nhanes 2005-2010. Circulation. 2014;Conference(var.
pagings):25
Cross-sectional
Table 6. Risk of bias of included adult cohort studies
Study Number lost to fol-
low-up
Baseline similarity
by total fat in-
take, funding, con-
trol groups
Adjust-
ments (where strat-
ified not counted
as not being ad-
justed)*
Method of assess-
ment
Risk of bias**
CARDIA Ludwig
1999 (1)
USA
5111 attended orig-
inal screening, 3609
attended at years 1,
7 and 10, 2909 in-
cluded in analysis
43% lost or not
analysed
Reasons: exclusion
of those who were
pregnant or lactat-
ing, with diabetes,
on lipid or BP med-
ication or with ex-
treme dietary factors
Different.
Those with lower
total fat intake were
more likely to be
women, non-smok-
ers, more physically
active, with higher
alcohol and vitamin
supplement intake
Funded by:
NHLBI, NIDDKD
Control group: in-
ternal
Weightwas adjusted
for baseline weight.
Analysis adjusted
for energy, sex, age,
field centre, edu-
cation, energy in-
take, physical activ-
ity, cigarette smok-
ing, alcohol intake,
vitamin supplement
use
All adjusted for
Interviewer-
administered FFQ
(700 foods)
Single (multiple di-
etary assessments -
but appear to use
baseline data only in
analysis)
High
Danish Diet Can-
cer&Health Study
Halkjaer 2009 (2-
4)
Denmark
57,043 at baseline,
44,897 re-assessed 5
years later
21% lost or not
analysed
Reasons:
1781 had died, 435
emigrated, remain-
der did not want
to participate or did
Data not reported
Unclear
Funded
by: National Dan-
ish Research Foun-
dation, DiOGenes
(EU funding)
Control group: in-
ternal
BMI, energy,
age, smoking, alco-
hol, wine, beer, spir-
its, sporting activity
Not adjusted for
ethnicity, or so-
cioeconomic status
192-
item semi-quanti-
tative FFQchecked
by dietitian
Single dietary as-
sessment used
High
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Table 6. Risk of bias of included adult cohort studies (Continued)
not reply
57,053 at baseline,
22,433 included in
5-year analysis.
61% lost or not
analysed
Reasons:
excluded aged ≥ 60
years (baseline) or≥
65 years (follow-up)
, did not attend fol-
low-up, illness
at baseline or dur-
ing follow-up, aver-
age weight gain or
loss > 5 kg/year or
waist circumference
> 7 cm/year, lack
of blood sample or
other baseline data
Data not reported.
Unclear
Funded
by: National Dan-
ish Research Foun-
dation, DiOGenes
(EU funding)
Control group: in-
ternal
Age, sex, physical
activity, smoking,
education, follow-
up time, fibre in-
take, glycaemic in-
dex, hormone treat-
ment and baseline
bodyweight orwaist
circum-
ference (analysed as
%E from fat, so ad-
justed for E)
Not adjusted for
ethnicity
192-
item semi-quanti-
tative FFQchecked
by dietitian
Single dietary as-
sessment used
High
Danish MONICA
Iqbal 2006 (5)
Denmark
2025 at baseline,
1762 re-assessed 5
years later
13% lost or not
analysed
Reasons:missing or
very high energy or
unknown history of
family obesity
Data not reported
Unclear
Funded
by: Apotekerfonden
& Danish Ministry
for Health
Control group: in-
ternal
Base-
line BMI, age, phys-
ical activity, smok-
ing, education level,
cohort, volume, en-
ergy intake
Not adjusted for
ethnicity
Weighed 7-day
food record
Single dietary as-
sessment used
Moderate
Diabetes Control
& Complications
Trial (DCCT) &
EDIC
Cundiff 2012 (6)
1441 at baseline,
1055 analysed at 14
to 19 years
27% lost or not
analysed
Reasons: omitted
137 with HbA1c >
9.5, otherwise losses
not described in this
publication
Note: also analysed
FAO/WHO
data from167 coun-
tries, but these ap-
pear cross-sectional
Data not reported
Unclear
Funded by: Data
collection by NIH,
General Clinical Re-
search Center Pro-
gram (NCRR),
analysis not funded
Control group: in-
ternal
Energy, fibre, satu-
rated,
mono- and poly-un-
saturated fat, alco-
hol, exercise (proba-
bly)
Not adjusted for
age, sex, ethnicity
or SES
1 week food record
(unclear whether re-
call or diary based)
Multiple dietary as-
sessments (baseline,
2, 5 yrs and comple-
tion averaged)
High
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Table 6. Risk of bias of included adult cohort studies (Continued)
EPIC-PANACEA
Vergnaud 2013 (7)
EPIC
Beulens 2014 (8)
521,448 recruited,
373,803 included in
analysis
28% lost or not
analysed
Reasons: omitted
23,713withmissing
or implausible base-
line data, 121,866
withmissing follow-
up weight,
2066 with implausi-
ble weight changes
Those with lower fat
intake tended to be
older, more physi-
cally active and less
likely to smoke
Dissimilar
Funded by: EU and
a wide range of
charities and gov-
ernment funders
Control group: in-
ternal
Ad-
justed for age, base-
line BMI, study cen-
tre, weekday, season,
total E (from non-
alcohol sources, and
from alcohol
sources), smoking,
education, physical
activity
Not adjusted for
ethnicity
Quant. dietary
questionnaire
of 88-266 items
(country-specific)
Single dietary as-
sessment used
High
Unclear how many
were included com-
pared with recruited
unclear% lost or
not analysed
Reasons: unclear
Data not reported
Unclear
Funded by: unclear
Control group: in-
ternal
Adjustments
unclear
Not adjusted for…
unclear
Country-specific
FFQs
High
Health Profession-
als Follow-Up
Study (HPFUS)
Coakley 1998 (9)
USA
36,353
returned 1992 ques-
tionnaires, of whom
19,478 were in-
cluded in this analy-
sis
46% lost or not
analysed
Reasons: 9345 had
cancer, heart
disease, diabetes or
stroke, 7530 were
missing key infor-
mation
Data not reported
Unclear
Funded by: NIH
and Centres for Dis-
ease Control
Control group: in-
ternal
Baseline weight, en-
ergy, height, activ-
ity, TV view-
ing, high BP, high
cholesterol
Not ad-
justed for ethnic-
ity, socioeconomic
status
FFQ
Single dietary as-
sessment used
High
Mel-
bourne Collabora-
tive Cohort Study
(MCCS)
MacInnis 2013
(10)
Australia
Of 9066 at base-
line, 5879 included
in analyses.
35% lost or not
analysed
Reasons: 656 died,
1894
declined, 21 did not
have waist circum-
ference or weight at
follow-up, and 616
lost≥ 5 kgweight so
excluded
Data not reported
Unclear
Funded by: Can-
cer Council Victo-
ria, VicHealth, Na-
tional
Health and Medical
Research Council
Control group: in-
ternal
Weight adjusted for
baseline weight,
waist for base-
line waist circum-
ference. All adjusted
for sex, age, physical
activity, alcohol, ed-
ucation, smok-
ing, marital status,
SES, total energy in-
take. Not adjusted
for ethnicity (all
described as ”Aus-
Self administered
121-item FFQ de-
veloped for study
Single dietary as-
sessment used
High
186Effects of total fat intake on body weight (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 6. Risk of bias of included adult cohort studies (Continued)
tralian-born“ but >
20% born in Eu-
rope)
Memphis
Klesges 1992 (11-
13)
USA
417 were enrolled,
294 were included
in weight change
analysis, and 230 in
the waist circumfer-
ence change analysis
29% lost or not
analysed (weight),
45% (waist)
Reasons: ”attrition“
for weight change,
no explanation of
further losses for
waist circumference
data
Data not reported
Unclear
Funded by:
NHLBI and Ten-
nessee Centres of
Excellence
Control group: in-
ternal
Sex, age, pregnancy
status, smoking, al-
cohol, family risk of
obesity, energy in-
take, sports activity,
work activity, leisure
activity, change
from baseline of en-
ergy, fat intake, ac-
tivity, cigarettes
Not adjusted for
socioeconomic sta-
tus
Willett’s FFQ
Single (multiple di-
etary assessments -
but appear to be us-
ing baseline data in
analysis)
High
NHANES Follow-
up
Kant 1995 (14)
USA
14,407 were en-
rolled and eligible,
7147 were included
in analysis
50% lost or not
analysed
Reasons: no dietary
info, unsatisfactory
24-
hour recalls, atypi-
cal intake, proxies,
mistakes, pregnant
or lactating partici-
pants, lack of weight
data, death
Higher fat as %E as-
so-
ciated with younger
age, more smoking,
higher levels of mor-
bidity
Funded by: unclear
Control group: in-
ternal
Baseline age, race,
education, BMI, en-
ergy intake, smok-
ing, physical activ-
ity, duration of fol-
low-up, alco-
hol, morbidity, spe-
cial diet, parity
All adjusted for
24-hour dietary re-
call
Single dietary as-
sessment used
High
Nurses’ Health
Study
Colditz 1990 (15)
Field 2007 (16)
USA
Of 121,700 women
enrolled, 38,
724 were eligible for
this study, 31,940
women included in
analyses
17% lost or not
analysed
Reasons: non-re-
spondent or invalid
FFQ
Data not reported
Unclear
Funded by: NIH
Control group: in-
ternal
Age, BMI, energy
intake
Not adjusted for
ethnicity, physical
activity, socioeco-
nomic status
61-item FFQ
Single dietary as-
sessment used
High
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Table 6. Risk of bias of included adult cohort studies (Continued)
Of 121,700 women
enrolled, 41,518 in-
cluded in analyses
66% lost or not
analysed
Reasons:
of 121,700, 41,518
assessed in 1986 and
at 8 years, were free
of cancer, hyperten-
sion and diabetes,
and eligible for this
study
Greater
fat intake associated
with greater baseline
weight
Unclear
Funded by: Boston
Obe-
sity Nutrition Re-
search Center and
National Cancer In-
stitute
Control group: in-
ternal
Age,
baseline BMI, activ-
ity, menopausal sta-
tus, smoking, pro-
tein intake, change
in protein intake
Not adjusted for
ethnicity or SES
136-item FFQ in
1986
Single dietary as-
sessment
used
High
Pawtucket HHP
Parker 1997 (17)
USA
Of 1081 enrolled,
FFQ administered
to random sub-sam-
ple of 556, 465 in-
cluded in analysis
16% lost or not
analysed
Reasons: those ex-
cluded were those
who did not at-
tend both relevant
appointments, and
were more male, less
educated, less active,
greater BMI
Data not reported
Unclear
Funded by:
NHLBI
Control group: in-
ternal
Age, BMI, energy,
smoking, activity
Not adjusted for
sex, ethnicity or so-
cioeconomic status
Willett’s FFQ with
categories
added for fats, oils,
sweets, snacks and
dairy products
Single dietary as-
sessment used
High
San Luis Val-
ley Diabetes Study
(SLVDS)
Mosca 2004 (18)
USA
Of 1351 enrolled,
782 ”in-
cluded in analysis“,
unclear how many
in prospective anal-
ysis
unclear% lost or
not analysed
Reasons:
unclear how many
lost and how many
excluded. Of 1351,
1027 had and 782
continued to have
normal glucose tol-
erance tests, 140 al-
tered smoking status
or became pregnant
Data not reported
Unclear
Funded by: not
stated
Control group: in-
ternal
Sex, ethnicity, phys-
ical activity, baseline
BMI, age, smoking
status, energy intake
Not adjusted for
SES
24-hour diet re-
call (bilingual inter-
viewers) with visual
aids for food por-
tions
High
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Table 6. Risk of bias of included adult cohort studies (Continued)
and were excluded.
782 completed visit
1, 536 visit 2 and
375 visit 3
SEASONS
Ma 2005 (19)
USA
Of 1257 in original
cohort, 641
completed baseline
questionnaire and
one blood draw, 572
included in analyses
11% lost or not
analysed
Reasons: unclear,
did not attend fur-
ther appointments
Data not reported
Unclear
Funded by:
NHLBI
Control group: in-
ternal
None (but analysed
as %E from fat, so
energy adjusted for
indirectly)
Not adjusted for
age, sex, ethnicity,
physical activity or
socioeconomic sta-
tus
7-day dietary recall
Single
(Multiple dietary as-
sessments -
but appear to be us-
ing baseline data in
analysis)
High
Women’s Gothen-
burg
Lissner 1997 (20)
Sweden
Of 1462 inmain co-
hort, 437 randomly
selected and asked
for dietary informa-
tion, 361 included
in analysis
17% lost or not
analysed Reasons:
64didnot return for
weight assessment,
12 had chronic ill-
ness so excluded
Higher fat as
%E associated with
younger age, higher
energy intake, more
walking and lifting
at work, greater like-
lihood of being a
smoker
Funded
by: Swedish Medi-
cal Research Coun-
cil
Control group: in-
ternal
Baseline
body weight, activ-
ity, smoking, age,
energy
Not adjusted for
ethnicity or socioe-
conomic status
Dietary inter-
view including fre-
quency of 69 food
items
Single dietary as-
sessment used
High
*Of age, sex, energy intake, ethnicity, physical activity (and/or TV watching) and socioeconomic (which includes educational) status.
**Moderate risk of bias was suggested where < 20% were lost to follow-up, up to two factors were unadjusted for in the design or
analysis, and diet was assessed using a 24-hour recall or diet diary. All other studies were at high risk of bias.
Reference numbers relate to references below Table 1.
Abbreviations: BMI: body mass index; BP: blood pressure; FAO: Food and Agriculture Organization; FFQ: food frequency ques-
tionnaire; NIH: National Institutes of Health; NHLBI: National Heart, Lung and Blood Institute; NIDDKD: National Institute of
Diabetes and Digestive and Kidney Diseases; SES: socioeconomic status; WHO: World Health Organization
Table 7. Risk of bias of included cohort studies in children and young people
Study Number lost to fol-
low-up
Baseline similarity,
funding, control
group
Adjustments* Method of dietary
assessment
Risk of bias**
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Table 7. Risk of bias of included cohort studies in children and young people (Continued)
Adelaide Nutrition
Study
Magarey 2001 (1)
Australia
Of 500 recruited to
ANS at birth only
130 were seen at age
11, so a further 113
from a separate co-
hort were added at
age 11
~74% lost (varied
for different fol-
low-ups)
Reason: did not at-
tend
Lost
characteristics: not
stated
Data not reported
Unclear
Funded by: Na-
tional Heart Foun-
dation of Australia,
Adelaide Children’s
Hospi-
tal Research Foun-
dation, National
Health and Medical
Research Council of
Australia
Control group: in-
ternal
Adjusted for energy
intake, previous adi-
posity, adiposity of
parent at a specific
age
Not ad-
justed for sex, eth-
nicity, physical ac-
tivity or SES (4)
3-day weighed
food record
High
Am-
sterdam Growth &
Health Long.
Study (AGAHLS)
Twisk 1998,
Koppes 2009 (2;3)
Netherlands
Of 307 13-year olds
recruited 181 were
reassessed at age 27
41% lost
Reason: unclear
Lost char-
acteristics: ”for the
variables of interest
no drop-out effects
were observed“
Data not reported
Unclear
Funded by: Dutch
Heart Foundation,
Dutch Prevention
Fund, Dutch Min-
istry of Wellbeing
and Public Health,
Dairy Foun-
dation on Nutrition
andHealth,Nether-
lands Olympic
Committee,
Netherlands Sports
Fed., no additional
funding was stated
for the 36-year old
analysis
Control group: in-
ternal
Adjusted for phys-
ical activity, smok-
ing, alcohol, dietary
energy
and macronutrient
intake. Did not ad-
just for sex, would
have if appropriate
Not adjusted for
ethnicity, parental
BMI, or SES (3)
Modified cross-
check dietary his-
tory interview re-
lating to previous
month
High
Of 698 13-year olds
recruited
(those above plus
another school with
fewer assessments)
350 had complete
data at age 36
50% lost
Reason: unclear
Lost characteris-
tics: girls
who completed fol-
Carried out for boys
and girls separately,
at each age. Skinfold
data (not % body
fat) additionally ad-
justed for physical
activity
Not adjusted for
ethnicity, parental
BMI, physical ac-
tivity or SES (4)
As above High
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Table 7. Risk of bias of included cohort studies in children and young people (Continued)
low-up had slightly
lower body
fat %age, and boys
who completed had
lower tobacco and
alcohol use at base-
line
Bogaert 2003 (4)
Australia
Of 59 recruited, 41
were re-assessed at
12 months
31% lost
Reason: unclear
Lost characteris-
tics: unclear
Data not reported
Unclear
Funded
by: Australian Ro-
tary Health Found.,
Financial
Markets Found. for
Children, National
Health & Medical
Research Council
Control group: in-
ternal
Adjustment not de-
scribed (or not
done) - unclear
Assume not ad-
justed for age, sex,
ethnicity, parental
BMI, physical ac-
tivity or SES (6)
2 food records and 1
24-hour recall from
High
Carruth& Skinner
2001 (5;6)
USA
Of 72 recruited 53
took part at 70
months
26% lost
Reason: 7 parents
declined, 7 not in
area, 5 could not be
scheduled in time-
frame
Lost characteris-
tics: unclear
Data not reported
Unclear
Funded by: Gerber
products, Tennessee
Agricultural Experi-
ment Station
Control group: in-
ternal
Adjusted for BMI
(all children white
and of same age)
Not adjusted for
sex, energy intake,
parental BMI,
physical activity or
SES (5)
3-day dietary intake
interviews by dieti-
tian
High
62 of 72 recruited
(98 recruited at 2
mo of age), plus 2
added at 1 year and
6 added at 2 years
took part
unclear % lost
Reason: as above?
Lost characteris-
tics: unclear
Adjusted for BMI
at 2 years and adi-
posity rebound age,
assessed across ages
2 to 8, all chil-
drenwhite and ”pre-
dominantly middle
or upper socioeco-
nomic status“
Factors assessed but
found non-signifi-
cant so not ad-
justed for included
sex, TV-watching,
parental BMI
All adjusted for (0)
3-day dietary intake
interviews
High
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Table 7. Risk of bias of included cohort studies in children and young people (Continued)
Davison 2001 (7) 197 participants at
study entry, 192 re-
assessed 2 years later
3% lost
Reason: unclear
Lost characteris-
tics: none stated
Data not reported
Unclear
Funded by: NIH
Control group: in-
ternal
BMI, levels of activ-
ity, familial risk of
overweight, change
in BMI (mother),
enjoyment of activ-
ity (father), total en-
ergy intake (father),
and girls’ percentage
fat intake (girls)
Not adjusted for
SES (1)
24-hour dietary re-
call
Moderate
ELANCE
Rolland-Cachera
2013 (8)
France
Unclear how many
10-month olds, but
222 attended at 10
months and either 2
or 4 years, 73 at-
tended at 20 years,
68 included in anal-
yses
> 67% lost
Reason: unclear
Lost character-
istics: ”similar“ be-
tween those lost to
follow-up and those
included
Data not reported
Unclear
Funded by: Institut
Benjamin Delessert
Control group: in-
ternal
Total energy intake,
sex, breast feeding,
mother’s BMI, fa-
ther’s occupation
Not adjusted for
ethnicity or physi-
cal activity (2)
Dietary history (di-
etitian discussion of
diet with parent
over past month)
High
European Youth
Heart Study
Brixval 2009 (9)
Denmark
384 of 589 baseline
chil-
dren attended fol-
low-up, 308 in re-
gression model
48% lost
Rea-
son: ”due to ethi-
cal consideration it
was not permitted
to contact subjects
who decided not to
participate at fol-
low-up“
Lost
characteristics: not
stated
Data not reported
Unclear
Funded by: not
stated
Control group: in-
ternal
Age, puberty status,
total energy intake,
parental income, ac-
tivity, overweight
parents, protein in-
take, birth weight.
Presented by sex
Not adjusted for
ethnicity (1)
Interview and ques-
tionnaire of children
and parents relating
to past 24 hours
High
Klesges 1995 (10)
USA
203
children at baseline,
146 at follow-up
Data not reported
Unclear
Funded by: Na-
Age, sex, BMI,
physical activity
Not adjusted for
Dietary FFQ High
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Table 7. Risk of bias of included cohort studies in children and young people (Continued)
28% lost
Reason: unclear
Lost char-
acteristics: ”no sig-
nificant differences“
(P value > 0.15) in
BMI, energy intake,
fat as %E, physical
activity, sex or famil-
ial obesity risk be-
tween those attend-
ing at 2 years and
those not attending
tional Heart Lung
and Blood Institute
Control group: in-
ternal
ethnicity, SES (2)
OMDCCLee 2012
(11)
Korea
2740+ baseline chil-
dren (unclear),
1504 followed up
45% lost
Reasons: ”analytic
sample“ - no reasons
given
Lost characteris-
tics: unclear
Data not reported
Unclear
Funded by: unclear
Control group: in-
ternal
Age, sex, sexualmat-
uration, baseline
BMI, exercise, TV
time, sleep, parental
BMI and education,
energy intake, food
habits and house-
hold income
Not adjusted for
ethnicity (1)
24-hour recall for
2 weekdays and 1
weekend day
High
TAAG
Cohen 2014 (12)
Of 303 randomly
selected at baseline,
265 analysed
13% lost
Reasons: 38 did not
have complete data
Lost char-
acteristics: no dif-
ference in race, age,
mother’s education
Data not reported
Unclear
Funded by: Na-
tional Heart Lung
and Blood Institute
Control group: in-
ternal
Age, ethnicity, phys-
ical activity
Not adjusted for
energy in-
take, parental BMI
or SES (3)
FFQ High
Viva la Fa-
milia Study Butte
2007 (13)
USA
1030 at baseline,
with 879 returning
after 1 year
15% lost
Reasons: unclear
Lost characteris-
tics: none stated
Data not reported
Unclear
Funded by: NIH,
USDA/ARS
Control group: in-
ternal
Ad-
justed for sex, age,
age squared, and
Tanner stage and
BMI status in Gen-
eralised Estimating
Equations
Not ad-
justed for parental
BMI, physical ac-
tivity and SES (3)
24-hour
recall, measured by
a registered dietitian
High
* Of age, sex, energy intake, ethnicity, parental BMI, physical activity (and/or TV watching) and socioeconomic (which includes
educational) status
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** Moderate risk of bias was suggested where < 20% were lost to follow-up, up to three factors were unadjusted for in the design or
analysis, and diet was assessed using a 24-hour recall or diet diary. All other studies were at high risk of bias.
References are the same as those following Table 2.
Abbreviations: ANS: Adelaide Nutrition Study; BMI: body mass index; FFQ: food frequency questionnaire; NIH: National Institutes
of Health; SES: socioeconomic status; USDA/ARS: US Department of Agriculture/ Agricultural Research Service.
Table 8. Subgrouping: effects on weight of reducing fat
Factor assessed Subgroup Ef-
fect on weight,
kg (95% CI)
Number of
comparisons
Number of par-
ticipants
I2 for subgroup Chi2 test for
subgroup
differences
Duration of di-
etary advice
6 to < 12months -1.7 (-2.3 to -1.
1)
10 5305 71% P value = 0.04
12 to < 24
months
-2.0 (-2.5 to -1.
5)
17 51367 71%
24 to < 60
months
-1.2 (-1.7 to -0.
7)
9 49,286 56%
60+ months -0.7 (-1.7 to 0.3) 4 40,838 58%
Fat intake in the
control group as-
sessed dur-
ing trial (equiv-
alent to baseline
fat intake)
> 35%E from fat -0.9 (-1.1 to -0.
8)
9 45,103 64% P value < 0.
00001
> 30% to 35%E
from fat
-0.8 (-1.2 to -0.
5)
9 7123 73%
> 25% to 30%E
from fat
-3.0 (-3.6 to -2.
3)
5 2109 77%
Sex Women only -1.4 (-1.9 to -0.
9)
15 50,154 72% P value = 0.20
Men only -2.7 (-4.3 to -1.
2)
4 1719 76%
Mixed men and
women
-1.1 (-2.0 to -0.
2)
5 2492 79%
Year of first pub-
lication of the
trial
1960s -4.1 (-8.1 to -0.
1)
1 1450 - P value = 0.07
1970s - 0 0 -
1980s -0.9 (-1.8 to -0.
01)
3 288 0%
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Table 8. Subgrouping: effects on weight of reducing fat (Continued)
1990s -1.9 (-2.6 to -1.
3)
14 5941 80%
2000s -0.9 (-1.6 to -0.
3)
6 46,686 77%
2010s - 0 0 -
Difference in
%E from fat be-
tween interven-
tion and control
groups
Up to 5%E from
fat
-0.2 (-0.9 to 0.6) 5 4567 30% P value = 0.003
5 to < 10%E
from fat
-2.1 (-2.9 to -1.
4)
11 44,356 84%
10 to < 15%E
from fat
-1.3 (-1.7 to -1.
0)
4 8311 26%
15+%E from fat -3.9 (-8.8 to 1.0) 3 319 68%
Dietary advice or
diet provided
Dietary advice -1.6 (-2.0 to -1.
1)
22 52,594 78% P value = 0.04
Diet provided -0.7 (-1.3 to -0.
1)
1 1741 -
Dietary fat goals
for in-
tervention (these
were not neces-
sarily achieved)
30%E from fat -1.0 (-1.7 to -0.
3)
3 1628 0% P value = 0.34
25 to < 30%E
from fat
-2.5 (-4.3 to -0.
6)
5 509 90%
20 to < 25%E
from fat
-0.9 (-1.2 to -0.
6)
5 43,878 31%
15 to < 20%E
from fat
-1.3 (-2.2 to -0.
4)
7 7860 58%
Total fat
achieved in in-
tervention group
> 30%E from fat -0.8 (-1.3 to -0.
4)
5 1767 0% P value = 0.42
≤ 30%E from
fat
-1.1 (-1.6 to -0.
6)
13 50,099 76%
BMI at baseline
(body mass in-
dex, kg/m2)
< 25 -1.0 (-1.7 to -0.
2)
8 1781 56% P value = 0.17
25 to < 30 -1.8 (-2.4 to -1.
3)
15 51,297 83%
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Table 8. Subgrouping: effects on weight of reducing fat (Continued)
30+ -1.8 (-3.5 to -0.
1)
1 69 -
Baseline health
of participants
Healthy -1.0 (-1.6 to -0.
4)
3 45,032 87% P value = 0.12
With risk factors -2.2 (-3.2 to -1.
2)
12 2166 79%
With disease -1.2 (-1.9 to -0.
6)
9 6449 44%
Amount of en-
ergy reduction in
the low fat arm
E in-
take the same or
greater in low fat
group
-0.5 (-1.5 to 0.5) 4 3352 25% P value = 0.04
1 to 100 kcal/
d less in low fat
arm
-1.5 (-2.9 to -0.
1)
4 2398 66%
101 to 200 kcal/
d less in low fat
arm
-1.1 (-2.2 to -0.
04)
5 43,755 80%
201+ kcal/d less
in low fat arm
-2.2 (-3.0 to -1.
5)
8 3954 78%
Note: studies that provide data at different time points or that fit into different categories have all been included, so studies may appear
more than once in any series of subgroups.
Table 9. Data on dietary intake of energy, sugars, carbohydrate, protein and alcohol during the diet period of RCTs comparing
low fat with usual fat intake
Trial Energy intake
(SD), kcal
Sugars intake,
%E
CHO intake, %E Protein intake,
%E
Alcohol intake,
%E
No. of
participants
Int. Cont Int. Cont Int. Cont Int. Cont Int. Cont Int. Cont
Auck-
land re-
duced
fat, 1 yr
1887
(672)
2269
(750)
- - 54.2
(10.5)
45.8
(10.9)
18.4 (3.
5)
16.6 (3.
9)
3.6 (7.
0)
5.7 (7.
0)
49 61
BDIT
pilot
studies,
9 yrs
1460
(376)
1578
(365)
- - 49.6 (7.
5)
46.9 (6.
2)
15.5 (2.
4)
15.3 (2.
6)
2.3 (3.
3)
1.7 (2.
4)
76 81
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Table 9. Data on dietary intake of energy, sugars, carbohydrate, protein and alcohol during the diet period of RCTs comparing
low fat with usual fat intake (Continued)
BeFIT (data not reported in control groups)
Bloem-
berg, 1
to 6 mo
- - - - 4.4 (6.
5)
1.2 (6.
1)
0.33 (2.
9)
0.57 (1.
7)
- - 39 41
BRIDGES,
6 mo
-34
(79)
+ 22
(79)
- - - - - - - - 48 46
Cana-
dian
DBCP,
2 yrs
1540
(317)
1759
(437)
- - 60.3 (8.
3)
48.8 (8.
1)
18.0 (3.
2)
16.9 (2.
8)
- - 104 100
De
Bont,
1 to 6
mo
-98
(369)
-120
(485)
- - 7.9 (9.
5)
-0.1
(10.9)
2.4 (7.
0)
1.7 (5.
9)
-0.2 (1.
6)
-0.4 (2.
6)
71 65
DEER
(diet
alone)
, 1 to 1
yr
Women:
-220
(356)
Men:
-285
(541)
Women:
-19
(367)
Men:
-25
(482)
- -
Women:
+5.5 (8.
0)
Men:
+8.0 (9.
3)
Women:
-0.2 (7.
3)
Men:
+1.1 (6.
6)
- - - - 46, 49 45, 46
DEER
(diet
and ex),
1 to 1
yr
Women:
-191
(343)
Men:
-167
(516)
Women:
-54
(410)
Men:
+141
(437)
- -
Women:
+7.8 (6.
2)
Men:
+9.3 (8.
3)
Women:
-0.3 (7.
9)
Men:
+1.4 (6.
3)
- - - - 43, 48 43, 47
Diet
and
hor-
mone
study, 1
yr
1921
(386)
2063
(610)
- - 64.3 (9.
0)
54.6 (9.
2)
14.5 (2.
9)
14.1 (3.
8)
est: 1
(2)
est: 1
(2)
81 96
Ken-
tucky
low fat,
1 yr
1882
(521)
2010
(528)
- - 53 (8.9) 50 (7.9) 17 (3.4) 18 (4.3) - - 47 51
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Table 9. Data on dietary intake of energy, sugars, carbohydrate, protein and alcohol during the diet period of RCTs comparing
low fat with usual fat intake (Continued)
Kuo-
pio,
wks 14
to 28
AHA
1791
(382)
Mono
1887
(478)
Low fat
1648
(430)
1982
(406)
- - AHA
48 (5)
Mono
47 (6)
Low fat
51 (5)
46 (6) AHA
17 (2)
Mono
17 (20)
Low fat
19 (3)
16 (2) - - AHA
41
Mono
41
Low fat
40
37
Mastopa-
thy
diet, 6
mo
1491
(NR)
1676
(NR)
- - 56.3
(NR)
48.1
(NR)
17.9
(NR)
15.8
(NR)
4.8
(NR)
4.2
(NR)
10 9
Me-
Diet, 6
mo
1676
(639)
1654
(498)
18.7 (6.
9)
21.9 (9.
2)
27.2
(17.0)
25.8
(11.0)
14.9 (4.
7)
16.2 (5.
1)
5.6 (11.
1)
1.6 (2.
2)
51? 55?
Moy, 2
yrs
1825
(NR)
2092
(NR)
- - - - - - - - 117 118
MS-
FAT, 6
mo
2460
(NR)
2699
(NR)
- - 47
(NR)
41
(NR)
16
(NR)
14
(NR)
3 (NR) 3 (NR) 117 103
NDHS
open
1st
6
mo (for
defini-
tions of
groups
B, C
and D
see
Charac-
teristics
of In-
cluded
Stud-
ies)
B: 2154
(432)
C:
2262
(435)
D:
2228
(456)
- - B: 48.7
(12.3)
C: 45.3
(12.1)
D: 44.7
(11.7)
B: 18.6
(3.4)
C: 17.6
(3.1)
D: 17.4
(3.1)
B: 3.7
(3.7)
C: 3.6
(4.0)
D: 3.8
(4.0)
B: 339 C: 355
D: 346
NDHS
open
2nd
6
BC:
2249
(492)
F: 2196
(427)
G:
2169
- - BC: 45.
7 (12.7)
F: 44.1
(11.1)
G: 43.3
BC: 17.
3 (3.5)
F: 7.3
(3.0)
G: 17.7
BC: 3.5
(4.2)
F: 4.2
(4.0)
G: 4.0
BC:
491
F: 214
G: 194
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Table 9. Data on dietary intake of energy, sugars, carbohydrate, protein and alcohol during the diet period of RCTs comparing
low fat with usual fat intake (Continued)
mo (for
defini-
tions of
groups
BC,
F andG
see
Charac-
teristics
of In-
cluded
Stud-
ies)
(420) (11.4) (2.9) (4.5)
Nutri-
tion
and
breast
health,
1 yr
1780
and
1960
1571
and
1687
- - - - - - - - 23 and
25
24 and
23
Nutri-
tion ed-
ucation
study, 6
to 9 mo
1534
(448)
1721
(620)
- - 43.4 (9.
5)
41.5 (8.
9)
19.9 (3.
7)
18.7 (4.
4)
4.5 (7.
2)
4.8 (9.
3)
224 69
Pilking-
ton, 1
yr
NR NR - - - - - - - - 12 23
Polyp
preven-
tion
trial, yr
4
1978
(471)
2030
(518)
- - 58.3 (7.
4)
47.1 (7.
2)
17.3 (2.
5)
16.5 (2.
4)
- - 605 581
Riv-
ellese, 6
mo
NR NR 14 10 55 48 18 16 - - 27 17
Simon
low fat,
1 yr
1570
(NR)
1594
(NR)
- - - - - - - - 65 68
Sonder-
gaard,
12 mo
- - - - 52.3 (6.
4)
48.5 (8.
7)
17.0 (2.
9)
16.6 (3.
1)
4.5 (5.
3)
6.4 (7.
4)
62 51
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Table 9. Data on dietary intake of energy, sugars, carbohydrate, protein and alcohol during the diet period of RCTs comparing
low fat with usual fat intake (Continued)
Strychar,
6 mo
NR NR - - - - - - - - 15 15
Swedish
breast
CA, 1
to 2 yrs
-215 (P
value <
0.01)
-143 (P
value <
0.01)
+4.8 (P
value <
0.01)
+1.4 (P
value <
0.01)
+11.0
(P value
< 0.01)
+2.7 (P
value <
0.01)
+1.7 (P
value <
0.01)
+0.3 (P
value >
0.05)
+0.2 (P
value >
0.05)
+0.4 (P
value >
0.05)
63 106
Vet-
eran’s
derma-
tology,
during
trial
1995
(564)
2196
(615)
- - 60.3 (6.
3)
44.6 (6.
9)
17.7 (2.
2)
15.7 (2.
4)
3.2 (3.
4)
3.2 (3.
9)
57? 58?
WHEL,
1 yr
1664
(345)
1635
(384)
- - 65.3 (8.
5)
57.1 (9.
3)
- - - - 197 196
WHI,
7.5 yrs
1446
(510)
1564
(595)
- - 52.7 (9.
8)
44.7 (8.
5)
- - - - 14246 22083
WHT:
feasibil-
ity, 2 yrs
1356
(358)
1617
(391)
- - 59.0 (8.
8)
46.9 (8.
9)
19.2 (3.
9)
16.8 (3.
8)
- - 163 101
WHT:
FSMP,
1 to 18
mo
-488
(NR)
-255
(NR)
- - - - - - - - 285 194
WINS,
5 yrs
-167 (p
value <
0.0001
vs cont)
0 - - - - - - - - 380 648
est: estimated by review authors from data on g/d and mean energy intakes
Abbreviations: AHA: American Heart Association; CHO: carbohydrates; DBCP: Diet and Breast Cancer Prevention; SD: standard
deviation
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A P P E N D I C E S
Appendix 1. MEDLINE search run to collect adult and child RCTs and cohort studies 15 November
2014
Search adapted from that run in 2010, to search for both adult and child RCTs and cohort studies, but omitting dietary exposures
other than dietary fat.
Run 15 November 2014.
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Weight Gain/ (24259)
2 exp Weight Loss/ (30933)
3 obesity.ab,ti. (152189)
4 obese.ab,ti. (86464)
5 adipos$.ab,ti. (71315)
6 weight gain.ab,ti. (44371)
7 weight loss.ab,ti. (59414)
8 overweight.ab,ti. (42626)
9 over weight.ab,ti. (349)
10 overeat$.ab,ti. (1934)
11 over eat$.ab,ti. (275)
12 weight change$.ab,ti. (8042)
13 ((bmi or body mass index) adj2 (gain or loss or change)).ab,ti. (2786)
14 body fat$.ab,ti. (24784)
15 body composition.ab,ti. (23804)
16 body constitution.ab,ti. (257)
17 exp Dietary Fats/ (73523)
18 exp Diet, Fat-Restricted/ (3040)
19 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti. (63037)
20 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 (366287)
21 17 or 18 or 19 (114331)
22 20 and 21 (28779)
23 randomized controlled trial.pt. (399992)
24 controlled clinical trial.pt. (90666)
25 Randomized controlled trials/ (99585)
26 random allocation.sh. (84070)
27 double blind method.sh. (132423)
28 single-blind method.sh. (20589)
29 23 or 24 or 25 or 26 or 27 or 28 (658672)
30 (animals not (human and animals)).sh. (5551801)
31 29 not 30 (590901)
32 clinical trial.pt. (501242)
33 exp Clinical trial/ (816129)
34 (clin$ adj25 trial$).ti,ab. (291641)
35 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab. (137043)
36 placebos.sh. (34004)
37 placebo$.ti,ab. (169148)
38 random$.ti,ab. (764596)
39 research design.sh. (82260)
40 comparative study.sh. (1730651)
41 exp Evaluation studies/ (206135)
42 follow up studies.sh. (520109)
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43 prospective studies.sh. (390949)
44 (control$ or prospectiv$ or volunteer$).ti,ab. (3243146)
45 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 (5767873)
46 45 not 30 (4293785)
47 31 or 46 (4323589)
48 exp Cohort Studies/ (1438154)
49 (cohort$ or quintile$ or quartile$ or quantile$ or tertile$).mp. (411555)
50 (follow-up$ or followup$).mp,tw. (970994)
51 longitud$.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary concept word, unique identifier] (208935)
52 ((prospectiv$ or observation$) adj5 (research$ or data$ or stud$)).mp. (587538)
53 48 or 49 or 50 or 51 or 52 (2092058)
54 53 not 30 (1996509)
55 47 or 54 (4973664)
56 22 and 55 (9237)
57 limit 56 to (english language and yr=”2010 - 2015“) (3294)
58 exp Case-Control Studies/ (710182)
59 (case adj3 control$).tw. (93452)
60 (case adj3 series).tw. (42174)
61 case study/ (1736496)
62 letter.pt. (885169)
63 exp Drug Therapy/ (1125358)
64 exp Surgery/ (35422)
65 exp Biochemical Phenomena/ (3179065)
66 exp OBESITY/dt, ec, ra, ri, rt, su, ve [Drug Therapy, Economics, Radiography, Radionuclide Imaging, Radiotherapy, Surgery,
Veterinary] (21417)
67 exp HIV/ (89024)
68 exp HIV infections/ (246055)
69 cancer.ti. (653428)
70 (tumour or tumor).ti. (242371)
71 lung.ti. (197074)
72 asthma.ti. (66394)
73 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 (8021499)
74 57 not 73 (1961)
Appendix 2. EMBASE search run to collect adult and child RCTs and cohort studies 14 November
2014
Search adapted from that run in 2010, to search for both adult and child RCTs and cohort studies, but omitting dietary exposures
other than dietary fat.
Run 14 November 2014.
Database: EMBASE <1974 to 2014 November 14>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Weight Gain/ (67847)
2 exp weight reduction/ (104267)
3 obesity.ab,ti. (197751)
4 obese.ab,ti. (114407)
5 overweight.ab,ti. (55916)
6 over weight.ab,ti. (671)
7 ((weight or bmi or body mass index) adj2 (gain or loss or change or reduc$)).ab,ti. (154396)
8 exp fat intake/ (42075)
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9 exp low fat diet/ (6962)
10 (fat$ adj2 (total or intake or consum$ or ate or eat or reduce$ or restrict$ or low$ or diet$)).ab,ti. (76246)
11 1 or 2 or 3 or 4 or 5 or 6 or 7 (440097)
12 8 or 9 or 10 (102724)
13 11 and 12 (27385)
14 controlled study/ (4458191)
15 randomized controlled trial/ (355956)
16 clinical trial/ (839688)
17 major clinical study/ (2275896)
18 (trial$ or control$).tw. (3805000)
19 (blind$ or placebo).tw. (383515)
20 placebo/ (260940)
21 14 or 15 or 16 or 17 or 18 or 19 or 20 (8434269)
22 exp human/ (15270878)
23 nonhuman/ (4404779)
24 23 not 22 (3499956)
25 21 not 24 (6542287)
26 exp Longitudinal Study/ (70712)
27 exp Prospective Study/ (266457)
28 (cohort$ or quintile$ or quartile$ or tertile$ or quantile$).mp. (498531)
29 (follow-up$ or followup$).mp,tw. (1184342)
30 longitud$.mp. (214152)
31 ((prospectiv$ or observation$) adj5 (research$ or data$ or stud$)).mp. (615851)
32 26 or 27 or 28 or 29 or 30 or 31 (2100044)
33 32 not 24 (2060027)
34 33 or 25 (7492226)
35 13 and 34 (12448)
36 limit 35 to (english language and yr=”2010 - 2015“) (6329)
37 exp Case-Control Studies/ (90210)
38 (case adj3 control$).tw. (107292)
39 (case adj3 series).tw. (51300)
40 case study/ (28823)
41 letter.pt. (860483)
42 exp Drug Therapy/ (1859698)
43 exp Surgery/ (3481521)
44 exp Biochemical Phenomena/ (81777)
45 exp obesity/cn, di, dr, dt, rt, su [Congenital Disorder, Diagnosis, Drug Resistance, Drug Therapy, Radiotherapy, Surgery] (33545)
46 exp HIV/ (138030)
47 exp HIV infections/ (303673)
48 cancer.ti. (812504)
49 (tumour or tumor).ti. (277200)
50 lung.ti. (240253)
51 asthma.ti. (82529)
52 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 (6915750)
53 36 not 52 (5003)
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Appendix 3. CINAHL search run to collect adult and child RCTs and cohort studies 1 December
2014 (Interface EBSCO host Research Databases, Advanced Search, CINAHL Complete)
# Query Limiters/Expanders Results
S1 (MH ”weight gain+“) Search modes - Boolean/Phrase 62,681
S2 (MH ”weight loss+“) Search modes - Boolean/Phrase 14,411
S3 TI obesity OR AB obesity Search modes - Boolean/Phrase 32,659
S4 TI obese OR AB obese Search modes - Boolean/Phrase 15,905
S5 TI adipos* OR AB adipos* Search modes - Boolean/Phrase 6,462
S6 TI weight gain OR AB weight gain Search modes - Boolean/Phrase 6,645
S7 TI weight loss OR AB weight loss Search modes - Boolean/Phrase 11,452
S8 TI overweight OR AB overweight Search modes - Boolean/Phrase 12,405
S9 TI over weight OR AB over weight Search modes - Boolean/Phrase 1,157
S10 TI overeat* OR AB overeat* Search modes - Boolean/Phrase 418
S11 TI over eat* OR AB over eat* Search modes - Boolean/Phrase 321
S12 TI weight change* OR AB weight
change*
Search modes - Boolean/Phrase 3,689
S13 (TI ((bmi or body mass index) N2 (gain
or loss or change))) OR (AB ((bmi or
body mass index) N2 (gain or loss or
change)))
Search modes - Boolean/Phrase 862
S14 TI body fat* OR AB body fat* Search modes - Boolean/Phrase 5,932
S15 TI body composition ORAB body com-
position
Search modes - Boolean/Phrase 5,353
S16 TI body constitution OR AB body con-
stitution
Search modes - Boolean/Phrase 26
S17 (MH ”Dietary Fats+“) Search modes - Boolean/Phrase 17,455
S18 (MM ”Diet, Fat-Restricted“) Search modes - Boolean/Phrase 901
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(Continued)
S19 (TI (fat* N2 (total or intake or consum*
or ate or eat or reduc* or restrict* or low*
or diet*))) OR (AB (fat* N2 (total or in-
take or consum* or ate or eat or reduc*
or restrict* or low* or diet*)))
Search modes - Boolean/Phrase 11,074
S20 (S1 OR S2OR S3OR S4OR S5OR S6
OR S7 OR S8 OR S9 OR S10 OR S11
OR S12 OR S13 OR S14 OR S15 OR
S16)
Search modes - Boolean/Phrase 99,408
S21 (S17 OR S18 OR S19) Search modes - Boolean/Phrase 25,122
S22 (S20 AND S21) Search modes - Boolean/Phrase 6,404
S23 PT randomized controlled trial Search modes - Boolean/Phrase 45,326
S24 TX ”controlled clinical trial“ Search modes - Boolean/Phrase 7,628
S25 MM ”Randomized Controlled Trials“ Search modes - Boolean/Phrase 668
S26 MM ”Random Assignment“ Search modes - Boolean/Phrase 147
S27 MM ”Double-Blind Studies“ Search modes - Boolean/Phrase 76
S28 MM ”Single-Blind Studies“ Search modes - Boolean/Phrase 26
S29 S23 OR S24 OR S25 OR S26 OR S27
OR S28
Search modes - Boolean/Phrase 52,650
S30 SU (animals not (human and animals)) Search modes - Boolean/Phrase 53,619
S31 S29 NOT S30 Search modes - Boolean/Phrase 52,575
S32 PT clinical trial Search modes - Boolean/Phrase 77,533
S33 MH ”Clinical Trials+“ Search modes - Boolean/Phrase 184,793
S34 TI (clin* N25 trial*) OR AB (clin* N25
trial*)
Search modes - Boolean/Phrase 53,327
S35 TI ((singl* or doubl* or trebl* or tripl*
or quad*) N (blind* or mask*)) OR AB
((singl* or doubl* or trebl* or tripl* or
quad*) N (blind* or mask*))
Search modes - Boolean/Phrase 300
S36 MM ”Placebos“ Search modes - Boolean/Phrase 828
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(Continued)
S37 TI placebo* OR AB placebo* Search modes - Boolean/Phrase 27,852
S38 TI random* OR AB random* Search modes - Boolean/Phrase 144,733
S39 MM ”study design“ Search modes - Boolean/Phrase 5,275
S40 MM ”comparative studies“ Search modes - Boolean/Phrase 283
S41 MH ”Evaluation Research+“ Search modes - Boolean/Phrase 20,984
S42 MM ”prospective studies“ Search modes - Boolean/Phrase 800
S43 TI (control* or prospectiv* or volun-
teer*) ORAB (control* or prospectiv* or
volunteer*)
Search modes - Boolean/Phrase 357,450
S44 S32 OR S33 OR S34 OR S35 OR S36
OR S37 OR S38 OR S39 OR S40 OR
S41 OR S42 OR S43
Search modes - Boolean/Phrase 542,974
S45 S44 NOT S30 Search modes - Boolean/Phrase 535,502
S46 S31 OR S45 Search modes - Boolean/Phrase 541,731
S47 MH ”prospective studies+“ Search modes - Boolean/Phrase 254,176
S48 TX cohort* or quintile* or quartile* or
quantile* or tertile*
Search modes - Boolean/Phrase 152,914
S49 TX follow-up* or followup* Search modes - Boolean/Phrase 249,854
S50 TX longitud* Search modes - Boolean/Phrase 103,954
S51 TX ((prospectiv* or observation*) N5
(research* or data* or stud*))
Search modes - Boolean/Phrase 382,309
S52 S47 OR S48 OR S49 OR S50 OR S51 Search modes - Boolean/Phrase 613,040
S53 S52 NOT S30 Search modes - Boolean/Phrase 610,840
S54 S46 OR S53 Search modes - Boolean/Phrase 963,714
S55 S22 AND S54 Search modes - Boolean/Phrase 3,017
S56 S22 AND S54 Limiters - Published Date: 20100101-
20151231; English Language
Search modes - Boolean/Phrase
1,236
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(Continued)
S57 MH ”Case Control Studies+“ Limiters - Published Date: 20100101-
20151231; English Language
Search modes - Boolean/Phrase
23,820
S58 TX case N3 control* Limiters - Published Date: 20100101-
20151231; English Language
Search modes - Boolean/Phrase
35,592
S59 TX case N3 series Limiters - Published Date: 20100101-
20151231; English Language
Search modes - Boolean/Phrase
10,407
S60 MM ”Case Studies“ Search modes - Boolean/Phrase 623
S61 PT letter Search modes - Boolean/Phrase 198,888
S62 MH ”Drug Therapy+“ Search modes - Boolean/Phrase 109,541
S63 MH ”Surgery, Operative+“ Search modes - Boolean/Phrase 385,583
S64 MH ”Biochemical Phenomena+“ Search modes - Boolean/Phrase 29,949
S65 MH ”Obesity+/DT/EC/RA/RT/SU“ Search modes - Boolean/Phrase 5,470
S66 MH ”Human Immunodeficiency
Virus+“
Search modes - Boolean/Phrase 5,947
S67 MH ”HIV Infections+“ Search modes - Boolean/Phrase 62,282
S68 TI cancer Search modes - Boolean/Phrase 137,532
S69 TI tumor OR tumour Search modes - Boolean/Phrase 21,392
S70 TI lung Search modes - Boolean/Phrase 24,925
S71 TI asthma Search modes - Boolean/Phrase 15,732
S72 S57 OR S58 OR S59 OR S60 OR S61
OR S62 OR S63 OR S64 OR S65 OR
S66 OR S67 OR S68 OR S69 OR S70
OR S71
Search modes - Boolean/Phrase 913,702
S73 S56 NOT S72 Search modes - Boolean/Phrase 765
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Appendix 4. CENTRAL search run as part of the update in March 2014
#1 lipid near (low* or reduc* or modifi*)
#2 cholesterol* near (low* or modifi* or reduc*)
#3 (#1 or #2)
#4 MeSH descriptor: [Nutrition Therapy] explode all trees
#5 diet* or food* or nutrition*
#6 (#4 or #5)
#7 (#3 and #6)
#8 fat* near (low* or reduc* or modifi* or animal* or saturat* or unsaturat*)
#9 MeSH descriptor: [Diet, Atherogenic] explode all trees
#10 MeSH descriptor: [Diet Therapy] explode all trees
#11 (#7 or #8 or #9 or #10)
#12 MeSH descriptor: [Cardiovascular Diseases] this term only
#13 MeSH descriptor: [Heart Diseases] explode all trees
#14 MeSH descriptor: [Vascular Diseases] explode all trees
#15 MeSH descriptor: [Cerebrovascular Disorders] this term only
#16 MeSH descriptor: [Brain Ischemia] explode all trees
#17 MeSH descriptor: [Carotid Artery Diseases] explode all trees
#18 MeSH descriptor: [Dementia, Vascular] explode all trees
#19 MeSH descriptor: [Intracranial Arterial Diseases] explode all trees
#20 MeSH descriptor: [Intracranial Embolism and Thrombosis] explode all trees
#21 MeSH descriptor: [Intracranial Hemorrhages] explode all trees
#22 MeSH descriptor: [Stroke] explode all trees
#23 coronar* near (bypas* or graft* or disease* or event*)
#24 cerebrovasc* or cardiovasc* or mortal* or angina* or stroke or strokes or tia or ischaem* or ischem*
#25 myocardi* near (infarct* or revascular* or ischaem* or ischem*)
#26 morbid* near (heart* or coronar* or ischaem* or ischem* or myocard*)
#27 vascular* near (peripheral* or disease* or complication*)
#28 heart* near (disease* or attack* or bypas*)
#29 (#12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28)
#30 (#11 and #29)
WH A T ’ S N E W
Last assessed as up-to-date: 12 November 2014.
Date Event Description
21 July 2015 New search has been performed The searches were run on 12 November 2014.
11 July 2015 New citation required and conclusions have changed We split a previously published review (Reduced and mod-
ified dietary fat for preventing cardiovascular disease, DOI:
10.1002/14651858.CD002137.pub3) into six smaller re-
view updates. The conclusions are therefore now focused on
the effects of total fat intake on body weight instead of the
effects of reducing or modifying fat intake overall on cardio-
vascular disease risk
At the request of the World Health Organization (WHO)
Nutrition Guidance Expert Advisory Group (NUGAG)
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(Continued)
group we extended this review to include cohort studies, and
studies in children and young people
This split review update includes 32 randomised controlled
trials and also 30 sets of analyses of 25 cohorts
H I S T O R Y
Protocol first published: Issue 2, 1999
Review first published: Issue 8, 2015
Date Event Description
11 June 2010 New citation required and conclusions have changed -
9 September 2008 Amended -
1 February 2000 New citation required and conclusions have changed Substantive amendment.
C O N T R I B U T I O N S O F A U T H O R S
The WHO NUGAG subgroup on diet and health (which included LH, MS and CDS) discussed and developed the question for this
review. The protocol was drafted by LH and approved by the NUGAG subgroup on diet and health. LH, WD, and HJM carried out
the searches for the first version of the review, AA and LH carried out searches for the update. LH, AA,WD, HJM and CSE assessed the
eligibility of the studies for inclusion of the first review, extracted data and assessed trial validity, while AA, DKB, TB and LH carried
this out for the update. LH carried out the first GRADE assessment, which was refined by the NUGAG subgroup on diet and health,
LH carried out the GRADE assessment for this update. LH wrote the first drafts of the original paper and this update. All authors
contributed to the analysis, as did the NUGAG subgroup on diet and health in response to the first draft of the review. All authors
agreed on the final draft of this review. LH is the guarantor.
D E C L A R A T I O N S O F I N T E R E S T
AA: none known.
TB: none known.
DB: none known.
LH: the World Health Organization (WHO) provided funding to the University of East Anglia towards the cost of carrying out the
update of this systematic review. LH is a member of the WHO NUGAG subgroup on diet and health and received funding from
WHO to cover expenses associated with attendance at meetings of the NUGAG subgroup on diet and health.
CMS: none known
CDS: none known.
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S O U R C E S O F S U P P O R T
Internal sources
• University of East Anglia, UK.
For the original version of this systematic review: help with acquiring papers for the review, time for Lee Hooper to work on the review.
External sources
• The World Health Organization (WHO) provided funding to Durham University towards the cost of carrying out the original
version of this systematic review, Other.
No funding was received for the searching, analysis, or writing up of the data from randomised controlled trials in adults for the first
version of the review. The funders did not have any vested interests in the findings of this research
• WHO provided funding to the University of East Anglia (PI Lee Hooper) for the update of this systematic review and
translation into a Cochrane review, Other.
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